地址：武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话：18372041646
传真：18372041646
邮箱：sales@amyjet.com
Immunostar公司主要制造和销售各种免疫多克隆和单克隆神经学的一抗。
ImmunoStar is the original manufacturer of primary polyclonal and monoclonal antibodies. We take pride in selling to neuroscience researchers at a high-titer and fair price. Since 1975, we have earned a reputation for trusted antibodies that work every time.
Our quality reputation has been validated in over seven thousand citations in biomedical literature of ImmunoStar antibodies. You can find and search them all on our Publications page. This user-friendly database can be searched by antibody, research area, species reactivity, or keyword. ImmunoStar’s core antibodies were previously sold and cited under the names Diasorin, Incstar, and ImmunoNuclear.
Immunostar的主要产品包括：
（1）Antibodies
5-HIAA (5-Hydroxyindoleacetic Acid) Antibody
5-HT (Serotonin) 1A Receptor Antibody
5-HT (Serotonin) 2A Receptor Antibody等
（2）Peptide Controls
5-HT (Serotonin) / BSA Conjugate Control
nNOS:C-Terminal Peptide Control
Opioid Receptor-Mu Peptide Control等
（3）Testimonials
<更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
" data-original="http://genvivo.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="ImmunoStar"> ImmunoStar
<艾美捷科技有限公司代理Echelon Biosciences的产品：
http://www.amyjet.com/Index/lists/catid/27/kid/57.html
Echelon Biosciences成立于1997年，致力于为脂质研究领域提供高品质的检测方法和检测试剂。
Echelon Biosciences Incorporated (EBI) was incorporated under the laws of the state of Utah as Echelon Research Laboratories, Inc. on October 3, 1997. Initially, EBI was formed from a project under the Center for Cell Signaling, a State of Utah Center of Excellence, with the aim to further the science of lipid cell signaling and critical metabolic enzymes, which provide new and viable targets for the development of potential drugs and diagnostics for cancer, diabetes, inflammation, infections, and cardiovascular disease.
Echelon Bioscience的产品和服务包括：
| (2S)-Oleyl LPA (Echelon Bioscience, CAT#L-0186) |
| (E,E,E)-Geranylgeraniol (Echelon Bioscience, CAT#S-0200) |
| (E,E)-Farnesoic acid (Echelon Bioscience, CAT#S-0151) |
| (E,E)-Methyl Farnesoate (Echelon Bioscience, CAT#S-0153) |
| (S,S) Bisoleoyl-lysobisphosphatidic acid (LBPA) (Echelon Bioscience, CAT#L-B181) |
| (S)-FTY720 Phosphate (Echelon Bioscience, CAT#B-0721) |
| [4-(Decanoylamino)benzyl]phosphonic acid (GWJ-23, GWJ-A-23) (Echelon Bioscience, CAT#L-3223) |
| [D-Ala2]-Deltorphin II (Echelon Bioscience, CAT#275-21) |
| [Hyp3]-Bradykinin (Echelon Bioscience, CAT#191-65) |
| [Ser25] Protein Kinase C Substrate (19-31) (Echelon Bioscience, CAT#871-21) |
| 1-Deoxy-D-xylulose (DX) (Echelon Bioscience, CAT#I-M050A) |
| 1-Deoxy-D-xylulose 5-phosphate (DXP) (Echelon Bioscience, CAT#I-M050) |
| 1-Hydroxy-2-methyl-2-buten-4-yl 4-diphosphate (HDMAPP) (Echelon Bioscience, CAT#I-M055) |
| 1-Methylhistamine dihydrochloride (Echelon Bioscience, CAT#B-0032) |
| 1-Naphthalenesulfonyl-Ile-Trp-CHO (Cathepsin L Inhibitor) (Echelon Bioscience, CAT#866-76) |
| 1-Stearoyl-2-Arachidonoyl-sn-Glycerol (Echelon Bioscience, CAT#L-0024) |
| 1,2-Distearoyl-sn-glycerol (Echelon Bioscience, CAT#L-0018) |
| 1,3-DPPE (16:0/16:0 PE) (Echelon Bioscience, CAT#L-2216) |
| 1,3-POPE (16:0/18:1 PE) (Echelon Bioscience, CAT#L-2368) |
| 16:0 LPE (Echelon Bioscience, CAT#L-2516) |
| 16:0 LPG (Echelon Bioscience, CAT#L-5216) |
| 16:0 LPThr (Echelon Bioscience, CAT#L-3316) |
| 18:1 LysoPEth (Echelon Bioscience, CAT#L-6030) |
| 18:2 LysoPC (Echelon Bioscience, CAT#L-1520) |
| 1D-O-(1,2-Di-O-oleoyl-sn-(2S)-glycerol-3-phospho)-3-(phosphothionate)-myo-inositol (Echelon Bioscience, CAT#P-3S18) |
| 1R,2R-B13 (Ceramidase inhibitor) (Echelon Bioscience, CAT#B-0042) |
| 2-Acetyl-5-tetrahydroxybutyl imidazole (THI) (Echelon Bioscience, CAT#B-0031) |
| 2-C-Methyl-D-erythritol 2,4-cyclophosphate (Echelon Bioscience, CAT#I-M054) |
| 2-C-Methyl-D-erythritol 4-phosphate (MEP) (Echelon Bioscience, CAT#I-M051) |
| 2-C-Methyl-erythritol (ME) (Echelon Bioscience, CAT#I-M051A) |
| 2-Furoyl-LIGR-Amide (Protease-Activated Receptor 2 (PAR2) Agonist) (Echelon Bioscience, CAT#873-12) |
| 2-Furoyl-LIGRL-Amide (Protease-Activated Receptor 2 (PAR2) Agonist) (Echelon Bioscience, CAT#873-11) |
| 2-Furoyl-LIGRLO-NH2 (Potent and Selective Protease-Activated Receptor 2 (PAR2) Agonist) (Echelon Bioscience, CAT#873-10) |
| 2-O-Butyryl-Ins(1,3,4,5,6)P5/PM (Echelon Bioscience, CAT#Q-M1396) |
| 2,3-Oxidosqualene (racemic) (Echelon Bioscience, CAT#S-0301) |
| 2,3,22,23-Dioxidosqualene (Echelon Bioscience, CAT#S-0302) |
| 2,3,5-Tri-O-butyryl-Ins(1,4,6)P3/AM (Echelon Bioscience, CAT#Q-M0146) |
| 2S-OMPT (Echelon Bioscience, CAT#L-9418) |
| 2Z,6Z-Farnesol (Echelon Bioscience, CAT#S-0170) |
| 2Z,6Z-Farnesyl Diphosphate (Echelon Bioscience, CAT#I-0170) |
| 3-a-Aminocholestane (3AC, SHIP1 Inhibitor) (Echelon Bioscience, CAT#B-0341) |
| 3,3′-Bisoleoyl-LBPA tetrabutylammonium salt (Echelon Bioscience, CAT#L-B182) |
| 3C-PtdIns(3,4,5)P3, diC16 (Echelon Bioscience, CAT#P-3C916) |
| 3C-PtdIns(3,4,5)P3, diC8 (Echelon Bioscience, CAT#P-3C908) |
| 3S-PtdIns(3,4,5)P3, diC16 (Echelon Bioscience, CAT#P-3S916) |
| 3S-PtdIns(3,4,5)P3, diC8 (Echelon Bioscience, CAT#P-3S908) |
| 4-Demethylaminosancycline (CMT-3) (Echelon Bioscience, CAT#B-0802) |
| 4-Diphosphocytidyl-2-C-methyl-D-erythritol (CDP-ME) (Echelon Bioscience, CAT#I-M052) |
| 4-Methylumbelliferone (Echelon Bioscience, CAT#JK201388) |
| 5-Ketoclomazone (DXP Synthase Inhibitor) (Echelon Bioscience, CAT#B-4101) |
| 5′ PtdIns(3,4,5)P3 Phosphatase Activity Fluorescence Polarization Assay (Echelon Bioscience, CAT#K-1400) |
| 6-O-palmitoyl-L-ascorbic acid (HAse Inhibitor) (Echelon Bioscience, CAT#B-0601) |
| 7-azido-4-methylcoumarin (AzMC, Hydrogen sulfide detector) (Echelon Bioscience, CAT#D-0010) |
| 9-tert-Butyl Doxycycline HCl (Echelon Bioscience, CAT#B-0801) |
| 9(10)-Nitrooleic Acid (Echelon Bioscience, CAT#L-0112) |
| 9Z-Octadecenyl phosphate (Echelon Bioscience, CAT#L-0418) |
| a-Secretase Substrate (Echelon Bioscience, CAT#640-55) |
| ABC294640 (SPHK2 Inhibitor) (Echelon Bioscience, CAT#B-0025) |
| Abz-Ala-Gly-Leu-Ala-p-nitrobenzylamide (Metalloendopeptidase Substrate) (Echelon Bioscience, CAT#855-46) |
| Ac-Ala-Arg-AMC (Echelon Bioscience, CAT#877-13) |
| Ac-Ala-Glu-Val-Asp-AFC (Caspase 3 Substrate) (Echelon Bioscience, CAT#863-65) |
| Ac-Ala-Glu-Val-Asp-CHO (Caspase 3 Inhibitor) (Echelon Bioscience, CAT#864-65) |
| Ac-Ala-Glu-Val-Asp-pNA (Caspase 3 Substrate) (Echelon Bioscience, CAT#860-65) |
| Ac-Arg-Ala-Arg-AMC (Echelon Bioscience, CAT#855-71) |
| Ac-Arg-Ala-Val-AMC (Echelon Bioscience, CAT#877-08) |
| Ac-Arg-Gly-Phe-Phe-Pro-AFC (Cathepsin D Substrate, fluorogenic) (Echelon Bioscience, CAT#874-19) |
| Ac-Arg-Gly-Phe-Phe-Pro-AMC (Echelon Bioscience, CAT#877-06) |
| Ac-Arg-Leu-Arg-AMC (Echelon Bioscience, CAT#920-75) |
| Ac-Arg-Ser-Leu-Lys-AMC (Site 1 Protease Substrate, fluorogenic) (Echelon Bioscience, CAT#877-09) |
| Ac-Asp-Gln-Met-Asp-AFC (Caspase 3 Substrate) (Echelon Bioscience, CAT#863-26) |
| Ac-Asp-Gln-Met-Asp-AMC (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#860-22) |
| Ac-Asp-Glu-Val-Asp-4MbNA (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#861-18) |
| Ac-Asp-Glu-Val-Asp-AMC (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#860-18) |
| Ac-Asp-Glu-Val-Asp-pNA (Caspase-3 (Apopain) Substrate) (Echelon Bioscience, CAT#860-20) |
| Ac-Asp-Met-Gln-Asp-AFC (Caspase 3 Substrate) (Echelon Bioscience, CAT#860-30) |
| Ac-Asp-Met-Gln-Asp-AMC (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#860-28) |
| Ac-Asp-Met-Gln-Asp-pNA (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#860-25) |
| Ac-DEVD-AFC, (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#863-17) |
| Ac-DEVD-CHO, Caspase 3 (Apopain) Inhibitor (Echelon Bioscience, CAT#864-20) |
| Ac-Glu-Ser-Met-Asp-AFC (Procaspase 3 Substrate, fluorogenic) (Echelon Bioscience, CAT#880-22) |
| Ac-Glu-Ser-Met-Asp-CHO (Procaspase 3 Inhibitor) (Echelon Bioscience, CAT#864-22) |
| Ac-Glu-Val-Asn-Leu-AMC (Echelon Bioscience, CAT#877-11) |
| Ac-Glu-Val-Asn-Leu-pNA (Echelon Bioscience, CAT#876-06) |
| Ac-Ile-Gln-Ala-Cys-Arg-Gly-OH (Caspase Active Site Peptide) (Echelon Bioscience, CAT#866-12) |
| Ac-Ile-Glu-Pro-Asp-AFC (Granzyme B Substrate) (Echelon Bioscience, CAT#863-30) |
| Ac-Ile-Glu-Pro-Asp-AMC (Caspase 8/Granzyme B Substrate) (Echelon Bioscience, CAT#860-69) |
| Ac-Ile-Glu-Pro-Asp-pNA (Granzyme B Substrate) (Echelon Bioscience, CAT#865-30) |
| Ac-Ile-Glu-Thr-Asp-AFC (Caspase 8 Substrate) (Echelon Bioscience, CAT#863-58) |
| Ac-Ile-Glu-Thr-Asp-AMC (Caspase 8/Granzyme B Substrate) (Echelon Bioscience, CAT#860-58) |
| Ac-Ile-Glu-Thr-Asp-CHO (Caspase 8 Inhibitor / Granzyme B Inhibitor II) (Echelon Bioscience, CAT#860-59) |
| Ac-Ile-Glu-Thr-Asp-pNA (Caspase 8 Substrate) (Echelon Bioscience, CAT#860-56) |
| Ac-Leu-Asp-Glu-Ser-Asp-AMC (Caspase 2/3 Substrate) (Echelon Bioscience, CAT#860-43) |
| Ac-Leu-Glu-Glu-Asp-AFC (Caspase 13 Substrate) (Echelon Bioscience, CAT#863-55) |
| Ac-Leu-Glu-Glu-Asp-AMC (Caspase 13 Substrate) (Echelon Bioscience, CAT#862-55) |
| Ac-Leu-Glu-Glu-Asp-CHO (Caspase 13 Inhibitor) (Echelon Bioscience, CAT#864-85) |
| Ac-Leu-Glu-Glu-Asp-pNA (Caspase 13 Substrate) (Echelon Bioscience, CAT#861-85) |
| Ac-Leu-Glu-His-Asp-AFC (Caspase 9 Substrate) (Echelon Bioscience, CAT#863-40) |
| Ac-Leu-Glu-His-Asp-AMC (Caspase 9 Substrate) (Echelon Bioscience, CAT#860-45) |
| Ac-Leu-Glu-His-Asp-CHO (Caspase 9 Inhibitor) (Echelon Bioscience, CAT#864-45) |
| Ac-Leu-Glu-His-Asp-pNA (Caspase 9 Substrate) (Echelon Bioscience, CAT#860-47) |
| Ac-Leu-Glu-Thr-Asp-AFC (Caspase 8 Substrate) (Echelon Bioscience, CAT#863-44) |
| Ac-Leu-Glu-Thr-Asp-CHO (Caspase 8 Inhibitor) (Echelon Bioscience, CAT#864-44) |
| Ac-Leu-Glu-Val-Asp-AFC (Caspase 4 (ICH-2) Substrate) (Echelon Bioscience, CAT#863-42) |
| Ac-Leu-Glu-Val-Asp-AMC (Caspase 4 Substrate) (Echelon Bioscience, CAT#860-49) |
| Ac-Leu-Glu-Val-Asp-CHO (Caspase 4 (ICH-2) Inhibitor) (Echelon Bioscience, CAT#864-42) |
| Ac-Leu-Glu-Val-Asp-pNA (Caspase 4 (ICH-2) Substrate) (Echelon Bioscience, CAT#860-42) |
| Ac-Leu-Leu-Arg-AMC (Echelon Bioscience, CAT#877-12) |
| Ac-Leu-Leu-Tyr-AFC (Echelon Bioscience, CAT#875-20) |
| Ac-Leu-Val-Lys-CHO (Cathepsin B Inhibitor II) (Echelon Bioscience, CAT#866-39) |
| Ac-Lys-Gln-Lys-Leu-Arg-4-methoxy-2-naphthylamide (Echelon Bioscience, CAT#878-02) |
| Ac-Lys-Pro-Arg-AMC (Echelon Bioscience, CAT#877-07) |
| Ac-Orn-Phe-Arg-AMC (Tryptase Substrate, fluorogenic) (Echelon Bioscience, CAT#871-94) |
| Ac-Phe-Ser-Arg-pNA (Echelon Bioscience, CAT#876-01) |
| Ac-Thr-Gln-Thr-Asp-AFC (DRONC Substrate) (Echelon Bioscience, CAT#850-16) |
| Ac-Thr-Gln-Thr-Glu-AFC (DRONC Substrate I) (Echelon Bioscience, CAT#850-17) |
| Ac-Trp-Glu-Ala-Asp-AMC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-61) |
| Ac-Trp-Glu-Ala-Asp-pNA (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-63) |
| Ac-Trp-Glu-His-Asp-AFC (Caspase 1 Substrate) (Echelon Bioscience, CAT#863-63) |
| Ac-Trp-Glu-His-Asp-AMC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-60) |
| Ac-Trp-Glu-His-Asp-pNA (Caspase 1 Substrate) (Echelon Bioscience, CAT#861-66) |
| Ac-Trp-Val-Ala-Asp-AMC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-64) |
| Ac-Trp-Val-Ala-Asp-pNA (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-66) |
| Ac-Tyr-Glu-Val-Asp-AMC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-41) |
| Ac-Tyr-Val-Ala-Asp-AFC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-17) |
| Ac-Tyr-Val-Ala-Asp-AMC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-16) |
| Ac-Tyr-Val-Ala-Asp-pNA (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-15) |
| Ac-Val-Ala-Asp-4MbNA (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#863-12) |
| Ac-Val-Ala-Asp-AFC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-12) |
| Ac-Val-Ala-Asp-CHO (Caspase 1 (ICE) Inhibitor) (Echelon Bioscience, CAT#864-12) |
| Ac-Val-Ala-Asp-pNA (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-11) |
| Ac-Val-Asn-Leu-Asp-AFC (Caspase Substrate) (Echelon Bioscience, CAT#863-70) |
| Ac-Val-Asp-Gln-Gln-Asp-pNA (Caspase 2 (ICH-1) Substrate) (Echelon Bioscience, CAT#860-44) |
| Ac-Val-Asp-Val-Ala-Asp-AFC (Caspase 2 (ICH-1) Substrate) (Echelon Bioscience, CAT#863-48) |
| Ac-Val-Asp-Val-Ala-Asp-AMC (Caspase 2 (ICH-1) Substrate) (Echelon Bioscience, CAT#860-48) |
| Ac-Val-Asp-Val-Ala-Asp-CHO (Caspase 2 (ICH-1) Inhibitor) (Echelon Bioscience, CAT#864-46) |
| Ac-Val-Asp-Val-Ala-Asp-pNA (Caspase 2 (ICH-1) Substrate) (Echelon Bioscience, CAT#860-46) |
| Ac-Val-Gln-Val-Asp-pNA (Caspase 3 Substrate) (Echelon Bioscience, CAT#860-54) |
| Ac-Val-Glu-His-Asp-AFC (Caspase Substrate) (Echelon Bioscience, CAT#863-74) |
| Ac-Val-Glu-Ile-Asp-AMC (Caspase 6 (Mch2) Substrate) (Echelon Bioscience, CAT#860-52) |
| Ac-Val-Glu-Ile-Asp-CHO (Caspase 6 (Mch2) Inhibitor) (Echelon Bioscience, CAT#860-57) |
| Ac-Val-Glu-Ile-Asp-pNA (Caspase 6 (Mch2) Substrate) (Echelon Bioscience, CAT#860-50) |
| Ac-Val-Glu-Thr-Asp-AMC (Caspase 8 Substrate) (Echelon Bioscience, CAT#860-26) |
| Ac-Val-Lys-Met-Asp-AFC (Caspase Substrate) (Echelon Bioscience, CAT#863-72) |
| Ac-VEID-AFC (Caspase 6 (Mch2) Substrate) (Echelon Bioscience, CAT#863-52) |
| Ac-YVAD-CHO, Caspase 1 (ICE) Inhibitor (Echelon Bioscience, CAT#864-15) |
| Acetyl Calcitonin, salmon (Echelon Bioscience, CAT#237-36) |
| Acetyl-Beta Amyloid (25-35) (Echelon Bioscience, CAT#641-59) |
| Acetyl-Neurotensin (8-13) (Echelon Bioscience, CAT#631-41) |
| Acid Sphingomyelinase Activity Assay Kit (Echelon Bioscience, CAT#K-3200) |
| ACTH (1-17), human (Echelon Bioscience, CAT#111-75) |
| ACTH (1-24), human (Echelon Bioscience, CAT#111-36) |
| ACTH (1-39), rat (Echelon Bioscience, CAT#115-10) |
| ACTH (7-38), human / Corticotropin Inhibiting Peptide (7-38), human (Echelon Bioscience, CAT#111-45) |
| Activity Dependant Neuroprotective Protein (74-81) (mouse, rat) (Echelon Bioscience, CAT#878-03) |
| ADAM substrate (Echelon Bioscience, CAT#825-15) |
| Adamantaneacetyl-Bradykinin [DArg0,Hyp3,Thi5,8,DPhe7] (Echelon Bioscience, CAT#191-84) |
| Adrenal Secretogranin, bovine (Echelon Bioscience, CAT#313-20) |
| Adrenomedullin (1-50), rat (Echelon Bioscience, CAT#335-75) |
| Adrenomedullin (1-52), human (Echelon Bioscience, CAT#331-80) |
| Adrenomedullin (11-50), rat (Echelon Bioscience, CAT#335-80) |
| Adrenomedullin (22-52), human (Echelon Bioscience, CAT#331-82) |
| Agatoxin IVa ( SS Cys 4,20 / Cys 12,25 / Cys 19,36 / Cys 27 (Echelon Bioscience, CAT#429-15) |
| Akt Substrate (Echelon Bioscience, CAT#868-15) |
| Alkyl-OMPT (Echelon Bioscience, CAT#L-9518) |
| Allatostatin B2, cockroach (Echelon Bioscience, CAT#781-20) |
| Alpha MSH [D-Phe7] (Echelon Bioscience, CAT#570-42) |
| Alpha MSH [Nle4,D-Phe7] (Echelon Bioscience, CAT#570-43) |
| Alpha MSH, Ac-NLe4c[Asp5,DNal7,Lys10](4-10) amide (Echelon Bioscience, CAT#571-49) |
| AMARA peptide substrate (Echelon Bioscience, CAT#890-23) |
| Aminocardiolipin (Amino-CL) (Echelon Bioscience, CAT#L-C16A) |
| Amylin (1-37), human, amide (Echelon Bioscience, CAT#641-50) |
| Amyloid Blocker (Echelon Bioscience, CAT#641-81) |
| Amyloid Fragment (Pro18,Asp21) (17-21) (Echelon Bioscience, CAT#641-64) |
| Angiotensin (1-5) (Echelon Bioscience, CAT#131-53) |
| Angiotensin (1-7) (Echelon Bioscience, CAT#131-41) |
| Angiotensin I (1-9), DRVYIHPFH-OH (Echelon Bioscience, CAT#131-55) |
| Angiotensin I (human) (Echelon Bioscience, CAT#131-25) |
| Angiotensin I [Asn1,Val5,Asn9], salmon (Echelon Bioscience, CAT#137-40) |
| Angiotensin I [Asn1,Val5], goosefish (Echelon Bioscience, CAT#137-39) |
| Angiotensin I [Val5,Asn9], bullfrog (Echelon Bioscience, CAT#137-36) |
| Angiotensin II Antipeptide (Echelon Bioscience, CAT#131-64) |
| Angiotensin II-[Sar1] (Echelon Bioscience, CAT#131-65) |
| Angiotensin II, human (Echelon Bioscience, CAT#131-49) |
| Angiotensin III, human / Angiotensin II-[Des Asp1] (Echelon Bioscience, CAT#131-76) |
| Angiotensinogen (1-14) Renin Substrate, porcine (Echelon Bioscience, CAT#131-82) |
| Anti human Vps34 Antibody (Echelon Bioscience, CAT#Z-R016) |
| Anti-hVps34 Antibody for IP (Echelon Bioscience, CAT#Z-R015) |
| Anti-PEth Autologous IgG ELISA (Echelon Bioscience, CAT#K-5000A) |
| Anti-PtdIns(3,4,5)P3 IgM HRP (Echelon Bioscience, CAT#Z-H345) |
| Anti-PtdIns(3,4,5)P3 IgM In Ascities (Echelon Bioscience, CAT#Z-A345) |
| Anti-PtdIns(4,5)P2 IgM In Ascites (Echelon Bioscience, CAT#Z-A045) |
| Anti-Rat F1-ATP Synthase Alpha Subunit Rabbit Polyclonal Antibody (Echelon Bioscience, CAT#Z-RATPA) |
| Anti-Rat F1-ATP Synthase Beta Subunit Rabbit Polyclonal Antibody (Echelon Bioscience, CAT#Z-RATPB) |
| Antibody Sample Pack (Echelon Bioscience, CAT#Z-P100) |
| AP-811 (NPR-C receptor ligand) (Echelon Bioscience, CAT#492-10) |
| Apamin, bee venom (SS1-11, SS3-15) (Echelon Bioscience, CAT#425-10) |
| APP Beta Secretase Inhibitor (Echelon Bioscience, CAT#649-10) |
| APP Gamma Secretase Inhibitor (Echelon Bioscience, CAT#649-22) |
| APP Gamma Secretase Inhibitor (Echelon Bioscience, CAT#649-23) |
| Arachidonoyl LPA, 20:4 LPA (Echelon Bioscience, CAT#L-0204) |
| Arachidoyl LPA, 20:0 LPA (Echelon Bioscience, CAT#L-0200) |
| Arg-Gly-Asp-Ser (RGDS) (Echelon Bioscience, CAT#450-29) |
| ARN14988 (aCDase Inhibitor) (Echelon Bioscience, CAT#B-0041) |
| AS1938909 (SHIP2 Inhibitor) (Echelon Bioscience, CAT#B-0343) |
| AS1949490 (SHIP2 Inhibitor) (Echelon Bioscience, CAT#B-0342) |
| AS604850 (PI3-K gamma Inhibitor 2) (Echelon Bioscience, CAT#B-0302) |
| AS605240 (PI3-K gamma Inhibitor 1) (Echelon Bioscience, CAT#B-0301) |
| Atrial Natriuretic Peptide (1-28), human / ANP (1-28), human (Echelon Bioscience, CAT#151-25) |
| Atrial Natriuretic Peptide (1-28), rat (Echelon Bioscience, CAT#155-56) |
| Atrial Natriuretic Peptide (4-28), rat / Auriculin B (Echelon Bioscience, CAT#155-62) |
| Atrial Natriuretic Peptide (ANP) (4-24), frog (Echelon Bioscience, CAT#153-15) |
| Atrial Natriuretic Peptide (ANP) Des[18-22] (4-23) amide, rat (Echelon Bioscience, CAT#155-40) |
| Atriopeptin III, rat [ANP (127-150), rat] (Echelon Bioscience, CAT#155-63) |
| ATX Sandwich ELISA Assay Service (Echelon Bioscience, CAT#T-5600) |
| ATX-Red AR-2 (Echelon Bioscience, CAT#L-2010) |
| Autocamptide-2 Related Inhibitoy Peptide (Echelon Bioscience, CAT#891-24) |
| Autocamtide-2 Related Inhibitory Peptide, myristoylated (Echelon Bioscience, CAT#891-26) |
| Autotaxin Activity Assay (Echelon Bioscience, CAT#K-4100) |
| Autotaxin Activity Assay Service (Echelon Bioscience, CAT#T-4100) |
| Autotaxin Enzyme, active (Echelon Bioscience, CAT#E-4000) |
| Autotaxin Inhibitor Screening Assay Service (Echelon Bioscience, CAT#T-4200) |
| Autotaxin Inhibitor Screening Kit (Echelon Bioscience, CAT#K-4200) |
| Autotaxin Sandwich ELISA Kit (Echelon Bioscience, CAT#K-5600) |
| BAM (6-22) Bovine Adrenal Medulla Peptide (6-22) (Echelon Bioscience, CAT#313-64) |
| BAM 3200 Bovine Adrenal Medulla Peptide E (Echelon Bioscience, CAT#313-65) |
| Benzo[a]pyrene (Echelon Bioscience, CAT#B-0050) |
| Beta Amyloid (25-35), human (Echelon Bioscience, CAT#641-40) |
| Beta Amyloid [Glu11] (10-16), human (Echelon Bioscience, CAT#641-45) |
| Beta Amyloid [Nle35] (1-40), human (Echelon Bioscience, CAT#641-13) |
| Beta Amyloid (1-16) [Gln11], human (Echelon Bioscience, CAT#641-35) |
| Beta Amyloid (1-16), rat (Echelon Bioscience, CAT#642-36) |
| Beta Amyloid (1-28), [Gln11], human (Echelon Bioscience, CAT#641-17) |
| Beta Amyloid (1-28), rat (Echelon Bioscience, CAT#642-18) |
| Beta Amyloid (1-40), human (Arctic) [Gly22] (Echelon Bioscience, CAT#641-14) |
| Beta Amyloid (1-40), rat (Echelon Bioscience, CAT#642-10) |
| Beta Amyloid (1-42), human (Echelon Bioscience, CAT#641-15) |
| Beta Amyloid (1-42), human – HFIP (Echelon Bioscience, CAT#641-00) |
| Beta Amyloid (1-42), human (Arctic) [Gly22] (Echelon Bioscience, CAT#641-22) |
| Beta Amyloid (1-42), rat (Echelon Bioscience, CAT#642-15) |
| Beta Amyloid (10-20), human (Echelon Bioscience, CAT#641-21) |
| Beta Amyloid (12-28), human (Echelon Bioscience, CAT#641-19) |
| Beta Amyloid (13-16), human (Echelon Bioscience, CAT#641-88) |
| Beta Amyloid (16-10), reverse, human (Echelon Bioscience, CAT#641-54) |
| Beta Amyloid (17-42), human (Echelon Bioscience, CAT#641-90) |
| Beta Amyloid (22-35), human (Echelon Bioscience, CAT#641-44) |
| Beta Amyloid (25-35) [Ala28] (Echelon Bioscience, CAT#640-19) |
| Beta Amyloid (25-35) [Gly35] (Echelon Bioscience, CAT#640-21) |
| Beta Amyloid (25-35) [Nle35], human (Echelon Bioscience, CAT#641-53) |
| Beta Amyloid (26-35), human (Echelon Bioscience, CAT#641-41) |
| Beta Amyloid (27-35), human (Echelon Bioscience, CAT#641-42) |
| Beta Amyloid (28-35), human (Echelon Bioscience, CAT#641-43) |
| Beta Amyloid (35-25), reverse, human (Echelon Bioscience, CAT#641-47) |
| Beta Amyloid (40-1), reverse, human (Echelon Bioscience, CAT#641-70) |
| Beta Amyloid (42-1) reverse, human (Echelon Bioscience, CAT#641-69) |
| Beta Amyloid [Gln 22] (1-40), human (Echelon Bioscience, CAT#640-20) |
| Beta Amyloid [Gln 22] (1-42), human (Echelon Bioscience, CAT#642-30) |
| Beta Amyloid [Gln11] (1-40) , human (Echelon Bioscience, CAT#641-11) |
| Beta Amyloid [Glp3] (3-42), human (Echelon Bioscience, CAT#641-16) |
| Beta Amyloid [Glu11] (1-16) (Echelon Bioscience, CAT#641-36) |
| Beta Amyloid [Glu11] (1-38), human (Echelon Bioscience, CAT#641-25) |
| Beta Amyloid [Glu11] (1-40), human (Echelon Bioscience, CAT#641-10) |
| Beta Amyloid [Glu11] (1-40), human – HFIP (Echelon Bioscience, CAT#641-01) |
| Beta Amyloid [Glu11], (1-28), human (Echelon Bioscience, CAT#641-18) |
| Beta Endorphin, human / Beta Lipotropin (61-91), human (Echelon Bioscience, CAT#291-25) |
| Beta MSH, human (Echelon Bioscience, CAT#571-47) |
| Beta Secretase Inhibitor II (Echelon Bioscience, CAT#649-18) |
| Big Endothelin (1-38), human (Echelon Bioscience, CAT#331-30) |
| Big Endothelin (1-39), porcine (Echelon Bioscience, CAT#334-10) |
| Big Endothelin (1-39), rat (Echelon Bioscience, CAT#335-50) |
| Big Endothelin 1 [D-Val22] (16-38), human (Echelon Bioscience, CAT#331-32) |
| Big Endothelin 2 (1-37), human (Echelon Bioscience, CAT#331-40) |
| Big Gastrin, sulfated (Echelon Bioscience, CAT#471-80) |
| Bilirubin (Echelon Bioscience, CAT#F-H120) |
| Bilirubin Conjugate (Echelon Bioscience, CAT#F-H130) |
| Bilirubin dimethyl ester (Echelon Bioscience, CAT#F-H110) |
| Biliverdin Hydrochloride (Echelon Bioscience, CAT#F-H100) |
| Biotin 18:0 LysoPC (Echelon Bioscience, CAT#L-15B18) |
| Biotin Monolysocardiolipin (Echelon Bioscience, CAT#L-M16B) |
| Biotin Phosphatidylinositol (Echelon Bioscience, CAT#C-00B6) |
| Biotin Phosphatidylinositol 3-phosphate (Echelon Bioscience, CAT#C-03B6) |
| Biotin Phosphatidylinositol 3,4-bisphosphate (Echelon Bioscience, CAT#C-34B6) |
| Biotin Phosphatidylinositol 3,5-bisphosphate (Echelon Bioscience, CAT#C-35B6) |
| Biotin Phosphatidylinositol 4-phosphate (Echelon Bioscience, CAT#C-04B6) |
| Biotin Phosphatidylinositol 4,5-bisphosphate (Echelon Bioscience, CAT#C-45B6) |
| Biotin Phosphatidylinositol 5-phosphate (Echelon Bioscience, CAT#C-05B6) |
| Biotin PI(3,4,5)P3 (Echelon Bioscience, CAT#C-39B6) |
| Biotin Sphingomyelin (Echelon Bioscience, CAT#S-400B) |
| biotin-C12-ether LBPA (Echelon Bioscience, CAT#L-B1B12) |
| Biotin-Cardiolipin (Echelon Bioscience, CAT#L-C16B) |
| Biotin-Ceramide (Echelon Bioscience, CAT#S-300B) |
| Biotin-Lactosylceramide (Echelon Bioscience, CAT#S-600B) |
| Biotin-monolysocardiolipin (Echelon Bioscience, CAT#L-MB16) |
| Biotin-Phosphatidic Acid (Echelon Bioscience, CAT#L-41B16) |
| Biotin-Phosphatidylcholine (Echelon Bioscience, CAT#L-11B16) |
| Biotin-Phosphatidylethanol (12:0/18:1) (Echelon Bioscience, CAT#L-60B18) |
| Biotin-Phosphatidylethanol (6:0/16:0) (Echelon Bioscience, CAT#L-60B16) |
| Biotin-Phosphatidylethanolamine (Echelon Bioscience, CAT#L-21B6) |
| Biotin-Phosphatidylglycerol (Echelon Bioscience, CAT#L-51B16) |
| Biotin-Phosphatidylserine (Echelon Bioscience, CAT#L-31B16) |
| Biotinyl-alpha MSH [Nle4,DPhe7] (Echelon Bioscience, CAT#570-46) |
| Biotinylated Anti-PtdIns(3,4,5)P3 IgG (Echelon Bioscience, CAT#Z-B345B) |
| Biotinylated Anti-PtdIns(3,4,5)P3 IgM (Echelon Bioscience, CAT#Z-B345) |
| Biotinylated Anti-PtdIns(3,4)P2 IgG (Echelon Bioscience, CAT#Z-B034) |
| Biotinylated Anti-PtdIns(4,5)P2 IgM (Echelon Bioscience, CAT#Z-B045) |
| Biotinylated Select-HA 1000k (Echelon Bioscience, CAT#HYA-B1000-200) |
| Biotinylated Select-HA 250k (Echelon Bioscience, CAT#HYA-B250-200) |
| Biotinylated Select-HA 500k (Echelon Bioscience, CAT#HYA-B500-200) |
| Biotinylated Select-HA 50k (Echelon Bioscience, CAT#HYA-B50-200) |
| Biotinylated Versican G1 Domain (Echelon Bioscience, CAT#G-HA02) |
| Bisepoxy Juvenile Hormone III (Echelon Bioscience, CAT#S-0157) |
| BOC-Lys(Ac)-AMC (Histone Deacetylase (HDAC) Substrate) (Echelon Bioscience, CAT#888-20) |
| Boc-Val-Gly-Arg-bNA (Plasminogen Activator Substrate) (Echelon Bioscience, CAT#875-17) |
| BOC-Val-Pro-Arg-AFC (Thrombin substrate, fluorogenic) (Echelon Bioscience, CAT#885-11) |
| BODIPY FL Phosphatidylinositol (Echelon Bioscience, CAT#C-00F6) |
| BODIPY FL Phosphatidylinositol 4,5-bisphosphate (Echelon Bioscience, CAT#C-45F6) |
| BODIPY FL PI(3,4,5)P3 (Echelon Bioscience, CAT#C-39F6) |
| BODIPY FL PI(3,4)P2 (Echelon Bioscience, CAT#C-34F6) |
| BODIPY FL PI(3,5)P2 (Echelon Bioscience, CAT#C-35F6) |
| BODIPY FL PI(3)P (Echelon Bioscience, CAT#C-03F6) |
| BODIPY FL PI(4)P (Echelon Bioscience, CAT#C-04F6) |
| BODIPY FL PI(5)P (Echelon Bioscience, CAT#C-05F6) |
| Bodipy Labeled PIP Sample Pack (Echelon Bioscience, CAT#C-99F6) |
| BODIPY TMR Phosphatidylinositol (Echelon Bioscience, CAT#C-00M6) |
| BODIPY TMR PI(3,4,5)P3 (Echelon Bioscience, CAT#C-39M6) |
| BODIPY TMR PI(3,4)P2 (Echelon Bioscience, CAT#C-34M6) |
| BODIPY TMR PI(3,5)P2 (Echelon Bioscience, CAT#C-35M6) |
| BODIPY TMR PI(3)P (Echelon Bioscience, CAT#C-03M6) |
| BODIPY TMR PI(4,5)P2 (Echelon Bioscience, CAT#C-45M6) |
| BODIPY TMR PI(4)P (Echelon Bioscience, CAT#C-04M6) |
| BODIPY TMR PI(5)P (Echelon Bioscience, CAT#C-05M6) |
| BODIPY-FL PEth (Echelon Bioscience, CAT#L-60F18) |
| Bombesin (Echelon Bioscience, CAT#177-25) |
| Bovine Adrenal Medulla Docosapeptide / BAM 22P (Echelon Bioscience, CAT#313-45) |
| Bovine Thrombin (Echelon Bioscience, CAT#E-9000) |
| Bradykinin (1-7) (Echelon Bioscience, CAT#191-72) |
| Bradykinin (1-9) (Echelon Bioscience, CAT#191-25) |
| Bradykinin B2 Antagonist (HOE 140) (Echelon Bioscience, CAT#191-85) |
| Bradykinin Ile-Ser, (T-Kinin) (Echelon Bioscience, CAT#191-49) |
| Bradykinin Potentiating Factor (Angiotensin Converting Enzyme Inhibitor) (Echelon Bioscience, CAT#131-95) |
| Brain Derived Acidic Fibroblast Growth Factor (1-11), bovine (Echelon Bioscience, CAT#510-42) |
| Brain Natriuretic Peptide (BNP) (1-32), human / Brain ANP (1-32), human (Echelon Bioscience, CAT#152-52) |
| BrP-LPA (Echelon Bioscience, CAT#L-7416) |
| C-Peptide [Tyr0] / Proinsulin (32-63) Tyr0 (Echelon Bioscience, CAT#211-27) |
| C-Type Natriuretic Peptide (CNP) (1-22), human (Echelon Bioscience, CAT#151-60) |
| C6NIB (H2O2 vapor sensor) (Echelon Bioscience, CAT#D-0020) |
| Caerulein (ceruletide) (Echelon Bioscience, CAT#471-65) |
| Calcitonin Gene Related Peptide (CGRP), human (Echelon Bioscience, CAT#231-27) |
| Calcitonin Gene Related Peptide I (8-37), human / CGRP Receptor Antagonist (Echelon Bioscience, CAT#231-31) |
| Calcitonin Gene Related Peptide II (8-37), human / Beta CGRP (Echelon Bioscience, CAT#231-22) |
| Calcitonin Gene Related Peptide II (CGRP II, human), cyclic (Echelon Bioscience, CAT#231-29) |
| Calcitonin, human, cyclic (Echelon Bioscience, CAT#231-25) |
| Calcitonin, salmon (Echelon Bioscience, CAT#237-26) |
| Calcitonin, salmon [Des-Cys1] (Echelon Bioscience, CAT#237-34) |
| Calcitonin, salmon [Des-Tyr22] (Echelon Bioscience, CAT#237-32) |
| Calmodulin Binding Domain Ca2+/Calmodulin Dependent Protein (Echelon Bioscience, CAT#740-60) |
| Calmodulin Dependent Protein Kinase Substrate (Echelon Bioscience, CAT#890-81) |
| Calmodulin Kinase II Inhibitor (281-309) (Echelon Bioscience, CAT#893-40) |
| Calpastatin Peptide (Ac 184-210 ) (Echelon Bioscience, CAT#870-20) |
| cAMP Dependent Protein Kinase Inhibitor 5-24 amide (Echelon Bioscience, CAT#891-14) |
| cAMP Dependent Protein Kinase Inhibitor PKI-tide (Echelon Bioscience, CAT#892-20) |
| Cardioexcitatory Peptide, African giant snail (Echelon Bioscience, CAT#610-74) |
| Cardiolipin Beads (Echelon Bioscience, CAT#P-BCLP) |
| Casein Kinase Substrate (Echelon Bioscience, CAT#871-56) |
| Casein Kinase Substrate (Echelon Bioscience, CAT#871-52) |
| Cathepsin D and E substrate, fluorogenic (Echelon Bioscience, CAT#866-41) |
| Cathepsin D Substrate (Echelon Bioscience, CAT#880-42) |
| Cathepsin L Inhibitor (Echelon Bioscience, CAT#866-23) |
| Cathepsin S Substrate, fluorogenic (Echelon Bioscience, CAT#866-80) |
| CDP-ME Kinase (IspE) (Echelon Bioscience, CAT#E-2000E) |
| CDP-ME Synthase (IspD) (Echelon Bioscience, CAT#E-2000D) |
| CDP-ME Synthase (IspD) Enzymatic Assay (Echelon Bioscience, CAT#K-2000D) |
| CDP-MEP Synthesis Kit (Echelon Bioscience, CAT#K-2000E) |
| Cecropin B (Echelon Bioscience, CAT#893-50) |
| Cecropin P1, porcine (Echelon Bioscience, CAT#893-60) |
| Cell Adhesion Inhibitor Peptide, cyclic (Echelon Bioscience, CAT#451-40) |
| Cell Permeable Caspase 1 Inhibitor (Echelon Bioscience, CAT#864-38) |
| Cell Permeable Caspase 3 Inhibitor (Echelon Bioscience, CAT#864-29) |
| Cell Permeable Caspase 6 Inhibitor (Echelon Bioscience, CAT#864-31) |
| Ceramide 1-Phosphate (C1P) Beads (Echelon Bioscience, CAT#P-BC1P) |
| Ceramide Beads (Echelon Bioscience, CAT#P-BCER) |
| Ceranib-2 (Ceramidase inhibitor) (Echelon Bioscience, CAT#B-0043) |
| cGMP Dep. Protein Kinase Substrate (BPDEide) (Echelon Bioscience, CAT#870-78) |
| Charybdotoxin, cyclic (Echelon Bioscience, CAT#429-60) |
| Chemotactic Peptide (Formyl-Met-Leu-Phe-OH) (Echelon Bioscience, CAT#850-15) |
| Chitin Polymer (Echelon Bioscience, CAT#H-10CH) |
| Cholecystokinin Octapeptide (26-33) / CCK 8 (Echelon Bioscience, CAT#471-47) |
| Cholecystokinin Octapeptide (26-33) Non-Sulfated / CCK-NSE O (Echelon Bioscience, CAT#471-48) |
| Cholesterol (Echelon Bioscience, CAT#L-6012) |
| Cholesterol Beads (Echelon Bioscience, CAT#P-BCHL) |
| Chromogranin A (324-337) WE 14, human (Echelon Bioscience, CAT#474-70) |
| Cionin (Echelon Bioscience, CAT#477-49) |
| Class I PI3-Kinase Reaction Buffer (Echelon Bioscience, CAT#K-KBZ) |
| Class III PI3K ELISA Kit (Echelon Bioscience, CAT#K-3000) |
| cMEPP Synthase (IspF) (Echelon Bioscience, CAT#E-2000F) |
| CML ELISA Kit II (Echelon Bioscience, CAT#K-3900S) |
| Coagulation Factor XIIIA (72-97) (Echelon Bioscience, CAT#459-15) |
| Colipase Activation Peptide (Echelon Bioscience, CAT#873-30) |
| Collagen Hybridizing Peptide – Biotin conjugate (CHP) (Echelon Bioscience, CAT#BIO) |
| Collagen Hybridizing Peptide – Cy3 Conjugate (Echelon Bioscience, CAT#RED) |
| Collagen Hybridizing Peptide – Fluorescein Conjugate (Echelon Bioscience, CAT#FLU) |
| Control Beads (Echelon Bioscience, CAT#P-B000) |
| Control PolyPIPosomes (Echelon Bioscience, CAT#Y-0000) |
| Corazonin, Periplaneta Americana (Echelon Bioscience, CAT#619-47) |
| Corticotropin Releasing Factor (CRF) human, rat (Echelon Bioscience, CAT#351-25) |
| Corticotropin Releasing Factor [Tyr0], ovine / CRF [Tyr0], o (Echelon Bioscience, CAT#352-37) |
| Corticotropin Releasing Factor, bovine, CRF, bovine (Echelon Bioscience, CAT#353-26) |
| Corticotropin Releasing Factor, ovine / CRF, ovine (Echelon Bioscience, CAT#352-26) |
| Cova PIP Screening Plate (Echelon Bioscience, CAT#H-6200) |
| CREBtide (Echelon Bioscience, CAT#890-15) |
| Cu(II) Protoporphyrin IX, 14494-37-2 (Echelon Bioscience, CAT#F-H070) |
| Custom Lipid Array Strip (Echelon Bioscience, CAT#P-6111) |
| CYM50308 (S1P4 Receptor Agonist) (Echelon Bioscience, CAT#B-0060) |
| D-erythro-Sphingosine (Echelon Bioscience, CAT#S-1000) |
| D-Ile-Pro-Arg-AMC (Echelon Bioscience, CAT#855-18) |
| D-Ile-Pro-Arg-pNA (Echelon Bioscience, CAT#855-19) |
| D-Phe-Pro-Lys-pNA (Thrombin Substrate colorimetric) (Echelon Bioscience, CAT#885-49) |
| D-sn-1-O-oleoyl-2-O-methylglyceryl-3-phosphothionate (2R-OMPT) (Echelon Bioscience, CAT#L-9318) |
| D-Val-Gly-Arg-pNA (Echelon Bioscience, CAT#855-31) |
| D-Val-Leu-Arg-AFC (Kallikrein substrate, fluorogenic) (Echelon Bioscience, CAT#871-84) |
| D-Val-Leu-Arg-AMC (Kallikrein Substrate, fluorogenic) (Echelon Bioscience, CAT#871-81) |
| D-Val-Leu-Arg-pNA (Kallikrein Substrate, colorimetric) (Echelon Bioscience, CAT#871-82) |
| D-Val-Leu-Lys-AFC (Plasmin Substrate, fluorogenic) (Echelon Bioscience, CAT#872-22) |
| D-Val-Leu-Lys-AMC (Plasmin Substrate, fluorogenic) (Echelon Bioscience, CAT#872-18) |
| D-Val-Leu-Lys-pNA (Plasmin substrate colorimetric) (Echelon Bioscience, CAT#872-21) |
| D-Val-Lys-Lys-Arg-AMC (Echelon Bioscience, CAT#855-44) |
| d5-PAPEth (Echelon Bioscience, CAT#L-6055) |
| d5-PLPEth (Echelon Bioscience, CAT#L-6052) |
| d5-POPEth (Echelon Bioscience, CAT#L-6051) |
| d5-SLPEth (Echelon Bioscience, CAT#L-6054) |
| d5-SOPEth (Echelon Bioscience, CAT#L-6053) |
| DAPC (20:0 PC) (Echelon Bioscience, CAT#L-1120) |
| DBPC (PLA2 Substrate) (Echelon Bioscience, CAT#L-3000) |
| Decorsin, Leech (Macrobdella decora) (Echelon Bioscience, CAT#459-10) |
| Decyl Rhamnoside (Echelon Bioscience, CAT#RL10-1) |
| Dermaseptin (Echelon Bioscience, CAT#889-15) |
| DES1 Inhibitor (Echelon Bioscience, CAT#B-0027) |
| Desmopressin, [D-Gln4] Disulfide Bridge 1-6, Acetate (Echelon Bioscience, CAT#671-18) |
| Desmopressin, [L-Arg8], Disulfide Bridge 1-6 (Echelon Bioscience, CAT#671-20) |
| Desmopressin, Disulfide Bridge 1-6 (Echelon Bioscience, CAT#671-19) |
| DHPS (6:0/6:0 PS) (Echelon Bioscience, CAT#L-3106) |
| Dibromobimane (Echelon Bioscience, CAT#F-0040) |
| Dilauroyl-sn-glycerol (Echelon Bioscience, CAT#L-0012) |
| Dimethylallyl Diphosphate (DMAPP) (Echelon Bioscience, CAT#I-0051) |
| Dimethylallyl S-Thiolodiphosphate (DMASPP) (Echelon Bioscience, CAT#I-S051) |
| Dimyristoyl-sn-glycerol (Echelon Bioscience, CAT#L-0014) |
| Dipalmitoyl-sn-glycerol (Echelon Bioscience, CAT#L-0016) |
| DLPA (12:0/12:0 PA) (Echelon Bioscience, CAT#L-4112) |
| DLPC (12:0/12:0 PC) (Echelon Bioscience, CAT#L-1112) |
| DLPE (12:0/12:0 PE) (Echelon Bioscience, CAT#L-2112) |
| DLPG (12:0/12:0 PG) (Echelon Bioscience, CAT#L-5112) |
| DMOG (dimethyloxalylglycine) (Echelon Bioscience, CAT#F-0010) |
| DMPA (14:0/14:0 PA) (Echelon Bioscience, CAT#L-4114) |
| DMPC (14:0/14:0 PC) (Echelon Bioscience, CAT#L-1114) |
| DMPE (14:0/14:0 PE) (Echelon Bioscience, CAT#L-2114) |
| DMPG (14:0/14:0 PG) (Echelon Bioscience, CAT#L-5114) |
| Dnp-Pro-Leu-Ala-Tyr-Trp-Ala-Arg-OH (MMP 8 Substrate) (Echelon Bioscience, CAT#868-44) |
| Dnp-Pro-Leu-Gly-Met-Trp-Ser-Arg-OH (MMP-2 / MMP-9 Substrate) (Echelon Bioscience, CAT#865-10) |
| DOPC (18:1/18:1 PC) (Echelon Bioscience, CAT#L-1182) |
| DOPE (18:1/18:1 PE) (Echelon Bioscience, CAT#L-2182) |
| DOPEth (18:1/18:1 PEth) (Echelon Bioscience, CAT#L-6018) |
| DPePC (Echelon Bioscience, CAT#L-1162) |
| DPPA (16:0/16:0 PA) (Echelon Bioscience, CAT#L-4116) |
| DPPC (16:0/16:0 PC) (Echelon Bioscience, CAT#L-1116) |
| DPPE (16:0/16:0 PE) (Echelon Bioscience, CAT#L-2116) |
| DPPG (16:0/16:0 PG) (Echelon Bioscience, CAT#L-5116) |
| DPPS (16:0/16:0 PS) (Echelon Bioscience, CAT#L-3116) |
| DSPA (18:0/18:0 PA) (Echelon Bioscience, CAT#L-4118) |
| DSPC (18:0 PC) (Echelon Bioscience, CAT#L-1118) |
| DSPE (18:0/18:0 PE) (Echelon Bioscience, CAT#L-2118) |
| DSPG (18:0/18:0 PG) (Echelon Bioscience, CAT#L-5118) |
| DXP Synthase (DXS) (Echelon Bioscience, CAT#E-20DXS) |
| Dynorphin A (1-8), porcine (Echelon Bioscience, CAT#274-82) |
| Dynorphin A, porcine [Prodynorphin (209-225)] (Echelon Bioscience, CAT#274-27) |
| Dynorphin B, porcine / Rimorphin / Prodynorphin (228-240) (Echelon Bioscience, CAT#274-50) |
| ECE-1 Substrate (Echelon Bioscience, CAT#331-72) |
| Endomorphin I (Echelon Bioscience, CAT#311-88) |
| Endomorphin II (Echelon Bioscience, CAT#311-89) |
| Endothelin 2, human / ET 2 (Echelon Bioscience, CAT#331-20) |
| Endothelin 1, human (Echelon Bioscience, CAT#331-25) |
| Endothelin 3, cyclic (human, mouse, rabbit, rat) (Echelon Bioscience, CAT#335-10) |
| Endothelin Antagonist BQ 123, cyclic (Echelon Bioscience, CAT#331-10) |
| Endothelin Antagonist PD 142893 (Echelon Bioscience, CAT#331-17) |
| Endothelin Beta Receptor Agonist IRL 1620 (Echelon Bioscience, CAT#331-11) |
| Endothelin Beta Receptor Antagonist IRL 1038 (Echelon Bioscience, CAT#331-13) |
| Endothelin Receptor Antagonist BQ 3020 / Acetyl-(Ala11,15)-ET (Echelon Bioscience, CAT#331-14) |
| Endothelin Receptor Antagonist W 7338A (Echelon Bioscience, CAT#331-16) |
| Enkephalin Analog (Echelon Bioscience, CAT#311-55) |
| Enkephalinamide [D-Met2,Pro5] (Echelon Bioscience, CAT#310-47) |
| Epidermal Growth Factor (20-31) [Cys (Acm 20,31)] / EGF (Echelon Bioscience, CAT#510-50) |
| ET A Receptor Antagonist JKC 301 (Echelon Bioscience, CAT#331-51) |
| ET Antagonist PD 156252 (Echelon Bioscience, CAT#331-19) |
| ET Receptor Antagonist (PD 145065) (Echelon Bioscience, CAT#331-18) |
| Ether C12 Lysobisphosphatidic acid (Echelon Bioscience, CAT#L-B120E) |
| Ether C18 Lysobisphosphatidic acid (Echelon Bioscience, CAT#L-B180E) |
| Exendin 3 (Echelon Bioscience, CAT#507-79) |
| Exendin 3 (9-39) Fragment (Echelon Bioscience, CAT#507-81) |
| Exendin 4 (Echelon Bioscience, CAT#507-77) |
| ExoClean – EV Purification Kit (Echelon Bioscience, CAT#K-4300a) |
| ExoTracker – Membrane (Echelon Bioscience, CAT#K-4300b) |
| ExoTracker – RNA (Echelon Bioscience, CAT#K-4300c) |
| ExoTracker – Total (Echelon Bioscience, CAT#K-4300d) |
| Extracellular Death Factor (Echelon Bioscience, CAT#950-10) |
| Farnesyl Diphosphate (FPP) (Echelon Bioscience, CAT#I-0150) |
| Farnesyl S-Thiolodiphosphate (FSPP) (Echelon Bioscience, CAT#I-S150) |
| Fibrinogen Binding Inhibitory Peptide (Echelon Bioscience, CAT#431-55) |
| Fibrinogen Fragment (Echelon Bioscience, CAT#450-16) |
| Fibrinopeptide A [Tyr0], human (Echelon Bioscience, CAT#431-31) |
| Fibrinopeptide B [Glu1], (human) (Echelon Bioscience, CAT#431-39) |
| Fibrinopeptide B, human (Echelon Bioscience, CAT#431-36) |
| Fibronectin Fragment (Echelon Bioscience, CAT#450-59) |
| Flow PIPs: Multiplex Lipid Beads (Echelon Bioscience, CAT#P-FB01) |
| Fluorescein conjugated Anti-PI(3,4,5)P3 IgM (Echelon Bioscience, CAT#Z-G345) |
| Fluorescein conjugated Anti-PI(4,5)P2 IgM (Echelon Bioscience, CAT#Z-G045) |
| Fluorescein Monolysocardiolipin (Echelon Bioscience, CAT#L-M16F) |
| Fluorescent Carrier Pack (Echelon Bioscience, CAT#P-9CFL) |
| FPA-124 (Akt Inhibitor) (Echelon Bioscience, CAT#B-0101) |
| FR-1, cyclic (Echelon Bioscience, CAT#450-53) |
| FR900098 (Echelon Bioscience, CAT#B-4202) |
| FS-3 (LysoPLD / Autotaxin substrate) (Echelon Bioscience, CAT#L-2000) |
| FTY720 (Echelon Bioscience, CAT#B-0720) |
| Furin Inhibitor II (Echelon Bioscience, CAT#855-10) |
| G-Subtide (Echelon Bioscience, CAT#871-15) |
| Galanin, rat (Echelon Bioscience, CAT#475-25) |
| Galanin, human (Echelon Bioscience, CAT#471-22) |
| Galanin, porcine (Echelon Bioscience, CAT#471-25) |
| Galantide (Echelon Bioscience, CAT#471-02) |
| Gamma Secretase Inhibitor (Echelon Bioscience, CAT#649-27) |
| Ganirelix (Echelon Bioscience, CAT#557-31) |
| Gastric Inhibitory Peptide (GIP), human (Echelon Bioscience, CAT#471-75) |
| Gastrin (1-17) [Gly18], human (Echelon Bioscience, CAT#471-89) |
| Gastrin (2-17) [Leu15,Gly18] / MSI 1771 (Echelon Bioscience, CAT#471-83) |
| Gastrin I (1-14) (Echelon Bioscience, CAT#471-79) |
| Gastrin I, human (Echelon Bioscience, CAT#471-73) |
| Gastrin II SE, human (Echelon Bioscience, CAT#471-74) |
| Gastrin Releasing Peptide, human / GRP, h (Echelon Bioscience, CAT#471-85) |
| Geranyl Diphosphate (GPP) (Echelon Bioscience, CAT#I-0100) |
| Geranyl S-Thiolodiphosphate (GSPP) (Echelon Bioscience, CAT#I-S100) |
| Geranylgeranyl Diphosphate (GGPP) (Echelon Bioscience, CAT#I-0200) |
| Geranylgeranyl S-thiodiphosphate (GGSPP) (Echelon Bioscience, CAT#I-S200) |
| Ghrelin (rat) (Echelon Bioscience, CAT#551-15) |
| Ghrelin, human (Echelon Bioscience, CAT#551-10) |
| GloPIPs Biotin-PI(3,4,5)P3 (Echelon Bioscience, CAT#C-39B6A) |
| GloPIPs Biotin-PI(3,4)P2 (Echelon Bioscience, CAT#C-34B6A) |
| GloPIPs Biotin-PI(3,5)P2 (Echelon Bioscience, CAT#C-35B6A) |
| GloPIPs Biotin-PI(3)P (Echelon Bioscience, CAT#C-03B6A) |
| GloPIPs Biotin-PI(4,5)P2 (Echelon Bioscience, CAT#C-45B6a) |
| GloPIPs Biotin-PI(4)P (Echelon Bioscience, CAT#C-04B6A) |
| GloPIPs Biotin-PI(5)P (Echelon Bioscience, CAT#C-05B6A) |
| GloPIPs BODIPY FL-PI(3,4,5)P3 (Echelon Bioscience, CAT#C-39F6A) |
| GloPIPs BODIPY FL-PI(3,4,5)P3, C16 (Echelon Bioscience, CAT#C-39F16A) |
| GloPIPs BODIPY FL-PI(3,5)P2 (Echelon Bioscience, CAT#C-35F6A) |
| GloPIPs BODIPY FL-PI(4,5)P2 (Echelon Bioscience, CAT#C-45F6A) |
| GloPIPs BODIPY FL-PI(4,5)P2, C16 (Echelon Bioscience, CAT#C-45F16A) |
| GloPIPs BODIPY FL-PI(4)P (Echelon Bioscience, CAT#C-04F6A) |
| GloPIPs BODIPY TMR PI(3)P (Echelon Bioscience, CAT#C-03M6A) |
| GloPIPs BODIPY TMR PI(4)P (Echelon Bioscience, CAT#C-04M6A) |
| GloPIPs BODIPY TMR-PI(3,4,5)P3 (Echelon Bioscience, CAT#C-39M6A) |
| GloPIPs BODIPY TMR-PI(3,4)P2 (Echelon Bioscience, CAT#C-34M6A) |
| GloPIPs BODIPY TMR-PtdIns(4,5)P2 (Echelon Bioscience, CAT#C-45M6A) |
| GloPIPs BODIPY TMR-PtdIns(4,5)P2, C16 (Echelon Bioscience, CAT#C-45M16A) |
| GLP 2 [Gly2], human (Echelon Bioscience, CAT#471-21) |
| GLP 2 [Tyr34] (1-34), human (Echelon Bioscience, CAT#471-19) |
| GLP-1 (9-36) , Glucagon-like Peptide 1 (Echelon Bioscience, CAT#471-42) |
| Glp-Pro-Val-pNA (Human Granulocyte Elastase Substrate, colorimetric) (Echelon Bioscience, CAT#871-19) |
| Glu-His-Tyr-Gln-AMC (Echelon Bioscience, CAT#877-01) |
| Glucagon-like Peptide-1, GLP-1 (7-36) / Preproglucagon (78-107) amide (Echelon Bioscience, CAT#471-28) |
| Glucagon-like Peptide-1, GLP-1 (7-37) human (Echelon Bioscience, CAT#471-39) |
| Glucagon-like Peptide-1, GLP-1 (Preproglucagon 72-107) amide (Echelon Bioscience, CAT#471-27) |
| Glucagon-like Peptide-1, human (Echelon Bioscience, CAT#471-26) |
| Glucagon-like Peptide-2, GLP-2 (1-33), rat / Preproglucagon (126-158) (Echelon Bioscience, CAT#471-23) |
| Glucagon-like Peptide-2, GLP-2, human / Preproglucagon (126-158), human (Echelon Bioscience, CAT#471-18) |
| Glucagon, human (Echelon Bioscience, CAT#471-30) |
| Gly-Arg-Ala-Asp-Ser-Pro (GRADSP) (Echelon Bioscience, CAT#450-36) |
| Gly-Arg-Gly-Asp-Ser (GRGDS) (Echelon Bioscience, CAT#450-38) |
| Gly-Arg-Gly-Asp-Ser-Pro (GRGDSP) (Echelon Bioscience, CAT#450-39) |
| Gly-Pro-Arg-Pro-NH2 (Echelon Bioscience, CAT#450-17) |
| Glycerophosphoinositol 5-phosphate (Gro PI(5)P) (Echelon Bioscience, CAT#P-5000) |
| GMAP (1-41), amide / Galanin Message Associated Peptide (1-41), amide (Echelon Bioscience, CAT#421-35) |
| Goat anti-human Autotaxin antibody (Echelon Bioscience, CAT#Z-P400) |
| Granuliberin R (Echelon Bioscience, CAT#880-87) |
| Granzyme A Substrate, fluorogenic (Echelon Bioscience, CAT#874-13) |
| GRF (1-44)NH2, bovine (Echelon Bioscience, CAT#535-15) |
| GRF, mouse (Echelon Bioscience, CAT#536-10) |
| GRI977143 (LPA2 Agonist) (Echelon Bioscience, CAT#B-0070) |
| GroPI (Echelon Bioscience, CAT#P-0000) |
| GroPI(3,4,5)P3 (Echelon Bioscience, CAT#P-3900) |
| GroPI(4,5)P2 (Echelon Bioscience, CAT#P-4500) |
| GroPI(4)P (Echelon Bioscience, CAT#P-4000) |
| Growth Hormone Releasing Factor [D-Ala2] (1-29) amide, human (Echelon Bioscience, CAT#531-76) |
| Growth Hormone Releasing Factor [His1,Nle27] (1-32) amide, human (Echelon Bioscience, CAT#531-74) |
| Growth Hormone Releasing Factor (1-29) amide, human / GRF (1-29), amide, human (Echelon Bioscience, CAT#531-75) |
| Growth Hormone Releasing Factor (1-40) amide, human; GRF (1-40) amide, human (Echelon Bioscience, CAT#531-67) |
| Growth Hormone Releasing Factor (1-40), human; GRF (1-40), human (Echelon Bioscience, CAT#531-68) |
| Growth Hormone Releasing Factor (1-44), porcine / GRF (1-44), porcine (Echelon Bioscience, CAT#534-29) |
| Growth Hormone Releasing Factor / GRF [Ac-Tyr1,D-Arg2] (1-29) amide (Echelon Bioscience, CAT#531-84) |
| Growth Hormone Releasing Factor, GRF (1-44) amide, human (Echelon Bioscience, CAT#531-66) |
| Growth Hormone Releasing Peptide 6 (GHRP-6) / GHRP [His1, Lys6] (Echelon Bioscience, CAT#531-18) |
| HA130 (Autotaxin Inhibitor) (Echelon Bioscience, CAT#B-0701) |
| HA30-BODIPY-FL (Echelon Bioscience, CAT#H-025F) |
| HA30-TexasRed (Echelon Bioscience, CAT#H-025R) |
| HA300-BODIPY-FL (Echelon Bioscience, CAT#H-250F) |
| HA300-TexasRed (Echelon Bioscience, CAT#H-250R) |
| HA850-BODIPY-FL (Echelon Bioscience, CAT#H-700F) |
| HA850-TexasRed (Echelon Bioscience, CAT#H-700R) |
| Helodermin [Gln8,9] (Echelon Bioscience, CAT#740-27) |
| Hemagglutination Inhibiting Peptide, human;from parotid secr (Echelon Bioscience, CAT#790-10) |
| Heme Oxygenase Inhibitor Toolbox (Echelon Bioscience, CAT#F-HOIT) |
| Hemin (Echelon Bioscience, CAT#F-H010) |
| Heparin ELISA (Echelon Bioscience, CAT#K-5300) |
| Hepatitis C Virus NS3 Protease Substrate, fluorogenic (Echelon Bioscience, CAT#732-35) |
| Herpes Virus Inhibitor 1 (Echelon Bioscience, CAT#732-36) |
| Herpes Virus Inhibitor 2 (Echelon Bioscience, CAT#872-39) |
| Hexadecyl-DHAP (ammonium salt) (Echelon Bioscience, CAT#L-0320) |
| High Mobility Group Box 1 (HMGB1) (Echelon Bioscience, CAT#G-HMGB1) |
| High Throughput Autotaxin Inhibitor Screening Kit (Echelon Bioscience, CAT#K-4200HTS) |
| Hirudin (54-65), Sulfated (Echelon Bioscience, CAT#873-20) |
| Hirudin Acetyl (54-65) Sulfated (Echelon Bioscience, CAT#873-15) |
| Histidine Tagged Versican G1 Domain (Echelon Bioscience, CAT#G-HA03) |
| Histone H2B (29-35) (Echelon Bioscience, CAT#870-75) |
| HIV Envelope Peptide GP 120, (307-330) (Echelon Bioscience, CAT#870-26) |
| HIV Substrate IV (Echelon Bioscience, CAT#870-15) |
| HIV-1 Protease Substrate (Echelon Bioscience, CAT#870-10) |
| HIV-TAT 48-57 JNK Inhibitor I (Echelon Bioscience, CAT#732-10) |
| HS014 / MSH Antagonist cyclic / File # 0045A (Echelon Bioscience, CAT#571-72) |
| Human Lysosomal Phospholipase A2 (hLPLA2), active (Echelon Bioscience, CAT#E-7000) |
| Humanin, human (Echelon Bioscience, CAT#640-52) |
| Hy-Pip Cova PIP Specificity Plate (Echelon Bioscience, CAT#H-6300) |
| Hyaluronan Enzyme-Linked Immunosorbent Assay (HA ELISA) (Echelon Bioscience, CAT#K-1200) |
| Hyaluronic Acid (HA) Screening Service (Echelon Bioscience, CAT#T-1200) |
| Hyaluronic Acid Sandwich ELISA (Echelon Bioscience, CAT#K-4800) |
| Hyaluronidase Activity ELISA (Echelon Bioscience, CAT#K-6000) |
| Hypertrehalosaemic Neuropeptide, german cockroach (Nauphoeta (Echelon Bioscience, CAT#619-58) |
| IC87114 (PI3-K delta inhibitor) (Echelon Bioscience, CAT#B-0305) |
| IGRP Catalytic Subunit (206-214) (Echelon Bioscience, CAT#471-58) |
| Innate Defense Regulator 1018 (IDR-1018) (Echelon Bioscience, CAT#745-20) |
| Inositol 1,2,6-trisphosphate (Ins(1,2,6)P3) (Echelon Bioscience, CAT#Q-0126) |
| Inositol 1,3-bisphosphate (Ins(1,3)P2) (Echelon Bioscience, CAT#Q-0013) |
| Inositol 1,3,4-trisphosphate (Ins(1,3,4)P3) (Echelon Bioscience, CAT#Q-0134) |
| Inositol 1,3,5-trisphosphate (Ins(1,3,5)P3) (Echelon Bioscience, CAT#Q-0135) |
| Inositol 1,4-bisphosphate (Ins(1,4)P2) (Echelon Bioscience, CAT#Q-0014) |
| Inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) (Echelon Bioscience, CAT#Q-0145) |
| Inositol 1,5-bisphosphate (Ins(1,5)P2) (Echelon Bioscience, CAT#Q-0015) |
| INPP4 Activity Kit (Echelon Bioscience, CAT#K-5200) |
| INPP4A, active (Echelon Bioscience, CAT#E-8000) |
| Ins(1,3,4,5)P4 (Echelon Bioscience, CAT#Q-1345) |
| Ins(1,3,4,5)P4 Beads (Echelon Bioscience, CAT#Q-B1345) |
| Ins(1,3,4,5)P4 Biotin (Echelon Bioscience, CAT#Q-139B) |
| Ins(1,3,4,6)P4 (Echelon Bioscience, CAT#Q-1346) |
| Ins(1,4,5)P3 Beads (Echelon Bioscience, CAT#Q-B0145) |
| Ins(1,4,5)P3 Biotin (Echelon Bioscience, CAT#Q-145B) |
| IP3 Receptor Inhibitor 911 [Diphenyl (2,6-diaminohexanoate-O,N)-borane] (Echelon Bioscience, CAT#B-0370) |
| Isopentenyl Diphosphate (IPP) (Echelon Bioscience, CAT#I-0050) |
| Isopentenyl S-Thiolodiphosphate (ISPP) (Echelon Bioscience, CAT#I-S050) |
| IspF Inhibitor 1 (Echelon Bioscience, CAT#B-4102) |
| Juvenile Hormone III (racemic) (Echelon Bioscience, CAT#S-0155) |
| K118 (SHIP1 Inhibitor) (Echelon Bioscience, CAT#B-0344) |
| K149 (SHIP2 Inhibitor) (Echelon Bioscience, CAT#B-0345) |
| Kemptide (Phosphate Acceptor Peptide) (Echelon Bioscience, CAT#870-65) |
| Ki16425 (LPA Receptor Antagonist) (Echelon Bioscience, CAT#B-0730) |
| KISS (107-121) (Echelon Bioscience, CAT#548-19) |
| KISS (112-121) (Echelon Bioscience, CAT#548-17) |
| KISS-1 (125-144) (Echelon Bioscience, CAT#548-21) |
| KISS-1 (58-65) (Echelon Bioscience, CAT#548-11) |
| KISS-1 (68-80) (Echelon Bioscience, CAT#548-13) |
| KISS-1 (68-91) (Echelon Bioscience, CAT#548-14) |
| KISS-1 (94-121) (Echelon Bioscience, CAT#548-12) |
| KP372-1 (Akt Inhibitor) (Echelon Bioscience, CAT#B-0102) |
| L-Ascorbyl-6-stearate (Echelon Bioscience, CAT#R-1218) |
| Lactosylceramide (LacCer) Beads (Echelon Bioscience, CAT#P-B0LC) |
| Laminin (929-933) (Echelon Bioscience, CAT#736-21) |
| Laminin A (2091-2108) (Echelon Bioscience, CAT#736-10) |
| LBPA Beads (Echelon Bioscience, CAT#P-BLBPA) |
| Leu-Enkephalin (Echelon Bioscience, CAT#310-75) |
| Leu-Enkephalin [D-Ala2] (Echelon Bioscience, CAT#310-84) |
| Leucokinin I (Echelon Bioscience, CAT#341-29) |
| Leumorphin (human) (Preproenkephalin B 226-254) (Echelon Bioscience, CAT#271-35) |
| LH-RH [D-Ala6] (Echelon Bioscience, CAT#550-44) |
| LH-RH [D-Lys6] (Echelon Bioscience, CAT#550-46) |
| LH-RH [D-Lys6] Free Acid (Echelon Bioscience, CAT#551-46) |
| LH-RH [D-Phe2,D-Ala6] (Echelon Bioscience, CAT#550-45) |
| LH-RH [Hyp9] (Echelon Bioscience, CAT#557-45) |
| LH-RH Free Acid (Echelon Bioscience, CAT#551-27) |
| LH-RH II alligator, chicken (Echelon Bioscience, CAT#558-39) |
| Linolenoyl LPA, 18:3 LPA (Echelon Bioscience, CAT#L-0183) |
| Linoleoyl LPA-d5, 18:2 LPA-d5 (Echelon Bioscience, CAT#L-0182d) |
| Linoleoyl LPA, 18:2 LPA (Echelon Bioscience, CAT#L-0182) |
| Locustapyrokinin [Glu6], Locusta Migratoria (Echelon Bioscience, CAT#361-26) |
| Locustapyrokinin, L. Migratoria (Echelon Bioscience, CAT#361-25) |
| LPA Beads (Echelon Bioscience, CAT#L-6101) |
| LPA Biotin (Echelon Bioscience, CAT#L-012B) |
| LPA ELISA Assay Service (Echelon Bioscience, CAT#T-2800S) |
| LPLA2 Activity Assay (Echelon Bioscience, CAT#K-7000A) |
| LPLA2 Inhibitor Screen (Echelon Bioscience, CAT#K-7000I) |
| LPS (16:0) (Echelon Bioscience, CAT#L-3216) |
| LY294002 (PI3-K Inhibitor) (Echelon Bioscience, CAT#B-0294) |
| Lysophosphatidic Acid Antibody (504B3) (Echelon Bioscience, CAT#Z-P200) |
| Lysophosphatidic Acid ELISA Kit (Echelon Bioscience, CAT#K-2800S) |
| LysoPI, 16:0 LPI (Echelon Bioscience, CAT#P-0160) |
| Malachite Green Assay Kit (Echelon Bioscience, CAT#K-1500) |
| Malachite Green Solution (Echelon Bioscience, CAT#K-1501) |
| Mast Cell Degranulating Peptide HR-1 (Echelon Bioscience, CAT#429-35) |
| Mast Cell Degranulating Peptide HR-2 (Echelon Bioscience, CAT#429-37) |
| Mastoparan, hornet Vespa basalis (Echelon Bioscience, CAT#887-20) |
| Mca-Tyr-Val-Ala-Asp-Ala-Pro-Lys(DNP)-OH (Caspase 1 Substrate) (Echelon Bioscience, CAT#865-21) |
| Mca-Val-Asp-Val-Ala-Asp-Gly-Trp-Lys(DNP)-NH2 (Caspase 2 (ICH-1) Substrate ) (Echelon Bioscience, CAT#866-10) |
| Melanotan II, cyclic α-MSH (Echelon Bioscience, CAT#571-56) |
| Melittin (Echelon Bioscience, CAT#920-32) |
| Membrane Lipid Arrays (Echelon Bioscience, CAT#P-6003) |
| Membrane Lipid Strips (Echelon Bioscience, CAT#P-6002) |
| MeOSuc-Ala-Ala-Pro-Val-4MbNA (Pancreatic Elastase Substrate, fluorogenic) (Echelon Bioscience, CAT#881-19) |
| MeOSuc-Ala-Ala-Pro-Val-AFC Pancreatic Leukocyte Elastase Substrate, fluorogenic) (Echelon Bioscience, CAT#881-17) |
| MEP Synthase (DXR) Enzyme Inhibitor Screen (Echelon Bioscience, CAT#K-2000C) |
| MEP Synthase (DXR), active (Echelon Bioscience, CAT#E-2000C) |
| Mesobiliverdin (microbial sourced) (Echelon Bioscience, CAT#F-H160) |
| Met Enkephalin [Lys 6] (Echelon Bioscience, CAT#310-59) |
| Metastin, KISS -1 (68-121) (Echelon Bioscience, CAT#548-25) |
| Methoxysuccinyl-Ala-Ala-Arg-pNA (Echelon Bioscience, CAT#876-07) |
| Methoxysuccinyl-Pro-Ser-Pro-Phe-AMC (Echelon Bioscience, CAT#877-02) |
| Methyl glucoside sesquistearate (Echelon Bioscience, CAT#R-1018) |
| MG-115 (Proteasome Inhibitor) (Echelon Bioscience, CAT#882-10) |
| MG-132 Proteasome Inhibitor (Echelon Bioscience, CAT#882-11) |
| Miltefosine (Echelon Bioscience, CAT#L-1216) |
| Mini Gastrin I, human (Echelon Bioscience, CAT#471-11) |
| MMP 13 Substrate, fluorogenic (Echelon Bioscience, CAT#868-30) |
| MMP 14 substrate Stomelysine-3, fluorogenic (Echelon Bioscience, CAT#868-42) |
| MMP 2 Substrate, fluorogenic (Echelon Bioscience, CAT#868-20) |
| MMP Inhibitor I (Echelon Bioscience, CAT#868-75) |
| MMP Substrate, fluorogenic (Echelon Bioscience, CAT#868-22) |
| MMP Substrate, fluorogenic (Echelon Bioscience, CAT#868-41) |
| MMP-3 Inhibitor 1 (Echelon Bioscience, CAT#868-60) |
| MMP-3 Substrate, fluorogenic (Echelon Bioscience, CAT#868-62) |
| MMV008138(1R,3S) (IspD Inhibitor) (Echelon Bioscience, CAT#B-4103) |
| MOG Protein (35-55), Myelin Oligodendrocyte Glycoprotein Peptide Fragment, human (Echelon Bioscience, CAT#651-10) |
| MOG Protein (35-55), Myelin Oligodendrocyte Glycoprotein Peptide Fragment, rat (Echelon Bioscience, CAT#645-10) |
| MOG Protein (68-84), Myelin Oligodendrocyte Glycoprotein Peptide Fragment, guinea pig (Echelon Bioscience, CAT#920-63) |
| Monobromobimane (Echelon Bioscience, CAT#F-0030) |
| Monocaprin (Echelon Bioscience, CAT#L-9010) |
| Monolaurin (Echelon Bioscience, CAT#L-9012) |
| Monomyristin (Echelon Bioscience, CAT#L-9014) |
| MOPC (17:0/18:1 PC) (Echelon Bioscience, CAT#L-1117) |
| MOPEth (17:0/18:1 PEth) (Echelon Bioscience, CAT#L-6017) |
| Morphine Modulating Neuropeptide (Echelon Bioscience, CAT#340-79) |
| Motilin, dog (Echelon Bioscience, CAT#496-25) |
| Motilin, human (Echelon Bioscience, CAT#491-15) |
| ms-PtdIns(4,5)P2 diC16 (Echelon Bioscience, CAT#P-F4516) |
| ms-PtdIns(4,5)P2 diC8 (Echelon Bioscience, CAT#P-F4508) |
| MultiPIP Grip (Echelon Bioscience, CAT#G-9901) |
| Myelin Proteolipid Protein (139-151) [Ser 140] (depalmitoylated), h, b, d, m, r (Echelon Bioscience, CAT#720-10) |
| Myosin Light Chain Kinase (11-19) amide (Echelon Bioscience, CAT#892-96) |
| Myosin Light Chain Kinase Substrate (Smooth muscle) (Echelon Bioscience, CAT#930-30) |
| MZ-4-169 (Echelon Bioscience, CAT#531-92) |
| MZ-4-181 (Echelon Bioscience, CAT#531-93) |
| MZ-4-71 (Echelon Bioscience, CAT#531-91) |
| N-Acetyl Beta Endorphin, human (Echelon Bioscience, CAT#291-29) |
| N-arachidonoyl-DPPE (NAPE 20:4) (Echelon Bioscience, CAT#L-2404) |
| N-Biotin Ceramide 1-phosphate (Echelon Bioscience, CAT#S-500B) |
| N-Linoleoyl-DPPE (Echelon Bioscience, CAT#L-2420) |
| N-NBD Ceramide 1-phosphate (Echelon Bioscience, CAT#S-500N6) |
| N-Oleoyl-DPPE (Echelon Bioscience, CAT#L-2419) |
| N-palmitoyl-DPPE (NAPE 16:0) (Echelon Bioscience, CAT#L-2416) |
| N-Stearoyl Ceramide 1-phosphate (Echelon Bioscience, CAT#S-5018) |
| N-Stearoyl-DPPE (Echelon Bioscience, CAT#L-2418) |
| nanoHA-5 (Echelon Bioscience, CAT#HYA-NANO5-1) |
| NBD-Phosphatidylethanol (Echelon Bioscience, CAT#L-60N16) |
| NeoBeads – PIP Purification System (Echelon Bioscience, CAT#P-B999) |
| Neryl Diphosphate (NPP) (Echelon Bioscience, CAT#I-0120) |
| Neurokinin A [Tyr5,DTrp6,8,9Lys10] (4-10) (Echelon Bioscience, CAT#631-70) |
| Neurokinin A [Ala5, BetaAla8],(4-10) (Echelon Bioscience, CAT#631-65) |
| Neuromedin B (Echelon Bioscience, CAT#630-62) |
| Neuromedin N (Echelon Bioscience, CAT#634-46) |
| Neuromedin U-8 (Echelon Bioscience, CAT#630-65) |
| Neuropeptide Y (3-36), human, rat / NPY (3-36) (Echelon Bioscience, CAT#614-41) |
| Neuropeptide Y (3-36), porcine / NPY (3-36) (Echelon Bioscience, CAT#614-39) |
| Neuropeptide Y (human, rat) (Echelon Bioscience, CAT#611-26) |
| Neuropeptide Y, porcine / NPY, porcine (Echelon Bioscience, CAT#614-30) |
| Neurotensin [D-Trp11] (Echelon Bioscience, CAT#631-38) |
| Neurotensin, human (Echelon Bioscience, CAT#631-27) |
| Neutral Sphingomyelinase Activity Assay Kit (Echelon Bioscience, CAT#K-1800) |
| Neutral Sphingomyelinase Assay Service (Echelon Bioscience, CAT#T-1800) |
| NFF 2 MMP Substrate, fluorogenic (Echelon Bioscience, CAT#868-25) |
| NFF 3 MMP Substrate, fluorogenic (Echelon Bioscience, CAT#868-10) |
| Nociceptin/Orphanin FQ (Echelon Bioscience, CAT#310-78) |
| NOG (N-oxalylglycine) (Echelon Bioscience, CAT#F-0020) |
| Non-A-Beta Component Amyloid (Echelon Bioscience, CAT#641-80) |
| Nonfluorescent Carrier Pack (Echelon Bioscience, CAT#P-9C00) |
| NVP-231 (Ceramide Kinase Inhibitor) (Echelon Bioscience, CAT#B-0040) |
| Obestatin (11-23), mouse (Echelon Bioscience, CAT#475-96) |
| Obestatin, human (Echelon Bioscience, CAT#471-97) |
| Obestatin, mouse (Echelon Bioscience, CAT#475-97) |
| Octreotide (Echelon Bioscience, CAT#690-44) |
| Oleoyl 3-carbacyclic Phosphatidic Acid (Echelon Bioscience, CAT#L-7218) |
| Oleoyl LPA, 18:1 LPA (Echelon Bioscience, CAT#L-0181) |
| Oral Formulation Vehicle (Echelon Bioscience, CAT#B-0706) |
| Orexin A (human, rat, mouse) (Echelon Bioscience, CAT#471-99) |
| Orexin A, Xenopus SS (4-10/5-12) (Echelon Bioscience, CAT#479-99) |
| Orexin B, human (Echelon Bioscience, CAT#471-98) |
| Oxyntomodulin (Glucagon 1-37) (Echelon Bioscience, CAT#471-33) |
| Oxytocin (Echelon Bioscience, CAT#670-67) |
| p-I-L-Phe4 human beta amyloid (1-40) (Echelon Bioscience, CAT#640-33) |
| P-lysoPC (16:0 LPC) (Echelon Bioscience, CAT#L-1516) |
| PACAP (1-27), ovine, human / Adenylate Cyclase Activating Po (Echelon Bioscience, CAT#350-37) |
| PACAP (1-38), ovine, human / Adenylate Cyclase Activating Po (Echelon Bioscience, CAT#350-35) |
| Palmitoyl-DHAP (ammonium salt) (Echelon Bioscience, CAT#L-0310) |
| Pancreastatin (1-52), human (Echelon Bioscience, CAT#481-20) |
| Pancreatic Elastase Substrate, colorimetric (Echelon Bioscience, CAT#883-18) |
| Pancreatic Leukocyte Elastase Substrate, colorimetric (Echelon Bioscience, CAT#881-15) |
| Pancreatic polypeptide bovine (Echelon Bioscience, CAT#474-21) |
| Pancreatic Polypeptide, avian (Echelon Bioscience, CAT#478-40) |
| PAPEth (16:0/20:4 PEth) (Echelon Bioscience, CAT#L-6024) |
| PAR (1-6) amide [Ala1], Mouse (Echelon Bioscience, CAT#875-28) |
| PAR-1 agonist (Echelon Bioscience, CAT#875-27) |
| PAR-2 (1-6)amide human (Echelon Bioscience, CAT#875-23) |
| Parathyroid Hormone (PTH) (1-34), human (Echelon Bioscience, CAT#231-40) |
| Parathyroid Hormone (PTH) (1-34), rat (Echelon Bioscience, CAT#235-36) |
| Parathyroid Hormone (PTH) (2-34), human (Echelon Bioscience, CAT#231-43) |
| Parathyroid Hormone (PTH) (3-34), human (Echelon Bioscience, CAT#231-46) |
| Parathyroid Hormone (PTH) (39-68), human (Echelon Bioscience, CAT#231-50) |
| Parathyroid Hormone (PTH) (39-84), human (Echelon Bioscience, CAT#231-55) |
| Parathyroid Hormone (PTH) (4-34), human (Echelon Bioscience, CAT#231-48) |
| Parathyroid Hormone (PTH) (5-34), human (Echelon Bioscience, CAT#231-51) |
| Parathyroid Hormone (PTH) (53-84), human (Echelon Bioscience, CAT#231-60) |
| Parathyroid Hormone (PTH) [Nle8,18,Tyr34] (3-34), amide, bovine (Echelon Bioscience, CAT#233-35) |
| Parathyroid Hormone [Nle8,18,Tyr34](1-34) amide, bovine (Echelon Bioscience, CAT#233-32) |
| PC Lipid Microparticles (Echelon Bioscience, CAT#P-B1PC) |
| PC/PS Lipid Microparticles (Echelon Bioscience, CAT#P-B1PCPS) |
| PDQ, Antimicrobial Peptide from Xenopus Laevis (Echelon Bioscience, CAT#745-10) |
| Peptide YY, PYY (3-36) , canine , mouse , porcine , rat (Echelon Bioscience, CAT#490-56) |
| Peptide YY, PYY (3-36), human (Echelon Bioscience, CAT#490-11) |
| PF-543 (Sphingosine Kinase I Inhibitor) (Echelon Bioscience, CAT#B-0026) |
| PF-8380 (Autotaxin Inhibitor) (Echelon Bioscience, CAT#B-0702) |
| Phe-Met-Arg-D-Phe-NH2 (Echelon Bioscience, CAT#610-49) |
| Phe-Met-Arg-Phe-NH2 (FMRF Peptide) (Echelon Bioscience, CAT#610-44) |
| Pheromonotropin, Pseudalatia (Echelon Bioscience, CAT#782-10) |
| PHI, rat (Echelon Bioscience, CAT#495-25) |
| Phosphatase Substrate (Echelon Bioscience, CAT#871-70) |
| Phosphatidic Acid (PA) Beads (Echelon Bioscience, CAT#P-B0PA) |
| Phosphatidylcholine (PC) Beads (Echelon Bioscience, CAT#P-B0PC) |
| Phosphatidylethanol (PEth) Beads (Echelon Bioscience, CAT#P-BPETH) |
| Phosphatidylethanol (PEth) ELISA (Echelon Bioscience, CAT#K-5000) |
| Phosphatidylethanolamine (PE) Beads (Echelon Bioscience, CAT#P-B0PE) |
| Phosphatidylinositol 4,5-bisphosphate 18:0/20:4 (Echelon Bioscience, CAT#P-4524) |
| Phosphatidylinositol diC16 (PI diC16) (Echelon Bioscience, CAT#P-0016) |
| Phosphatidylinositol diC4 (PI diC4) (Echelon Bioscience, CAT#P-0004) |
| Phosphatidylinositol diC8 (ammonium salt) (Echelon Bioscience, CAT#P-0008A) |
| Phosphatidylinositol diC8 (PI diC8) (Echelon Bioscience, CAT#P-0008) |
| Phosphatidylserine (PS) Beads (Echelon Bioscience, CAT#P-B0PS) |
| Phospholipase A2 activating peptide (Echelon Bioscience, CAT#495-26) |
| PI PolyPIPosomes (Echelon Bioscience, CAT#Y-P000) |
| PI-103 (PI3-K alpha Inhibitor 1) (Echelon Bioscience, CAT#B-0303) |
| PI(3,4,5)P3 17:0/16:0 (Echelon Bioscience, CAT#P-3917) |
| PI(3,4,5)P3 18:0/20:4 (Echelon Bioscience, CAT#P-3924) |
| PI(3,4,5)P3 diC16 (Echelon Bioscience, CAT#P-3916) |
| PI(3,4,5)P3 diC16 (ammonium salt) (Echelon Bioscience, CAT#P-3916A) |
| PI(3,4,5)P3 diC4 (Echelon Bioscience, CAT#P-3904) |
| PI(3,4,5)P3 diC8 (Echelon Bioscience, CAT#P-3908) |
| PI(3,4,5)P3 Grip (Grp1-PH) (Echelon Bioscience, CAT#G-3901) |
| PI(3,4,5)P3 PIP Beads (Echelon Bioscience, CAT#P-B345A) |
| PI(3,4,5)P3 PolyPIPosomes (Echelon Bioscience, CAT#Y-P039) |
| PI(3,4)P2 diC16 (Echelon Bioscience, CAT#P-3416) |
| PI(3,4)P2 diC16 (ammonium salt) (Echelon Bioscience, CAT#P-3416A) |
| PI(3,4)P2 diC4 (Echelon Bioscience, CAT#P-3404) |
| PI(3,4)P2 diC8 (Echelon Bioscience, CAT#P-3408) |
| PI(3,4)P2 Mass ELISA (Echelon Bioscience, CAT#K-3800) |
| PI(3,4)P2 PIP Beads (Echelon Bioscience, CAT#P-B034A) |
| PI(3,4)P2 PolyPIPosomes (Echelon Bioscience, CAT#Y-P034) |
| PI(3,5)P2 diC16 (Echelon Bioscience, CAT#P-3516) |
| PI(3,5)P2 diC4 (Echelon Bioscience, CAT#P-3504) |
| PI(3,5)P2 diC8 (Echelon Bioscience, CAT#P-3508) |
| PI(3,5)P2 PIP Beads (Echelon Bioscience, CAT#P-B035A) |
| PI(3,5)P2 PolyPIPosomes (Echelon Bioscience, CAT#Y-P035) |
| PI(3)P diC16 (Echelon Bioscience, CAT#P-3016) |
| PI(3)P diC4 (Echelon Bioscience, CAT#P-3004) |
| PI(3)P diC8 (Echelon Bioscience, CAT#P-3008) |
| PI(3)P diC8 (ammonium salt) (Echelon Bioscience, CAT#P-3008A) |
| PI(3)P Grip (p40 PX) (Echelon Bioscience, CAT#G-0302) |
| PI(3)P Mass ELISA (Echelon Bioscience, CAT#K-3300) |
| PI(3)P PIP Beads (Echelon Bioscience, CAT#P-B003A) |
| PI(3)P PolyPIPosomes (Echelon Bioscience, CAT#Y-P003) |
| PI(4,5)P2 diC16 (Echelon Bioscience, CAT#P-4516) |
| PI(4,5)P2 diC4 (Echelon Bioscience, CAT#P-4504) |
| PI(4,5)P2 diC8 (Echelon Bioscience, CAT#P-4508) |
| PI(4,5)P2 Grip (PLC-d1-PH) (Echelon Bioscience, CAT#G-4501) |
| PI(4,5)P2 Mass ELISA Kit (Echelon Bioscience, CAT#K-4500) |
| PI(4,5)P2 PIP Beads (Echelon Bioscience, CAT#P-B045A) |
| PI(4,5)P2 PolyPIPosomes (Echelon Bioscience, CAT#Y-P045) |
| PI(4)P 5-Kinase (PIP5KI) Activity Assay (Echelon Bioscience, CAT#K-5700) |
| PI(4)P diC16 (Echelon Bioscience, CAT#P-4016) |
| PI(4)P diC4 (Echelon Bioscience, CAT#P-4004) |
| PI(4)P diC8 (Echelon Bioscience, CAT#P-4008) |
| PI(4)P diC8 (ammonium salt) (Echelon Bioscience, CAT#P-4008A) |
| PI(4)P Grip (SidC-3C) (Echelon Bioscience, CAT#G-0402) |
| PI(4)P Mass ELISA Kit (Echelon Bioscience, CAT#K-4000E) |
| PI(4)P PIP Beads (Echelon Bioscience, CAT#P-B004A) |
| PI(4)P PolyPIPosomes (Echelon Bioscience, CAT#Y-P004) |
| PI(5)P 4-Kinase (PIP4KII) Activity Assay (Echelon Bioscience, CAT#K-5400) |
| PI(5)P diC16 (Echelon Bioscience, CAT#P-5016) |
| PI(5)P diC4 (Echelon Bioscience, CAT#P-5004) |
| PI(5)P diC8 (Echelon Bioscience, CAT#P-5008) |
| PI(5)P diC8 (ammonium salt) (Echelon Bioscience, CAT#P-5008A) |
| PI(5)P PIP Beads (Echelon Bioscience, CAT#P-B005A) |
| PI(5)P PolyPIPosomes (Echelon Bioscience, CAT#Y-P005) |
| PI3-K alpha Inhibitor 2 (Echelon Bioscience, CAT#B-0304) |
| PI3-K Alpha Inhibitor Screening Service (Echelon Bioscience, CAT#T-1300A) |
| PI3-K Beta Inhibitor Screening Service (Echelon Bioscience, CAT#T-1300B) |
| PI3-Kinase Activity AlphaScreen Assay (Echelon Bioscience, CAT#K-1300) |
| PI3-Kinase Activity ELISA: Pico (Echelon Bioscience, CAT#K-1000S) |
| PI3-Kinase Activity Fluorescence Polarization Assay (Echelon Bioscience, CAT#K-1100) |
| PI3-Kinase alpha (PI3Ka), active (Echelon Bioscience, CAT#E-2000) |
| PI3K (p110alpha/p85alpha), active (Echelon Bioscience, CAT#P27-18H) |
| PI3K (p110beta/p85alpha), active (Echelon Bioscience, CAT#P28-102H) |
| PI3Ka, E545K – Active Mutant (Echelon Bioscience, CAT#P27-15H) |
| PI4-Kinase Activity Assay (Echelon Bioscience, CAT#K-4000K) |
| PI4-Kinase beta (PI4Kb), active (Echelon Bioscience, CAT#P32-102G) |
| PI4-Kinase II alpha (PI4KIIa), active (Echelon Bioscience, CAT#P21-10G) |
| PI4-Kinase II beta (PI4KIIb), active (Echelon Bioscience, CAT#P22-10G) |
| PIK-93 (PI4KIIIb inhibitor) (Echelon Bioscience, CAT#B-0306) |
| PIP Array – Lipid-Protein Interaction Assay (Echelon Bioscience, CAT#P-6100) |
| PIP Beads Sample Pack (Echelon Bioscience, CAT#P-B00S) |
| PIP Pack (Echelon Bioscience, CAT#P-P100) |
| PIP Strips (Echelon Bioscience, CAT#P-6001) |
| PIP3 Mass ELISA Kit (Echelon Bioscience, CAT#K-2500S) |
| PKA Inhibitor (Echelon Bioscience, CAT#867-10) |
| PKA Substrate (Echelon Bioscience, CAT#866-25) |
| PKC Isoenzyme Inhibitor (myristoylated) (Echelon Bioscience, CAT#880-17) |
| PKC Isoenzyme Inhibitor / PKC Y translocation peptide (Echelon Bioscience, CAT#880-15) |
| PKC(e) Translocation Inhibitor – negative control (Echelon Bioscience, CAT#880-69) |
| PKG Substrate, Glasstide, H2Btide (Echelon Bioscience, CAT#870-74) |
| PKI (5-24), PKA Inhbibitor (Echelon Bioscience, CAT#890-98) |
| Plasmepsin II substrate (Echelon Bioscience, CAT#871-13) |
| PLPC (16:0/12:0 PC) (Echelon Bioscience, CAT#L-1612) |
| PLPC (16:0/18:2 PC) (Echelon Bioscience, CAT#L-1122) |
| PLPEth (16:0/18:2 PEth) (Echelon Bioscience, CAT#L-6020) |
| Pneumadin, rat (Echelon Bioscience, CAT#675-85) |
| PNPP Substrate & Solution (Echelon Bioscience, CAT#K-1208T) |
| Poly-Selective Phosphoinositide Phosphate Antibody (Echelon Bioscience, CAT#Z-P999) |
| POPC (16:0/18:1 PC) (Echelon Bioscience, CAT#L-1618) |
| POPEth (16:0/18:1 PEth) (Echelon Bioscience, CAT#L-6019) |
| Porphobilinogen (Echelon Bioscience, CAT#F-H020) |
| PPlases Substare, fluorogenic (Echelon Bioscience, CAT#869-20) |
| PPLases Substrate, colorimetric (Echelon Bioscience, CAT#869-10) |
| ProAM N20, human / Proadrenomedullin N-term 20 Peptide, huma (Echelon Bioscience, CAT#331-81) |
| ProAM N20, rat / Proadrenomedullin N terminal 20 peptide, rat (Echelon Bioscience, CAT#335-81) |
| Prodynorphin 228-256 (porcine) (Dynorphin B 29, Leumorphin) (Echelon Bioscience, CAT#274-56) |
| Propargyl-farnesol (Echelon Bioscience, CAT#S-0160) |
| Propargyl-geraniol (Echelon Bioscience, CAT#S-0110) |
| Prostate Specific Antigen Substrate (Echelon Bioscience, CAT#891-15) |
| Prot. Kin. C Pseudosubstrate Inhibitor (Echelon Bioscience, CAT#890-91) |
| Protein Kinase C (19-31), Protein Kinase C pseudosubstrate, (Echelon Bioscience, CAT#871-20) |
| Protein Kinase C Substrate (Echelon Bioscience, CAT#890-82) |
| Protein Kinase C substrate from EGF Receptor (Echelon Bioscience, CAT#871-55) |
| Protein Kinase Inhibitor Cdk2 (Echelon Bioscience, CAT#871-87) |
| Protein Tyrosine Phosphatase Substrate, fluorogenic (Echelon Bioscience, CAT#871-62) |
| Protoporphyrin IX (Echelon Bioscience, CAT#F-H050) |
| PS Lipid Microparticles (Echelon Bioscience, CAT#P-B1PS) |
| PS48 (PDK1 Activator) (Echelon Bioscience, CAT#B-0360) |
| PtdIns PIP Beads (Echelon Bioscience, CAT#P-B001) |
| PtdIns(4,5)P2 a-fluorovinylphosphate diC8 (Echelon Bioscience, CAT#P-FV4508) |
| PTEN Activity ELISA Kit (Echelon Bioscience, CAT#K-4700) |
| PTEN Enzyme, active (Echelon Bioscience, CAT#E-3000) |
| PTH Related Peptide (7-34) amide, human (Echelon Bioscience, CAT#231-94) |
| PTH Related Peptide [Asn10,Leu11] (7-34) amide, human (Echelon Bioscience, CAT#231-95) |
| PTH Related Peptide [Leu11, DTrp12] (7-34) amide, human (Echelon Bioscience, CAT#231-96) |
| PTH Related protein (1-40); Hypercalcemia Malignancy Factor (Echelon Bioscience, CAT#231-85) |
| Purified Anti-LPLA2 Antibody (Echelon Bioscience, CAT#Z-PLPLA2) |
| Purified Anti-Phosphatidylethanol Antibody (Echelon Bioscience, CAT#Z-PETH) |
| Purified Anti-PtdIns(3,4,5)P3 IgG (Echelon Bioscience, CAT#Z-P345B) |
| Purified Anti-PtdIns(3,4,5)P3 IgM (Echelon Bioscience, CAT#Z-P345) |
| Purified Anti-PtdIns(3,4)P2 IgG (Echelon Bioscience, CAT#Z-P034B) |
| Purified Anti-PtdIns(3,4)P2 IgG (Echelon Bioscience, CAT#Z-P034) |
| Purified Anti-PtdIns(3,5)P2 IgG (Echelon Bioscience, CAT#Z-P035) |
| Purified Anti-PtdIns(3)P IgG (Echelon Bioscience, CAT#Z-P003) |
| Purified Anti-PtdIns(4,5)P2 IgM (Echelon Bioscience, CAT#Z-P045) |
| Purified Anti-PtdIns(4)P IgM (Echelon Bioscience, CAT#Z-P004) |
| Purified Mouse Anti-LBPA (BMP) (Echelon Bioscience, CAT#Z-PLBPA) |
| Rabbit Anti-Human DGK Zeta Antibody (Echelon Bioscience, CAT#Z-DGKZ) |
| Ranakinin, frog (Echelon Bioscience, CAT#361-50) |
| Renin Substrate I (Echelon Bioscience, CAT#131-20) |
| Resveratrol (Echelon Bioscience, CAT#B-0021) |
| Rha(rac)C10C10 (Echelon Bioscience, CAT#RL10105) |
| Rha(rac)C12C12 (Echelon Bioscience, CAT#RL12125) |
| RR-SRC, Insulin receptor kinase substrate (Echelon Bioscience, CAT#870-68) |
| S-lysoPC, (18:0 LPC) (Echelon Bioscience, CAT#L-1518) |
| S1P Beads (Echelon Bioscience, CAT#S-6110) |
| S1P Fluorescein (Echelon Bioscience, CAT#S-200F) |
| S1P Lyase Fluorogenic Substrate (Echelon Bioscience, CAT#S-200U) |
| S1P TAMRA (Echelon Bioscience, CAT#S-200T) |
| S32826 [4-(Tetradecanoylamino)benzyl]phosphonic acid disodium salt] (Echelon Bioscience, CAT#L-3282) |
| S6 Phosphate Acceptor Peptide (Echelon Bioscience, CAT#890-72) |
| Sarafotoxin 6b (Echelon Bioscience, CAT#339-10) |
| Sarilesin – Angiotensin II [Sar1,Ile8] (Echelon Bioscience, CAT#131-63) |
| Sauvagine, frog (Echelon Bioscience, CAT#357-26) |
| SDT1 (Pyrimidine 5′-nucleotidase) (Echelon Bioscience, CAT#E-20SDT1) |
| Select-HA 1000k (Echelon Bioscience, CAT#HYA-1000KEF-1) |
| Select-HA 500k (Echelon Bioscience, CAT#HYA-500KEF-1) |
| Select-HA 50k (Echelon Bioscience, CAT#HYA-50KEF-1) |
| Select-HA 601k (Echelon Bioscience, CAT#HYA-601KEF-1) |
| Select-HA HiLadder (Echelon Bioscience, CAT#HYA-HILAD-20) |
| Select-HA LoLadder (Echelon Bioscience, CAT#HYA-LOLAD-20) |
| Senktide ;Substance P [Suc-,Asp6,Me-Phe8] (6-11) (Echelon Bioscience, CAT#712-14) |
| SF1670 (PTEN Inhibitor) (Echelon Bioscience, CAT#B-0350) |
| Sheep Anti-Human DGK Alpha Peptide Antibody (Echelon Bioscience, CAT#Z-DGKA) |
| SHIP2 Lipid Phosphatase Enzyme, active (Echelon Bioscience, CAT#E-1000) |
| SHIP2 Reaction Buffer (Echelon Bioscience, CAT#K-S2RB) |
| Shuttle PIP Kit, PtdIns(3,4,5)P3 (Echelon Bioscience, CAT#P-9039) |
| Shuttle PIP Kit, PtdIns(3,4)P2 (Echelon Bioscience, CAT#P-9034) |
| Shuttle PIP Kit, PtdIns(3,5)P2 (Echelon Bioscience, CAT#P-9035) |
| Shuttle PIP Kit, PtdIns(3)P (Echelon Bioscience, CAT#P-9003) |
| Shuttle PIP Kit, PtdIns(4,5)P2 (Echelon Bioscience, CAT#P-9045) |
| Shuttle PIP Kit, PtdIns(4)P (Echelon Bioscience, CAT#P-9004) |
| Shuttle PIP Kit, PtdIns(5)P (Echelon Bioscience, CAT#P-9005) |
| SKI-178 (SPHK1 Inhibitor) (Echelon Bioscience, CAT#B-0028) |
| SLPEth (18:0/18:2 PEth) (Echelon Bioscience, CAT#L-6022) |
| SMPC (18:0/14:0 PC) (Echelon Bioscience, CAT#L-1814) |
| sn-1-Fluorescein-labeled Cardiolipin (Echelon Bioscience, CAT#L-C16F) |
| Sn(IV) Protoporphyrin IX, 14325-05-4 (Echelon Bioscience, CAT#F-H080) |
| SNP-1 (Echelon Bioscience, CAT#888-10) |
| Somatostatin 28 (1-12) (Echelon Bioscience, CAT#691-77) |
| Somatostatin 28, cyclic (Echelon Bioscience, CAT#691-65) |
| Somatostatin Antagonist, cyclic / Coy (Echelon Bioscience, CAT#691-63) |
| Somatostatin, cyclic (Echelon Bioscience, CAT#691-25) |
| SOPEth (18:0/18:1 PEth) (Echelon Bioscience, CAT#L-6021) |
| Sorbitan monostearate (Echelon Bioscience, CAT#R-1318) |
| Spantide ([D-Arg1,D-Trp7,9,Substance P Leu11] (Echelon Bioscience, CAT#712-31) |
| Spantide II (Echelon Bioscience, CAT#712-36) |
| Specific NFAT Inhibitor / VIVIT-16 (Echelon Bioscience, CAT#887-16) |
| Sperm Activating Peptide, Sea Urchin (Echelon Bioscience, CAT#610-52) |
| Sphinganine-biotin (Echelon Bioscience, CAT#S-110B) |
| Sphinganine-fluorescein (Echelon Bioscience, CAT#S-110F) |
| Sphingo Arrays (Echelon Bioscience, CAT#S-6001) |
| Sphingo Beads (Echelon Bioscience, CAT#S-6100) |
| Sphingo Beads Sample Pack (Echelon Bioscience, CAT#P-B00SS) |
| Sphingo Strips (Echelon Bioscience, CAT#S-6000) |
| Sphingomyelin Beads (Echelon Bioscience, CAT#P-B0SM) |
| Sphingosine 1-Phosphate (S1P) (Echelon Bioscience, CAT#S-2000) |
| Sphingosine 1-Phosphate Antibody (Echelon Bioscience, CAT#Z-P300) |
| Sphingosine 1-Phosphate Assay Service (Echelon Bioscience, CAT#T-1900) |
| Sphingosine 1-phosphate biotin (S1P-biotin) (Echelon Bioscience, CAT#S-200B) |
| Sphingosine 1-Phosphate ELISA Kit (Echelon Bioscience, CAT#K-1900) |
| Sphingosine 1-Phosphate Lyase Overexpression Lysate, active (Echelon Bioscience, CAT#E-5000L) |
| Sphingosine 1-Phosphate Lyase, active (Echelon Bioscience, CAT#E-5000P) |
| Sphingosine kinase 1, active (Echelon Bioscience, CAT#E-K068) |
| Sphingosine kinase 2, active (Echelon Bioscience, CAT#E-K069) |
| Sphingosine Kinase Activity Assay (Echelon Bioscience, CAT#K-3500) |
| Sphingosine Kinase Inhibitor (SKI-II) (Echelon Bioscience, CAT#B-0024) |
| Sphingosine-biotin (Echelon Bioscience, CAT#S-100B) |
| Sphingosine-fluorescein (Echelon Bioscience, CAT#S-100F) |
| Sphingosine-tetramethylrhodamine (Echelon Bioscience, CAT#S-100T) |
| Squalene, purified (Echelon Bioscience, CAT#S-0300) |
| SS14 Tumor Inhibitor Analog (Echelon Bioscience, CAT#691-60) |
| Stercobilin Hydrochloride (Echelon Bioscience, CAT#F-H150) |
| Substance P (Echelon Bioscience, CAT#711-25) |
| Substance P (5-11) / Hepta-Substance P (Echelon Bioscience, CAT#711-66) |
| Substance P [Nle11] (Echelon Bioscience, CAT#711-36) |
| Substance P [Sar9] (Echelon Bioscience, CAT#711-48) |
| Substance P [Tyr8] (Echelon Bioscience, CAT#711-33) |
| Substance P, (p-Cl-Phe7,8) (Echelon Bioscience, CAT#712-55) |
| Substrate for E. Coli Leader Peptidase (Echelon Bioscience, CAT#887-10) |
| Substrate for Factor VIIa (Echelon Bioscience, CAT#871-77) |
| Substrate for Factor VIIa (Echelon Bioscience, CAT#871-78) |
| Suc-Ala-Ala-Ala-Ala-pNA (Echelon Bioscience, CAT#876-02) |
| Suc-Ala-Ala-Leu-pNA (Echelon Bioscience, CAT#876-03) |
| Suc-Ala-Ala-Phe-AMC (Chymotrypsin Substrate, fluorogenic) (Echelon Bioscience, CAT#881-32) |
| Suc-Ala-Ala-Pro-Phe-AFC (Pancreatic Elastase Substrate (human), fluorogenic) (Echelon Bioscience, CAT#881-34) |
| Suc-Ala-Ala-Pro-Phe-AMC (Chymotrypsin Substrate, fluorogenic) (Echelon Bioscience, CAT#881-31) |
| Suc-Ala-Ala-Pro-Phe-pNA (Pancreatic Leukocyte Elastase (human) Substrate, colorimetric) (Echelon Bioscience, CAT#881-30) |
| Suc-Gly-Gly-Phe-pNA (Chymotrypsin Substrate , colorimetric) (Echelon Bioscience, CAT#881-33) |
| Suc-Leu-Leu-Val-Tyr-AFC (Chymotrypsin like Enzyme Substrate, fluorogenic) (Echelon Bioscience, CAT#881-21) |
| Suc-Leu-Leu-Val-Tyr-AMC (Proteosome Substrate) (Echelon Bioscience, CAT#881-18) |
| Suc-Leu-Tyr-4-methoxy-2-naphthylamide (Calpain I & II, Papain Substrate, fluorogenic) (Echelon Bioscience, CAT#878-01) |
| Suc-Phe-Ala-His-Phe-AMC (Echelon Bioscience, CAT#877-10) |
| Suc-Phe-Ala-His-Phe-pNA (Echelon Bioscience, CAT#876-04) |
| Synthetic 16:0 Cardiolipin (Echelon Bioscience, CAT#L-C160) |
| Synthetic 16:0 Monolysocardiolipin (Echelon Bioscience, CAT#L-M160) |
| Syntide 2, CaMKII Substrate (Echelon Bioscience, CAT#105-77) |
| TACE Substrate (Fluorogenic) (Echelon Bioscience, CAT#860-78) |
| Thio-ccPA (Echelon Bioscience, CAT#L-7118) |
| Thrombin , Trypsin , Papain Substrate (Echelon Bioscience, CAT#920-13) |
| Thrombin Receptor Activator Peptide 6 / TRAP-6 (Echelon Bioscience, CAT#920-51) |
| Thrombin Receptor Agonist (Echelon Bioscience, CAT#920-29) |
| Thrombin Receptor Agonist (Echelon Bioscience, CAT#920-53) |
| Thrombin Receptor Agonist; (Echelon Bioscience, CAT#920-52) |
| Thrombin Receptor Antagonist (Echelon Bioscience, CAT#920-50) |
| Thymosin b4 (1-4) (Echelon Bioscience, CAT#885-21) |
| TMB Precipitating (Echelon Bioscience, CAT#K-TMBP) |
| TMR Labeled Carrier 1 (Neomycin B Sulfate) (Echelon Bioscience, CAT#P-9C1R) |
| TMR Labeled Shuttle PIP Carrier 2 (Echelon Bioscience, CAT#P-9C2R) |
| TNF coverting enzyme substrate (Echelon Bioscience, CAT#882-50) |
| Trismethoxyresveratrol (Echelon Bioscience, CAT#B-0022) |
| Tyr(PO3H2)4 Angiotensin II, human (Echelon Bioscience, CAT#131-48) |
| Tyrosine Specific Protein Kinase Inhibitor Peptide A (Echelon Bioscience, CAT#890-88) |
| Unlabeled Shuttle PIP Carrier 1 (Echelon Bioscience, CAT#P-9C1) |
| Unlabeled Shuttle PIP Carrier 2 (Echelon Bioscience, CAT#P-9C2) |
| Unlabeled Shuttle PIP Carrier 3 (Echelon Bioscience, CAT#P-9C3) |
| Uridine Diphosphate-Bodipy-FL (UDP-Bodipy-FL) (Echelon Bioscience, CAT#N-100F) |
| Urobilin Hydrochloride (Echelon Bioscience, CAT#F-H140) |
| Urocortin, human (Echelon Bioscience, CAT#353-10) |
| Urocortin, rat (Echelon Bioscience, CAT#353-20) |
| Urodilatin (Echelon Bioscience, CAT#151-30) |
| Uroporphyrin I dihydrochloride (Echelon Bioscience, CAT#F-H040) |
| Uroporphyrin III dihydrochloride (Echelon Bioscience, CAT#F-H030) |
| Urotensin I, carp (Echelon Bioscience, CAT#817-40) |
| Urotensin I, suckerfish (Echelon Bioscience, CAT#817-30) |
| Urotensin II, human (Echelon Bioscience, CAT#817-50) |
| Vasoactiv Intestinal Peptide [Lys1,Pro2,5,Arg3,4,Tyr6] / VI (Echelon Bioscience, CAT#491-32) |
| Vasoactive Intestinal Constrictor / Mouse Beta Endothelin / (Echelon Bioscience, CAT#337-10) |
| Vasoactive Intestinal Peptide (6-28),human, porcine, rat / V (Echelon Bioscience, CAT#491-29) |
| Vasoactive Intestinal Peptide / VIP, human, porcine, rat (Echelon Bioscience, CAT#491-25) |
| Vasopressin ( Pmp1,Tyr(Et)2,Val4,Arg8 ) cyclic (Echelon Bioscience, CAT#670-32) |
| Vasopressin [Arg8] (AVP), cyclic (Echelon Bioscience, CAT#670-18) |
| Vasopressin [Deamino-Pen1,Val4,D-Arg8] (Echelon Bioscience, CAT#670-36) |
| Vasopressin [Lys-8] (Echelon Bioscience, CAT#670-17) |
| Vasopressin [Pmp1, Tyr(0Me)2, Arg8] (Echelon Bioscience, CAT#670-24) |
| Vasotocin [Arg8] cyclic (Echelon Bioscience, CAT#670-65) |
| Versican G1 Domain (Echelon Bioscience, CAT#G-HA01) |
| VIP Antagonist [Ac-Tyr1,D-Phe2]-GRF(1-29)NH2 (Echelon Bioscience, CAT#491-41) |
| VO-OHpic (PTEN Inhibitor) (Echelon Bioscience, CAT#B-0351) |
| VPC 23019 (S1P1/3 Antagonist) (Echelon Bioscience, CAT#B-0061) |
| Whole-Cell MEP Pathway-Selective Antibacterial Screening Assay Service (Echelon Bioscience, CAT#T-2000) |
| Wortmannin (Echelon Bioscience, CAT#B-0222) |
| XY-14 (Lipid Phosphate Phosphatase 1 Inhibitor) (Echelon Bioscience, CAT#L-9218) |
| XY-17 (LPA3 Agonist) (Echelon Bioscience, CAT#L-9118) |
| XY-4 (LPA analog) (Echelon Bioscience, CAT#L-1160) |
| Z-Ala-Ala-Asp-AFC (Cathepsin S Substrate, fluorogenic) (Echelon Bioscience, CAT#874-06) |
| Z-Ala-Arg-Arg-MbNA (Cathepsin B Substrate II, fluorogenic) (Echelon Bioscience, CAT#866-29) |
| Z-Ala-Lys-Arg-AMC (Echelon Bioscience, CAT#877-03) |
| Z-Arg-Arg-AMC (Cathepsin B substrate, fluorogenic) (Echelon Bioscience, CAT#866-30) |
| Z-Arg-Arg-MbNA (Cathepsin B Substrate, fluorogenic) (Echelon Bioscience, CAT#866-31) |
| Z-Arg-Arg-pNA (Cathepsin B substrate, colorimetric) (Echelon Bioscience, CAT#866-27) |
| Z-Asp-Glu-Val-Asp-AFC (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#863-18) |
| Z-Asp-Glu-Val-Asp-pNA (Caspase 3 (Apopain) substrate) (Echelon Bioscience, CAT#861-20) |
| Z-Glu-Ala-Asp-CHO (Echelon Bioscience, CAT#878-05) |
| Z-Gly-Gly-Arg-AMC (Urokinase Substrate III, fluorogenic) (Echelon Bioscience, CAT#869-25) |
| Z-Gly-Gly-Leu-AMC (Proteasome Substrate, fluorogenic) (Echelon Bioscience, CAT#882-31) |
| Z-Gly-Val-Val-AMC (Echelon Bioscience, CAT#877-04) |
| Z-Ile-Glu-Thr-Asp-AFC (Granzyme B Substrate) (Echelon Bioscience, CAT#863-56) |
| Z-Ile-Glu-Thr-Asp-pNA (Granzyme B Substrate) (Echelon Bioscience, CAT#863-61) |
| Z-Leu-Arg-AMC (Cathepsin, Kallikrein, Falcipain II substrate, fluorogenic) (Echelon Bioscience, CAT#877-14) |
| Z-Leu-Leu-Glu-AMC (Proteasome Substrate 2, fluorogenic) (Echelon Bioscience, CAT#882-21) |
| Z-Leu-Leu-Leu-AMC (Proteasome Substrate 1, fluorogenic) (Echelon Bioscience, CAT#882-20) |
| Z-Leu-Leu-Phe-CHO (Proteasome Inhibitor 2) (Echelon Bioscience, CAT#882-12) |
| Z-Phe-Ala-pNA (Echelon Bioscience, CAT#876-05) |
| Z-Phe-Arg-AFC (Cathepsin L Substrate, fluorogenic) (Echelon Bioscience, CAT#866-75) |
| Z-Phe-Arg-AMC (Kallikrein substrate) (Echelon Bioscience, CAT#871-75) |
| Z-Phe-CHO (Echelon Bioscience, CAT#878-06) |
| Z-Phe-Tyr-CHO (Cathepsin L Inhibitor) (Echelon Bioscience, CAT#866-28) |
| Z-Tyr-Val-Ala-Asp-AFC (Caspase 1 Substrate) (Echelon Bioscience, CAT#861-17) |
| Z-Tyr-Val-Ala-Asp-pNA (Caspase 1 Substrate) (Echelon Bioscience, CAT#861-28) |
| Z-Val-Asp-Val-Ala-Asp-AFC (Caspase 2 (ICH-1) Substrate) (Echelon Bioscience, CAT#863-49) |
| Z-Val-Gly-Arg-pNA (Urokinase Substrate I, colorimetric) (Echelon Bioscience, CAT#869-31) |
| Z-Val-Ile-Ala-AMC (IRCM Serine Protease I Substrate, fluorogenic) (Echelon Bioscience, CAT#877-05) |
| Z-Val-Lys-Met-AMC (Proteasome Substrate 4, fluorogenic) (Echelon Bioscience, CAT#882-23) |
| Z-Val-Phe-CHO (Calpain Inhibitor III) (Echelon Bioscience, CAT#870-50) |
| Z-Val-Pro-Arg-pNA (Echelon Bioscience, CAT#876-08) |
| Z-Val-Val-Arg-AFC (Echelon Bioscience, CAT#874-01) |
| Zn (II) Deuteroporphyrin IX 2,4 bisethylene glycol (Echelon Bioscience, CAT#F-H090) |
| Zn Protoporphyrin IX (Echelon Bioscience, CAT#F-H060) |
| ZSTK474 (PI3K Inhibitor) (Echelon Bioscience, CAT#B-0307) |
更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
" data-original="http://genvivo.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Echelon Biosciences"> Echelon Biosciences
<Nanostructured & Amorphous Materials, Inc.致力于纳米材料科技的应用。主要的业务包括：生产、研发、加工纳米级和非结晶材料。
Nanostructured & Amorphous Materials Inc. (NanoAmor) was founded in Los Alamos, New Mexico, USA, in September 2001. We are a leading nanomaterials company involved in all aspects of the business: manufacturing, research and development, processing, supplying and marketing of nanostructured materials and their dispersions.
Nanostructured & Amorphous Materials的主要产品包括：
Application-Oriented Carbon-Nanotubes Products
Carbon Nanotubes & Nanofibers
Carbon Nanotube Dispersions
Elements, Oxides, Carbides & Nitrides Nanoparticles
Fullerene
Graphenes, Graphene Oxides & Graphene Nanoplatelets
Graphene Film
Nanopowder Dispersions
Nanowires & Nanorods
Amorphous Ribbons
Nanocrystalline Ribbons
Amorphous & Nanocrystalline Cores
Amorphous and Nanocrystalline Magnetic Bars
Amorphous & Nanocrystalline Powders
Amorphous Brazing Foils
Superhard Materials
Surface-Modified Oxide Nanoparticles
| 品名 | 货号 | 规格 |
| CNTs Additives for Lithium-ion Battery | 1376YJ | 1kg; |
| Carbon Nanotubes Fibers | 1356YJ | meter; |
| Carbon Nanotubes Papers | 1348YJ | piece; |
| Carbon Nanotubes Films | 1350YJ | piece; |
| Carbon Nanotubes Films | 1351YJ | 咨询 |
| Water-based carbon nanotubes coatings | 1332YJ | kg; |
| Water-based carbon nanotubes coatings | 1333YJ | kg; |
| Antistatic carbon-nanotubes coatings | 1331YJA | kg; |
| Antistatic carbon-nanotubes coatings | 1331YJB | kg; |
| Conductive/heating carbon-nanotubes coatings | 1378YJA | kg; |
| 20wt% CNTs/80wt% ABS Masterbatch | 1335YJ | 1kg; 5kg; 10kg; |
| 25wt% CNTs/75wt% HDPE Masterbatch | 1337YJ | 1kg; 5kg; 10kg; |
| 25wt% CNTs/75wt% HIPS Masterbatch | 1338YJ | 1kg; 5kg; 10kg; |
| 25wt% CNTs/75wt% LLDPE Masterbatch | 1339YJ | 1kg; 5kg; 10kg; |
| 20wt% CNTs/80wt% PA6 Masterbatch | 1340YJ | 1kg; 5kg; 10kg; |
| 20wt% CNTs/80wt% PP Masterbatch | 1341YJ | 1kg; 5kg; 10kg; |
| 0.2 wt% SWCNTs (> 95%, D < 2 nm)/Water Dispersion | 8040YJ | 500g; |
| 0.2 wt% SWCNTs-COOH (> 95%, OD 1-2 nm)/Water Dispersion | 8042YJ | 500g; |
| 2 wt% MWCNTs (> 98%, D 5-15 nm)/Water Dispersion | 8028YJ | 500ml; |
| 2 wt% MWCNTs-COOH (> 98%, D 5-15 nm)/Water Dispersion | 8027YJ | 500 ml; |
| 10 wt% MWCNTs (> 98%, D 30-80 nm)/Water Dispersion | 8030YJ | 500 ml; |
| 10 wt% MWCNTs-COOH (>98%, D 30-80 nm)/Water Dispersion | 8029YJ | 500 ml; |
| 0.2 wt% SWCNTs (> 95%, D < 2 nm)/Water Paste | 8038YJ | kg; |
| 0.2 wt% SWCNTs-COOH (> 95%, OD 1-2 nm)/Water Paste | 8039YJ | 500g; kg; |
| 2 wt% MWCNTs (> 95%, D 5-15 nm)/Water Paste | 8032YJ | kg; |
| 2 wt% MWCNTs-COOH (> 95%, D 5-15 nm)/Water Paste | 8033YJ | kg; |
| 10 wt% MWCNTs (> 95%, D 30-80 nm)/Water Slurry | 8034YJ | kg; |
| 10 wt% MWCNTs-COOH (> 95%, D 30-80 nm)/Water Paste | 8035YJ | kg; |
| 12-14 wt% MWCNTs (> 95%, D 30-80 nm)/Water Paste | 8036YJ | kg; |
| 12-14 wt% MWCNTs-COOH (>95%, D 30-80 nm)/Water Paste | 8037YJ | kg; |
| 0.2-0.3 wt% SWCNTs (> 95%, D 1-2 nm)/BA Dispersion | 8116YJ | 500 ml; |
| 0.2-0.3 wt% SWCNTs (> 95%, D 1-2 nm)/DMAC Dispersion | 8118YJ | 500 ml; |
| 0.2-0.3 wt% SWCNTs (> 95%, D 1-2 nm)/DMF Dispersion | 8115YJ | 500 ml; |
| 0.2-0.3 wt% SWCNTs (> 95%, D 1-2 nm)/IPA Dispersion | 8117YJ | 500 ml; |
| 0.2-0.3 wt% SWCNTs (> 95%, D 1-2 nm)/NMP Dispersion | 8114YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/BA Dispersion | 8124YJ | 500 ml; |
| 8-10 wt% MWCNTs (> 98%, D 30-80 nm)/BA Dispersion | 8123YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/DMAC Dispersion | 8126YJ | 500 ml; |
| 10 wt% MWCNTs (> 98%, D 30-80 nm)/DMAC Dispersion | 8125YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/DMF Dispersion | 8122YJ | 500 ml; |
| 10 wt% MWCNTs (> 98%, D 30-80 nm)/DMF Dispersion | 8121YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/IPA Dispersion | 8130YJ | 500 ml; |
| 8-10 wt% MWCNTs (> 98%, D 30-80 nm)/IPA Dispersion | 8129YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/NMP Dispersion | 8120YJ | 500 ml; |
| 5 wt% MWCNTs (> 98%, D 30-80 nm)/NMP Dispersion | 8119YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/PMA Dispersion | 8128YJ | 500 ml; |
| 10 wt% MWCNTs (> 98%, D 30-80 nm)/PMA Dispersion | 8127YJ | 500 ml; |
| Fullerence powder (C60, 95+%) | 8072YJ | 1g; 5g; |
| Fullerence powder (C60, 98+%) | 8073YJ | 1g; 5g; |
| Fullerence powder (C60, 99+%) | 8074YJ | 1g; 5g; |
| Fullerene powder (C60, 99.5+%) | 8075YJ | 1g; 5g; |
| Fullerene powder (C60, 99.9+%) | 8076YJ | 1g; 5g; |
| Fullerence powder (C70, 95+%) | 8077YJ | 1g; 5g; |
| Fullerence powder (C70, 98+%) | 8078YJ | 1g; 5g; |
| Fullerence powder (C70, 99+%) | 8079YJ | 1g; 5g; |
| Fullerenol Powder (hydroxylated fullerence C60) | 8080YJ | 1g; 10g; |
| Three-Dimensional Graphene (> 60 wt%, D 6-8 um, 3-4 layers) | 8109YJ | 1g; 5g; |
| 1.0-1.5 wt% Graphenes (> 98 wt%, Dia. 4-6 um, < 10 layers)/NMP paste | 8064YJ | 1g (graphene); 5g (graphene); |
| Highly Elastic Graphene Aerogel (Dia. 2.0 cm, Height 2.0 cm) | 8095YJ | 1 cylinder; 5 cylinders; |
| Ultra-light Graphene Aerogel (Dia. 2.0 cm, Height 2.0 cm) | 8093YJ | 1 cylinder; 5 cylinders; |
| Carbon Nanotubes (10 wt%) Doped Graphene Aerogel (Dia. 1.2 cm, Height 1.2 cm) | 8090YJ | 1 cylinder; 5 cylinders; |
| Carbon Nanotubes (10 wt%) Doped Graphene Aerogel (Dia. 2.0 cm, Height 2.0 cm) | 8091YJ | 1 cylinder; 5 cylinders; |
| Magnetic Graphene Aerogel (47 wt% Fe3O4, Dia. 1 cm, Height 1 cm) | 8096YJA | 1 cylinder; 5 cylinders; |
| Magnetic Graphene Aerogel (47 wt% Fe3O4, Dia. 2 cm, Height 2 cm) | 8096YJB | 1 cylinder; 5 cylinders; |
| Magnetic Graphene Aerogel (63 wt% Fe3O4, Dia. 1 cm, Height 1 cm) | 8097YJA | 1 cylinder; 5 cylinders; |
| Magnetic Graphene Aerogel (63 wt% Fe3O4, Dia. 2 cm, Height 2 cm) | 8097YJB | 1 cylinder; 5 cylinders; |
| Graphene Foam on Nickel Foam (thickness 1-1.2 mm) | 1319YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene Foam (nickel foam etched, thickness 1-1.2 mm) | 1320YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| 1-3 wt% Graphene Oxide (> 98 wt%, D 1-5 um, 1-2 layers)/Water Gel, pH = 3-4 | 8047YJB34 | 1g (graphene oxide); 5g (graphene oxide); |
| Graphene Oxide Paper (Dia. 9 cm, thickness 10 um) | 8089YJ | 1 piece; 5 pieces; |
| Industrial-Grade Graphene Nanoplatelets (> 90 wt%, D 2-13 um, < 30 layers) | 8055YJ2 | 50g; 250g; 1kg; |
| 5 wt% Graphene Nanoplatelets (> 90 wt%, D 2-16 um, < 30 layers)/NMP Paste | 8059YJ | kg (paste); |
| Industrial-Grade Graphene-Nanoplatelets/Carbon-Nanotubes Composites (> 90 wt%) | 8071YJ | 50g; 100g; |
| 5 wt% (Graphene Nanoplatelets & Carbon Nanotubes)/Water Paste | 8060YJ | kg (paste); |
| 5 wt% (Graphene Nanoplatelets & Carbon Nanotubes)/NMP Paste | 8061YJ | kg (paste); |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 97% area covered | 1304YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 97% area covered | 1304YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 97% area covered | 1304YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 97% area covered | 1304YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 97% area covered | 1304YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 85% area covered | 1305YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 85% area covered | 1305YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 85% area covered | 1305YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 85% area covered | 1305YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 85% area covered | 1305YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layers) graphene/copper substrate | 1306YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layers) graphene/copper substrate | 1306YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layers) graphene/copper substrate | 1306YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layers) graphene/copper substrate | 1306YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layers) graphene/copper substrate | 1306YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 97% area covered | 1307YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 97% area covered | 1307YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 97% area covered | 1307YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 85% area covered | 1308YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 85% area covered | 1308YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 85% area covered | 1308YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layer) graphene/PVC substrate | 1309YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layer) graphene/PVC substrate | 1309YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layer) graphene/PVC substrate | 1309YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 97% area covered | 1310YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 97% area covered | 1310YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 97% area covered | 1310YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 97% area covered | 1310YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 85% area covered | 1311YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 85% area covered | 1311YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 85% area covered | 1311YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 85% area covered | 1311YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on silicon-oxide substrate | 1312YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on silicon-oxide substrate | 1312YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on silicon-oxide substrate | 1312YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on silicon-oxide substrate | 1312YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Single-layered graphene on quartz substrate, > 97% area covered | 1313YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Single-layered graphene on quartz substrate, > 97% area covered | 1313YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Single-layered graphene on quartz substrate, > 97% area covered | 1313YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on quartz substrate, > 85% area covered | 1314YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on quartz substrate, > 85% area covered | 1314YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on quartz substrate, > 85% area covered | 1314YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on quartz substrate | 1315YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on quartz substrate | 1315YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on quartz substrate | 1315YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 97% area covered | 1316YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 97% area covered | 1316YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 97% area covered | 1316YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 97% area covered | 1316YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 85% area covered | 1317YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 85% area covered | 1317YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 85% area covered | 1317YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 85% area covered | 1317YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on PET substrate | 1318YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on PET substrate | 1318YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on PET substrate | 1318YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on PET substrate | 1318YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Graphene Foam on Nickel Foam (thickness 1-1.2 mm) | 1319YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene Foam on Nickel Foam (thickness 1-1.2 mm) | 1319YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene Foam on Nickel Foam (thickness 1-1.2 mm) | 1319YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene Foam on Nickel Foam (thickness 1-1.2 mm) | 1319YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene on PVC (nickel foam removed) | 1320YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene on PVC (nickel foam removed) | 1320YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene on PVC (nickel foam removed) | 1320YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene on PVC (nickel foam removed) | 1320YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Silver Nanopowder (Ag, 99.9+%, 20 nm) 0.1 - 1 wt% Dispersion in Water with Anionic Surfactant | 7031HW | 500ml; 1L; |
| Silver Nanopowder (Ag, 99.9+%, 50 nm) 0.1 - 1 wt% Dispersion in Water with Anionic Surfactant | 7033HW | 500ml; |
| Silver Nanopowder (Ag, 99.9+%, 100 nm) 0.1 - 1 wt% Dispersion in Water with Anionic Surfactant | 7035HW | 500ml; |
| Silver Nanopowder (Ag, 99.9+%, 200 nm) 0.1 - 1 wt% Dispersion in Water with Anionic Surfactant | 7038HW | 500ml; |
| Gold Nanopowder (Au, 99.99%, 20 nm) 0.1 - 1 wt% Dispersion in Water | 7041HW | 500ml; |
| Platinum Nanopowder (Pt, 99.9+%, 20-30nm) 0.1wt% Dispersion in Water | 0488HW | 500ml; |
| Palladium Nanopowder (Pd, 99.99%, 20 nm) 0.1 - 1 wt% Dispersion in Water | 7051HW | 500ml; |
| Palladium Nanopowder (Pd, 99.9+%, 10 nm) 0.1wt% Dispersion in Water | 0466HW | kg; |
| Germanium Nanopowder (Ge, 99.9+%, 400 nm) Dispersed in 850ml of Ethanol | 0388HW | 咨询 |
| Aluminum Oxide (alpha, 20 wt%, 30-60nm) in Water | 7017WJWA | 1kg; |
| Aluminum Oxide (gamma, 20 wt%, 30 nm) in Water | 7017WJWG | 1kg; |
| Aluminum Oxide (gamma, 20 wt%, 10 nm) in water | 7016WJWG | 1kg; |
| CuO, 1 wt%, in water, APS 30 nm | 9019WJ | kg; |
| Silicon Oxide (15 wt%, 30 nm) in water | 7019WJ | 30kg; |
| Silicon Oxide (25 wt%, 30 nm) in water | 7015WJ | 1kg; |
| Silicon Oxide (25 wt%, 30 nm) in water | 7016WJ | 1kg; 10kg; |
| Titanium Oxide (Rutile, 40 wt%, 30-50 nm) in water | 7013WJWR | 1kg; |
| Titanium oxide TiO2 (40wt%, Rutile, 30-50 nm ) in Isopropanol | 5006WJ | kg; |
| Titanium Oxide (TiO2, Rutile, >99.5%, 5-30 nm,15 wt%) in water | 7012WJWR | 1kg; |
| Titanium Oxide (Anatase, 20 wt%, 5-30 nm) in IPA | 7014WJWA | 1kg; |
| Titanium Oxide (Anatase, ATO doped, 20 wt%, 15-25 nm) Slurry | 7030WJ | 5kg; |
| Titanium Oxide (Anatase, 20 wt%, 5-30 nm) in water | 7012WJWA | 1kg; |
| Titanium Oxide (Anatase, 15 wt%, 5-30 nm) in water | 7011WJWA | 1kg; |
| Titanium Oxide (TiO2, Anatase, >99.5%, 15 nm, 15 wt%) in water, negatively charged | 7011WJWANC | 咨询 |
| Titanium Oxide Nanopowder (anatase, 5 wt%, 10-20 nm) in ethanol | 7019HT | 1L; 5L; |
| Zinc Oxide (20 wt%, 40 nm) in water | 7006WJ | 1L |
| Indium Tin Oxide (ITO, 30 wt%, 20-30 nm) in Water | 7026HZW | 100g; |
| Silver nanowires (Dia. 70 - 80 nm, Length > 10 um) | 0475HW6 | 1 g (silver nanowires); 5 g (silver nanowires); |
| Silver nanowires (Dia. 30 - 50 nm, Length > 10 um) | 0475HW5 | 1 g (silver nanowires); 5 g (silver nanowires); |
| Silver Nanowires (Dia. 20 - 30 nm, Length > 10 um) | 0475HW4 | 1 g (silver nanowires); 5 g (silver nanowires); |
| Silver nanowires (D = 14-31 nm, L = 5-40 um, 99.95+%, 1 wt% Ag in ethanol) | 0475NW2E | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 14-31 nm, L = 5-40 um, 99.95+%, 1 wt% Ag in isopropanol) | 0475NW2I | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 14-31 nm, L = 5-40 um, 99.95+%, 1 wt% Ag in water) | 0475NW2W | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 25-35 nm, L = 15-25 um, 99.95+%, 1 wt% Ag in ethanol) | 0475NW3E | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 25-35 nm, L = 15-25 um, 99.95+%, 1 wt% Ag in isopropanol) | 0475NW3I | 1 g (Ag nanowires); 2 g (Ag nanowires); 3 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 25-35 nm, L = 15-25 um, 99.95+%, 1 wt% Ag in water) | 0475NW3W | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 35-45 nm, L = 10-20 um, 99.95+%, 1 wt% Ag in ethanol) | 0475NW5E | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 35-45 nm, L = 10-20 um, 99.95+%, 1 wt% Ag in isopropanol) | 0475NW5I | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 35-45 nm, L = 10-20 um, 99.95+%, 1 wt% Ag in water) | 0475NW5W | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 55-75 nm, L = 20-40 um, 99.95+%, 1 wt% Ag in ethanol) | 0475NW6E | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 55-75 nm, L = 20-40 um, 99.95+%, 1 wt% Ag in isopropanol) | 0475NW6I | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 55-75 nm, L = 20-40 um, 99.95+%, 1 wt% Ag in water) | 0475NW6W | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Single-walled Carbon nanotubes - 60%SWNTs (90%CNTs) | 1283YJ | 1g; 5g; |
| SWNT-OH (90% CNTs, 60% SWNTs) | 1285YJF | 1g; 5g; |
| SWNT-COOH (90% CNTs, 60% SWNTs) | 1287YJF | 1g; 5g; |
| Short SWNTs (90% CNTs, 60% SWNTs) | 1281YJS | 1g; 5g; |
| SWNT-OH (> 60%, OD 1-2 nm, Length 1-3 um) | 1285YJFS | 1g; |
| SWNT-COOH (> 60%, OD 1-2 nm, Length 1-3 um) | 1287YJFS | 1g; |
| High-Purity SWNTs (> 95%, OD < 2 nm, Length 5-30 um) | 1288YJ | g; |
| Single-walled carbon nanotubes - 90%SWNTs (95%CNTs) | 1284YJ | g; 5g; |
| SWNT-OH (95% CNTs, 90% SWNTs) | 1286YJF | 1g; |
| SWNT-COOH (95% CNTs, 90% SWNTs) | 1288YJF | 1g; |
| SWCNTs (> 90%, OD 1-2 nm, Length 1-3 um) | 1246YJS | 1g; 5g; |
| Single-Walled Carbon Nanotubes (90+%), -OH Functionalized | 1586YJF | 1g; |
| Single-Walled Carbon Nanotubes (90+%), -COOH Functionalized | 1588YJF | 1g; |
| High-Purity SWNTs (> 95%, OD < 2 nm, Length 5-30 um) | 1288YJ | 1g; |
| High-Purity SWNTs, -OH functionalized (> 95%, OD 1-2 nm, Length 5-30 um) | 1368YJF | 1g; |
| High-Purity SWNTs, -COOH functionalized (> 95%, OD 1-2 nm, Length 5-30 um) | 1369YJF | 1g; |
| High-Purity Short SWNTs (> 95%, OD 1-2 nm, Length 1-3 um) | 1372YJ | 1g; |
| High-Purity Short SWNTs, -OH Functionalized (> 95%, OD 1-2 nm, Length 1-3 um) | 1373YJF | 1g; |
| High-Purity Short SWNTs, -COOH Functionalized (> 95%, OD 1-2 nm, Length 1-3 um) | 1374YJF | 1g; |
| High-Purity SWNTs (> 95%), -NH2 functionalized | 1370YJF | 1g; 5g; |
| High-Purity Short SWNTs (> 95%), -NH2 functionalized | 1371YJFS | 1g; 5g; |
| High-Purity SWNTs (> 95 %, surface area > 1,075 m2/g) | 1300YJ | 1g; |
| DWNTs (> 60%, OD 2-4 nm, Length ~50 um) | 1280YJD | 1g; 5g; 25g; |
| DWNTs-COOH (> 60%, OD 2-4 nm, Length ~50 um) | 1281YJD | g; |
| Multi-Walled Carbon Nanotube -MWNT (98%, OD 4-6 nm) | 1389YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (98%, OD 5-15 nm) | 1203YJ | 10g; 25g; |
| Multi-walled carbon nanotube -MWNT (99%, OD 5-15 nm) | 8101YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (95+%, OD 8-15 nm) | 1204YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (>98%, OD 10-20 nm) | 1205YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (>98%, OD 20-30 nm) | 1229YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (98+%, OD 30-50 nm) | 1231YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (>98%, OD 30-80 nm) | 1233YJ | 10g; 25g; |
| Short MWNT (98+%, OD 4-6 nm, Length 0.5-2 um) | 1392YJS | 5g; |
| Short MWNT (98+%, OD 5-15 nm, Length 0.5-2 um) | 1225YJS | 5g; |
| Short MWNT (99+%, OD 5-15 nm, Length 0.5-2 um) | 8104YJS | 5g; |
| Short MWNT (95+%, OD 8-15 nm, Length 0.5-2 um) | 1235YJS | 5g; |
| Short MWNT (>98%, OD 10-20 nm, Length 0.5-2 um) | 1236YJS | 10g; |
| Short MWNT (98+%, OD 20-30 nm, Length 0.5-2 um) | 1237YJS | 5g; |
| Short MWNT (98+%, OD 30-50 nm, Length 0.5-2 um) | 1238YJS | 5g; |
| Short MWNT (98+%, OD 30-80 nm, Length 0.5-2 um) | 1227YJS | 5g; |
| Graphitized MWNT (99.9%, OD 8-15 nm) | 1219YJ | 10g; 25g; |
| Graphitized MWNT (99.9%, OD 10-20 nm) | 1220YJ | 10g; |
| Graphitized MWNT (99.9%, OD 20-30 nm) | 1221YJ | 5g; |
| Graphitized MWNT (99.9%, OD 30-50 nm) | 1222YJ | 5g; |
| Graphitized MWNT (99.9%, OD 30-80 nm) | 1223YJ | 5g; |
| Industrial-grade MWNT (95+%, OD 4-6 nm) | 1395YJ | 1kg; |
| Industrial-Grade MWNT (95+%, OD 5-15 nm) | 1201YJG | 1kg; |
| Industrial-grade MWNT (95%, OD 8-15 nm) | 1201YJA | 1kg; |
| Industrial-grade MWNT (95+%, OD 10-20 nm) | 1201YJB | 1kg; |
| Industrial-grade MWNT (95+%, OD 10-30 nm) | 1201YJC | 1kg; |
| Industrial-grade MWNT (95+%, OD 20-40 nm) | 1201YJD | 1kg; |
| Industrial-Grade MWNT (95+%, OD 30-80 nm) | 1201YJE | 1kg; |
| MWNT-OH (98+%, OD 4-6 nm) | 1390YJF | 10g; |
| MWNT-OH (98+%, OD 5-15 nm) | 1261YJF | 5g; |
| MWNT-OH (99+%, OD 5-15 nm) | 8103YJF | 5g; |
| MWNT-OH (95+%, OD 8-15 nm) | 1262YJF | 5g; |
| MWNT-OH (98+%, OD 10-20 nm) | 1263YJF | 5g; |
| MWNT-OH (98+%, OD 20-30 nm) | 1264YJF | 5g; 25g; 100g; |
| MWNT-OH (98+%, OD 30-50 nm) | 1265YJF | 5g; |
| MWNT-OH (98+%, OD 30-80 nm) | 1266YJF | 5g; |
| Short MWNT-OH (98+%, OD 4-6 nm, Length 0.5-2 um) | 1393YJF | 5 g; 100 g; |
| Short MWNT-OH (98+%, OD 5-15 nm, Length 0.5-2 um) | 1247YJF | 5g; |
| Short MWNT-OH (99+%, OD 5-15 nm, Length 0.5-2 um) | 8106YJF | 5g; |
| Short MWNT-OH (95+%, OD 8-15 nm, Length 0.5-2 um) | 1248YJF | 5g; |
| Short MWNT-OH (98+%, OD 10-20 nm, Length 0.5-2 um) | 1249YJF | 5g; |
| Short MWNT-OH (98+%, OD 20-30 nm, Length 0.5-2 um) | 1251YJF | 5g; |
| Short MWNT-OH (98+%, OD 30-50 nm, Length 0.5-2 um) | 1252YJF | 5g; |
| Short MWNT-OH (98+%, OD 30-80 nm, Length 0.5-2 um) | 1253YJF | 1g; 5g; |
| Graphitized MWNT-OH (99.9%, OD 8-15 nm) | 1224YJF | 1g; |
| Graphitized MWNT-OH (99.9%, OD 10-20 nm) | 1228YJF | 1g; 5g; |
| Graphitized MWNT-OH (99.9%, OD 20-30 nm) | 1235YJF | 1g; 5g; |
| Graphitized MWNT-OH (99.9%, OD 30-50 nm) | 1239YJF | 1g; 5g; |
| Graphitized MWNT-OH (99.9%, OD 30-80 nm) | 1240YJF | 1g; 5g; |
| Industrial-grade MWNT-OH (95+%, OD 5-15 nm) | 1201YJI | 1kg; |
| Industrial-grade MWNT-OH (95+%, OD 8-15 nm) | 1201YJL | 1kg; |
| Industrial-grade MWNT-OH (95+%, OD 10-30 nm) | 1207YJF | 1kg; |
| Industrial-grade MWNT-OH (95+%, OD 20-40 nm) | 1208YJF | 1kg; |
| Industrial-grade MWNT-OH (95+%, OD 30-80 nm) | 1209YJF | 1kg; |
| MWNT-COOH (98+%, OD 4-6 nm) | 1391YJF | 10g; |
| MWNT-COOH (98+%, OD 5-15 nm) | 1267YJF | 5g; |
| MWNT-COOH (99+%, OD 5-15 nm) | 8102YJF | 10g; |
| MWNT-COOH (95+%, OD 8-15 nm) | 1268YJF | 5g; |
| MWNT-COOH (98+%, OD 10-20 nm) | 1269YJF | 5g; |
| MWNT-COOH (98+%, OD 20-30 nm) | 1270YJF | 5g; |
| MWNT-COOH (98+%, OD 30-50 nm) | 1271YJF | 5g; |
| MWNT-COOH (98+%, OD 30-80 nm) | 1272YJF | 5g; |
| Short MWNT-COOH (98+%, OD 4-6 nm, Length 0.5-2 um) | 1394YJF | 5g; |
| Short MWNT-COOH (98+%, OD 5-15 nm, Length 0.5-2 um) | 1254YJF | 5g; |
| Short MWNT-COOH (99+%, OD 5-15 nm, Length 0.5-2 um) | 8105YJF | 5g; |
| Short MWNT-COOH (95+%, OD 8-15 nm, Length 0.5-2 um) | 1255YJF | 1g; 5g; |
| Short MWNT-COOH (98+%, OD 10-20 nm, Length 0.5-2 um) | 1256YJF | 5g; |
| Short MWNT-COOH (98+%, OD 20-30 nm, Length 0.5-2 um) | 1257YJF | 1g; 5g; |
| Short MWNT-COOH (98+%, OD 30-50 nm, Length 0.5-2 um) | 1259YJF | 1g; 5g; |
| Short MWNT-COOH (98+%, OD 30-80 nm, Length 0.5-2 um) | 1273YJF | 1g; 5g; |
| Graphitized MWNT-COOH (99.9%, OD 8-15 nm) | 1241YJF | 10g; |
| Graphitized MWNT-COOH (99.9%, OD 10-20 nm) | 1242YJF | 10g; |
| Graphitized MWNT-COOH (99.9%, OD 20-30 nm) | 1243YJF | 10g; |
| Graphitized MWNT-COOH (99.9%, OD 30-50 nm) | 1244YJF | 1g; 5g; |
| Graphitized MWNT-COOH (99.9%, OD 30-80 nm) | 1245YJF | 1g; 5g; |
| Industrial-grade MWNT-COOH (95+%, OD 5-15 nm) | 1201YJH | 1kg; |
| Industrial-grade MWNT-COOH (95+%, OD 8-15 nm) | 1201YJK | 1kg; |
| Industrial-grade MWNT-COOH (95+%, OD 10-30 nm) | 1210YJF | 1kg; |
| Industrial-grade MWNT-COOH (95+%, OD 20-40 nm) | 1216YJF | 1kg; |
| Industrial-grade MWNT-COOH (95+%, OD 30-80 nm) | 1218YJF | 1kg; |
| Aligned MWNT (98+%, OD 8-15 nm, Length: 30-50 um) | 1215YJA | 25g; |
| Carbon nanofibers (70+%, D = 200-600 nm, L = 5-50 um) | 1177YJ | 10g; |
| Carbon Nanofibers (95+%, D = 50-200 nm, L = 1-15 um) | 8107YJ | 10g; |
| Graphitized carbon nanofibers (95+%, OD = 50-200 nm, L = 1-15 um) | 1178YJ | 10g; |
| Graphene (> 98 wt%, D > 50 um, < 3 layers) | 2191YJ | 1g; 5g; |
| Graphene Oxide (> 99 wt%, D 0.5-3 um, < 3 Layers) | 2192YJ | 1g; 5g; |
| Graphene Nanoplatelets (> 99.5 wt%, D 5-10 um, < 20 layers) | 8056YJ | 1g; 5g; 25g; |
| Industrial-Grade Graphene Nanoplatelets (> 90 wt%, D 2-16 um, < 30 layers) | 8055YJ | 50g; 250g; 1kg; |
| *60% Ni/38% MWNT (95+%, OD 8-15 nm) | 1293YJ | 10g; |
| *60% Ni/38% MWNT (95+%, OD 10-20 nm) | 1294YJ | 10g; |
| *60% Ni/38% MWNT (95+%, OD 20-30 nm) | 1295YJ | 10g; |
| *60% Ni/38% MWNT (95+%, OD 30-50 nm) | 1296YJ | 10g; |
| *60% Ni/38% MWNT (95+%, OD 30-80 nm) | 1297YJ | 10g; |
| MWNT-NH2 (95+%, OD 8-15 nm, 0.45 wt% amino) | 1562YJF | 5g; |
| Nitrogen-doped MWNTs (98%, OD 30-80 nm) | 8054YJ | 5g; |
| Large inner diameter thin-walled multi-walled carbon nanotubes | 1563YJF | 5g; |
| Coiled CNTs (60+%, OD 100-200 nm, Length 1-10 um) | 1298YJ | 5g; |
| Silver Nanopowder (Ag, 99.99%, 400 nm ) | 0487HW | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 200 nm ) | 0479HW | 咨询 |
| Silver Nanopowder (Ag, 99.99%, 100 nm ) | 0489HW | 咨询 |
| Silver Nanopowder (Ag, 99%, 90-210 nm) | 0471CD | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 80 nm ) | 0475HW | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 80 nm, w/~0.3% PVP ) | 0476HW | 咨询 |
| Silver Nanopowder (Ag, 99.9% , 40 nm ) | 0473HW | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 40 nm, w/~0.3% PVP ) | 0474HW | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 30-50 nm, w/0.2 wt% PVP) | 0477YD | 咨询 |
| Silver Nanopowder (Ag, 35 nm, 99.5%, metal basis) | 0476JY | 咨询 |
| Silver Nanopowder (Ag, 99.9% , 20 nm ) | 0477HW | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 20 nm, w/~0.3% PVP ) | 0478HW | 咨询 |
| Aluminum Powder (99.9%, 500 um) | 0156HW | 咨询 |
| Aluminum Powder (99.9%, 50 um) | 0154HW | 咨询 |
| Aluminum Powder (99.9%, 5 um) | 0152HW | 咨询 |
| Aluminum Nanoparticles (99.9%, 500 nm) | 0150HW | 咨询 |
| Aluminum Nanopowder (Al, 99.9+%, 70-80 nm) | 0137HW | 咨询 |
| Aluminum Nanopowder (99.9+%, 70-80 nm, w/PVP) | 0140HW | 咨询 |
| Aluminum Nanopowder (Al, 99.9+%, 40-50 nm) | 0138HW | 咨询 |
| Aluminum Nanopowder (99.9+%, 40-50 nm, w/PVP) | 0139HW | 咨询 |
| Aluminum Nanopowder (Al, 99+%, metal basis, 18 nm) | 0136JY | 咨询 |
| Gold (Au) Nanopowder (99.9%, 50-100 nm) | 0795CD | 咨询 |
| Gold (Au) Nanopowder (25nm, 99.9%) | 8801HW | 咨询 |
| Gold (Au) Nanopowder (10-20 nm, 99.95%) | 8796HW | 咨询 |
| Gold (Au) Nanopowder (10nm, 99.9%) | 8799HW | 咨询 |
| Bismuth Nanopowder (Bi, 99.9%, 80-100 nm) | 0832HW | 咨询 |
| Bismuth Nanopowder (Bi, 99.5%, 40-60 nm) | 0831HW | 咨询 |
| Nano Activated Carbon (C, 88+%, 100 nm) | 1211NH | 咨询 |
| Diamond Nanopowder (synthesized, 55-70%, 4-15nm) | 1311JGY | 咨询 |
| Diamond Nanopowder (synthesized, 98+%, 3-10 nm) | 1321JGY | 咨询 |
| Diamond Nanopowder (synthesized, 97%, 3-6 nm) | 1350SL | 咨询 |
| Graphite Nanopowder (400 nm, 99.9%) | 1250HT | 咨询 |
| *Cobalt Nanopowder, Carbon Coated (Co, 99%, 40 nm) | 0286HW | 咨询 |
| *Cobalt Nanopowder (Passivated, 99.8%, 28 nm) | 0276JY | 咨询 |
| *Chromium Nanopowder (Cr, 99.5%, 50 nm) | 0240XX | 咨询 |
| *Copper Nanopowder (Cu, 99%, 500 nm) | 0293HW | 100g; |
| *Copper Nanopowder (Cu, 99.9%, 200 nm) | 0290HW | 25g; |
| *Copper Nanopowder (Cu, 99.9%, 100 nm) | 0298HW | 25g; |
| *Copper Nanopowder (Partially Passivated, 99+%, 80 nm) | 0294HW | 25g; |
| *Copper Nanopowder (Cu, 99.9%, 70 nm) | 0291HW | 25g; |
| *Copper Nanopowder (Cu, 99.5%, 50-80 nm) | 0292HW | 25g; |
| *Copper Nanopowder (Cu, 99.9%, 40 nm) | 0295HW | 25g; |
| *Copper Nanopowder (Cu, carbon coated, 99.8%, 25 nm) | 0297JY | 5g; |
| *Iron Nanopowder (Fe, 99.9%, 500nm) | 0272YM | 100g; 1kg; |
| *Iron Nanopowder (Fe, 99.9%, 100 nm) | 0264HW | 25g; |
| *Iron Nanopowder (Fe, 99.9%, 70 nm) | 0263HW | 25g; 100g; |
| *Iron Nanopowder (Fe, 99.9%, 40 nm) | 0262HW | 25g; 100g; |
| *Iron nanopowder, carbon coated (Fe/C, 99.6%, 25 nm) | 0267JY | 25g; |
| Germanium Nanopowder (Ge, 99.9+%, 600 nm) | 0327HW | 25g; |
| Germanium Nanopowder (Ge, 99.9%, 500 nm) | 0331HW | 1kg; |
| Germanium Nanopowder (Ge, 99.9+%, 400 nm) | 0326HW | 1kg; |
| Germanium Nanopowder (Ge, 99.9+%, 300 nm) | 0325HW | 1kg; |
| Germanium Nanopowder (Ge, 99.9+%, 200 nm) | 0323HW | 100g; kg; |
| Germanium Nanopowder (Ge, 99.9+%, 150 nm) | 0322HW | 咨询 |
| Germanium Nanopowder (Ge, 99.9+%, < 100 nm) | 0322HH | 咨询 |
| Germanium Nanopowder (Ge, 99.9+%, 20-50 nm) | 0321HW | 5g; |
| Iridium Nanopowder (Ir, 99.95%, 20-30 nm), wet powder in Deionized Water | 0771HW | 咨询 |
| *Molybdenum Nanopowder (Mo, 99.5%, 70 nm) | 0423HW | 咨询 |
| Niobium Nanopowder (Nb, 99.9%, 40-60 nm) | 0411HW | 咨询 |
| *Nickel Nanopowder (Ni, 99%, 800 nm) | 0302HW | 咨询 |
| *Nickel Nanopowder (Ni, 99%, 400 nm) | 0301HW | 100g; 1kg; |
| *Nickel Nanopowder (Ni, 99+%, 300 nm) | 0289HW | 1kg; |
| *Nickel Nanopowder (Ni, 99.5%, 100 nm) | 0285HW | 25g; |
| *Nickel Nanopowder (Ni, 99.9%, 80 nm) | 0284HW | 300g; |
| *Nickel Nanopowder (Ni, 99.5%, 70 nm) | 0288HW | 25g; |
| *Nickel Nanopowder (Ni, 99.5%, 40 nm) | 0283HW | 25g; |
| *Nickel Nanopowder, carbon coated (Ni/C, 99.9%, 20 nm) | 0287JY | 5g; |
| Palladium Nanopowder (Pd, 99.95%, 20-30 nm) | 0462HW | 咨询 |
| Platinum Nanopowder (Pt, 99.95%, 20-30 nm) | 0782HW | 咨询 |
| Platinum Nanopowder, PVP coated (Pt, 99.95%, 20-30 nm) | 0787HW | 1g; |
| Platinum Nanopowder (Pt, 99.9%, 20-30 nm) | 0786HW | 1g; 5g; |
| Rhodium Nanopowder (Rh, 99.95%, 20-30 nm) | 0451HW | 咨询 |
| Ruthenium Nanopowder (Ru, 99.95%, 20-30 nm) | 0441HW | 1g; |
| *Silicon Nanopowder (Si, 99%, 400 nm) | 0144HW | 100g; |
| *Silicon Nanopowder (Si, 99.9%, 100 nm) | 0149HW | 100g; |
| *Silicon Nanopowder (Si, > 97%, 50 nm) | 0145KE | 咨询 |
| *Silicon Nanopowder (Si, 99%, 30-50 nm) | 0147HW | 50g; |
| *Silicon Nanopowder (Si, 98+%, 30-50 nm) | 0141JS | 50g; 100g; 500g; 1kg; |
| Tin Nanopowder (Sn, 70 nm, w/PVP ) | 5522HW | 500g; |
| Tin Nanopowder (Sn, 99.9%, 60-80 nm) | 0501HW | 咨询 |
| *Tantalum Nanopowder (Ta, 99.9%, 40 nm) | 0225HW | 25g; |
| *Tantalum Nanopowder (Ta, 99.9%, 70 nm) | 0224HW | 25g; |
| *Titanium Nanopowder (Ti, 99%, 60-80 nm) | 0227HW | 25g / $361; |
| *Tungsten Powder (W, 99.5+%, 1-2 um) | 0747HW | 100g; |
| *Tungsten Nanopowder (W, 99.5%, 500 nm) | 0749HW | 1kg; |
| *Tungsten Nanopowder (W, 99.5%, <100 nm) | 0745HW | 100g; |
| *Zinc Nanopowder (Zn, 99%, 500 nm) | 0318HW | 1kg; |
| *Zinc Nanopowder (Zn, 99.5%, 130 nm) | 0303HW | 25g; |
| *Zinc Nanopowder (Zn, 99.9+%, 100 nm) | 0306JY | 25g; |
| *Zinc Nanopowder (Zn, 99.5%, 80 nm) | 0304HW | 25g; |
| *Aluminum Nitride Nanopowder (AlN, Amorphous, <0.5um, 99.9%) | 1004HW | 咨询 |
| Aluminum Nitride Nanopowder (AlN, 99.9 %, 0.5 um) | 1005HW | 咨询 |
| *Aluminum Nitride Nanopowder (AlN, 99.5 %, 70-80 nm) | 1002HW | 咨询 |
| Boron Carbide Powder (B4C, 99%, 500 μm) | 1175HW | 咨询 |
| Boron Carbide Powder (B4C, 99%, 50 μm) | 1177HW | 咨询 |
| Boron Carbide Powder (B4C, 99%, 40 μm) | 1179HW | 1kg; |
| Boron Carbide Powder (B4C, 98%, 20μm) | 1172HW | 1kg; |
| Boron Carbide Powder (B4C, 98%, 10μm) | 1169HW | 1kg; |
| Boron Carbide Powder (B4C, 99%, 5 μm) | 1165HW | 1kg; |
| Boron Carbide Powder (B4C, 99%, 2 um) | 1183HW | 1 kg; |
| Boron Carbide Powder (B4C, 99+%, 1-2 μm) | 1162HW | 咨询 |
| Boron Carbide Nanopowder (B4C, 99+%, 500 nm) | 1160HW | 500g; |
| Boron Carbide Nanopowder (B4C, 99%, 50nm) | 1161HY | 100g; |
| Boron Nitride Powder (BN, hexagonal, 99.8%, 0.6-1.2um) | 1182HW | 咨询 |
| Boron Nitride Nanopowder (BN, hexagonal, 99%, 137 nm) | 1180YL | 25g; |
| Boron Nitride Nanoplates (BN, 99.5+%, 100 nm) | 1183NJ | 100g; |
| Chromium Carbide Nanopowder (Cr3C2, 99.9%, <100 nm) | 0247HW | 500g; 1kg; |
| Hafnium Boride Nanopowder (HfB2, 99+%, 60 nm) | 1010JC | 100g; |
| Hafnium Carbide Nanopowder (HfC, 99+%, 200 nm) | 1005JC | 500g; |
| Hafnium Carbide Nanopowder (HfC, 99+%, 60 nm) | 1006JC | 100g; |
| Hafnium Carbide Nanopowder (HfC, 99%, 50nm) | 1022JC | kg; |
| Niobium Carbide Nanopowder (NbC, 99.9%, 500 nm) | 3860YM | 咨询 |
| Silicon Carbide Powder (SiC, 500 um, 99%, Hexagonal) | 4652HW | 1kg; ; |
| Silicon Carbide Powder (SiC, 50 um, 99%, Hexagonal) | 4654HW | 1kg; ; |
| Silicon Carbide Micron Powder (SiC, Beta, 40um, 99+%) | 4645HW | 1kg; ; |
| Silicon Carbide Powder (SiC, Beta, 20um, 99+%) | 4643HW | 1kg; ; |
| Silicon Carbide Powder (SiC, Beta, 10um, 99+%) | 4641HW | 1kg; ; |
| Silicon Carbide Micron Powder (SiC, Beta, 7um, 99+%) | 4639HW | 100g; 1kg; ; |
| Silicon Carbide Powder (SiC, beta, 99.8%, 5 μm) | 4637HW | 100g; ; |
| Silicon Carbide Powder (SiC, beta, 99+%, 2 μm) | 4635HW | 咨询 |
| Silicon Carbide Powder (SiC, alpha, 99.9%, 2um) | 4627HY | 1kg; |
| Silicon Carbide Powder (SiC, 500 nm, 99%, Cubic) | 4656HW | 1kg; ; |
| Silicon Carbide Nanopowder (SiC, beta, 99%, 80-100 nm) | Stock # 4629HW | 100g; |
| Silicon Carbide Nanopowder (SiC, alpha, 99.9%, 55 nm) | 4625HY | 100g; |
| Silicon Carbide Nanopowder (SiC, beta, 97.5%, 45-55 nm) | 4620KE | 200g; |
| Silicon Carbide Nanopowder (SiC, alpha, 99.9%, 30 nm) | 4626HY | 100 g; 150 g; |
| Silicon Carbide Nanowhisker (beta, SiC, 99+%) | 4622HW | 25g; |
| Silicon Nitride Nanopowder (Si3N4, amorphous, 98.5+%, 15-30 nm) | 4750KE | 100g; |
| Titanium Boride Powder (TiB2, 2-12 μm ) | 5180HW | 100g |
| *Titanium Carbide Powder (TiC, 1 micron, 99%) | 5218YL | 500g; |
| *Titanium Carbide Nanoparticles (TiC, 100-200nm, 99+%) | 5217HW | 1kg; |
| Titanium Carbide (TiC, 99+%, 100 nm) | 5217JC | 100g; |
| *Titanium Carbide (TiC, 98+%, 80 nm) | 5220HT | 25g; 100g; |
| *Titanium Carbide Nanopowder (TiC, 97+%, 50 nm) | 5216KE | 100g; |
| *Titanium Nitride Powder (TiN, 99%, 1-3um) | 5352JC | 500g; 1kg; |
| *Titanium Nitride Nanoparticles (TiN, 99%, 100-200 nm) | 5357HW | 500g; |
| *Titanium Nitride Nanopowder (TiN, 97+%, 20 nm) | 5350KE | 100g; |
| Tungsten Carbide/Cobalt Nanopowder (8wt%Co/WC, < 200 nm, 99.5%) | 5561HW | 100g |
| Zirconium Carbide Nanopowder (ZrC, 99%, 8 um) | 5905KE | 100g; 250g; 500g; |
| *Zirconium Carbide Nanopowder (ZrC, 97%, 60 nm) | 5901KE | 100g; |
| *Zirconium Nitride Nanopowder (ZrN, 99.5%, 1-3um) | 6101JC | 500g; kg; |
| Zirconium Boride Nanopowder (ZrB2, 99%, 60 nm) | 5950JC | 100g; |
| Aluminum Oxide (Al2O3) Nanopowder (alpha, 99.9+%, 500 nm) | 1037HT | 100g; |
| Aluminum Oxide (Al2O3) Nanopowder (alpha, 99+%, 500 nm) | 1038HT | 100g; |
| Aluminum Oxide Nanopowder (alpha, aluminate coated, 98+%, 500 nm) | 1039HT | 100g; |
| Aluminum Oxide (Al2O3) Nanopowder (alpha, 99.9%, 200 nm) | Stock #:1040LQS | 100g |
| Aluminum Oxide (Al2O3) Nanopowder (alpha, 99.9%, 150 nm) | 1005MR | 100g ; |
| Aluminum Oxide (Al2O3) Nanopowder (alpha, 99.9+%, 40-50 nm) | 1044HT | 100g; |
| Aluminum Oxide (Al2O3) Nanopowder (alpha/theta, 99.99%, ~30nm ) | 1018WJ | 100g ; |
| Aluminum Oxide (Al2O3) Nanopowder (gamma, 99+%, 500 nm) | 1045HT | 100g; |
| Aluminum Oxide (Al2O3) Nanopowder (gamma, 99.97%, 20-30 nm) | 1020MR | 100g; 500g; 1kg; |
| Aluminum Oxide Nanopowder (gamma, 99.5%, 50 nm) | 1007XX | 咨询 |
| Aluminum Oxide (Al2O3) Nanopowder (gamma, 99.99%, 10 nm) | 1043HT | 100g; |
| Aluminum oxide nanopowder, (γ-phase) APS 20-30 nm, 99.95+% | 0125HW | 咨询 |
| Aluminum Oxide Nanopowder ( 99.99%, 30 nm ) for Lithium Batteries | 1016WJ | 咨询 |
| Aluminum Hydroxide Nanopowder (99.5 %, 50 nm) | 1040WJ | 咨询 |
| Boron Oxide Nanopowder (B2O3, 98%, 40-80 nm) | 1185DF | 咨询 |
| Boron Oxide Nanopowder (B2O3, 99%, 40-80 nm) | 1186DF | 1kg; |
| Bismuth Oxide Nanopowder (Bi2O3 , 99.9%, 100 nm) | 1171HT | kg; |
| Cerium Oxide, (CeO2, 99.99%, 200 nm) | 1445MG | 100g; |
| Cerium Oxide Nanopowder (CeO2, 99%, 50-100 nm) | 1408HW | 100g; |
| Cerium Oxide (CeO2, 99.99%, 20-30 nm) | 1444ZQ | 100g; |
| Cerium Oxide Nanopowder (CeO2, 99.9%, 15-30 nm) | 1406RE | 100g; |
| Cobalt(II,III) Oxide Nanopowder (Co3O4, 99%, 50-80 nm) | 1720HT | 咨询 |
| Chromium Oxide Powder (Cr2O3, 99.8%, 1 um) | 1920FY | 25g; 1kg; |
| Chromium Oxide Powder (Cr2O3, 99.9%, 100 nm) | 1925FY | 100g; 1kg; |
| Chromium Oxide Nanopowder (Cr2O3, 99+%, 60 nm) | 1910FY | 25g; |
| Copper(II) Oxide Nanopowder (CuO, 99+%, 30-50 nm) | 2110FY | 咨询 |
| Copper(I) Oxide Nanopowder (Cu2O, 99%, 30-50 nm) | 2113HW | 25g; 100g; 500g; 1kg; |
| Dysprosium Oxide Nanopowder (Dy2O3, 99.9%, 55 nm) | 2252YS | 25g; |
| Dysprosium Oxide Nanopowder (Dy2O3, 99.9%, 30-70 nm) | 2253ZQ | 25g; |
| Erbium Oxide Nanopowder (Er2O3, 99.9%, 43 nm) | 2310ZQ | 65g; |
| Erbium Oxide Nanopowder (Er2O3, 99.9%, 41-53 nm) | 2350YS | 25g; |
| Erbium Oxide Nanopowder (Er2O3, 99.9%, 20-30 nm) | 2330RE | 25g ; |
| Europium Oxide Nanopowder (Eu2O3, 99.995%, 58 nm) | 2410ZQ | 5g; |
| Europium Oxide Nanopowder (Eu2O3, 99.99%, 45-58 nm) | 2450YS | 5g; |
| Europium Oxide Nanopowder (Eu2O3, 99.99%, 30-50 nm) | 2411RE | 5g; |
| Iron(III) Oxide Nanopowder (Fe2O3, gamma, 99.98%, 50 nm) | 2527YM | 1kg |
| Iron(III) Oxide Nanopowder (Fe2O3, alpha, 99%, 30-50 nm) | 2520ZH | 25g; 100g; |
| Iron(III) Oxide Nanopowder (Fe2O3, alpha, 99%, 30 nm) | 2525WJ | 100g; |
| Iron(II,III) Oxide Nanopowder (Fe3O4, 99%, 100-200 nm) | 2653HW | 100g; |
| Iron(II,III) Oxide Nanopowder (Fe3O4, 97%, 50-100 nm) | 2650TS | 100g; |
| Iron(II,III) Oxide Nanopowder (Fe3O4, 99%, SSA: 9-14 m2/g, 50-100 nm) | 2655HW | 100g; 500g; 1kg; |
| Iron(II,III) Oxide Nanopowder (Fe3O4, 99%, 30 nm) | 2651WJ | 100g; |
| Iron Oxide Nanopowder (Fe3O4, PVP coated, 99+%, 20-30 nm) | 2657HW | 100g; 1kg; |
| Gadolinium Oxide Nanopowder (Gd2O3, 99.9+%, 20-80 nm) | 2680ZQ | 咨询 |
| Gadolinium Oxide Nanopowder (Gd2O3, 99.9%, 15-30 nm) | 2681RE | 咨询 |
| Hafnium Oxide Powder (HfO2, 99.99%, 48um) | 1045HW | 咨询 |
| Hafnium Oxide Powder (HfO2, 99%, 45um) | 1042HW | 咨询 |
| Indium Oxide Nanopowder (In2O3, 99.99%, 100-200 nm) | 2711TN | 咨询 |
| Indium Hydroxide Nanopowder (In(OH)3, 99.99%, 20-70 nm) | 2810TN | 咨询 |
| Lanthanum Oxide Nanopowder (La2O3, 99%, 50 nm) | 2922RE | 咨询 |
| Lanthanum Oxide Nanopowder (La2O3, 99.99%, 15-30 nm) | 2920RE | 咨询 |
| Magnesium Oxide Nanopowder (MgO, 99+%, 40-60 nm) | 3305HT | 咨询 |
| Neodymium Oxide Nanopowder (Nd2O3, 99.9%, 40nm) | 3912RE | 1kg; |
| Magnesium Oxide Nanopowder (MgO, 99+%, 40 nm) | 3304HT | 咨询 |
| Magnesium Hydroxide Nanopowder (Mg(OH)2, 98+%, 100 nm) | 3321HT | 咨询 |
| Molybdenum(VI) Oxide Nanopowder (MoO3 , 99.5%, 100 nm) | 3851XW | 咨询 |
| Neodymium Oxide Nanopowder (Nd2O3, 99.9+%, 83 nm) | 3910ZQ | 咨询 |
| Neodymium Oxide Nanopowder (Nd2O3, 99.9%, 49-64 nm) | 3950YS | 咨询 |
| Neodymium Oxide Nanopowder (Nd2O3, 99.9%, 40nm) | 3912RE | 咨询 |
| Neodymium Oxide Nanopowder (Nd2O3, 99.9%, 15-30 nm) | 3911RE | 25g; |
| Nickel Oxide Nanopowder (Ni2O3, 99.9%, 20-30 nm) | 4216HW | 100g; |
| Praseodymium Oxide Nanopowder (Pr6O11, 99.9%, 15-30 nm) | 4451RE | 25g; |
| Antimony Oxide Nanoparticles (Sb2O3, 99.99%, 20-30nm) | 6850HW | 咨询 |
| Silicon Oxide Powder (SiO2 , quartz, 99.99%, 1-3.5 μm) | 4856WG | 咨询 |
| Silicon Oxide Powder (SiO2 , quartz, 99.998%, 1-3.5um) | 4855WG | 咨询 |
| Silicon Oxide Nanopowder (SiO2 , 99+%, 20 nm) | 4830HT | 咨询 |
| Silicon Oxide Nanopowder (99+%, 20 nm, hydrophilic & lipophilic) | 4831HT | 咨询 |
| Silicon Oxide Nanopowder (99+%, 20 nm, hydrophilic & lipophilic) | 4832HT | 咨询 |
| Silicon Oxide Nanopowder (99+%, 20 nm, hydrophilic & lipophilic) | 4833HT | 咨询 |
| Samarium Oxide Nanopowder (Sm2O3, 99.9%, 42-55 nm) | 4950YS | 咨询 |
| Samarium Oxide Nanopowder (Sm2O3, 99.9%, 15-30 nm) | 4951RE | 咨询 |
| Titanium Oxide Nanopowder (TiO2, amorphous/anatase, 99+%, 5 nm) | 5416HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, anatase, 99%, 10-30 nm) | 5420HT | 咨询 |
| Titanium Oxide Nanopowder(TiO2, anatase, 99%,15 nm) | 5430MR | 咨询 |
| Titanium Oxide Nanopowder (TiO2, anatase, 99+%, 10 nm) | 5417HT | 咨询 |
| Titanium Oxide Nanopowder (tungsten oxide doped, TiO2/WO3, anatase, 10 nm) | 5418HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, anatase, 5 nm) | 5421ZH | 咨询 |
| Titanium Oxide Nanotubes (TiO2, anatase, 99%, 10-15 nm) | 5432HW | 咨询 |
| Titanium Oxide Nanopowder (TiO2, anatase/rutile, 99+%, 20 nm) | 5419HT | 咨询 |
| Titanium oxide, silica & alumina coated (anatase/rutile, 30 nm) | 5426HT | 咨询 |
| Titanium oxide (silica, alumina & stearic acid coated, anatase/rutile, 30 nm) | 5427HT | 咨询 |
| Titanium Oxide Nanopowder (silica, alumina & silicone oil coated, anatase/rutile, 30 nm) | 5428HT | 咨询 |
| Titanium oxide, silica coated (anatase/rutile, 20 nm) | 5422HT | 咨询 |
| Titanium oxide, silica & alumina coated (anatase/rutile, 20 nm) | 5423HT | 咨询 |
| Titanium oxide, silica & stearic acid coated (anatase/rutile, 20 nm) | 5424HT | 咨询 |
| Titanium oxide, silica & silicone oil coated (anatase/rutile, 20 nm) | 5425HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, rutile, 99.9+%, 500 nm) | 5429HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, rutile, 99.9+%, 150 nm) | 5430HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, rutile, 99.9+%, 100 nm) | 5431HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, rutile, 99.8%, 60 nm) | 5486WJ | 咨询 |
| Titanium Oxide Nanopowder (TiO2, rutile, 99.8%, 20-50 nm) | 5484WJ | 咨询 |
| Titanium Oxide (TiO2, rutile, coated with silicon oxide, 20 nm) | 0302HT | 咨询 |
| Titanium Oxide (TiO2, rutile, coated with silicon oxide, 20 nm) | 0301HT | 咨询 |
| Vanadium Oxide Nanopowder (VO2, 99.9+%, 100 - 200 nm) | 5495HW | 咨询 |
| 1.5% Tungsten-doped Vanadium Oxide Nanopowder (W-doped VO2, 99.9+%, 30 - 50 nm) | 5499HW | 咨询 |
| 1% Tungsten-doped Vanadium Oxide Nanopowder (W-doped VO2, 99.9+%, 30 - 50 nm) | 5498HW | 咨询 |
| Tungsten Oxide Nanopowder (WO3, 99.5%, 60-120 nm) | 5508YL | 咨询 |
| Tungsten Oxide Nanopowder (WO3, 99.9+%, 40-50 nm) | 5506BD | 咨询 |
| Tungsten Oxide Nanopowder (WO3, 99+%, 30-70 nm) | 5505YL | 咨询 |
| Tungsten Oxide Nanopowder (WO3, 99+%, 30-70 nm, PVP-coated) | 5506YL | 咨询 |
| Yttrium Oxide Nanopowder (Y2O3, 99.995%, 50-70 nm) | 5610ZQ | 咨询 |
| Yttrium Oxide Nanopowder (Y2O3, 99.99%, 20-40 nm) | 5611RE | 咨询 |
| Yttrium Oxide Nanopowder (Y2O3, 99.9%, 32-36 nm) | 5650YS | 咨询 |
| Yttrium Oxide Nanopowder (Y2O3, 99.995%, 20-40 nm) | 5611ZQ | 咨询 |
| Ytterbium Oxide Nanopowder (Yb2O3, 10-80 nm, 99.9%) | 5671RE | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 99+%, 800 nm) | 5816HT | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 99%, 30 nm) | 5811HT | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 98+%, 30 nm, hydrophilic & lipophilic) | 5812HT | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 98+%, 30 nm, silicone oil coated) | 5814HT | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 98+%, 30 nm, stearic acid coated) | 5815HT | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 99%, 20 nm) | 5810HT | 咨询 |
| Zirconium Oxide Nanopowder (ZrO2, 99+%, 50 nm) | 5936HT | 咨询 |
| Zirconium Oxide Nanopowder (ZrO2, 99.5+%, 20 nm) | 5931HT | 咨询 |
| Zirconia Nanopowder, Yttria Doped (ZrO2/3 mol% Y2O3, 99.5+%, 15-50 nm) | 5932HT | 咨询 |
| Zirconia Nanopowder, Yttria Doped (ZrO2/5 mol% Y2O3, 99.5+%, 15-50 nm) | 5934HT | 咨询 |
| Zirconia Nanopowder, Yttria Doped (ZrO2/8 mol% Y2O3, 99.5+%, 15-50 nm) | 5933HT | 咨询 |
| Zirconia Nanopowder, Calcia Doped (ZrO2/8 mol%CaO, 99.9%, 20-30 nm) | 5934ZS | 咨询 |
| Barium Titanate Nanopowder (BaTiO3 , 99.9%, 400 nm) | 1146DY | 100g; |
| Barium Titanate Nanopowder (BaTiO3 , 99.9%, 300 nm) | 1144DY | 咨询 |
| Barium Titanate Nanopowder (BaTiO3 , 99.5%, 100-200 nm) | 1148DY | 咨询 |
| Cobalt Iron Oxides Nanopowder (CoFe2O4, 98%, 35-55 nm) | 1510FY | 25g ; 100g; |
| Cobalt-Zinc Iron Oxide Nanopowder (Co0.5Zn0.5Fe2O4, 99.5%, 30-50 nm) | 1515FY | 25g ; 100g; |
| Indium Tin Oxide Nanopowder (In2O3:SnO2 = 90wt%:10wt%, 99.99%, 20-70 nm) | 2730TN | 5g; 25g; |
| Indium Tin Oxide Nanopowder (In2O3:SnO2 = 95 wt%:5 wt%, 99.99%, 30-50 nm) | 2731BY | 5g; 25g; |
| Nickel-Zinc Iron Oxide Nanopowder (Ni0.5Zn0.5Fe2O4, 98.5%, 10-30 nm) | 4115FY | 100g; 500g; |
| *Ni80Fe17Mo3 permalloy nanopowder (99+%, 70 nm) | 9288HW | 100g; |
| Yttrium Aluminate w/Nd doped (Y2.98Nd0.02Al5O12, Nd-YAG, 99.5%, 40 nm) | 5571FY | 25g; 100g; |
| Zinc Iron Oxide Nanopowder (ZnFe2O4, 98.5%, 40 nm) | 5710FY | 100g; |
更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
Synaptic Systems为神经科学家和细胞生物学科学家提供研究工具,致力于为神经科学和细胞生物学访方面提供最好的抗体。
Synaptic Systems strives to provide you with the best antibodies in neuroscience and cell biology. Most antibodies are exclusively available from Synaptic Systems and have been developed in-house in close collaboration with renowned experts in the field. Our antibodies are well characterized and known for their excellent quality. We are constantly adding new products and offer attractive licensing conditions.
Synaptic system的主要产品包括：
突触活性区相关抗体
Alzheimer's相关抗体
钙离子结合蛋白相关抗体
细胞粘附分子相关抗体
细胞骨架相关抗体
离子通道相关抗体
神经递质转运体相关抗体
突触后蛋白相关抗体
受体蛋白相关抗体
RNA修饰蛋白相关抗体
SNARE蛋白相关抗体
snRNPs相关抗体
突触粘附蛋白相关抗体
转录因子相关抗体
囊泡相关抗体
其它神经/细胞生物学研究抗体
<更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
" data-original="http://genvivo.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Synaptic Systems"> Synaptic Systems
艾美捷科技代理Badrilla 品牌。
Badrilla公司拥有一支由经验丰富的科学家和工程师组成的研发团队，他们在心血管研究领域具有深厚的专业知识和丰富的实践经验，特别是蛋白质S-棕榈酰化在疾病中的作用，并确保在您的实验系统中准确、精确和可靠地测量生物标志物浓度。Badrilla公司的主要产品包括用于心血管研究的各种高质量试剂和工具。这些产品旨在帮助研究人员深入了解心血管系统的生理和病理过程，从而推动心血管疾病的治疗和预防。
具体来说，Badrilla公司的产品和服务可能涵盖以下几个方面：
（1）蛋白质研究工具：提供高质量的蛋白质试剂，帮助研究人员研究蛋白质的结构和功能，以及蛋白质在心血管疾病中的作用。
（2）心血管研究试剂：包括用于研究心肌兴奋-收缩耦联、心律失常、心肌肥大和心脏衰竭等心血管疾病的试剂。
（3）定制服务：根据研究人员的具体需求，提供定制化的试剂和服务，以满足其独特的研究需求。
<<< " data-original="http://genvivo.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Badrilla品牌"> 艾美捷科技代理Badrilla品牌
艾美捷科技代理Bachem全系列产品。
Bachem是世界上最著名的多肽合成产品生产企业。总部设在瑞士（Bubendorf），两个生产厂位于瑞士和美国加利福尼亚。30多年开发生产合成多肽原料药的经验，在世界合成多肽市场占垄断地位。有世界上最大的液相和固相多肽合成能力，除医药生产用GMP产品外，还提供包括7000多种供给实验室研究所应用的多肽片段、保护氨基酸、酶阻遏剂、生物免疫产品，以及免疫诊断学试剂。
Bachem的产品列表如下：
| 品名 | 结构 | 货号 | 老货号 |
| (Trp⁴)-Octreotide acetate salt | H-D-Phe-Cys-Phe-Trp-Lys-Thr-Cys-L-threoninol | 4051517 | |
| (Des-His¹)-Glucagon trifluoroacetate salt | H-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr-OH | 4090288 | |
| (Des-Gly²⁹)-Liraglutide trifluoroacetate salt | H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(γ-Glu-palmitoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Arg-Gly-OH | 4100023 | |
| (Des-Gly³¹)-Liraglutide trifluoroacetate salt | H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(γ-Glu-palmitoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-OH | 4100024 | |
| (Kyn²⁵)-Liraglutide trifluoroacetate salt | H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(γ-Glu-palmitoyl)-Glu-Phe-Ile-Ala-Kyn-Leu-Val-Arg-Gly-Arg-Gly-OH | 4100025 | |
| (D-Ala¹⁸)-Liraglutide trifluoroacetate salt | H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-D-Ala-Ala-Lys(γ-Glu-palmitoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH | 4108787 | |
| (2-(1,3-Dithiolan-2-yl)-Trp²⁵)-Liraglutide trifluoroacetate salt | -His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(γ-Glu-palmitoyl)-Glu-Phe-Ile-Ala-2-(1,3-dithiolan-2-yl)-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH | 4109712 | |
| (2-(2-Trifluoromethyl-1,3-dithiolan-2-yl)-Trp²⁵)-Liraglutide trifluoroacetate salt | H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(γ-Glu-palmitoyl)-Glu-Phe-Ile-Ala-2-(2-trifluoromethyl-1,3-dithiolan-2-yl)-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH | 4109713 | |
| (Aspartimide¹⁵)-Glucagon trifluoroacetate salt | H-His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Aspartimide-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr-OH | 4141504 | |
| Acetyl-(Phe¹)-Octreotide trifluoroacetate salt | Ac-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-L-threoninol | 4141615 | |
| (Des-Ser⁸)-Liraglutide trifluoroacetate salt | H-His-Ala-Glu-Gly-Thr-Phe-Thr-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(γ-Glu-palmitoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH | 4144462 | |
| (β-Ala²⁹)-Glucagon trifluoroacetate salt | H-His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-β-Ala-OH | 4141502 | |
| (Aspartimide²¹)-Glucagon trifluoroacetate salt | H-His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Aspartimide-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr-OH | 4141503 | |
| (2-Hydroxy-Trp²⁵)-Liraglutide trifluoroacetate salt | H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(γ-Glu-palmitoyl)-Glu-Phe-Ile-Ala-2-hydroxy-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH | 4144317 | |
| Palmitoyl-Gly-Gln-Pro-Arg-OH | Palmitoyl-Gly-Gln-Pro-Arg-OH | 4145516 | |
| Pal-GHK | Palmitoyl-Gly-His-Lys-OH | 4142828 | |
| H-Pro-Hyp-OH | H-Pro-Hyp-OH | 4001630 | G-3025 |
| Z-Gly-Pro-Gly-Gly-Pro-Ala-OH | Z-Gly-Pro-Gly-Gly-Pro-Ala-OH | 4002149 | M-1260 |
| Z-Gly-Gly-Arg-AMC · HCl | Z-Gly-Gly-Arg-AMC · HCl | 4002155 | I-1140 |
| H-Leu-Leu-Leu-OH | H-Leu-Leu-Leu-OH | 4002312 | H-3915 |
| (H-Cys-Gly-OH)₂ | (H-Cys-Gly-OH)₂ (Disulfide bond) | 4002368 | G-1815 |
| Glutaryl-Gly-Arg-AMC | Glutaryl-Gly-Arg-AMC | 4005950 | I-1195 |
| Angiotensin II | H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-OH | 4006473 | H-1705 |
| Dynorphin A | H-Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln-OH | 4007832 | H-2620 |
| H-Gly-Pro-Hyp-OH | H-Gly-Pro-Hyp-OH | 4008512 | H-3630 |
| Ac-muramyl-Ala-D-Glu-NH₂ | Ac-muramyl-Ala-D-Glu-NH₂ | 4009623 | G-1055 |
| CRF (human, rat) | H-Ser-Glu-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-Leu-Met-Glu-Ile-Ile-NH₂ | 4011473 | H-2435 |
| pTH (1-34) (human) | H-Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-OH | 4011474 | H-4835 |
| α-CGRP (human) | H-Ala-Cys-Asp-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH₂ (Disulfide bond) | 4013281 | H-1470 |
| Amyloid β-Protein (1-42) | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | 4014447 | H-1368 |
| Ac-muramyl-Ala-D-Glu(Lys(stearoyl)-OH)-NH₂ | Ac-muramyl-Ala-D-Glu(Lys(stearoyl)-OH)-NH₂ | 4015937 | H-9905 |
| ω-Conotoxin GVIA | H-Cys-Lys-Ser-Hyp-Gly-Ser-Ser-Cys-Ser-Hyp-Thr-Ser-Tyr-Asn-Cys-Cys-Arg-Ser-Cys-Asn-Hyp-Tyr-Thr-Lys-Arg-Cys-Tyr-NH₂ (Disulfide bonds between Cys¹ and Cys¹⁶/Cys⁸ and Cys¹⁹/ Cys¹⁵ and Cys²⁶) | 4016306 | H-6615 |
| Cyclo(-Asp-Phe) | Cyclo(-Asp-Phe) | 4016611 | G-1695 |
| Boc-Glu(OBzl)-Ala-Arg-AMC · HCl | Boc-Glu(OBzl)-Ala-Arg-AMC · HCl | 4017302 | I-1575 |
| MCH (human, mouse, rat) | H-Asp-Phe-Asp-Met-Leu-Arg-Cys-Met-Leu-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp-Gln-Val-OH (Disulfide bond) | 4025037 | H-1482 |
| (D-Trp⁶,D-Leu⁷)-LHRH | Pyr-His-Trp-Ser-Tyr-D-Trp-D-Leu-Arg-Pro-Gly-NH₂ | 4025366 | H-4648 |
| H-Ala-Ala-Gln-OH | H-Ala-Ala-Gln-OH | 4026080 | H-2552 |
| H-Gly-Gly-Gly-OH | H-Gly-Gly-Gly-OH | 4026410 | H-3350 |
| Z-Val-Ala-DL-Asp-fluoromethylketone | Z-Val-Ala-DL-Asp-fluoromethylketone | 4026865 | N-1510 |
| Z-Val-Ala-DL-Asp(OMe)-fluoromethylketone | Z-Val-Ala-DL-Asp(OMe)-fluoromethylketone | 4027403 | N-1560 |
| Homoglutathione | H-Glu(Cys-β-Ala-OH)-OH | 4027578 | H-3944 |
| MART-1 (26-35) (human) | H-Glu-Ala-Ala-Gly-Ile-Gly-Ile-Leu-Thr-Val-OH | 4027904 | H-4102 |
| Orexin A (human, mouse, rat) | Pyr-Pro-Leu-Pro-Asp-Cys-Cys-Arg-Gln-Lys-Thr-Cys-Ser-Cys-Arg-Leu-Tyr-Glu-Leu-Leu-His-Gly-Ala-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Leu-NH₂ (Disulfide bonds between Cys⁶ and Cys¹²/Cys⁷ and Cys¹⁴) | 4028262 | H-4172 |
| Orexin B (human) | H-Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH₂ | 4028263 | H-4174 |
| ω-Agatoxin IVa | H-Lys-Lys-Lys-Cys-Ile-Ala-Lys-Asp-Tyr-Gly-Arg-Cys-Lys-Trp-Gly-Gly-Thr-Pro-Cys-Cys-Arg-Gly-Arg-Gly-Cys-Ile-Cys-Ser-Ile-Met-Gly-Thr-Asn-Cys-Glu-Cys-Lys-Pro-Arg-Leu-Ile-Met-Glu-Gly-Leu-Gly-Leu-Ala-OH (Disulfide bonds between Cys⁴ and Cys²⁰/Cys¹² and Cys²⁵/Cys¹⁹ and Cys³⁶/Cys²⁷ and Cys³⁴) | 4030173 | H-1544 |
| Amylin (human) | H-Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH₂ (Disulfide bond) | 4030200 | H-7905 |
| Antipain | [(S)-1-Carboxy-2-phenyl-ethyl]-carbamoyl-Arg-Val-Arg-aldehyde | 4030290 | H-1765 |
| ACTH (1-39) (human) | H-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe-OH | 4030325 | H-1160 |
| Gastric Juice Peptide Fragment | H-Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val-OH | 4030660 | H-2074 |
| rec HIV-1 Protease (affinity purified) (expressed in E. coli) | 4030740 | H-1256 | |
| KALA Amphipathic Peptide | H-Trp-Glu-Ala-Lys-Leu-Ala-Lys-Ala-Leu-Ala-Lys-Ala-Leu-Ala-Lys-His-Leu-Ala-Lys-Ala-Leu-Ala-Lys-Ala-Leu-Lys-Ala-Cys-Glu-Ala-OH | 4030798 | H-4096 |
| Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH₂ | Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH₂ | 4030842 | M-2110 |
| (Ile⁸)-Oxytocin | H-Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Ile-Gly-NH₂ (Disulfide bond) | 4030888 | H-2505 |
| Nociceptin | H-Phe-Gly-Gly-Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-Leu-Ala-Asn-Gln-OH | 4031112 | H-3036 |
| pp60 c-src (521-533) (phosphorylated) | H-Thr-Ser-Thr-Glu-Pro-Gln-Tyr(PO₃H₂)-Gln-Pro-Gly-Glu-Asn-Leu-OH | 4031184 | H-3258 |
| Cholecystokinin Octapeptide (sulfated) | H-Asp-Tyr(SO₃H)-Met-Gly-Trp-Met-Asp-Phe-NH₂ | 4033010 | H-2080 |
| Glucagon (1-29) (human, rat, porcine) | H-His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr-OH | 4033017 | H-6790 |
| Biotinyl-α-CGRP (human) | Biotinyl-Ala-Cys-Asp-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH₂ (Disulfide bond) | 4038212 | H-5688 |
| Hepcidin-25 (human) | H-Asp-Thr-His-Phe-Pro-Ile-Cys-Ile-Phe-Cys-Cys-Gly-Cys-Cys-His-Arg-Ser-Lys-Cys-Gly-Met-Cys-Cys-Lys-Thr-OH (Disulfide bonds between Cys⁷ and Cys²³/Cys¹⁰ and Cys¹³/Cys¹¹ and Cys¹⁹/Cys¹⁴ and Cys²²) | 4040671 | H-5926 |
| H-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-OH | H-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-OH | 4040952 | H-6256 |
| LL-37 | H-Leu-Leu-Gly-Asp-Phe-Phe-Arg-Lys-Ser-Lys-Glu-Lys-Ile-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-Thr-Glu-Ser-OH | 4042456 | H-7298 |
| GLP-1 (7-36)-Lys(biotinyl) amide (human, bovine, guinea pig, mouse, rat) | H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Lys(biotinyl)-NH₂ | 4042611 | H-5956 |
| Thymosin β₄ (human, bovine, horse, rat) | Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser-OH | 4043020 | H-2608 |
| Enterotoxin STp (E. coli) | H-Asn-Thr-Phe-Tyr-Cys-Cys-Glu-Leu-Cys-Cys-Asn-Pro-Ala-Cys-Ala-Gly-Cys-Tyr-OH (Disulfide bonds between Cys⁵ and Cys¹⁰/Cys⁶ and Cys¹⁴/Cys⁹ and Cys¹⁷) | 4044297 | H-6248 |
| DABCYL-Lys-HCoV-SARS Replicase Polyprotein 1ab (3235-3246)-Glu-EDANS | DABCYL-Lys-Thr-Ser-Ala-Val-Leu-Gln-Ser-Gly-Phe-Arg-Lys-Met-Glu-EDANS | 4045664 | M-2575 |
| BAM-22P (8-22) | H-Val-Gly-Arg-Pro-Glu-Trp-Trp-Met-Asp-Tyr-Gln-Lys-Arg-Tyr-Gly-OH | 4047224 | H-7618 |
| Biotinyl-Hepcidin-25 (human) | Biotinyl-Asp-Thr-His-Phe-Pro-Ile-Cys-Ile-Phe-Cys-Cys-Gly-Cys-Cys-His-Arg-Ser-Lys-Cys-Gly-Met-Cys-Cys-Lys-Thr-OH (Disulfide bonds between Cys⁷ and Cys²³/Cys¹⁰ and Cys¹³/Cys¹¹ and Cys¹⁹/Cys¹⁴ and Cys²²) | 4056950 | H-6674 |
| Amyloid β-Protein (1-42) | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | 4061966 | H-8146 |
| Cyclo(-Arg-Gly-Asp-D-Phe-Cys) | Cyclo(-Arg-Gly-Asp-D-Phe-Cys) | 4069272 | H-7226 |
| Cyclo(-Arg-Gly-Asp-D-Phe-Lys) | Cyclo(-Arg-Gly-Asp-D-Phe-Lys) | 4069635 | H-7326 |
| Cyclo(-Arg-Ala-Asp-D-Tyr-Lys) | Cyclo(-Arg-Ala-Asp-D-Tyr-Lys) | 4088969 | H-8144 |
| Covidyte™ TF670 | H-Lys(TQ5)-Thr-Ser-Ala-Val-Leu-Gln-Ser-Gly-Phe-Arg-Lys-Met-Glu-Cys(TF5)-OH | 4152546 | |
| Liver Cell Growth Factor | H-Gly-His-Lys-OH | 4000308 | H-3510 |
| H-Phe-Phe-OH | H-Phe-Phe-OH | 4000605 | G-2925 |
| H-Ala-Lys-OH · HCl | H-Ala-Lys-OH · HCl | 4000977 | G-1290 |
| H-Leu-Ala-OH | H-Leu-Ala-OH | 4001002 | G-2460 |
| Fmoc-Ala-Ala-OH | Fmoc-Ala-Ala-OH | 4003251 | B-1470 |
| Cholecystokinin Octapeptide (desulfated) | H-Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe-NH₂ | 4003323 | H-2085 |
| Neurotensin | Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu-OH | 4006469 | H-4435 |
| β-Endorphin (bovine, camel, mouse) | H-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-His-Lys-Lys-Gly-Gln-OH | 4007396 | H-2705 |
| Boc-Glu-Lys-Lys-AMC | Boc-Glu-Lys-Lys-AMC | 4007739 | I-1095 |
| H-Gly-Arg-Gly-Asp-Ser-OH | H-Gly-Arg-Gly-Asp-Ser-OH | 4008998 | H-1345 |
| Thymic Factor | Pyr-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn-OH | 4009914 | H-4865 |
| Neuropeptide Y (human, rat) | H-Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH₂ | 4012616 | H-6375 |
| Beauvericin | Cyclo(-D-α-hydroxyisovaleryl-N-Me-Phe)₃ | 4013628 | H-2135 |
| (Thr⁴,Gly⁷)-Oxytocin | H-Cys-Tyr-Ile-Thr-Asn-Cys-Gly-Leu-Gly-NH₂ (Disulfide bond) | 4013837 | H-7710 |
| Fmoc-Phe-Phe-OH | Fmoc-Phe-Phe-OH | 4015688 | B-2150 |
| CRF (ovine) | H-Ser-Gln-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Thr-Lys-Ala-Asp-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-Leu-Leu-Asp-Ile-Ala-NH₂ | 4016199 | H-2445 |
| Oxytocin | H-Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH₂ (Disulfide bond) | 4016373 | H-2510 |
| pTH-Related Protein (1-34) (human, mouse, rat) | H-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-OH | 4017147 | H-6630 |
| TRAP-6 | H-Ser-Phe-Leu-Leu-Arg-Asn-OH | 4017752 | H-8365 |
| Defensin HNP-2 (human) | H-Cys-Tyr-Cys-Arg-Ile-Pro-Ala-Cys-Ile-Ala-Gly-Glu-Arg-Arg-Tyr-Gly-Thr-Cys-Ile-Tyr-Gln-Gly-Arg-Leu-Trp-Ala-Phe-Cys-Cys-OH (Disulfide bonds between Cys¹ and Cys²⁹/Cys³ and Cys¹⁸/Cys⁸ and Cys²⁸) | 4025474 | H-9005 |
| H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH₂ | H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH₂ (Disulfide bond) | 4025623 | H-2186 |
| Decanoyl-Arg-Val-Lys-Arg-chloromethylketone | Decanoyl-Arg-Val-Lys-Arg-chloromethylketone | 4026850 | N-1505 |
| L-Anserine · nitrate | H-β-Ala-His(3-Me)-OH · nitrate | 4027810 | G-4555 |
| GLP-2 (1-34) (human) | H-His-Ala-Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Ala-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp-Arg-OH | 4029353 | H-4766 |
| Cyclo(-Phe-Pro) | Cyclo(-Phe-Pro) | 4029456 | G-4720 |
| Cyclo(-Pro-Val) | Cyclo(-Pro-Val) | 4029472 | G-4730 |
| Adrenomedullin (human) | H-Tyr-Arg-Gln-Ser-Met-Asn-Asn-Phe-Gln-Gly-Leu-Arg-Ser-Phe-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH₂ (Disulfide bond) | 4030315 | H-2932 |
| α-Dendrotoxin | Pyr-Pro-Arg-Arg-Lys-Leu-Cys-Ile-Leu-His-Arg-Asn-Pro-Gly-Arg-Cys-Tyr-Asp-Lys-Ile-Pro-Ala-Phe-Tyr-Tyr-Asn-Gln-Lys-Lys-Lys-Gln-Cys-Glu-Arg-Phe-Asp-Trp-Ser-Gly-Cys-Gly-Gly-Asn-Ser-Asn-Arg-Phe-Lys-Thr-Ile-Glu-Glu-Cys-Arg-Arg-Thr-Cys-Ile-Gly-OH (Disulfide bonds between Cys⁷ and Cys⁵⁷/Cys¹⁶ and Cys⁴⁰/Cys³² and Cys⁵³) | 4030552 | H-1088 |
| (Ser¹⁴⁰)-Myelin Proteolipid Protein (139-151) (depalmitoylated) (human, bovine, dog, mouse, rat) | H-His-Ser-Leu-Gly-Lys-Trp-Leu-Gly-His-Pro-Asp-Lys-Phe-OH | 4030575 | H-2478 |
| H-Gly-Arg-Gly-Asp-Ser-Pro-Cys-OH | H-Gly-Arg-Gly-Asp-Ser-Pro-Cys-OH | 4030599 | H-7245 |
| rec IGF-II (1-67) (human) | H-Ala-Tyr-Arg-Pro-Ser-Glu-Thr-Leu-Cys-Gly-Gly-Glu-Leu-Val-Asp-Thr-Leu-Gln-Phe-Val-Cys-Gly-Asp-Arg-Gly-Phe-Tyr-Phe-Ser-Arg-Pro-Ala-Ser-Arg-Val-Ser-Arg-Arg-Ser-Arg-Gly-Ile-Val-Glu-Glu-Cys-Cys-Phe-Arg-Ser-Cys-Asp-Leu-Ala-Leu-Leu-Glu-Thr-Tyr-Cys-Ala-Thr-Pro-Ala-Lys-Ser-Glu-OH | 4030639 | H-7020 |
| Gastric Inhibitory Polypeptide (human) | H-Tyr-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln-OH | 4030658 | H-5645 |
| GLP-1 (7-36) amide (human, bovine, guinea pig, mouse, rat) | H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH₂ | 4030663 | H-6795 |
| rec HIV-1 Protease (expressed in E. coli) | 4030739 | H-9040 | |
| Anthranilyl-HIV Protease Substrate | Abz-Thr-Ile-Nle-p-nitro-Phe-Gln-Arg-NH₂ | 4030748 | H-2992 |
| PACAP-38 (human, mouse, ovine, porcine, rat) | H-His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH₂ | 4031157 | H-8430 |
| Stichodactyla helianthus Neurotoxin (ShK) | H-Arg-Ser-Cys-Ile-Asp-Thr-Ile-Pro-Lys-Ser-Arg-Cys-Thr-Ala-Phe-Gln-Cys-Lys-His-Ser-Met-Lys-Tyr-Arg-Leu-Ser-Phe-Cys-Arg-Lys-Thr-Cys-Gly-Thr-Cys-OH (Disulfide bonds between Cys³ and Cys³⁵/Cys¹² and Cys²⁸/Cys¹⁷ and Cys³²) | 4031286 | H-2358 |
| Thymosin α₁ | Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH | 4031308 | H-6945 |
| Biotinyl-ACTH (1-39) (human) | Biotinyl-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe-OH | 4033441 | H-7676 |
| (Ser(tBu)⁶,Azagly¹⁰)-LHRH | Pyr-His-Trp-Ser-Tyr-Ser(tBu)-Leu-Arg-Pro-Azagly-NH₂ | 4035307 | H-6644 |
| Aprotinin | H-Arg-Pro-Asp-Phe-Cys-Leu-Glu-Pro-Pro-Tyr-Thr-Gly-Pro-Cys-Lys-Ala-Arg-Ile-Ile-Arg-Tyr-Phe-Tyr-Asn-Ala-Lys-Ala-Gly-Leu-Cys-Gln-Thr-Phe-Val-Tyr-Gly-Gly-Cys-Arg-Ala-Lys-Arg-Asn-Asn-Phe-Lys-Ser-Ala-Glu-Asp-Cys-Met-Arg-Thr-Cys-Gly-Gly-Ala-OH (Disulfide bonds between Cys⁵ and Cys⁵⁵/Cys¹⁴ and Cys³⁸/Cys³⁰ and Cys⁵¹) | 4035911 | H-5834 |
| GHRP-2 | H-D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH₂ | 4037820 | H-5558 |
| (D-Ser(tBu)⁶,Azagly¹⁰)-LHRH | Pyr-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-Azagly-NH₂ | 4038252 | H-6395 |
| rec β-Defensin 1 (human) | 4038285 | H-5584 | |
| Xylazine · HCl | 4039613 | Q-1440 | |
| Biotinyl-α-CGRP (mouse, rat) | Biotinyl-Ser-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH₂ (Disulfide bond) | 4039845 | H-5684 |
| Carbetocin | Butyryl-Tyr(Me)-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH₂ (Sulfide bond between Butyryl-4-yl and Cys) | 4040269 | H-5832 |
| Tyrosinase (206-214) (human) | H-Ala-Phe-Leu-Pro-Trp-His-Arg-Leu-Phe-OH | 4040740 | H-3848 |
| LL-37 amide | H-Leu-Leu-Gly-Asp-Phe-Phe-Arg-Lys-Ser-Lys-Glu-Lys-Ile-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-Thr-Glu-Ser-NH₂ | 4046855 | H-6224 |
| Neuromedin S (human) | H-Ile-Leu-Gln-Arg-Gly-Ser-Gly-Thr-Ala-Ala-Val-Asp-Phe-Thr-Lys-Lys-Asp-His-Thr-Ala-Thr-Trp-Gly-Arg-Pro-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH₂ | 4048153 | H-6232 |
| HIV-1 tat Protein (47-57) | H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-OH | 4048761 | H-6254 |
| Lepirudin | H-Leu-Thr-Tyr-Thr-Asp-Cys-Thr-Glu-Ser-Gly-Gln-Asn-Leu-Cys-Leu-Cys-Glu-Gly-Ser-Asn-Val-Cys-Gly-Gln-Gly-Asn-Lys-Cys-Ile-Leu-Gly-Ser-Asp-Gly-Glu-Lys-Asn-Gln-Cys-Val-Thr-Gly-Glu-Gly-Thr-Pro-Lys-Pro-Gln-Ser-His-Asn-Asp-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu-Gln-OH (Disulfide bonds, random oxidized) | 4048773 | H-6618 |
| pTH (1-84) (rat) | H-Ala-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Ala-Ser-Val-Glu-Arg-Met-Gln-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-Val-Ser-Leu-Gly-Val-Gln-Met-Ala-Ala-Arg-Glu-Gly-Ser-Tyr-Gln-Arg-Pro-Thr-Lys-Lys-Glu-Glu-Asn-Val-Leu-Val-Asp-Gly-Asn-Ser-Lys-Ser-Leu-Gly-Glu-Gly-Asp-Lys-Ala-Asp-Val-Asp-Val-Leu-Val-Lys-Ala-Lys-Ser-Gln-OH | 4051303 | H-6396 |
| (Ser(Ac)⁴,D-Ser(tBu)⁶,Azagly¹⁰)-LHRH | Pyr-His-Trp-Ser(Ac)-Tyr-D-Ser(tBu)-Leu-Arg-Pro-Azagly-NH₂ | 4054732 | H-6646 |
| Spexin | H-Asn-Trp-Thr-Pro-Gln-Ala-Met-Leu-Tyr-Leu-Lys-Gly-Ala-Gln-NH₂ | 4057143 | H-6538 |
| Ac-Gly-Ala-Lys(Ac)-AMC | Ac-Gly-Ala-Lys(Ac)-AMC | 4060671 | I-1975 |
| (Cys⁴⁷)-HIV-1 tat Protein (47-57) | H-Cys-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-OH | 4066788 | H-7512 |
| Amyloid β-Protein (1-42) (HFIP-treated) | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH (HFIP-treated) | 4090148 | H-7442 |
| 5-FAM-HIV-1 tat Protein (47-57) | Fluorescein-5-carbonyl-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-OH | 4091600 | H-7522 |
| Collagen Type I α1 chain (502-516) | H-Gly-Phe-Hyp-Gly-Glu-Arg-Gly-Val-Glu-Gly-Pro-Hyp-Gly-Pro-Ala-NH₂ | 4109341 | |
| H-Lys-Phe-Glu-Arg-Gln-OH | H-Lys-Phe-Glu-Arg-Gln-OH | 4144562 | |
| Maurocalcine | H-Gly-Asp-Cys-Leu-Pro-His-Leu-Lys-Leu-Cys-Lys-Glu-Asn-Lys-Asp-Cys-Cys-Ser-Lys-Lys-Cys-Lys-Arg-Arg-Gly-Thr-Asn-Ile-Glu-Lys-Arg-Cys-Arg-OH (Disulfide bonds, air oxidized) | 4147994 | |
| H-Gly-Gly-Gly-Gly-OH | H-Gly-Gly-Gly-Gly-OH | 4000406 | H-3380 |
| Aspartame | H-Asp-Phe-OMe | 4000411 | G-1545 |
| Z-Phe-Phe-OH | Z-Phe-Phe-OH | 4000601 | C-2420 |
| H-Leu-Leu-OMe · HBr | H-Leu-Leu-OMe · HBr | 4000725 | G-2550 |
| Z-Leu-Leu-OH | Z-Leu-Leu-OH | 4001607 | C-2150 |
| H-Ala-Glu-OH | H-Ala-Glu-OH | 4002318 | G-1200 |
| H-Trp-Lys-OH | H-Trp-Lys-OH | 4002439 | G-3800 |
| Thymopentin | H-Arg-Lys-Asp-Val-Tyr-OH | 4002968 | H-5805 |
| Ac-Met-OH | Ac-Met-OH | 4003668 | E-1135 |
| H-Ala-Ala-OH | H-Ala-Ala-OH | 4004429 | G-1120 |
| Dynorphin B | H-Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Gln-Phe-Lys-Val-Val-Thr-OH | 4007171 | H-2675 |
| Boc-Phe-Leu-Phe-Leu-Phe-OH | Boc-Phe-Leu-Phe-Leu-Phe-OH | 4007828 | A-2200 |
| H-Arg-Gly-Asp-Ser-OH | H-Arg-Gly-Asp-Ser-OH | 4008997 | H-1155 |
| Substance P | H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH₂ | 4010600 | H-1890 |
| H-Ala-His-Lys-OH | H-Ala-His-Lys-OH | 4012005 | H-1555 |
| pTH (1-34) (rat) | H-Ala-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Ala-Ser-Val-Glu-Arg-Met-Gln-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-OH | 4012212 | H-5460 |
| Biotinyl-pTH (1-34) (human) | Biotinyl-Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-OH | 4012222 | H-2150 |
| (Deamino-Cys¹,D-Arg⁸)-Vasopressin | 3-Mercaptopropionyl-Tyr-Phe-Gln-Asn-Cys-Pro-D-Arg-Gly-NH₂ (Disulfide bond) | 4012273 | H-7675 |
| Mastoparan | H-Ile-Asn-Leu-Lys-Ala-Leu-Ala-Ala-Leu-Ala-Lys-Lys-Ile-Leu-NH₂ | 4013168 | H-3810 |
| Calcitonin (human) | H-Cys-Gly-Asn-Leu-Ser-Thr-Cys-Met-Leu-Gly-Thr-Tyr-Thr-Gln-Asp-Phe-Asn-Lys-Phe-His-Thr-Phe-Pro-Gln-Thr-Ala-Ile-Gly-Val-Gly-Ala-Pro-NH₂ (Disulfide bond) | 4014409 | H-2250 |
| µ-Conotoxin GIIIB | H-Arg-Asp-Cys-Cys-Thr-Hyp-Hyp-Arg-Lys-Cys-Lys-Asp-Arg-Arg-Cys-Lys-Hyp-Met-Lys-Cys-Cys-Ala-NH₂ (Disulfide bonds between Cys³ and Cys¹⁵/Cys⁴ and Cys²⁰/Cys¹⁰ and Cys²¹) | 4016344 | H-9015 |
| H-Lys-Pro-OH | H-Lys-Pro-OH | 4016384 | G-4190 |
| Boc-Gln-Gly-Arg-AMC · HCl | Boc-Gln-Gly-Arg-AMC · HCl | 4016429 | I-1595 |
| BNP-32 (human) | H-Ser-Pro-Lys-Met-Val-Gln-Gly-Ser-Gly-Cys-Phe-Gly-Arg-Lys-Met-Asp-Arg-Ile-Ser-Ser-Ser-Ser-Gly-Leu-Gly-Cys-Lys-Val-Leu-Arg-Arg-His-OH (Disulfide bond) | 4016567 | H-9060 |
| Exendin (9-39) | H-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂ | 4017799 | H-8740 |
| Substance P (1-7) | H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-OH | 4019809 | H-1582 |
| Gluten Exorphin B5 | H-Tyr-Gly-Gly-Trp-Leu-OH | 4025007 | H-1666 |
| Defensin HNP-1 (human) | H-Ala-Cys-Tyr-Cys-Arg-Ile-Pro-Ala-Cys-Ile-Ala-Gly-Glu-Arg-Arg-Tyr-Gly-Thr-Cys-Ile-Tyr-Gln-Gly-Arg-Leu-Trp-Ala-Phe-Cys-Cys-OH (Disulfide bonds between Cys² and Cys³⁰/Cys⁴ and Cys¹⁹/Cys⁹ and Cys²⁹) | 4025473 | H-9855 |
| Astressin | H-D-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Nle-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-cyclo(-Glu-Ala-His-Lys)-Asn-Arg-Lys-Leu-Nle-Glu-Ile-Ile-NH₂ | 4026664 | H-3422 |
| Z-Asp(OMe)-Glu(OMe)-Val-DL-Asp(OMe)-fluoromethylketone | Z-Asp(OMe)-Glu(OMe)-Val-DL-Asp(OMe)-fluoromethylketone | 4027402 | N-1555 |
| (Des-Gly¹⁰,D-His²,D-Leu⁶,Pro-NHEt⁹)-LHRH | Pyr-D-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt | 4028311 | H-4316 |
| Polyphemusin II-Derived Peptide | H-Arg-Arg-2-Nal-Cys-Tyr-Arg-Lys-D-Lys-Pro-Tyr-Arg-Cit-Cys-Arg-OH (Disulfide bond) | 4029155 | H-4626 |
| (Pyr³)-Amyloid β-Protein (3-42) | Pyr-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | 4029424 | H-4796 |
| Amylin (mouse, rat) | H-Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH₂ (Disulfide bond) | 4030201 | H-9475 |
| CART (55-102) (rat) | H-Ile-Pro-Ile-Tyr-Glu-Lys-Lys-Tyr-Gly-Gln-Val-Pro-Met-Cys-Asp-Ala-Gly-Glu-Gln-Cys-Ala-Val-Arg-Lys-Gly-Ala-Arg-Ile-Gly-Lys-Leu-Cys-Asp-Cys-Pro-Arg-Gly-Thr-Ser-Cys-Asn-Ser-Phe-Leu-Leu-Lys-Cys-Leu-OH (Disulfide bonds between Cys⁶⁸ and Cys⁸⁶/Cys⁷⁴ and Cys⁹⁴/Cys⁸⁸ and Cys¹⁰¹) | 4030509 | H-4446 |
| rec Human Growth Hormone (expressed in E. coli) | 4030632 | H-3148 | |
| Gastrin I (human) | Pyr-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH₂ | 4030646 | H-3085 |
| Guanylin (human) | H-Pro-Gly-Thr-Cys-Glu-Ile-Cys-Ala-Tyr-Ala-Ala-Cys-Thr-Gly-Cys-OH (Disulfide bonds between Cys⁴ and Cys¹²/Cys⁷ and Cys¹⁵) | 4030693 | H-2996 |
| Iberiotoxin | Pyr-Phe-Thr-Asp-Val-Asp-Cys-Ser-Val-Ser-Lys-Glu-Cys-Trp-Ser-Val-Cys-Lys-Asp-Leu-Phe-Gly-Val-Asp-Arg-Gly-Lys-Cys-Met-Gly-Lys-Lys-Cys-Arg-Cys-Tyr-Gln-OH (Disulfide bonds between Cys⁷ and Cys²⁸/Cys¹³ and Cys³³/Cys¹⁷ and Cys³⁵) | 4030755 | H-9940 |
| Melittin | H-Gly-Ile-Gly-Ala-Val-Leu-Lys-Val-Leu-Thr-Thr-Gly-Leu-Pro-Ala-Leu-Ile-Ser-Trp-Ile-Lys-Arg-Lys-Arg-Gln-Gln-NH₂ | 4030808 | H-4310 |
| Mastoparan 7 | H-Ile-Asn-Leu-Lys-Ala-Leu-Ala-Ala-Leu-Ala-Lys-Ala-Leu-Leu-NH₂ | 4030846 | H-3002 |
| H-Ser-OH | H-Ser-OH | 4031220 | E-2375 |
| TRAP-5 amide | H-Ser-Phe-Leu-Leu-Arg-NH₂ | 4031273 | H-2938 |
| Biotinyl-BNP-32 (human) | Biotinyl-Ser-Pro-Lys-Met-Val-Gln-Gly-Ser-Gly-Cys-Phe-Gly-Arg-Lys-Met-Asp-Arg-Ile-Ser-Ser-Ser-Ser-Gly-Leu-Gly-Cys-Lys-Val-Leu-Arg-Arg-His-OH (Disulfide bond) | 4034106 | H-6314 |
| (Des-Gly¹⁰,Ser(Ac)⁴,D-Leu⁶,Pro-NHEt⁹)-LHRH | Pyr-His-Trp-Ser(Ac)-Tyr-D-Leu-Leu-Arg-Pro-NHEt | 4034724 | H-6172 |
| (D-Ser(tBu)⁶,D-Leu⁷,Azagly¹⁰)-LHRH | Pyr-His-Trp-Ser-Tyr-D-Ser(tBu)-D-Leu-Arg-Pro-Azagly-NH₂ | 4037082 | H-5418 |
| Endothelin-1 (human, bovine, dog, mouse, porcine, rat) | H-Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp-OH (Disulfide bonds between Cys¹ and Cys¹⁵/Cys³ and Cys¹¹) | 4040254 | H-6995 |
| (D-Leu⁷)-LHRH | Pyr-His-Trp-Ser-Tyr-Gly-D-Leu-Arg-Pro-Gly-NH₂ | 4041861 | H-5958 |
| Cyclo(-Arg-Gly-Asp-D-Tyr-Lys) | Cyclo(-Arg-Gly-Asp-D-Tyr-Lys) | 4043237 | H-7702 |
| Galanin-Like Peptide (human) | H-Ala-Pro-Ala-His-Arg-Gly-Arg-Gly-Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Val-Leu-His-Leu-Pro-Gln-Met-Gly-Asp-Gln-Asp-Gly-Lys-Arg-Glu-Thr-Ala-Leu-Glu-Ile-Leu-Asp-Leu-Trp-Lys-Ala-Ile-Asp-Gly-Leu-Pro-Tyr-Ser-His-Pro-Pro-Gln-Pro-Ser-OH | 4044537 | H-6078 |
| DOTA-(Tyr³)-Octreotate | 4,7,10-Tricarboxymethyl-1,4,7,10-tetraaza-cyclododecan-1-yl-acetyl-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Thr-OH (Disulfide bond) | 4046724 | H-6318 |
| Ac-Arg-Gly-Lys-AMC | Ac-Arg-Gly-Lys-AMC | 4048929 | I-1990 |
| Acetyl-(D-Arg¹⁰,Cys¹¹,D-Phe¹⁴,Cys¹⁷)-β-MSH (10-17) amide | Ac-D-Arg-Cys-Glu-His-D-Phe-Arg-Trp-Cys-NH₂ (Disulfide bond) | 4049312 | H-6268 |
| Bz-Nle-Lys-Arg-Arg-AMC | Bz-Nle-Lys-Arg-Arg-AMC | 4055312 | I-1995 |
| Z-Val-Arg-Pro-DL-Arg-fluoromethylketone | Z-Val-Arg-Pro-DL-Arg-fluoromethylketone | 4055669 | N-2010 |
| Hepcidin-1 (mouse) | H-Asp-Thr-Asn-Phe-Pro-Ile-Cys-Ile-Phe-Cys-Cys-Lys-Cys-Cys-Asn-Asn-Ser-Gln-Cys-Gly-Ile-Cys-Cys-Lys-Thr-OH (Disulfide bonds between Cys⁷ and Cys²³/Cys¹⁰ and Cys²²/Cys¹¹ and Cys¹⁹/Cys¹³ and Cys¹⁴) | 4062144 | H-7364 |
| Neurotensin (8-13) | H-Arg-Arg-Pro-Tyr-Ile-Leu-OH | 4100575 | H-8178 |
| (Arg⁸)-Vasotocin (Salt form acetate) | H-Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-NH₂ (Disulfide bond) | 4100576 | H-8182 |
| (Pro⁸)-Oxytocin | H-Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Pro-Gly-NH₂ (Disulfide bond) | 4145232 | |
| H-Ala-Gly-OH | H-Ala-Gly-OH | 4000163 | G-1215 |
| H-Gly-Met-OH | H-Gly-Met-OH | 4001203 | G-2155 |
| Boc-Met-Leu-Phe-OH | Boc-Met-Leu-Phe-OH | 4001506 | A-2690 |
| Suc-Ala-Ala-Pro-Phe-pNA | Suc-Ala-Ala-Pro-Phe-pNA | 4002299 | L-1400 |
| H-Lys-Lys-Lys-OH | H-Lys-Lys-Lys-OH | 4002495 | H-4175 |
| Kyotorphin | H-Tyr-Arg-OH | 4003049 | G-2450 |
| Z-Phe-Arg-AMC · HCl | Z-Phe-Arg-AMC · HCl | 4003379 | I-1160 |
| Boc-Val-Pro-Arg-AMC | Boc-Val-Pro-Arg-AMC | 4003460 | I-1120 |
| (D-Ala²)-Leu-Enkephalin | H-Tyr-D-Ala-Gly-Phe-Leu-OH | 4003792 | H-2750 |
| Ac-Trp-OH | Ac-Trp-OH | 4003876 | E-1220 |
| Dynorphin A (1-8) | H-Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-OH | 4005845 | H-2655 |
| β-Endorphin (human) | H-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr-Lys-Lys-Gly-Glu-OH | 4006426 | H-2700 |
| H-Arg-Gly-Asp-OH | H-Arg-Gly-Asp-OH | 4009173 | H-1830 |
| LHRH (free acid) | Pyr-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-OH | 4009735 | H-4010 |
| Tos-Gly-Pro-Lys-pNA | Tos-Gly-Pro-Lys-pNA | 4010701 | L-1515 |
| Pyr-Ala-OH | Pyr-Ala-OH | 4011428 | G-3090 |
| GRP (human) | H-Val-Pro-Leu-Pro-Ala-Gly-Gly-Gly-Thr-Val-Leu-Thr-Lys-Met-Tyr-Pro-Arg-Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH₂ | 4011693 | H-6785 |
| (Des-Gly¹⁰,D-Ala⁶,Pro-NHEt⁹)-LHRH | Pyr-His-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-NHEt | 4012028 | H-4070 |
| Peptide YY (human) | H-Tyr-Pro-Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH₂ | 4013882 | H-9180 |
| H-Ser-Asp-Gly-Arg-Gly-OH | H-Ser-Asp-Gly-Arg-Gly-OH | 4015321 | H-7740 |
| Ac-Ser-Asp-Lys-Pro-OH | Ac-Ser-Asp-Lys-Pro-OH | 4016348 | H-1156 |
| (Des-Gly¹⁰,D-Arg⁶,Pro-NHEt⁹)-LHRH (salmon) | Pyr-His-Trp-Ser-Tyr-D-Arg-Trp-Leu-Pro-NHEt | 4016385 | H-9205 |
| Boc-Gly-Arg-Arg-AMC | Boc-Gly-Arg-Arg-AMC | 4017086 | I-1565 |
| Ac-Tyr-Val-Ala-Asp-chloromethylketone | Ac-Tyr-Val-Ala-Asp-chloromethylketone | 4018838 | N-1330 |
| Neuromedin B | H-Gly-Asn-Leu-Trp-Ala-Thr-Gly-His-Phe-Met-NH₂ | 4020211 | H-3280 |
| GRF (1-29) amide (rat) | H-His-Ala-Asp-Ala-Ile-Phe-Thr-Ser-Ser-Tyr-Arg-Arg-Ile-Leu-Gly-Gln-Leu-Tyr-Ala-Arg-Lys-Leu-Leu-His-Glu-Ile-Met-Asn-Arg-NH₂ | 4025114 | H-1902 |
| H-Gly-Pro-Arg-Pro-NH₂ | H-Gly-Pro-Arg-Pro-NH₂ | 4025347 | H-1998 |
| (D-Tyr⁵,D-Trp⁶)-LHRH | Pyr-His-Trp-Ser-D-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH₂ | 4025365 | H-4646 |
| (DL-Isoser¹)-TRAP-6 | H-DL-Isoser-Phe-Leu-Leu-Arg-Asn-OH | 4025390 | H-1944 |
| H-His-Cys-Lys-Phe-Trp-Trp-OH | H-His-Cys-Lys-Phe-Trp-Trp-OH | 4026848 | H-3524 |
| ([D₈]Val⁷·¹⁰)-C-Peptide (human) | H-Glu-Ala-Glu-Asp-Leu-Gln-[D₈]Val-Gly-Gln-[D₈]Val-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Ser-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ser-Leu-Gln-OH | 4028385 | H-4242 |
| Cyclo(-Met-Pro) | Cyclo(-Met-Pro) | 4029457 | G-4725 |
| 1-O-Octadecyl-2-O-methyl-rac-glycero-3-phosphocholine | 1-O-Octadecyl-2-O-methyl-rac-glycero-3-phosphocholine | 4030361 | O-1415 |
| ω-Conotoxin MVIIC | H-Cys-Lys-Gly-Lys-Gly-Ala-Pro-Cys-Arg-Lys-Thr-Met-Tyr-Asp-Cys-Cys-Ser-Gly-Ser-Cys-Gly-Arg-Arg-Gly-Lys-Cys-NH₂ (Disulfide bonds between Cys¹ and Cys¹⁶/Cys⁸ and Cys²⁰/Cys¹⁵ and Cys²⁶) | 4030522 | H-8835 |
| H-Gly-Arg-Gly-Asp-Asn-Pro-OH | H-Gly-Arg-Gly-Asp-Asn-Pro-OH | 4030603 | H-3174 |
| rec IGF-I (human) | 4030778 | H-5555 | |
| (Arg⁸)-Vasotocin (Salt form trifluoroacetate) | H-Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-NH₂ (Disulfide bond) | 4031338 | H-1785 |
| H-D-Phe-Pro-Arg-chloromethylketone | H-D-Phe-Pro-Arg-chloromethylketone | 4033019 | N-1065 |
| Ghrelin (human) | H-Gly-Ser-Ser(octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Arg-Val-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg-OH | 4033077 | H-4864 |
| FITC-β-Ala-Amyloid β-Protein (1-42) | FITC-β-Ala-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | 4033502 | M-2585 |
| Apelin-36 (human) | H-Leu-Val-Gln-Pro-Arg-Gly-Ser-Arg-Asn-Gly-Pro-Gly-Pro-Trp-Gln-Gly-Gly-Arg-Arg-Lys-Phe-Arg-Arg-Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe-OH | 4034005 | H-4896 |
| Z-Leu-Arg-AMC | Z-Leu-Arg-AMC | 4034611 | I-1960 |
| (D-Tyr⁵,D-Ser(tBu)⁶,Azagly¹⁰)-LHRH | Pyr-His-Trp-Ser-D-Tyr-D-Ser(tBu)-Leu-Arg-Pro-Azagly-NH₂ | 4035302 | H-5734 |
| Penetratin | H-Arg-Gln-Ile-Lys-Ile-Trp-Phe-Gln-Asn-Arg-Arg-Met-Lys-Trp-Lys-Lys-NH₂ | 4036091 | H-7514 |
| Pep-1-cysteamide | Ac-Lys-Glu-Thr-Trp-Trp-Glu-Thr-Trp-Trp-Thr-Glu-Trp-Ser-Gln-Pro-Lys-Lys-Lys-Arg-Lys-Val-cysteamide | 4039296 | H-7508 |
| Biotinyl-Somatostatin-14 | Biotinyl-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys-OH (Disulfide bond) | 4039552 | H-6242 |
| Xylazine (free base) | 4039614 | Q-1445 | |
| Cecropin A (1-7)-Melittin A (2-9) amide | H-Lys-Trp-Lys-Leu-Phe-Lys-Lys-Ile-Gly-Ala-Val-Leu-Lys-Val-Leu-NH₂ | 4042609 | H-5948 |
| Ac-Arg-Gly-Lys(Ac)-AMC | Ac-Arg-Gly-Lys(Ac)-AMC | 4044046 | I-1925 |
| 6-FAM-AEEAc-Stichodactyla helianthus Neurotoxin (ShK) | Fluorescein-6-carbonyl-AEEAc-Arg-Ser-Cys-Ile-Asp-Thr-Ile-Pro-Lys-Ser-Arg-Cys-Thr-Ala-Phe-Gln-Cys-Lys-His-Ser-Met-Lys-Tyr-Arg-Leu-Ser-Phe-Cys-Arg-Lys-Thr-Cys-Gly-Thr-Cys-OH (Disulfide bonds between Cys³ and Cys³⁵/Cys¹² and Cys²⁸/Cys¹⁷ and Cys³²) | 4044280 | H-6088 |
| Amyloid β-Protein (1-42) | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | 4045866 | H-6466 |
| Ac-Val-Arg-Pro-Arg-AMC | Ac-Val-Arg-Pro-Arg-AMC | 4048494 | I-1965 |
| Endothelin-1 (human, bovine, dog, mouse, porcine, rat) | H-Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp-OH (Disulfide bonds between Cys¹ and Cys¹⁵/Cys³ and Cys¹¹) | 4048904 | H-7758 |
| (Cys⁴⁶)-HIV-1 tat Protein (46-57) amide | H-Cys-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-NH₂ | 4049177 | H-7518 |
| Biotinyl-Amylin (human) | Biotinyl-Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH₂ (Disulfide bond) | 4059629 | H-7398 |
| BKT140 | 4-Fluorobenzoyl-Arg-Arg-2-Nal-Cys-Tyr-Cit-Lys-D-Lys-Pro-Tyr-Arg-Cit-Cys-Arg-NH₂ (Disulfide bond) | 4073017 | H-8452 |
| H-Gly-His-Gly-OH | H-Gly-His-Gly-OH | 4000273 | H-3505 |
| H-D-Ala-D-Ala-OH | H-D-Ala-D-Ala-OH | 4000279 | G-1135 |
| Ac-Tyr-NH₂ | Ac-Tyr-NH₂ | 4001968 | E-1245 |
| H-Gly-Pro-Ala-OH | H-Gly-Pro-Ala-OH | 4002533 | H-3615 |
| H-Ala-Gln-OH | H-Ala-Gln-OH | 4003766 | G-1210 |
| Dynorphin A (1-13) | H-Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-OH | 4004062 | H-2625 |
| H-Met-Arg-Phe-Ala-OH | H-Met-Arg-Phe-Ala-OH | 4004330 | H-4320 |
| Angiotensin I/II (1-7) | H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH | 4006081 | H-1715 |
| H-Gly-Gly-His-OH | H-Gly-Gly-His-OH | 4006117 | H-3417 |
| (D-Pen²,D-Pen⁵)-Enkephalin | H-Tyr-D-Pen-Gly-Phe-D-Pen-OH (Disulfide bond) | 4008254 | H-2905 |
| Neurotensin (8-13) | H-Arg-Arg-Pro-Tyr-Ile-Leu-OH | 4008910 | H-1810 |
| C-Peptide (human) | H-Glu-Ala-Glu-Asp-Leu-Gln-Val-Gly-Gln-Val-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Ser-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ser-Leu-Gln-OH | 4009494 | H-2470 |
| H-D-Ala-Gln-OH | H-D-Ala-Gln-OH | 4011870 | G-3690 |
| ACTH (1-24) (human, bovine, rat) | H-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-OH | 4011958 | H-1150 |
| Suc-Ala-Ala-Pro-Phe-AMC | Suc-Ala-Ala-Pro-Phe-AMC | 4012873 | I-1465 |
| H-D-Phe-Phe-Arg-chloromethylketone | H-D-Phe-Phe-Arg-chloromethylketone | 4014271 | N-1215 |
| (Nle⁸·¹⁸,Tyr³⁴)-pTH (1-34) (human) | H-Ser-Val-Ser-Glu-Ile-Gln-Leu-Nle-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Nle-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Tyr-OH | 4015469 | H-9110 |
| Z-D-Phe-Phe-Gly-OH | Z-D-Phe-Phe-Gly-OH | 4015768 | H-9430 |
| Acetyl-Pepstatin | Ac-Val-Val-Sta-Ala-Sta-OH | 4015928 | N-1250 |
| Exenatide | H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂ | 4019602 | H-8730 |
| ω-Conotoxin MVIIA | H-Cys-Lys-Gly-Lys-Gly-Ala-Lys-Cys-Ser-Arg-Leu-Met-Tyr-Asp-Cys-Cys-Thr-Gly-Ser-Cys-Arg-Ser-Gly-Lys-Cys-NH₂ (Disulfide bonds between Cys¹ and Cys¹⁶/Cys⁸ and Cys²⁰/Cys¹⁵ and Cys²⁵) | 4025279 | H-8210 |
| (Des-Gly)-Glutathione (reduced) | H-Glu(Cys-OH)-OH | 4025354 | G-4305 |
| (Des-Cys¹,cyclo(Ser²-Asu⁷))-Calcitonin (eel) | Cyclo(-Ser-Asn-Leu-Ser-Thr-Asu)-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asp-Val-Gly-Ala-Gly-Thr-Pro-NH₂ | 4025810 | H-2214 |
| (D-Trp⁶)-LHRH (free acid) | Pyr-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-OH | 4026526 | H-3078 |
| Acetyl-(Nle⁴,Asp⁵,D-2-Nal⁷,Lys¹⁰)-cyclo-α-MSH (4-10) amide | Ac-Nle-cyclo(-Asp-His-D-2-Nal-Arg-Trp-Lys-NH₂) | 4027601 | H-3952 |
| Ac-Trp-Glu-His-Asp-AMC | Ac-Trp-Glu-His-Asp-AMC | 4027662 | I-1715 |
| Z-Val-Asp-Val-Ala-Asp-AFC | Z-Val-Asp-Val-Ala-Asp-AFC | 4027893 | I-1770 |
| H-Glu-Ala-Leu-Phe-Gln-pNA | H-Glu-Ala-Leu-Phe-Gln-pNA | 4028277 | L-2050 |
| Acetyl-(Cys³,Nle⁴,Arg⁵,D-2-Nal⁷,Cys¹¹)-α-MSH (3-11) amide | Ac-Cys-Nle-Arg-His-D-2-Nal-Arg-Trp-Gly-Cys-NH₂ (Disulfide bond) | 4029134 | H-4598 |
| (D-Ser⁴)-LHRH | Pyr-His-Trp-D-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH₂ | 4029233 | H-4706 |
| Amyloid β-Protein (25-35) | H-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-OH | 4030205 | H-1192 |
| Caerulein | Pyr-Gln-Asp-Tyr(SO₃H)-Thr-Gly-Trp-Met-Asp-Phe-NH₂ | 4030451 | H-3220 |
| H-Arg-Gly-Asp-Cys-OH | H-Arg-Gly-Asp-Cys-OH | 4030602 | H-3156 |
| H-Gly-Arg-Gly-Glu-Ser-Pro-OH | H-Gly-Arg-Gly-Glu-Ser-Pro-OH | 4030609 | H-3136 |
| H-Tyr-Arg-Gly-Asp-Ser-OH | H-Tyr-Arg-Gly-Asp-Ser-OH | 4030618 | H-3154 |
| pTH (1-84) (human) | H-Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-Val-Ala-Leu-Gly-Ala-Pro-Leu-Ala-Pro-Arg-Asp-Ala-Gly-Ser-Gln-Arg-Pro-Arg-Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly-Glu-Ala-Asp-Lys-Ala-Asp-Val-Asn-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln-OH | 4031199 | H-1370 |
| Mca-(Asn⁶⁷⁰,Leu⁶⁷¹)-Amyloid β/A4 Protein Precursor₇₇₀ (667-676)-Lys(Dnp)-Arg-Arg amide | Mca-Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Arg-Lys(Dnp)-Arg-Arg-NH₂ | 4033760 | M-2465 |
| Osteocalcin (1-49) (human) | H-Tyr-Leu-Tyr-Gln-Trp-Leu-Gly-Ala-Pro-Val-Pro-Tyr-Pro-Asp-Pro-Leu-Gla-Pro-Arg-Arg-Gla-Val-Cys-Gla-Leu-Asn-Pro-Asp-Cys-Asp-Glu-Leu-Ala-Asp-His-Ile-Gly-Phe-Gln-Glu-Ala-Tyr-Arg-Arg-Phe-Tyr-Gly-Pro-Val-OH (Disulfide bond) | 4034491 | H-4912 |
| (d(CH₂)₅¹,Tyr(Me)²,Orn⁸)-Oxytocin | β-Mercapto-β,β-cyclopentamethylene-propionyl-Tyr(Me)-Ile-Gln-Asn-Cys-Pro-Orn-Gly-NH₂ (Disulfide bond) | 4034493 | H-4928 |
| (D-His²,D-Ser(tBu)⁶,Azagly¹⁰)-LHRH | Pyr-D-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-Azagly-NH₂ | 4035303 | H-5796 |
| (D-Ser⁴,D-Ser(tBu)⁶,Azagly¹⁰)-LHRH | Pyr-His-Trp-D-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-Azagly-NH₂ | 4035304 | H-5654 |
| Relaxin H2 (human) | (Pyr-Leu-Tyr-Ser-Ala-Leu-Ala-Asn-Lys-Cys-Cys-His-Val-Gly-Cys-Thr-Lys-Arg-Ser-Leu-Ala-Arg-Phe-Cys-OH)A(H-Asp-Ser-Trp-Met-Glu-Glu-Val-Ile-Lys-Leu-Cys-Gly-Arg-Glu-Leu-Val-Arg-Ala-Gln-Ile-Ala-Ile-Cys-Gly-Met-Ser-Thr-Trp-Ser-OH)B (Disulfide bonds between Cys¹⁰A and Cys¹⁵A/Cys¹¹A and Cys¹¹B/Cys²⁴A and Cys²³B) | 4039910 | H-6784 |
| RVG-9R | H-Tyr-Thr-Ile-Trp-Met-Pro-Glu-Asn-Pro-Arg-Pro-Gly-Thr-Pro-Cys-Asp-Ile-Phe-Thr-Asn-Ser-Arg-Gly-Lys-Arg-Ala-Ser-Asn-Gly-Gly-Gly-Gly-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-OH | 4058134 | H-7502 |
| Hepcidin-20 (human) | H-Ile-Cys-Ile-Phe-Cys-Cys-Gly-Cys-Cys-His-Arg-Ser-Lys-Cys-Gly-Met-Cys-Cys-Lys-Thr-OH (Disulfide bonds, air oxidized) | 4065374 | H-7358 |
| Biotinyl-εAhx-Amyloid β-Protein (1-42) | Biotinyl-εAhx-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | 4090155 | H-7454 |
| H-Cys(NPys)-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-NH₂ | H-Cys(NPys)-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-NH₂ | 4091599 | H-7516 |
| Neuropeptide Y-Lys(biotinyl) (free acid) (human, rat) | H-Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-Lys(biotinyl)-OH | 4095553 | H-7614 |
| Vesicular Stomatitis Virus Nucleoprotein (52-59) | H-Arg-Gly-Tyr-Val-Tyr-Gln-Gly-Leu-OH | 4095713 | H-7654 |
| Histone H3 (1-21)-Gly-Gly-Lys(biotinyl) amide | H-Ala-Arg-Thr-Lys-Gln-Thr-Ala-Arg-Lys-Ser-Thr-Gly-Gly-Lys-Ala-Pro-Arg-Lys-Gln-Leu-Ala-Gly-Gly-Lys(biotinyl)-NH₂ | 4096115 | H-7794 |
| Abaloparatide | H-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Glu-Leu-Leu-Glu-Lys-Leu-Leu-Aib-Lys-Leu-His-Thr-Ala-NH₂ | 4105586 | H-8334 |
| α-Synuclein (32-37) (human) | H-Lys-Thr-Lys-Glu-Gly-Val-OH | 4148082 | |
| Met-Enkephalin | H-Tyr-Gly-Gly-Phe-Met-OH | 4000010 | H-2785 |
| H-Ala-Ala-Ala-Ala-OH | H-Ala-Ala-Ala-Ala-OH | 4000024 | H-1260 |
| Boc-Thr(Bzl)-OH | Boc-Thr(Bzl)-OH | 4000026 | A-1355 |
| ACTH (4-10) | H-Met-Glu-His-Phe-Arg-Trp-Gly-OH | 4000032 | H-1180 |
| H-Tyr-βNA | H-Tyr-βNA | 4000054 | K-1530 |
| H-Arg-Arg-OH | H-Arg-Arg-OH | 4000091 | G-1465 |
| H-Arg-Arg-βNA · 3 HCl | H-Arg-Arg-βNA · 3 HCl | 4000098 | K-1085 |
| Boc-Tyr(Bzl)-OH | Boc-Tyr(Bzl)-OH | 4000101 | A-1390 |
| H-Met-Thr-OH | H-Met-Thr-OH | 4000109 | G-2810 |
| H-Met-Trp-OH | H-Met-Trp-OH | 4000110 | G-2815 |
| H-Gly-Lys-OH · HCl | H-Gly-Lys-OH · HCl | 4000112 | G-3630 |
| H-Gly-His-OH · HCl | H-Gly-His-OH · HCl | 4000115 | G-2125 |
| Boc-Tyr(Boc)-OH | Boc-Tyr(Boc)-OH | 4000116 | A-1040 |
| Boc-Val-OSu | Boc-Val-OSu | 4000117 | A-2470 |
| Boc-Thr-OH | Boc-Thr-OH | 4000124 | A-2305 |
| H-Phe-Leu-OH | H-Phe-Leu-OH | 4000130 | G-2900 |
| H-Leu-Gly-OH | H-Leu-Gly-OH | 4000131 | G-2495 |
| H-Trp-OMe · HCl | H-Trp-OMe · HCl | 4000133 | N-1165 |
| Z-Tyr-OMe | Z-Tyr-OMe | 4000134 | C-4040 |
| Z-Tyr(tBu)-OMe | Z-Tyr(tBu)-OMe | 4000137 | C-3065 |
| H-Lys-Phe-OH · HCl | H-Lys-Phe-OH · HCl | 4000141 | G-2685 |
| Ac-Ser-OMe | Ac-Ser-OMe | 4000152 | E-1205 |
| Z-Gly-Gly-OSu | Z-Gly-Gly-OSu | 4000154 | C-1710 |
| H-Met-Gly-OH | H-Met-Gly-OH | 4000157 | G-2745 |
| Z-Pyr-OH | Z-Pyr-OH | 4000161 | C-2555 |
| H-Gly-Phe-OH | H-Gly-Phe-OH | 4000165 | G-2175 |
| H-Gly-Ala-OH | H-Gly-Ala-OH | 4000168 | G-2020 |
| H-β-Ala-β-Ala-OH | H-β-Ala-β-Ala-OH | 4000175 | G-1150 |
| H-Leu-Val-OH | H-Leu-Val-OH | 4000177 | G-2620 |
| H-Pro-Leu-OH | H-Pro-Leu-OH | 4000181 | G-3035 |
| H-Leu-Phe-OH | H-Leu-Phe-OH | 4000185 | G-2565 |
| Boc-Tyr-OH | Boc-Tyr-OH | 4000198 | A-2405 |
| H-Met-Met-OH | H-Met-Met-OH | 4000202 | G-2770 |
| H-Val-OtBu · HCl | H-Val-OtBu · HCl | 4000213 | E-2590 |
| Z-Pro-Pro-OH | Z-Pro-Pro-OH | 4000216 | C-2545 |
| H-Pro-Pro-OH · HCl | H-Pro-Pro-OH · HCl | 4000217 | G-3060 |
| Z-Phe-Ala-OH | Z-Phe-Ala-OH | 4000227 | C-2360 |
| Boc-Tyr-OMe | Boc-Tyr-OMe | 4000251 | A-2420 |
| H-Tyr-OMe · HCl | H-Tyr-OMe · HCl | 4000255 | E-2555 |
| H-Lys-Tyr-Lys-OH | H-Lys-Tyr-Lys-OH | 4000280 | H-4280 |
| H-Gly-Trp-OH | H-Gly-Trp-OH | 4000291 | G-2220 |
| Z-Gly-Pro-OH | Z-Gly-Pro-OH | 4000301 | C-1880 |
| H-His-Leu-OH | H-His-Leu-OH | 4000307 | G-2310 |
| H-Lys-Glu-OH | H-Lys-Glu-OH | 4000314 | G-2645 |
| H-Lys-Gly-OH · HCl | H-Lys-Gly-OH · HCl | 4000317 | G-2650 |
| H-Glu-Glu-Glu-OH | H-Glu-Glu-Glu-OH | 4000321 | H-3160 |
| Leu-Enkephalin | H-Tyr-Gly-Gly-Phe-Leu-OH | 4000332 | H-2740 |
| H-Thr(tBu)-OMe · HCl | H-Thr(tBu)-OMe · HCl | 4000336 | E-1680 |
| H-His-Asp-OH | H-His-Asp-OH | 4000339 | G-2295 |
| Melanocyte-Stimulating Hormone-Release Inhibiting Factor | H-Pro-Leu-Gly-NH₂ | 4000343 | H-4305 |
| H-Glu(Gly-Gly-OH)-OH | H-Glu(Gly-Gly-OH)-OH | 4000347 | H-3180 |
| H-Arg-Tyr-OH | H-Arg-Tyr-OH | 4000375 | G-1535 |
| H-Glu-Tyr-Glu-OH | H-Glu-Tyr-Glu-OH | 4000397 | H-3225 |
| Z-Val-OH | Z-Val-OH | 4000403 | C-2805 |
| H-Val-Gly-OH | H-Val-Gly-OH | 4000404 | G-3525 |
| Z-Gly-Gly-Gly-Gly-OH | Z-Gly-Gly-Gly-Gly-OH | 4000405 | C-1745 |
| H-Arg-Leu-OH | H-Arg-Leu-OH | 4000415 | G-1495 |
| Z-Ile-Pro-OH | Z-Ile-Pro-OH | 4000418 | C-3145 |
| Boc-Val-OH | Boc-Val-OH | 4000426 | A-2455 |
| H-Gly-Gly-Gly-Gly-Gly-Gly-OH | H-Gly-Gly-Gly-Gly-Gly-Gly-OH | 4000432 | H-3405 |
| H-Phe-Tyr-OH | H-Phe-Tyr-OH | 4000440 | G-2955 |
| H-Ser-Met-OH | H-Ser-Met-OH | 4000449 | G-3210 |
| H-Ala-Asn-OH | H-Ala-Asn-OH | 4000461 | G-1180 |
| H-Glu-Glu-OH | H-Glu-Glu-OH | 4000466 | G-1915 |
| Phenylmethylsulfonyl fluoride | Phenylmethylsulfonyl fluoride | 4000472 | Q-1395 |
| Z-Phe-Leu-OH | Z-Phe-Leu-OH | 4000487 | M-1310 |
| Z-Gly-Gly-OH | Z-Gly-Gly-OH | 4000488 | C-1700 |
| H-Thr-OMe · HCl | H-Thr-OMe · HCl | 4000503 | E-2455 |
| H-Glu-Asp-OH | H-Glu-Asp-OH | 4000513 | G-1910 |
| H-Pro-Lys-OH | H-Pro-Lys-OH | 4000520 | G-3040 |
| H-Gly-Leu-OH | H-Gly-Leu-OH | 4000534 | M-1460 |
| H-Tyr-OEt · HCl | H-Tyr-OEt · HCl | 4000537 | E-2550 |
| H-Arg-Gly-OH · HCl | H-Arg-Gly-OH · HCl | 4000541 | G-3940 |
| H-Gly-Ile-OH | H-Gly-Ile-OH | 4000546 | G-2135 |
| H-Gly-Arg-OH | H-Gly-Arg-OH | 4000548 | G-2050 |
| H-Glu-Trp-OH | H-Glu-Trp-OH | 4000564 | G-1990 |
| H-Val-Glu-OH | H-Val-Glu-OH | 4000570 | G-3520 |
| Ac-Thr-OH | Ac-Thr-OH | 4000580 | E-1210 |
| Z-Phe-His-Leu-OH | Z-Phe-His-Leu-OH | 4000599 | M-1305 |
| H-D-Ala-Ala-OH | H-D-Ala-Ala-OH | 4000600 | G-1130 |
| Sar-Gly-OH | Sar-Gly-OH | 4000603 | G-3105 |
| H-Pro-Ser-OH | H-Pro-Ser-OH | 4000621 | G-3065 |
| H-Gly-Phe-Gly-OH | H-Gly-Phe-Gly-OH | 4000624 | H-3595 |
| H-Gly-Tyr-Gly-OH | H-Gly-Tyr-Gly-OH | 4000627 | H-3670 |
| H-Tyr(Bzl)-OH | H-Tyr(Bzl)-OH | 4000637 | E-1595 |
| H-Glu(Glu-OH)-OH | H-Glu(Glu-OH)-OH | 4000639 | G-1920 |
| H-Phe-Asp-OH | H-Phe-Asp-OH | 4000640 | G-2870 |
| H-Leu-Gly-Gly-OH | H-Leu-Gly-Gly-OH | 4000645 | M-1530 |
| Ac-Tyr-OEt | Ac-Tyr-OEt | 4000673 | M-1080 |
| H-Gly-Ser-OH | H-Gly-Ser-OH | 4000679 | G-2200 |
| H-Val-Gly-Ser-Glu-OH | H-Val-Gly-Ser-Glu-OH | 4000705 | H-2915 |
| H-Glu(Met-OH)-OH | H-Glu(Met-OH)-OH | 4000709 | H-3195 |
| H-Gly-Pro-4MβNA | H-Gly-Pro-4MβNA | 4000721 | J-1210 |
| H-Arg-Arg-Arg-OH | H-Arg-Arg-Arg-OH | 4000744 | H-1790 |
| Chloroac-Trp-OH | Chloroac-Trp-OH | 4000756 | E-1735 |
| Pyr-OPcp | Pyr-OPcp | 4000759 | E-2350 |
| Z-Gly-Pro-Arg-pNA | Z-Gly-Pro-Arg-pNA | 4000768 | L-1560 |
| Gastrin Tetrapeptide | H-Trp-Met-Asp-Phe-NH₂ | 4000794 | H-3110 |
| Tos-Gly-Pro-OH | Tos-Gly-Pro-OH | 4000810 | G-3310 |
| H-Val-Pro-OH · HCl | H-Val-Pro-OH · HCl | 4000815 | G-3575 |
| H-Tyr-Lys-OH | H-Tyr-Lys-OH | 4000819 | G-3445 |
| Pz-Pro-Leu-Gly-Pro-D-Arg-OH | Pz-Pro-Leu-Gly-Pro-D-Arg-OH | 4000833 | M-1715 |
| H-Ala-Phe-Pro-βNA · HCl | H-Ala-Phe-Pro-βNA · HCl | 4000852 | K-1070 |
| H-Gly-Gly-Lys-OH | H-Gly-Gly-Lys-OH | 4000882 | H-3445 |
| H-Phe-Arg-βNA · 2 HCl | H-Phe-Arg-βNA · 2 HCl | 4000885 | K-1450 |
| H-Ile-His-OH | H-Ile-His-OH | 4000894 | G-2400 |
| H-Tyr-Trp-OH | H-Tyr-Trp-OH | 4000897 | G-3470 |
| H-Ala-Ala-Ala-pNA · HCl | H-Ala-Ala-Ala-pNA · HCl | 4000901 | L-1090 |
| Suc-Ala-Ala-Ala-pNA | Suc-Ala-Ala-Ala-pNA | 4000902 | L-1385 |
| Z-Gly-Gly-Arg-βNA · HCl | Z-Gly-Gly-Arg-βNA · HCl | 4000903 | K-1175 |
| H-Lys-Lys-Lys-Lys-Lys-OH | H-Lys-Lys-Lys-Lys-Lys-OH | 4000970 | H-4185 |
| H-Gly-His-OH | H-Gly-His-OH | 4000976 | G-2120 |
| (H-Cys-Tyr-OH)₂ | (H-Cys-Tyr-OH)₂ (Disulfide bond) | 4000996 | G-1835 |
| H-Pro-Gly-Gly-OH | H-Pro-Gly-Gly-OH | 4001014 | M-1730 |
| H-Tyr-OtBu | H-Tyr-OtBu | 4001023 | E-2535 |
| H-Phe-Val-OH | H-Phe-Val-OH | 4001025 | G-2965 |
| H-Glu(H-Lys-OH)-OH | H-Glu(H-Lys-OH)-OH | 4001034 | G-1970 |
| Hippuryl-Lys-OH | Hippuryl-Lys-OH | 4001040 | G-2275 |
| H-Asp-Leu-OH | H-Asp-Leu-OH | 4001054 | G-1590 |
| H-Asp-Val-OH | H-Asp-Val-OH | 4001055 | G-1635 |
| H-Ser-Ala-OH | H-Ser-Ala-OH | 4001058 | G-3160 |
| H-Pro-Ile-OH | H-Pro-Ile-OH | 4001060 | G-3030 |
| H-Pro-Gly-OH | H-Pro-Gly-OH | 4001061 | G-3015 |
| Z-Sar-OH | Z-Sar-OH | 4001068 | C-2570 |
| Boc-Ser-OH Bachem Quality Grade | Boc-Ser-OH Bachem Quality Grade | 4001097 | A-2275 |
| Sar-OtBu · HCl | Sar-OtBu · HCl | 4001102 | E-2360 |
| H-Tyr-Phe-OH | H-Tyr-Phe-OH | 4001110 | G-3455 |
| Boc-Sar-OH | Boc-Sar-OH | 4001115 | A-2265 |
| Sar-NMe₂ | Sar-NMe₂ | 4001134 | E-2365 |
| H-His-Trp-OH | H-His-Trp-OH | 4001146 | G-2350 |
| Z-Tyr-OH | Z-Tyr-OH | 4001149 | C-2730 |
| Boc-Ala-Ala-OH | Boc-Ala-Ala-OH | 4001154 | A-2680 |
| Boc-Ser-OtBu | Boc-Ser-OtBu | 4001192 | A-3025 |
| H-Arg-Ile-OH | H-Arg-Ile-OH | 4001206 | G-1490 |
| H-Gly-Asn-OH | H-Gly-Asn-OH | 4001207 | G-2055 |
| H-Gly-Phe-βNA | H-Gly-Phe-βNA | 4001208 | K-1325 |
| Z-Trp-OH | Z-Trp-OH | 4001218 | C-2665 |
| H-Ser(Ac)-OH · HCl | H-Ser(Ac)-OH · HCl | 4001221 | E-1200 |
| H-Ser-Phe-OH | H-Ser-Phe-OH | 4001222 | G-3220 |
| H-His-Gly-OH | H-His-Gly-OH | 4001227 | G-2305 |
| H-Leu-Gly-βNA | H-Leu-Gly-βNA | 4001233 | K-1400 |
| H-Gly-Sar-OH | H-Gly-Sar-OH | 4001240 | G-2195 |
| H-Gly-Tyr-OH | H-Gly-Tyr-OH | 4001241 | G-2235 |
| β-Endorphin (30-31) (bovine, camel, mouse, ovine) | H-Gly-Gln-OH | 4001242 | N-1070 |
| H-Glu(Gln-OH)-OH | H-Glu(Gln-OH)-OH | 4001245 | G-1930 |
| Z-Thr(tBu)-OH · DCHA | Z-Thr(tBu)-OH · DCHA | 4001246 | C-1475 |
| Z-Thr(tBu)-OSu | Z-Thr(tBu)-OSu | 4001247 | C-1490 |
| Boc-Tyr(2-bromo-Z)-OH | Boc-Tyr(2-bromo-Z)-OH | 4001250 | A-1420 |
| Bz-Tyr-pNA | Bz-Tyr-pNA | 4001259 | L-1155 |
| H-Val-Tyr-Val-OH | H-Val-Tyr-Val-OH | 4001260 | H-5300 |
| H-Ala-Ala-Tyr-OH | H-Ala-Ala-Tyr-OH | 4001262 | H-1445 |
| Boc-Trp(For)-OH | Boc-Trp(For)-OH | 4001264 | A-1625 |
| H-His-Tyr-OH | H-His-Tyr-OH | 4001317 | G-2355 |
| H-Thr-Gly-OH | H-Thr-Gly-OH | 4001319 | G-3280 |
| Pyr-Val-OH | Pyr-Val-OH | 4001328 | G-1310 |
| H-Ser-OMe · HCl | H-Ser-OMe · HCl | 4001336 | E-2395 |
| H-Thr-OBzl · oxalate (1:1) | H-Thr-OBzl · oxalate (1:1) | 4001337 | E-2430 |
| H-Ala-Thr-OH | H-Ala-Thr-OH | 4001340 | G-1390 |
| H-His-Pro-OH | H-His-Pro-OH | 4001351 | G-2335 |
| H-Ser-Gly-OH | H-Ser-Gly-OH | 4001372 | G-3190 |
| H-Ala-Phe-OH | H-Ala-Phe-OH | 4001376 | G-1320 |
| H-Lys-Ala-OH | H-Lys-Ala-OH | 4001389 | G-2630 |
| H-Asp-Gly-OH | H-Asp-Gly-OH | 4001395 | G-1580 |
| H-Met-Ala-Ser-OH | H-Met-Ala-Ser-OH | 4001423 | H-4315 |
| H-Asp(Ala-OH)-OH | H-Asp(Ala-OH)-OH | 4001437 | G-1560 |
| H-D-Ala-Gly-Gly-OH | H-D-Ala-Gly-Gly-OH | 4001438 | H-5985 |
| Z-Ser-OH | Z-Ser-OH | 4001465 | C-2590 |
| H-Val-Asp-OH | H-Val-Asp-OH | 4001466 | G-3510 |
| H-Glu-Ala-OH | H-Glu-Ala-OH | 4001473 | G-1900 |
| H-Asp-Phe-OH | H-Asp-Phe-OH | 4001477 | G-1620 |
| H-Lys-Tyr-OH | H-Lys-Tyr-OH | 4001484 | G-2700 |
| (D-Ala²,D-Leu⁵)-Enkephalin | H-Tyr-D-Ala-Gly-Phe-D-Leu-OH | 4001508 | H-2860 |
| For-Met-Leu-Phe-OH | For-Met-Leu-Phe-OH | 4001509 | H-3030 |
| Boc-Ser(tBu)-OH · DCHA | Boc-Ser(tBu)-OH · DCHA | 4001527 | A-1430 |
| Bradykinin (1-5) | H-Arg-Pro-Pro-Gly-Phe-OH | 4001554 | H-1945 |
| H-Phe-Met-Arg-Phe-NH₂ | H-Phe-Met-Arg-Phe-NH₂ | 4001566 | H-2975 |
| H-Met-Lys-OH | H-Met-Lys-OH | 4001594 | G-2765 |
| H-Gly-Asp-Asp-Asp-Asp-Lys-βNA | H-Gly-Asp-Asp-Asp-Asp-Lys-βNA | 4001598 | K-1310 |
| 7-Amino-4-methylcoumarin | 7-Amino-4-methylcoumarin | 4001606 | Q-1025 |
| H-Leu-Leu-OH | H-Leu-Leu-OH | 4001608 | M-1535 |
| Z-D-Trp-OH | Z-D-Trp-OH | 4001610 | C-2670 |
| H-Arg-Asp-OH | H-Arg-Asp-OH | 4001631 | G-1470 |
| 4-Methoxy-β-naphthylamine | 4-Methoxy-β-naphthylamine | 4001634 | Q-1315 |
| H-Arg-Trp-OH | H-Arg-Trp-OH | 4001652 | G-1530 |
| H-Ile-Phe-OH | H-Ile-Phe-OH | 4001668 | G-2420 |
| Z-Glu-Tyr-OH | Z-Glu-Tyr-OH | 4001669 | M-1245 |
| H-Glu-Val-OH | H-Glu-Val-OH | 4001676 | G-2010 |
| H-Val-Ile-OH | H-Val-Ile-OH | 4001684 | G-3540 |
| Z-Ser(tBu)-OH | Z-Ser(tBu)-OH | 4001692 | C-1455 |
| H-Ser(tBu)-OH | H-Ser(tBu)-OH | 4001695 | E-1655 |
| H-Glu-Thr-Tyr-Ser-Lys-OH · 2 TFA | H-Glu-Thr-Tyr-Ser-Lys-OH · 2 TFA | 4001724 | H-3215 |
| H-Met-Ala-OH | H-Met-Ala-OH | 4001725 | G-2710 |
| Z-Gly-Gly-Gly-OSu | Z-Gly-Gly-Gly-OSu | 4001727 | C-1735 |
| H-Trp-Gly-OH | H-Trp-Gly-OH | 4001732 | G-3340 |
| H-Gly-Trp-Gly-OH | H-Gly-Trp-Gly-OH | 4001801 | H-3655 |
| H-Hyp-Gly-OH | H-Hyp-Gly-OH | 4001823 | G-2365 |
| (H-Cys-Phe-OH)₂ | (H-Cys-Phe-OH)₂ (Disulfide bond) | 4001825 | G-1825 |
| Boc-N-Me-Val-OH | Boc-N-Me-Val-OH | 4001829 | A-2100 |
| H-Tyr-His-OH | H-Tyr-His-OH | 4001846 | G-3415 |
| Ophthalmic Acid | H-Glu(Abu-Gly-OH)-OH | 4001847 | H-3145 |
| H-Phe-Met-OH | H-Phe-Met-OH | 4001858 | G-2915 |
| H-Ile-Arg-OH | H-Ile-Arg-OH | 4001862 | G-2375 |
| H-Gly-Hyp-OH | H-Gly-Hyp-OH | 4001866 | G-2130 |
| H-Pro-AMC | H-Pro-AMC | 4001869 | I-1290 |
| H-Gly-Gly-Ala-OH | H-Gly-Gly-Ala-OH | 4001910 | H-3290 |
| H-Met-Phe-OH | H-Met-Phe-OH | 4001914 | G-2790 |
| Z-Ala-Ala-OH | Z-Ala-Ala-OH | 4001947 | C-1045 |
| Boc-Ser(Bzl)-OH | Boc-Ser(Bzl)-OH | 4001958 | A-1330 |
| H-Tyr(tBu)-OH | H-Tyr(tBu)-OH | 4001967 | E-1685 |
| H-Gly-Pro-OH | H-Gly-Pro-OH | 4001970 | G-2190 |
| H-Pro-Phe-OH | H-Pro-Phe-OH | 4001974 | G-3050 |
| H-Val-Tyr-OH | H-Val-Tyr-OH | 4001976 | G-3585 |
| H-Met-Leu-OH | H-Met-Leu-OH | 4001988 | G-2760 |
| H-Ile-Trp-OH | H-Ile-Trp-OH | 4001989 | G-2435 |
| H-Val-Phe-OH | H-Val-Phe-OH | 4001995 | G-3565 |
| H-Ile-Val-OH | H-Ile-Val-OH | 4001998 | G-2445 |
| TRH (free acid) | Pyr-His-Pro-OH | 4002023 | H-4910 |
| H-Glu(Tyr-OH)-OH | H-Glu(Tyr-OH)-OH | 4002026 | G-2005 |
| H-Lys-Arg-OH | H-Lys-Arg-OH | 4002034 | G-2635 |
| Bz-Phe-Val-Arg-pNA · HCl | Bz-Phe-Val-Arg-pNA · HCl | 4002044 | L-1150 |
| Z-Gly-Pro-Arg-AMC · HCl | Z-Gly-Pro-Arg-AMC · HCl | 4002047 | I-1150 |
| Pentagastrin | Boc-β-Ala-Trp-Met-Asp-Phe-NH₂ | 4002096 | A-1130 |
| Boc-Phe-Phe-OH | Boc-Phe-Phe-OH | 4002106 | A-3205 |
| Bz-Arg-Gly-Phe-Phe-Pro-4MβNA · HCl | Bz-Arg-Gly-Phe-Phe-Pro-4MβNA · HCl | 4002124 | J-1065 |
| Oxythiamine · HCl | Oxythiamine · HCl | 4002126 | Q-1365 |
| H-Trp-Trp-OH | H-Trp-Trp-OH | 4002133 | G-3370 |
| H-Arg-Phe-OH | H-Arg-Phe-OH | 4002139 | G-1515 |
| Hippuryl-His-Leu-OH | Hippuryl-His-Leu-OH | 4002147 | M-1485 |
| H-Ser-Ser-Ser-OH | H-Ser-Ser-Ser-OH | 4002153 | H-4980 |
| H-Trp-OEt · HCl | H-Trp-OEt · HCl | 4002156 | E-2510 |
| Boc-D-Ser(Bzl)-OH | Boc-D-Ser(Bzl)-OH | 4002168 | A-1335 |
| H-Ala-Ala-Ala-OH | H-Ala-Ala-Ala-OH | 4002181 | H-1225 |
| H-His-Ala-OH | H-His-Ala-OH | 4002185 | G-2285 |
| H-Gly-Arg-AMC | H-Gly-Arg-AMC | 4002196 | I-1215 |
| H-Val-Ser-OH | H-Val-Ser-OH | 4002210 | G-3580 |
| Boc-N-Me-Ser-OH | Boc-N-Me-Ser-OH | 4002217 | A-2085 |
| Cyclo(-Val-Val) | Cyclo(-Val-Val) | 4002223 | G-3760 |
| Z-Gln-Gly-OH | Z-Gln-Gly-OH | 4002246 | C-1635 |
| H-Ala-D-Ala-OH | H-Ala-D-Ala-OH | 4002261 | G-1125 |
| H-Thr-Met-OH | H-Thr-Met-OH | 4002269 | G-3290 |
| H-Ile-Tyr-OH | H-Ile-Tyr-OH | 4002273 | G-2440 |
| H-Trp-Ser-OH | H-Trp-Ser-OH | 4002277 | G-3365 |
| H-Val-AMC | H-Val-AMC | 4002284 | I-1380 |
| H-Pro-Pro-Pro-OH | H-Pro-Pro-Pro-OH | 4002285 | H-4795 |
| Bz-Tyr-OEt | Bz-Tyr-OEt | 4002293 | E-1530 |
| H-His-Phe-OH | H-His-Phe-OH | 4002294 | N-1095 |
| Suc-Gly-Gly-Phe-pNA | Suc-Gly-Gly-Phe-pNA | 4002298 | L-1415 |
| H-Gln-Gln-OH | H-Gln-Gln-OH | 4002313 | G-1885 |
| H-Met-Asp-OH | H-Met-Asp-OH | 4002325 | G-2730 |
| H-Ala-Ala-βNA | H-Ala-Ala-βNA | 4002328 | K-1040 |
| Angiotensin I | H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-OH | 4002346 | H-1680 |
| H-Trp-Tyr-OH | H-Trp-Tyr-OH | 4002348 | G-3375 |
| Cyclo(-Ala-Ala) | Cyclo(-Ala-Ala) | 4002354 | G-1655 |
| H-Gly-Ala-Gly-OH | H-Gly-Ala-Gly-OH | 4002360 | H-3250 |
| H-Trp-βNA | H-Trp-βNA | 4002361 | K-1525 |
| H-Glu(Phe-OH)-OH | H-Glu(Phe-OH)-OH | 4002375 | G-1975 |
| H-Glu-Lys-OH | H-Glu-Lys-OH | 4002376 | G-1955 |
| β-Casomorphin (1-2) | H-Tyr-Pro-OH | 4002382 | G-3625 |
| H-Val-Gln-OH | H-Val-Gln-OH | 4002392 | G-3925 |
| Ac-Trp-NH₂ | Ac-Trp-NH₂ | 4002401 | E-1225 |
| β-Endorphin (30-31) (human) | H-Gly-Glu-OH | 4002438 | G-2080 |
| H-Ala-Pro-OH | H-Ala-Pro-OH | 4002443 | G-1350 |
| H-Thr(tBu)-OH | H-Thr(tBu)-OH | 4002448 | E-1670 |
| H-Met-Glu-OH | H-Met-Glu-OH | 4002459 | G-2735 |
| H-Tyr-Glu-OH | H-Tyr-Glu-OH | 4002463 | G-3395 |
| H-Gly-Gly-Phe-OH | H-Gly-Gly-Phe-OH | 4002475 | H-3465 |
| Z-Pro-Ala-OH | Z-Pro-Ala-OH | 4002476 | C-2485 |
| Pyr-pNA | Pyr-pNA | 4002484 | L-1375 |
| H-Ile-Pro-OH | H-Ile-Pro-OH | 4002494 | G-2425 |
| Z-Gly-Pro-AMC | Z-Gly-Pro-AMC | 4002518 | I-1145 |
| H-Gly-Pro-AMC · HBr | H-Gly-Pro-AMC · HBr | 4002520 | I-1225 |
| H-Lys-Ala-4MβNA · 2 HCl | H-Lys-Ala-4MβNA · 2 HCl | 4002544 | J-1250 |
| H-Tyr-Leu-OH | H-Tyr-Leu-OH | 4002549 | G-3430 |
| H-Ser-Pro-OH | H-Ser-Pro-OH | 4002551 | G-3230 |
| H-Val-OMe · HCl | H-Val-OMe · HCl | 4002561 | E-2595 |
| H-Ala-Ala-Phe-AMC (free base) | H-Ala-Ala-Phe-AMC (free base) | 4002571 | I-1415 |
| H-Ser-AMC | H-Ser-AMC | 4002585 | I-1305 |
| H-Ser(tBu)-OtBu | H-Ser(tBu)-OtBu | 4002610 | E-1660 |
| Cyclo(-Ala-Gly) | Cyclo(-Ala-Gly) | 4002623 | G-1660 |
| H-Arg-Glu-OH | H-Arg-Glu-OH | 4002632 | G-1475 |
| H-Gly-Trp-βNA · HCl | H-Gly-Trp-βNA · HCl | 4002635 | K-1345 |
| H-Phe-Ala-OH | H-Phe-Ala-OH | 4002640 | G-2850 |
| N-Me-Ser-OH | N-Me-Ser-OH | 4002644 | E-2190 |
| Hippuryl-Arg-OH | Hippuryl-Arg-OH | 4002651 | G-2265 |
| H-Ala-His-OH | H-Ala-His-OH | 4002657 | G-1245 |
| H-Ser(tBu)-OMe · HCl | H-Ser(tBu)-OMe · HCl | 4002681 | E-1665 |
| H-Leu-Trp-Met-Arg-OH | H-Leu-Trp-Met-Arg-OH | 4002689 | H-3975 |
| Ac-Phe-Phe-OH | Ac-Phe-Phe-OH | 4002695 | G-1070 |
| H-Leu-His-OH | H-Leu-His-OH | 4002700 | G-2520 |
| H-Ala-Pro-pNA | H-Ala-Pro-pNA | 4002751 | L-1115 |
| H-Ala-Ala-Phe-pNA | H-Ala-Ala-Phe-pNA | 4002753 | L-1095 |
| Cyclo(-Met-Met) | Cyclo(-Met-Met) | 4002806 | G-1760 |
| H-Ala-Ile-OH | H-Ala-Ile-OH | 4002856 | G-1260 |
| Cyclo(-Phe-Phe) | Cyclo(-Phe-Phe) | 4002860 | G-1765 |
| H-Ser(PO₃H₂)-OH | H-Ser(PO₃H₂)-OH | 4002875 | F-2030 |
| H-Ser-Tyr-βNA | H-Ser-Tyr-βNA | 4002888 | K-1505 |
| H-Val-His-OH | H-Val-His-OH | 4002910 | G-3535 |
| Z-Gly-Gly-Leu-pNA | Z-Gly-Gly-Leu-pNA | 4002941 | L-1230 |
| Bradykinin | H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH | 4002961 | H-1970 |
| H-Tyr-Gly-OH | H-Tyr-Gly-OH | 4002964 | G-3405 |
| H-Cys-Gly-OH | H-Cys-Gly-OH | 4002969 | G-3755 |
| H-Tyr-NH₂ | H-Tyr-NH₂ | 4002971 | E-2520 |
| H-Leu-Pro-OH · HCl | H-Leu-Pro-OH · HCl | 4002984 | G-2585 |
| H-Val-Arg-OH | H-Val-Arg-OH | 4002985 | G-3810 |
| H-Leu-Ile-OH | H-Leu-Ile-OH | 4002987 | G-2525 |
| H-Tyr-AMC | H-Tyr-AMC | 4003008 | I-1375 |
| Tuftsin | H-Thr-Lys-Pro-Arg-OH | 4003033 | H-5035 |
| H-His-Pro-NH₂ · 2 HBr | H-His-Pro-NH₂ · 2 HBr | 4003035 | G-4185 |
| Ac-Ala-Ala-Ala-OH | Ac-Ala-Ala-Ala-OH | 4003070 | M-1010 |
| Cyclo(-D-Leu-D-Pro) | Cyclo(-D-Leu-D-Pro) | 4003077 | G-1755 |
| Fmoc-Ser(tBu)-OH | Fmoc-Ser(tBu)-OH | 4003086 | B-1235 |
| Z-Thr-OSu | Z-Thr-OSu | 4003112 | C-2650 |
| Cyclo(-Leu-Pro) | Cyclo(-Leu-Pro) | 4003115 | G-1750 |
| H-Gly-Arg-4MβNA · 2 HCl | H-Gly-Arg-4MβNA · 2 HCl | 4003122 | J-1200 |
| Bz-Phe-Val-Arg-AMC | Bz-Phe-Val-Arg-AMC | 4003131 | I-1080 |
| H-Asp-Ala-OH | H-Asp-Ala-OH | 4003132 | G-1550 |
| H-Thr-Ala-OH | H-Thr-Ala-OH | 4003133 | G-3255 |
| Cyclo(-Ser-Ser) | Cyclo(-Ser-Ser) | 4003140 | G-1785 |
| Fmoc-Gly-Gly-Gly-OH | Fmoc-Gly-Gly-Gly-OH | 4003169 | B-1490 |
| Bradykinin (2-9) | H-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH | 4003176 | H-2200 |
| Fmoc-Gly-Phe-OH | Fmoc-Gly-Phe-OH | 4003182 | B-1495 |
| Fmoc-Trp-OH | Fmoc-Trp-OH | 4003185 | B-1445 |
| Fmoc-D-Trp-OH | Fmoc-D-Trp-OH | 4003200 | B-1450 |
| Cyclo(-Glu-Glu) | Cyclo(-Glu-Glu) | 4003229 | G-1700 |
| Lys-Bradykinin | H-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH | 4003280 | H-2180 |
| Bz-Val-Gly-Arg-AMC | Bz-Val-Gly-Arg-AMC | 4003312 | I-1085 |
| Wang resin (200-400 mesh, 0.80-1.20 mmol/g) | 4-Alkoxybenzyl alcohol resin | 4003214 | D-1250 |
| β-Casomorphin (bovine) | H-Tyr-Pro-Phe-Pro-Gly-Pro-Ile-OH | 4003340 | H-2280 |
| Z-Gly-Pro-Arg-4MβNA | Z-Gly-Pro-Arg-4MβNA | 4003347 | J-1120 |
| β-Casomorphin (1-4) (bovine) | H-Tyr-Pro-Phe-Pro-OH | 4003351 | H-2350 |
| β-Casomorphin (1-4) amide (bovine) | H-Tyr-Pro-Phe-Pro-NH₂ | 4003374 | H-2355 |
| Met-Enkephalin-Arg-Phe | H-Tyr-Gly-Gly-Phe-Met-Arg-Phe-OH | 4003395 | H-2830 |
| H-His-Met-OH | H-His-Met-OH | 4003456 | G-2325 |
| H-Asp-Lys-OH | H-Asp-Lys-OH | 4003468 | G-1605 |
| Suc-Ala-Ala-Val-pNA | Suc-Ala-Ala-Val-pNA | 4003470 | L-1405 |
| H-Glu-Tyr-OH | H-Glu-Tyr-OH | 4003475 | G-2000 |
| Z-Thr-OBzl | Z-Thr-OBzl | 4003488 | C-2640 |
| H-Glu(Gly-OH)-OH | H-Glu(Gly-OH)-OH | 4003498 | G-1940 |
| Fmoc-Val-OSu | Fmoc-Val-OSu | 4003501 | B-1465 |
| Mating Factor α | H-Trp-His-Trp-Leu-Gln-Leu-Lys-Pro-Gly-Gln-Pro-Met-Tyr-OH | 4003514 | H-2925 |
| Abz-Gly-p-nitro-Phe-Pro-OH | Abz-Gly-p-nitro-Phe-Pro-OH | 4003531 | M-1100 |
| Z-Ala-Pro-pNA | Z-Ala-Pro-pNA | 4003575 | L-1215 |
| Boc-Gly-Gly-Gly-OH | Boc-Gly-Gly-Gly-OH | 4003590 | A-4380 |
| H-Ser-Tyr-OH | H-Ser-Tyr-OH | 4003606 | G-3240 |
| FA-Gly-Leu-NH₂ | FA-Gly-Leu-NH₂ | 4003615 | M-1375 |
| H-Leu-Tyr-OH | H-Leu-Tyr-OH | 4003621 | G-2610 |
| Z-Glu-Gly-OH | Z-Glu-Gly-OH | 4003632 | C-1640 |
| FA-Phe-Gly-Gly-OH | FA-Phe-Gly-Gly-OH | 4003634 | M-1400 |
| Suc-Ala-Ala-Pro-Leu-pNA | Suc-Ala-Ala-Pro-Leu-pNA | 4003646 | L-1390 |
| Z-Gly-Pro-pNA | Z-Gly-Pro-pNA | 4003649 | L-1235 |
| Z-Ala-Leu-OH | Z-Ala-Leu-OH | 4003652 | C-3155 |
| H-Gly-Pro-pNA · p-tosylate | H-Gly-Pro-pNA · p-tosylate | 4003654 | L-1295 |
| Cyclo(-His-Pro) | Cyclo(-His-Pro) | 4003655 | G-1745 |
| H-Gly-Gly-Arg-OH | H-Gly-Gly-Arg-OH | 4003702 | H-3305 |
| H-Glu(Val-OH)-OH | H-Glu(Val-OH)-OH | 4003707 | G-2015 |
| H-Trp-Leu-OH | H-Trp-Leu-OH | 4003710 | G-3345 |
| Bradykinin (1-7) | H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-OH | 4003752 | H-1955 |
| H-Gly-Phe-AMC | H-Gly-Phe-AMC | 4003759 | I-1220 |
| H-DL-Ala-DL-Ala-OH | H-DL-Ala-DL-Ala-OH | 4003762 | G-1140 |
| H-Gly-Gly-Gly-NH₂ · HCl | H-Gly-Gly-Gly-NH₂ · HCl | 4003770 | H-3355 |
| H-Val-Val-Val-OH | H-Val-Val-Val-OH | 4003788 | H-5305 |
| (Nle⁴,D-Phe⁷)-α-MSH | Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH₂ | 4003800 | H-1100 |
| Z-Phe-Ala-diazomethylketone | Z-Phe-Ala-diazomethylketone | 4003801 | N-1040 |
| Z-Ser(Bzl)-OH | Z-Ser(Bzl)-OH | 4003805 | C-1400 |
| H-Leu-Arg-OH | H-Leu-Arg-OH | 4003808 | G-2480 |
| Boc-Ala-Ala-Pro-OH | Boc-Ala-Ala-Pro-OH | 4003849 | A-1100 |
| H-Glu(Ala-OH)-OH | H-Glu(Ala-OH)-OH | 4003870 | G-1905 |
| Bz-Ile-Glu-Gly-Arg-pNA | Bz-Ile-Glu-Gly-Arg-pNA | 4003874 | L-1475 |
| H-Met-D-Met-OH | H-Met-D-Met-OH | 4003884 | G-2775 |
| Pyr-βNA | Pyr-βNA | 4003907 | K-1480 |
| H-Trp-Pro-OH | H-Trp-Pro-OH | 4003908 | G-3790 |
| H-Val-Ala-pNA | H-Val-Ala-pNA | 4003920 | L-1845 |
| Ac-Tyr-NHMe | Ac-Tyr-NHMe | 4003924 | E-1255 |
| H-Glu-Glu-βNA | H-Glu-Glu-βNA | 4003953 | K-1250 |
| Suc-Gly-Pro-Leu-Gly-Pro-AMC | Suc-Gly-Pro-Leu-Gly-Pro-AMC | 4003958 | I-1350 |
| H-Phe-Arg-OH | H-Phe-Arg-OH | 4003975 | G-2865 |
| H-Tyr(Me)-OH | H-Tyr(Me)-OH | 4003985 | E-3260 |
| Suc-Ala-Phe-Lys-AMC | Suc-Ala-Phe-Lys-AMC | 4004022 | I-1325 |
| H-Pro-Phe-Arg-AMC | H-Pro-Phe-Arg-AMC | 4004023 | I-1295 |
| Z-Phe-Phe-diazomethylketone | Z-Phe-Phe-diazomethylketone | 4004026 | N-1045 |
| Pyr-AMC | Pyr-AMC | 4004069 | I-1300 |
| Characteristic MSH-Tetrapeptide | H-His-Phe-Arg-Trp-OH | 4004112 | H-3750 |
| H-Arg-Arg-AMC | H-Arg-Arg-AMC | 4004120 | I-1055 |
| Fibrinopeptide A (human) | H-Ala-Asp-Ser-Gly-Glu-Gly-Asp-Phe-Leu-Ala-Glu-Gly-Gly-Gly-Val-Arg-OH | 4004131 | H-1465 |
| Fmoc-Ser(Bzl)-OH | Fmoc-Ser(Bzl)-OH | 4004135 | B-1200 |
| Head activator | Pyr-Pro-Pro-Gly-Gly-Ser-Lys-Val-Ile-Leu-Phe-OH | 4004158 | H-3790 |
| H-Asn-Val-OH | H-Asn-Val-OH | 4004205 | G-3720 |
| Z-D-Ser(tBu)-OH | Z-D-Ser(tBu)-OH | 4004207 | C-1460 |
| H-Val-pNA | H-Val-pNA | 4004208 | L-1440 |
| Muscimol | 5-(Aminomethyl)-3(2H)-isoxazolone | 4004216 | Q-1345 |
| MeOSuc-Ala-Ala-Pro-Val-pNA | MeOSuc-Ala-Ala-Pro-Val-pNA | 4004221 | L-1335 |
| Z-Ser-OBzl | Z-Ser-OBzl | 4004231 | C-2600 |
| 1,2-Dipalmitoyl-sn-glycero-3-phosphocholine | 1,2-Dipalmitoyl-sn-glycero-3-phosphocholine | 4004249 | O-1195 |
| L-β-Oleoyl-γ-palmitoyl-α-lecithin | L-β-Oleoyl-γ-palmitoyl-α-lecithin | 4004281 | O-1410 |
| n-Hexyltrioxyethylene | n-Hexyltrioxyethylene | 4004291 | P-1095 |
| H-D-Ala-D-Ala-D-Ala-OH | H-D-Ala-D-Ala-D-Ala-OH | 4004324 | H-1245 |
| Boc-Ala-D-Glu(OBzl)-NH₂ | Boc-Ala-D-Glu(OBzl)-NH₂ | 4004424 | A-1110 |
| H-D-Ala-Leu-Lys-AMC | H-D-Ala-Leu-Lys-AMC | 4004459 | I-1040 |
| Boc-Val-Leu-Lys-AMC | Boc-Val-Leu-Lys-AMC | 4004467 | I-1115 |
| H-Thr-NH₂ · HCl | H-Thr-NH₂ · HCl | 4004473 | E-2425 |
| Hippuryl-Phe-OH | Hippuryl-Phe-OH | 4004489 | M-1490 |
| H-Glu-Gly-OH | H-Glu-Gly-OH | 4004492 | G-1935 |
| H-Gly-Pro-Arg-Pro-OH | H-Gly-Pro-Arg-Pro-OH | 4004545 | H-2935 |
| H-Gly-Gly-Tyr-Arg-OH | H-Gly-Gly-Tyr-Arg-OH | 4004633 | N-1080 |
| H-Leu-D-Leu-OH | H-Leu-D-Leu-OH | 4004638 | G-2530 |
| p-Hydroxyhippuryl-His-Leu-OH | p-Hydroxyhippuryl-His-Leu-OH | 4004645 | M-1505 |
| H-β-Ala-Leu-OH | H-β-Ala-Leu-OH | 4004650 | G-1280 |
| H-Lys-Lys-OH | H-Lys-Lys-OH | 4004666 | G-2675 |
| (D-Arg¹,D-Pro²,D-Trp⁷·⁹,Leu¹¹)-Substance P | H-D-Arg-D-Pro-Lys-Pro-Gln-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH₂ | 4004685 | H-1930 |
| (D-Arg¹,D-Trp⁷·⁹,Leu¹¹)-Substance P | H-D-Arg-Pro-Lys-Pro-Gln-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH₂ | 4004691 | H-1925 |
| Cyclo(-Phe-Ser) | Cyclo(-Phe-Ser) | 4004737 | G-1770 |
| Cyclo(-Gly-Leu) | Cyclo(-Gly-Leu) | 4004738 | G-1710 |
| TRH-βNA | Pyr-His-Pro-βNA | 4004755 | K-1490 |
| Fmoc-Cl | Fmoc-Cl | 4004776 | Q-1235 |
| H-D-Val-Leu-Lys-pNA · 2 HCl | H-D-Val-Leu-Lys-pNA · 2 HCl | 4004781 | L-1470 |
| Z-Arg-Arg-AMC | Z-Arg-Arg-AMC | 4004789 | I-1135 |
| H-β-Ala-Gly-OH | H-β-Ala-Gly-OH | 4004822 | G-1230 |
| H-Ala-Ala-Pro-pNA · HCl | H-Ala-Ala-Pro-pNA · HCl | 4004827 | L-1100 |
| H-Gly-Thr-OH | H-Gly-Thr-OH | 4004835 | G-2205 |
| Cyclo(-Gly-His) | Cyclo(-Gly-His) | 4004905 | G-1705 |
| H-Thr-Phe-OH | H-Thr-Phe-OH | 4004907 | G-3295 |
| Fibrinopeptide B (human) | Pyr-Gly-Val-Asn-Asp-Asn-Glu-Glu-Gly-Phe-Phe-Ser-Ala-Arg-OH | 4004951 | H-2947 |
| Boc-Ile-Glu-Gly-Arg-AMC | Boc-Ile-Glu-Gly-Arg-AMC | 4004961 | I-1100 |
| H-D-Ala-D-Ala-D-Ala-D-Ala-D-Ala-OH | H-D-Ala-D-Ala-D-Ala-D-Ala-D-Ala-OH | 4004970 | H-1275 |
| H-Ser-OBzl | H-Ser-OBzl | 4004981 | E-2950 |
| Fmoc-D-Thr(tBu)-OH | Fmoc-D-Thr(tBu)-OH | 4004993 | B-1250 |
| H-Glu(Leu-OH)-OH | H-Glu(Leu-OH)-OH | 4005004 | G-1950 |
| H-Phe-Pro-OH | H-Phe-Pro-OH | 4005005 | G-2935 |
| H-Ala-Leu-OH | H-Ala-Leu-OH | 4005016 | G-1265 |
| H-D-Leu-D-Leu-OH | H-D-Leu-D-Leu-OH | 4005019 | G-2540 |
| H-Gly-Gly-Met-OH | H-Gly-Gly-Met-OH | 4005023 | H-3460 |
| H-Val-Val-OH | H-Val-Val-OH | 4005024 | G-3595 |
| Ac-Phe-Gly-pNA | Ac-Phe-Gly-pNA | 4005053 | L-1060 |
| H-Glu(Abu-OH)-OH | H-Glu(Abu-OH)-OH | 4005138 | G-3900 |
| H-Ala-Tyr-OH | H-Ala-Tyr-OH | 4005177 | G-1405 |
| MeOSuc-Ala-Ala-Pro-Val-AMC | MeOSuc-Ala-Ala-Pro-Val-AMC | 4005227 | I-1270 |
| H-Trp-Trp-Trp-OH | H-Trp-Trp-Trp-OH | 4005236 | H-6970 |
| H-Phe-Trp-OH | H-Phe-Trp-OH | 4005237 | G-2950 |
| H-Tyr-Tyr-Tyr-OH | H-Tyr-Tyr-Tyr-OH | 4005242 | H-5230 |
| H-Leu-Ser-OH | H-Leu-Ser-OH | 4005263 | G-2595 |
| H-Glu-Ser-OH | H-Glu-Ser-OH | 4005267 | G-1980 |
| H-Tyr-Ala-OH | H-Tyr-Ala-OH | 4005303 | G-3390 |
| β-Casomorphin (1-3) | H-Tyr-Pro-Phe-OH | 4005317 | H-2375 |
| Suc-Gly-Pro-AMC | Suc-Gly-Pro-AMC | 4005321 | I-1345 |
| 1,2-Dilauroyl-sn-glycerol | 1,2-Dilauroyl-sn-glycerol | 4005366 | O-1065 |
| H-Ile-Gly-OH | H-Ile-Gly-OH | 4005399 | G-2395 |
| (Arg⁸)-Vasopressin (free acid) | H-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-OH (Disulfide bond) | 4005475 | H-1775 |
| H-Ala-Phe-Lys-AMC | H-Ala-Phe-Lys-AMC | 4005499 | I-1045 |
| Cyclo(-D-Trp-Tyr) | Cyclo(-D-Trp-Tyr) | 4005514 | G-1805 |
| Proctolin | H-Arg-Tyr-Leu-Pro-Thr-OH | 4005531 | N-1015 |
| H-Thr-AMC | H-Thr-AMC | 4005542 | I-1360 |
| Boc-Leu-Gly-Arg-AMC | Boc-Leu-Gly-Arg-AMC | 4005550 | I-1105 |
| 1,2-Distearoyl-rac-glycerol | 1,2-Distearoyl-rac-glycerol | 4005604 | O-1220 |
| 1,2-Dipalmitoyl-rac-glycerol | 1,2-Dipalmitoyl-rac-glycerol | 4005607 | O-1180 |
| 1,2-Dipalmitoyl-rac-glycero-3-phosphocholine | 1,2-Dipalmitoyl-rac-glycero-3-phosphocholine | 4005610 | O-1615 |
| 1,2-O-Dihexadecyl-sn-glycerol | 1,2-O-Dihexadecyl-sn-glycerol | 4005611 | O-1040 |
| 1,2-Dimyristoyl-sn-glycerol | 1,2-Dimyristoyl-sn-glycerol | 4005615 | O-1115 |
| 1,2-Dipalmitoyl-sn-glycerol | 1,2-Dipalmitoyl-sn-glycerol | 4005618 | O-1175 |
| 1,2-Distearoyl-sn-glycero-3-phosphocholine | 1,2-Distearoyl-sn-glycero-3-phosphocholine | 4005619 | O-1235 |
| 3-Palmitoyl-sn-glycerol | 3-Palmitoyl-sn-glycerol | 4005623 | O-1425 |
| 1,2-Distearoyl-rac-glycero-3-phosphocholine | 1,2-Distearoyl-rac-glycero-3-phosphocholine | 4005624 | O-1240 |
| 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine | 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine | 4005625 | O-1205 |
| 1,2-Dimyristoyl-sn-glycero-3-phosphocholine | 1,2-Dimyristoyl-sn-glycero-3-phosphocholine | 4005627 | O-1135 |
| 1,2-O-Dioctadecyl-sn-glycerol | 1,2-O-Dioctadecyl-sn-glycerol | 4005640 | O-1155 |
| Octyl glucoside | Octyl glucoside | 4005687 | P-1110 |
| H-D-Met-Met-OH | H-D-Met-Met-OH | 4005703 | G-2780 |
| H-D-Met-D-Met-OH | H-D-Met-D-Met-OH | 4005705 | G-2785 |
| H-Pro-Pro-Pro-Pro-OH | H-Pro-Pro-Pro-Pro-OH | 4005913 | H-4800 |
| H-Phe-Gly-His-p-nitro-Phe-Phe-Ala-Phe-OMe | H-Phe-Gly-His-p-nitro-Phe-Phe-Ala-Phe-OMe | 4005937 | H-4540 |
| Suc-Ala-Pro-Ala-AMC | Suc-Ala-Pro-Ala-AMC | 4005965 | I-1335 |
| Z-Tyr-Lys-Arg-pNA · 2 TFA | Z-Tyr-Lys-Arg-pNA · 2 TFA | 4005988 | L-1250 |
| H-Ala-Arg-OH | H-Ala-Arg-OH | 4005990 | G-1175 |
| β-Neoendorphin | H-Tyr-Gly-Gly-Phe-Leu-Arg-Lys-Tyr-Pro-OH | 4006024 | H-4420 |
| H-Ala-Val-OH | H-Ala-Val-OH | 4006109 | G-1420 |
| H-Pro-Arg-OH | H-Pro-Arg-OH | 4006116 | G-2990 |
| Boc-Ala-Ala-Gly-pNA | Boc-Ala-Ala-Gly-pNA | 4006118 | L-1170 |
| H-Gly-Gly-Cys-OH | H-Gly-Gly-Cys-OH | 4006119 | H-3325 |
| Ac-Asp-Glu-OH | Ac-Asp-Glu-OH | 4006232 | G-1015 |
| H-Gly-D-Phe-OH | H-Gly-D-Phe-OH | 4006237 | G-2180 |
| H-Val-Leu-OH · HCl | H-Val-Leu-OH · HCl | 4006243 | G-3545 |
| H-Ser-Gln-OH | H-Ser-Gln-OH | 4006251 | G-3180 |
| H-Ala-Asp-OH | H-Ala-Asp-OH | 4006259 | G-1195 |
| Boc-Ala-Ala-pNA | Boc-Ala-Ala-pNA | 4006301 | L-1160 |
| H-Ala-Ala-pNA | H-Ala-Ala-pNA | 4006302 | L-1085 |
| Suc-Ala-Ala-Ala-AMC | Suc-Ala-Ala-Ala-AMC | 4006305 | I-1310 |
| Suc-Ala-Ala-Phe-AMC | Suc-Ala-Ala-Phe-AMC | 4006306 | I-1315 |
| H-Gly-Ala-Tyr-OH | H-Gly-Ala-Tyr-OH | 4006341 | H-3275 |
| H-Ala-Trp-OH | H-Ala-Trp-OH | 4006342 | G-1395 |
| Ac-α-benzyl-4,6-O-benzylidene-muramic acid | Ac-α-benzyl-4,6-O-benzylidene-muramic acid | 4006354 | Q-1005 |
| n-Octyltetraoxyethylene | n-Octyltetraoxyethylene | 4006356 | P-1120 |
| DL-Aminoglutethimide | (RS)-3-(4-Amino-phenyl)-3-ethyl-piperidine-2,6-dione | 4006364 | Q-1020 |
| H-DL-Isoser-OH | H-DL-Isoser-OH | 4006366 | F-1695 |
| Fmoc-Ser(tBu)-Wang resin (200-400 mesh, 0.5-1.0 mmol/g) | Fmoc-Ser(tBu)-4-alkoxybenzyl alcohol resin | 4006433 | D-1070 |
| (Trp⁴)-Kemptide | H-Leu-Arg-Arg-Trp-Ser-Leu-Gly-OH | 4006462 | M-1525 |
| Fmoc-Ser(BSi)-OH | Fmoc-Ser(BSi)-OH | 4006501 | B-1225 |
| Fmoc-D-Ser(BSi)-OH | Fmoc-D-Ser(BSi)-OH | 4006507 | B-1230 |
| n-Octyltrioxyethylene | n-Octyltrioxyethylene | 4006522 | P-1125 |
| 1,2-Dimyristoyl-rac-glycero-3-phosphocholine | 1,2-Dimyristoyl-rac-glycero-3-phosphocholine | 4006546 | O-1140 |
| 1-O-Hexadecyl-2-O-acetyl-sn-glycero-3-phosphocholine | 1-O-Hexadecyl-2-O-acetyl-sn-glycero-3-phosphocholine | 4006552 | O-1270 |
| H-DL-β-(3,4-Dihydroxyphenyl)-DL-Ser-OH | H-DL-β-(3,4-Dihydroxyphenyl)-DL-Ser-OH | 4006570 | F-1525 |
| n-Decylpentaoxyethylene | n-Decylpentaoxyethylene | 4006590 | P-1005 |
| Suc-Ala-Ala-Val-Ala-pNA | Suc-Ala-Ala-Val-Ala-pNA | 4006610 | L-1410 |
| Suc-Phe-Leu-Phe-SBzl | Suc-Phe-Leu-Phe-SBzl | 4006633 | M-1740 |
| H-Met-Asn-OH | H-Met-Asn-OH | 4006671 | G-2725 |
| (Des-Arg⁹)-Bradykinin | H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-OH | 4006675 | H-1965 |
| FA-Leu-Gly-Pro-Ala-OH | FA-Leu-Gly-Pro-Ala-OH | 4006713 | M-1385 |
| H-Leu-Ser-p-nitro-Phe-Nle-Ala-Leu-OMe | H-Leu-Ser-p-nitro-Phe-Nle-Ala-Leu-OMe | 4006749 | M-1540 |
| Cyclo(-His-Phe) | Cyclo(-His-Phe) | 4006752 | G-1740 |
| MeOSuc-Ala-Phe-Lys-AMC | MeOSuc-Ala-Phe-Lys-AMC | 4006754 | I-1275 |
| Suc-Ala-Ala-Pro-Met-pNA | Suc-Ala-Ala-Pro-Met-pNA | 4006760 | L-1395 |
| Fmoc-OSu | Fmoc-OSu | 4006805 | Q-1240 |
| H-β-(2-Thienyl)-Ala-OH | H-β-(2-Thienyl)-Ala-OH | 4006811 | F-2110 |
| Z-Gly-Gly-Gly-Gly-Gly-OH | Z-Gly-Gly-Gly-Gly-Gly-OH | 4006909 | C-1755 |
| H-Gly-Gly-Gly-Gly-Gly-OH | H-Gly-Gly-Gly-Gly-Gly-OH | 4006911 | H-3395 |
| Fmoc-D-Tyr(tBu)-OH | Fmoc-D-Tyr(tBu)-OH | 4006924 | B-1260 |
| Fmoc-Tyr(Bzl)-OH | Fmoc-Tyr(Bzl)-OH | 4006928 | B-1215 |
| Cyclo(-Gly-Ser) | Cyclo(-Gly-Ser) | 4007008 | G-1725 |
| H-Val-OBzl · HCl | H-Val-OBzl · HCl | 4007018 | E-2575 |
| H-Gly-Asp-OH | H-Gly-Asp-OH | 4007025 | G-2065 |
| H-Met-Val-OH | H-Met-Val-OH | 4007030 | G-2825 |
| Boc-Tyr(tBu)-OH | Boc-Tyr(tBu)-OH | 4007047 | A-1450 |
| H-Phe-Gly-OH | H-Phe-Gly-OH | 4007063 | G-2880 |
| Z-Val-Ala-OH | Z-Val-Ala-OH | 4007093 | C-2835 |
| H-Val-Ala-OH | H-Val-Ala-OH | 4007094 | G-3500 |
| H-Thr-Gln-OH | H-Thr-Gln-OH | 4007099 | G-3277 |
| H-Ala-Ala-OMe · HCl | H-Ala-Ala-OMe · HCl | 4007203 | G-1160 |
| H-Gly-Val-OH | H-Gly-Val-OH | 4007209 | G-2250 |
| H-Ser-Ser-OH | H-Ser-Ser-OH | 4007228 | G-3235 |
| H-Trp-Phe-OH | H-Trp-Phe-OH | 4007230 | G-3360 |
| Z-Val-Gly-Arg-pNA | Z-Val-Gly-Arg-pNA | 4007266 | L-1555 |
| H-His-Lys-OH · HBr | H-His-Lys-OH · HBr | 4007285 | G-2320 |
| Hippuryl-Phe-Arg-OH | Hippuryl-Phe-Arg-OH | 4007291 | H-3725 |
| Tos-Gly-Pro-Lys-AMC | Tos-Gly-Pro-Lys-AMC | 4007328 | I-1370 |
| H-Gly-Arg-pNA · 2 HCl | H-Gly-Arg-pNA · 2 HCl | 4007356 | L-1285 |
| Angiotensin III | H-Arg-Val-Tyr-Ile-His-Pro-Phe-OH | 4007359 | H-1755 |
| (Sar¹)-Angiotensin II | Sar-Arg-Val-Tyr-Ile-His-Pro-Phe-OH | 4007360 | H-1740 |
| H-Arg-Lys-OH | H-Arg-Lys-OH | 4007373 | G-1505 |
| H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Val-Tyr-Ser-OH | H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Val-Tyr-Ser-OH | 4007374 | M-1115 |
| H-Val-Met-OH | H-Val-Met-OH | 4007536 | G-3555 |
| H-Pro-Val-OH | H-Pro-Val-OH | 4007540 | G-3085 |
| Fmoc-D-Val-OH | Fmoc-D-Val-OH | 4007570 | B-1460 |
| H-Ala-D-Glu-NH₂ | H-Ala-D-Glu-NH₂ | 4007604 | G-1255 |
| Cyclo-Somatostatin | Cyclo(-7-aminoheptanoyl-Phe-D-Trp-Lys-Thr(Bzl)) | 4007608 | H-2485 |
| H-Gly-Ala-Hyp-OH | H-Gly-Ala-Hyp-OH | 4007631 | H-3260 |
| H-Ile-Ile-OH | H-Ile-Ile-OH | 4007632 | G-2405 |
| H-Lys-Ala-AMC | H-Lys-Ala-AMC | 4007641 | I-1260 |
| Endotoxin Substrate | Boc-Leu-Gly-Arg-pNA | 4007683 | L-1195 |
| (Pyr⁶,Pro⁹)-Substance P (6-11) | Pyr-Phe-Phe-Pro-Leu-Met-NH₂ | 4007705 | H-4925 |
| H-Lys-Asp-OH | H-Lys-Asp-OH | 4007825 | G-2640 |
| (D-Ala²,N-Me-Phe⁴,glycinol⁵)-Enkephalin | H-Tyr-D-Ala-Gly-N-Me-Phe-glycinol | 4007829 | H-2535 |
| Boc-Ala-Ala-Asp-pNA | Boc-Ala-Ala-Asp-pNA | 4007883 | L-1165 |
| H-Gly-Gly-Tyr-OH | H-Gly-Gly-Tyr-OH | 4007920 | H-3495 |
| H-Gly-Leu-Phe-OH | H-Gly-Leu-Phe-OH | 4007924 | H-3555 |
| H-Ala-Ala-Ala-Ala-Ala-OH | H-Ala-Ala-Ala-Ala-Ala-OH | 4007939 | H-1270 |
| H-Leu-Asn-OH | H-Leu-Asn-OH | 4007960 | G-2485 |
| H-Trp-Asn-OH | H-Trp-Asn-OH | 4007967 | G-3325 |
| H-Lys-Trp-OH | H-Lys-Trp-OH | 4007980 | G-2695 |
| Cholecystokinin Octapeptide (1-2) (desulfated) | H-Asp-Tyr-OH | 4007984 | G-1630 |
| H-D-Val-Leu-Lys-AMC | H-D-Val-Leu-Lys-AMC | 4008009 | I-1390 |
| H-His-Ser-OH | H-His-Ser-OH | 4008023 | G-2340 |
| Z-Arg-Arg-pNA · 2 HCl | Z-Arg-Arg-pNA · 2 HCl | 4008026 | L-1225 |
| Z-Lys-Arg-pNA · 2 HCl | Z-Lys-Arg-pNA · 2 HCl | 4008028 | L-1240 |
| H-Lys-Lys-Lys-Lys-OH | H-Lys-Lys-Lys-Lys-OH | 4008050 | H-4180 |
| Z-Sar-OSu | Z-Sar-OSu | 4008051 | C-2575 |
| H-D-Ala-D-Ala-D-Ala-D-Ala-OH | H-D-Ala-D-Ala-D-Ala-D-Ala-OH | 4008059 | H-1265 |
| H-D-Ile-Phe-Lys-pNA | H-D-Ile-Phe-Lys-pNA | 4008063 | L-1300 |
| H-Ala-Ala-Phe-chloromethylketone · TFA | H-Ala-Ala-Phe-chloromethylketone · TFA | 4008089 | N-1005 |
| H-Phe-Leu-Glu-Glu-Leu-OH | H-Phe-Leu-Glu-Glu-Leu-OH | 4008097 | M-1700 |
| (Sar¹,Ile⁸)-Angiotensin II | Sar-Arg-Val-Tyr-Ile-His-Pro-Ile-OH | 4008098 | H-1730 |
| H-D-Phe-Homopro-Arg-pNA · 2 acetate | H-D-Phe-Homopro-Arg-pNA · 2 acetate | 4008145 | L-1490 |
| H-Gly-Phe-pNA | H-Gly-Phe-pNA | 4008150 | L-1290 |
| N-Me-Tyr(Me)-OH | N-Me-Tyr(Me)-OH | 4008161 | E-2160 |
| H-Trp-Arg-OH · 2 HCl | H-Trp-Arg-OH · 2 HCl | 4008165 | G-3320 |
| H-Val-Trp-OH | H-Val-Trp-OH | 4008196 | N-1170 |
| H-β-(2-Thienyl)-D-Ala-OH | H-β-(2-Thienyl)-D-Ala-OH | 4008202 | F-2115 |
| H-D-Phe-D-Phe-OH | H-D-Phe-D-Phe-OH | 4008206 | G-3805 |
| H-Tyr-Val-OH | H-Tyr-Val-OH | 4008208 | G-3490 |
| Z-Trp-OSu | Z-Trp-OSu | 4008236 | C-2680 |
| H-Glu(Trp-OH)-OH | H-Glu(Trp-OH)-OH | 4008246 | G-1995 |
| H-Met-Pro-OH · HCl | H-Met-Pro-OH · HCl | 4008251 | G-2800 |
| Ac-Lys(Ac)-D-Ala-D-lactic acid | Ac-Lys(Ac)-D-Ala-D-lactic acid | 4008293 | M-1330 |
| H-Pro-Asn-OH | H-Pro-Asn-OH | 4008296 | G-2995 |
| H-Pro-Asp-OH | H-Pro-Asp-OH | 4008298 | G-3000 |
| H-D-allo-Thr-OH | H-D-allo-Thr-OH | 4008353 | F-1180 |
| 1-O-Hexadecyl-sn-glycero-3-phosphocholine | 1-O-Hexadecyl-sn-glycero-3-phosphocholine | 4008363 | O-1300 |
| H-allo-Thr-OH | H-allo-Thr-OH | 4008379 | F-1175 |
| (D-Trp⁷,Ala⁸,D-Phe¹⁰)-α-MSH (6-11) amide | H-His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂ | 4008401 | H-9990 |
| α-MSH | Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH₂ | 4008476 | H-1075 |
| H-Met-His-OH | H-Met-His-OH | 4008532 | G-2750 |
| H-Gln-Gly-OH | H-Gln-Gly-OH | 4008606 | G-1890 |
| Tos-Gly-Pro-Arg-AMC · HCl | Tos-Gly-Pro-Arg-AMC · HCl | 4008607 | I-1365 |
| (D-2-Nal⁶)-LHRH | Pyr-His-Trp-Ser-Tyr-D-2-Nal-Leu-Arg-Pro-Gly-NH₂ | 4008670 | H-6095 |
| H-Asp-Glu-OH | H-Asp-Glu-OH | 4008675 | G-1575 |
| γ₁-MSH | H-Tyr-Val-Met-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-NH₂ | 4008707 | H-4395 |
| γ₂-MSH | H-Tyr-Val-Met-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-Gly-OH | 4008709 | H-4400 |
| Bz-Arg-Gly-Phe-Phe-Leu-4MβNA | Bz-Arg-Gly-Phe-Phe-Leu-4MβNA | 4008815 | J-1060 |
| Acetyl-Neurotensin (8-13) | Ac-Arg-Arg-Pro-Tyr-Ile-Leu-OH | 4008911 | H-1020 |
| Fmoc-3,5-dibromo-Tyr-OH | Fmoc-3,5-dibromo-Tyr-OH | 4008952 | B-1275 |
| Cyclo(-Gly-Pro) | Cyclo(-Gly-Pro) | 4008953 | G-1720 |
| H-Asp(Leu-OH)-OH | H-Asp(Leu-OH)-OH | 4008958 | G-1600 |
| (Val⁵)-Angiotensin II | H-Asp-Arg-Val-Tyr-Val-His-Pro-Phe-OH | 4008960 | H-1750 |
| ACTH (18-39) (human) | H-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe-OH | 4008985 | H-1215 |
| H-Thr-Arg-OH | H-Thr-Arg-OH | 4009134 | G-3265 |
| Xenopsin (XP) | Pyr-Gly-Lys-Arg-Pro-Trp-Ile-Leu-OH | 4009139 | H-4885 |
| H-Met-Arg-OH | H-Met-Arg-OH | 4009164 | G-2720 |
| Suc-Leu-Tyr-AMC | Suc-Leu-Tyr-AMC | 4009168 | I-1355 |
| Z-Phe-Arg-pNA · HCl | Z-Phe-Arg-pNA · HCl | 4009170 | L-1242 |
| H-Leu-Ser-Phe-OH | H-Leu-Ser-Phe-OH | 4009213 | H-3960 |
| H-Ser-Asp-OH | H-Ser-Asp-OH | 4009225 | G-3175 |
| H-Nle-Arg-Phe-NH₂ | H-Nle-Arg-Phe-NH₂ | 4009465 | H-2970 |
| Z-Gly-Gly-Phe-chloromethylketone | Z-Gly-Gly-Phe-chloromethylketone | 4009487 | N-1030 |
| H-Asp-Ala-His-Lys-OH | H-Asp-Ala-His-Lys-OH | 4009490 | H-2020 |
| α-Endorphin | H-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-OH | 4009491 | H-2695 |
| Fmoc-D-Ser(tBu)-OH | Fmoc-D-Ser(tBu)-OH | 4009509 | B-1240 |
| H-Pro-Tyr-OH | H-Pro-Tyr-OH | 4009513 | G-3075 |
| H-Thr-Asp-OH | H-Thr-Asp-OH | 4009517 | G-3275 |
| H-Trp-Ala-OH | H-Trp-Ala-OH | 4009521 | G-3315 |
| H-Pro-Trp-OH | H-Pro-Trp-OH | 4009531 | G-3070 |
| Fmoc-Ser(Ac)-OH | Fmoc-Ser(Ac)-OH | 4009560 | B-1010 |
| Boc-Thr(tBu)-OH | Boc-Thr(tBu)-OH | 4009568 | A-1440 |
| H-Trp-Met-OH | H-Trp-Met-OH | 4009571 | G-3350 |
| Boc-Ala-Gly-Gly-OH | Boc-Ala-Gly-Gly-OH | 4009580 | A-1120 |
| Fmoc-N-Me-Val-OH | Fmoc-N-Me-Val-OH | 4009586 | B-1380 |
| H-Gly-Gly-Ile-OH | H-Gly-Gly-Ile-OH | 4009599 | H-3430 |
| Neurotensin (1-8) | Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-OH | 4009606 | H-4445 |
| β-Casomorphin (human) | H-Tyr-Pro-Phe-Val-Glu-Pro-Ile-OH | 4009611 | H-2275 |
| H-Phe-Phe-Phe-Phe-OH | H-Phe-Phe-Phe-Phe-OH | 4009626 | H-4565 |
| H-Ser-Leu-OH | H-Ser-Leu-OH | 4009711 | G-3200 |
| Diprotin A | H-Ile-Pro-Ile-OH | 4009723 | H-3825 |
| (D-Ala⁶)-LHRH | Pyr-His-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH₂ | 4009745 | H-4020 |
| Fmoc-β-(2-thienyl)-Ala-OH | Fmoc-β-(2-thienyl)-Ala-OH | 4009752 | B-1665 |
| H-Leu-Leu-Ala-OH | H-Leu-Leu-Ala-OH | 4009785 | H-3905 |
| Fmoc-Sar-OH | Fmoc-Sar-OH | 4009790 | B-1720 |
| (3,5-Diiodo-Tyr¹,D-Ala²,N-Me-Phe⁴,glycinol⁵)-Enkephalin | H-3,5-Diiodo-Tyr-D-Ala-Gly-N-Me-Phe-glycinol | 4009810 | H-2595 |
| Suc-Ala-Ala-Pro-Phe-SBzl | Suc-Ala-Ala-Pro-Phe-SBzl | 4009924 | M-1735 |
| MeOSuc-Ala-Ala-Pro-Val-chloromethylketone | MeOSuc-Ala-Ala-Pro-Val-chloromethylketone | 4009927 | N-1055 |
| Z-Arg-Arg-Pro-Phe-His-Sta-Ile-His-Lys(Boc)-OMe | Z-Arg-Arg-Pro-Phe-His-Sta-Ile-His-Lys(Boc)-OMe | 4009949 | C-3195 |
| Galanin (porcine) | H-Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Ile-Asp-Asn-His-Arg-Ser-Phe-His-Asp-Lys-Tyr-Gly-Leu-Ala-NH₂ | 4009988 | H-1365 |
| H-Arg-Met-OH | H-Arg-Met-OH | 4009994 | G-2115 |
| H-Pro-Glu-OH | H-Pro-Glu-OH | 4010051 | G-3005 |
| H-Tyr(tBu)-OtBu · HCl | H-Tyr(tBu)-OtBu · HCl | 4010073 | E-1690 |
| Pz-Pro-Leu-OH | Pz-Pro-Leu-OH | 4010074 | G-2970 |
| H-Trp-Glu-OH | H-Trp-Glu-OH | 4010085 | G-3335 |
| Boc-D-Trp(For)-OH | Boc-D-Trp(For)-OH | 4010099 | A-2500 |
| H-Asp-Asp-OH | H-Asp-Asp-OH | 4010210 | G-1565 |
| H-Lys-Val-OH | H-Lys-Val-OH | 4010216 | G-2705 |
| H-Ile-Leu-OH | H-Ile-Leu-OH | 4010222 | G-2410 |
| H-Leu-Asp-OH | H-Leu-Asp-OH | 4010272 | G-3835 |
| H-Ser-Glu-OH | H-Ser-Glu-OH | 4010304 | G-3185 |
| H-Ser-His-OH | H-Ser-His-OH | 4010339 | G-3195 |
| 1-O-Octadecyl-sn-glycerol | 1-O-Octadecyl-sn-glycerol | 4010401 | O-1365 |
| 1-O-Hexadecyl-sn-glycerol | 1-O-Hexadecyl-sn-glycerol | 4010402 | O-1285 |
| 1-O-Octadecyl-2-O-benzyl-sn-glycerol | 1-O-Octadecyl-2-O-benzyl-sn-glycerol | 4010407 | O-1360 |
| R(+)-2-Chloropropionic acid | R(+)-2-Chloropropionic acid | 4010408 | Q-1175 |
| n-Decyltetraoxyethylene | n-Decyltetraoxyethylene | 4010419 | P-1010 |
| 2-Hydroxyethyloctylsulfoxide | 2-Hydroxyethyloctylsulfoxide | 4010421 | P-1105 |
| Chemotactic Domain of Elastin | H-Val-Gly-Val-Ala-Pro-Gly-OH | 4010536 | H-2390 |
| H-Val-His-Leu-Thr-Pro-OH | H-Val-His-Leu-Thr-Pro-OH | 4010555 | H-5275 |
| Bombesin | Pyr-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH₂ | 4010579 | H-2155 |
| Kemptide | H-Leu-Arg-Arg-Ala-Ser-Leu-Gly-OH | 4010606 | M-1510 |
| H-Ala-Ala-Ala-Ala-Ala-Ala-OH | H-Ala-Ala-Ala-Ala-Ala-Ala-OH | 4010634 | H-1280 |
| H-Ala-Ala-Ala-OMe | H-Ala-Ala-Ala-OMe | 4010702 | M-1090 |
| H-Ala-Trp-Ala-OH | H-Ala-Trp-Ala-OH | 4010739 | H-5425 |
| H-Phe-Ser-OH | H-Phe-Ser-OH | 4010741 | G-2940 |
| Pyr-Phe-Leu-pNA | Pyr-Phe-Leu-pNA | 4010747 | L-1460 |
| MeOSuc-Ala-Ala-Pro-Met-AMC | MeOSuc-Ala-Ala-Pro-Met-AMC | 4010774 | I-1405 |
| Cyclo(-Trp-Tyr) | Cyclo(-Trp-Tyr) | 4010776 | G-1800 |
| Z-Gly-Gly-Phe-OH | Z-Gly-Gly-Phe-OH | 4010787 | C-1795 |
| Neurokinin B | H-Asp-Met-His-Asp-Phe-Phe-Val-Gly-Leu-Met-NH₂ | 4010836 | H-2045 |
| Calcitonin (eel) | H-Cys-Ser-Asn-Leu-Ser-Thr-Cys-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asp-Val-Gly-Ala-Gly-Thr-Pro-NH₂ (Disulfide bond) | 4011079 | H-2255 |
| H-Phe-Phe-Phe-OH | H-Phe-Phe-Phe-OH | 4011114 | H-4560 |
| H-Ala-Ser-OH | H-Ala-Ser-OH | 4011129 | G-1380 |
| MEGA-10 | MEGA-10 | 4011133 | P-1000 |
| Pyr-Gly-OH | Pyr-Gly-OH | 4011222 | G-3695 |
| Enterostatin (human, mouse, rat) | H-Ala-Pro-Gly-Pro-Arg-OH | 4011240 | H-6405 |
| H-Pro-Ala-OH | H-Pro-Ala-OH | 4011264 | G-2985 |
| Pyr-Phe-OH | Pyr-Phe-OH | 4011273 | G-3910 |
| LHRH (salmon) | Pyr-His-Trp-Ser-Tyr-Gly-Trp-Leu-Pro-Gly-NH₂ | 4011291 | H-6845 |
| H-Thr-Pro-OH · HCl | H-Thr-Pro-OH · HCl | 4011293 | G-3960 |
| H-Gly-Arg-Gly-Asp-Ser-Pro-OH | H-Gly-Arg-Gly-Asp-Ser-Pro-OH | 4011294 | H-7630 |
| H-Phe-Glu-OH | H-Phe-Glu-OH | 4011365 | G-2875 |
| H-Arg-Pro-OH | H-Arg-Pro-OH | 4011377 | G-3675 |
| Mating Factor α (1-6) | H-Trp-His-Trp-Leu-Gln-Leu-OH | 4011391 | H-6205 |
| Suc-Leu-Leu-Val-Tyr-AMC | Suc-Leu-Leu-Val-Tyr-AMC | 4011369 | I-1395 |
| H-Gly-Arg-Gly-Asp-Ser-Pro-Lys-OH | H-Gly-Arg-Gly-Asp-Ser-Pro-Lys-OH | 4011392 | H-6190 |
| Ac-muramic acid | Ac-muramic acid | 4011440 | Q-1015 |
| FA-Phe-Phe-OH | FA-Phe-Phe-OH | 4011445 | M-1760 |
| Motilin (human, porcine) | H-Phe-Val-Pro-Ile-Phe-Thr-Tyr-Gly-Glu-Leu-Gln-Arg-Met-Gln-Glu-Lys-Glu-Arg-Asn-Lys-Gly-Gln-OH | 4011471 | H-4385 |
| GRF (human) | H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH₂ | 4011472 | H-3695 |
| pTH (1-34) (bovine) | H-Ala-Val-Ser-Glu-Ile-Gln-Phe-Met-His-Asn-Leu-Gly-Lys-His-Leu-Ser-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-OH | 4011476 | H-1660 |
| 1-O-(cis-9-Octadecenyl)-2-O-acetyl-sn-glycero-3-phosphocholine | 1-O-(cis-9-Octadecenyl)-2-O-acetyl-sn-glycero-3-phosphocholine | 4011530 | O-1030 |
| 1,2-Dilauroyl-sn-glycero-3-phosphocholine | 1,2-Dilauroyl-sn-glycero-3-phosphocholine | 4011534 | O-1455 |
| Minigastrin I (human) | H-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH₂ | 4011601 | H-3105 |
| VIP (human, mouse, rat) | H-His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH₂ | 4011611 | H-3775 |
| H-Glu-Gly-Arg-pNA | H-Glu-Gly-Arg-pNA | 4011619 | L-1455 |
| H-D-Leu-Thr-Arg-pNA | H-D-Leu-Thr-Arg-pNA | 4011623 | L-1380 |
| Suc-Phe-Leu-Phe-4MβNA | Suc-Phe-Leu-Phe-4MβNA | 4011631 | J-1320 |
| (Des-Asp¹)-Angiotensin I | H-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-OH | 4011641 | H-1700 |
| Neuropeptide Y (porcine) | H-Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH₂ | 4011654 | H-4430 |
| (Tyr⁴)-Bombesin | Pyr-Gln-Arg-Tyr-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH₂ | 4011655 | H-2165 |
| (Leu¹⁵)-Gastrin I (human) | Pyr-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Leu-Asp-Phe-NH₂ | 4011661 | H-3090 |
| Proinsulin C-Peptide (55-89) (human) | H-Arg-Arg-Glu-Ala-Glu-Asp-Leu-Gln-Val-Gly-Gln-Val-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Ser-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ser-Leu-Gln-Lys-Arg-OH | 4011662 | H-1800 |
| GRP (18-27) (human, porcine, canine) | H-Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH₂ | 4011670 | H-3120 |
| GRP (14-27) (human, porcine, canine) | H-Met-Tyr-Pro-Arg-Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH₂ | 4011671 | H-3115 |
| H-Tyr-Ile-Gly-Ser-Arg-OH | H-Tyr-Ile-Gly-Ser-Arg-OH | 4011700 | H-6825 |
| Substance P (free acid) | H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-OH | 4011702 | H-1885 |
| H-Thr-Leu-OH | H-Thr-Leu-OH | 4011818 | G-3285 |
| Cyclo(-Trp-Trp) | Cyclo(-Trp-Trp) | 4011825 | G-1795 |
| N-Me-Tyr-OH | N-Me-Tyr-OH | 4011845 | F-2235 |
| 3-Methoxytyramine · HCl | 3-Methoxytyramine · HCl | 4011849 | Q-1330 |
| Fmoc-Ser(tBu)-OPfp | Fmoc-Ser(tBu)-OPfp | 4011856 | B-1180 |
| Fmoc-Thr(tBu)-OPfp | Fmoc-Thr(tBu)-OPfp | 4011857 | B-1185 |
| Fmoc-Val-OPfp | Fmoc-Val-OPfp | 4011858 | B-1565 |
| Fmoc-Tyr(tBu)-OPfp | Fmoc-Tyr(tBu)-OPfp | 4011861 | B-1195 |
| H-Ala-D-Gln-OH | H-Ala-D-Gln-OH | 4011868 | G-3685 |
| Fmoc-Ser(tBu)-ODhbt | Fmoc-Ser(tBu)-ODhbt | 4011891 | B-1640 |
| Neurokinin A | H-His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH₂ | 4011920 | H-3745 |
| Atrial Natriuretic Factor (1-28) (human) | H-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH (Disulfide bond) | 4011941 | H-2095 |
| Fmoc-Tyr-OH | Fmoc-Tyr-OH | 4012011 | B-1580 |
| N-Me-Val-OBzl · p-tosylate | N-Me-Val-OBzl · p-tosylate | 4012062 | E-2200 |
| MeOSuc-Ala-Ala-Pro-Ala-chloromethylketone | MeOSuc-Ala-Ala-Pro-Ala-chloromethylketone | 4012071 | N-1280 |
| H-Ser(Bzl)-OH | H-Ser(Bzl)-OH | 4012097 | E-1575 |
| H-Met-Tyr-OH | H-Met-Tyr-OH | 4012103 | G-2820 |
| H-Asp-Trp-OH | H-Asp-Trp-OH | 4012139 | G-3705 |
| Z-Pro-Leu-Gly-OH | Z-Pro-Leu-Gly-OH | 4012145 | C-2515 |
| H-Phe-Phe-Phe-Phe-Phe-OH | H-Phe-Phe-Phe-Phe-Phe-OH | 4012151 | H-4570 |
| α-MSH (free acid) | Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-OH | 4012160 | H-1070 |
| H-Pro-Leu-Gly-NHOH · HCl | H-Pro-Leu-Gly-NHOH · HCl | 4012165 | M-1775 |
| H(-Asn-Pro-Asn-Ala)₆-OH | H(-Asn-Pro-Asn-Ala)₆-OH | 4012169 | H-6340 |
| TRH-AMC | Pyr-His-Pro-AMC | 4012171 | I-1440 |
| H-His-Glu-OH | H-His-Glu-OH | 4012206 | G-2300 |
| (Arg⁸)-Vasopressin | H-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH₂ (Disulfide bond) | 4012215 | H-1780 |
| Pancreatic Polypeptide (bovine) | H-Ala-Pro-Leu-Glu-Pro-Glu-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Gln-Tyr-Ala-Ala-Glu-Leu-Arg-Arg-Tyr-Ile-Asn-Met-Leu-Thr-Arg-Pro-Arg-Tyr-NH₂ | 4012218 | H-6610 |
| ACTH (1-16) | H-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-OH | 4012231 | H-6050 |
| (Diacetyl)-α-MSH | Ac-Ser(Ac)-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH₂ | 4012248 | H-7080 |
| Ac-Pro-Leu-Gly-[(S)-2-mercapto-4-methyl-pentanoyl]-Leu-Gly-OEt | Ac-Pro-Leu-Gly-[(S)-2-mercapto-4-methyl-pentanoyl]-Leu-Gly-OEt | 4012251 | H-7145 |
| Bz-Pro-Phe-Arg-pNA · HCl | Bz-Pro-Phe-Arg-pNA · HCl | 4012267 | L-1545 |
| Gastric Inhibitory Polypeptide (porcine) | H-Tyr-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-Arg-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Ser-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln-OH | 4012268 | H-6220 |
| Boc-Phe-Ser-Arg-AMC | Boc-Phe-Ser-Arg-AMC | 4012340 | I-1400 |
| L-2-Oxothiazolidine-4-carboxylic acid | L-2-Oxothiazolidine-4-carboxylic acid | 4012415 | Q-1535 |
| 1,2-O-Dihexadecyl-sn-glycero-3-phosphoethanolamine | 1,2-O-Dihexadecyl-sn-glycero-3-phosphoethanolamine | 4012420 | O-1435 |
| Succinyl-(Asp⁶,N-Me-Phe⁸)-Substance P (6-11) | Suc-Asp-Phe-N-Me-Phe-Gly-Leu-Met-NH₂ | 4012515 | H-5600 |
| Methoxycarbonyl-D-Nle-Gly-Arg-pNA | Methoxycarbonyl-D-Nle-Gly-Arg-pNA | 4012563 | L-1565 |
| Fmoc-NH₂ | Fmoc-NH₂ | 4012755 | Q-1830 |
| SASRIN™ resin (200-400 mesh, 0.80-1.20 mmol/g) | 2-Methoxy-4-alkoxybenzyl alcohol resin | 4012712 | D-1295 |
| Magainin I | H-Gly-Ile-Gly-Lys-Phe-Leu-His-Ser-Ala-Gly-Lys-Phe-Gly-Lys-Ala-Phe-Val-Gly-Glu-Ile-Met-Lys-Ser-OH | 4012844 | H-6565 |
| H-Tyr-Ile-OH | H-Tyr-Ile-OH | 4012855 | G-3425 |
| Splenopentin | H-Arg-Lys-Glu-Val-Tyr-OH | 4012856 | H-6930 |
| H-Gly-Arg-Gly-Asp-Thr-Pro-OH | H-Gly-Arg-Gly-Asp-Thr-Pro-OH | 4012897 | H-7725 |
| Z-Gly-Gly-Leu-AMC | Z-Gly-Gly-Leu-AMC | 4013102 | I-1425 |
| For-Met-Ala-Ser-OH | For-Met-Ala-Ser-OH | 4013146 | H-6210 |
| H-Gly-Lys-Gly-OH | H-Gly-Lys-Gly-OH | 4013188 | H-8510 |
| ACTH (1-10) | H-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-OH | 4013257 | H-1130 |
| (Des-acetyl)-α-MSH | H-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH₂ | 4013258 | H-4390 |
| TBTU | N-[(1H-Benzotriazol-1-yl)(dimethylamino)methylene]-N-methylmethanaminium tetrafluoroborate N-oxide | 4013268 | Q-1665 |
| Endothelin-3 (human, mouse, rabbit, rat) | H-Cys-Thr-Cys-Phe-Thr-Tyr-Lys-Asp-Lys-Glu-Cys-Val-Tyr-Tyr-Cys-His-Leu-Asp-Ile-Ile-Trp-OH (Disulfide bonds between Cys¹ and Cys¹⁵/Cys³ and Cys¹¹) | 4013291 | H-9025 |
| H-Gly-D-Gln-OH | H-Gly-D-Gln-OH | 4013323 | G-3730 |
| H-Ala-Gly-Ala-OH | H-Ala-Gly-Ala-OH | 4013351 | H-1480 |
| Ac-Pro-Leu-Gly-OH | Ac-Pro-Leu-Gly-OH | 4013355 | H-6480 |
| H-Ser-OEt · HCl | H-Ser-OEt · HCl | 4013411 | E-2680 |
| H-Trp-AMC | H-Trp-AMC | 4013433 | I-1670 |
| Leupeptin | Ac-Leu-Leu-Arg-aldehyde · sulfate salt | 4013467 | N-1000 |
| Fmoc-Trp-SASRIN™ resin (200-400 mesh, 0.4-0.7 mmol/g) | Fmoc-Trp-2-methoxy-4-alkoxybenzyl alcohol resin | 4013504 | D-1395 |
| 4-Nitrophenyl β-D-galactopyranoside | 4-Nitrophenyl β-D-galactopyranoside | 4013562 | M-1625 |
| ε-Maleimidocaproic acid-(2-nitro-4-sulfo)-phenyl ester · sodium salt | ε-Maleimidocaproic acid-(2-nitro-4-sulfo)-phenyl ester · sodium salt | 4013577 | Q-1615 |
| α-CGRP (8-37) (human) | H-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH₂ | 4013696 | H-9895 |
| Magainin II | H-Gly-Ile-Gly-Lys-Phe-Leu-His-Ser-Ala-Lys-Lys-Phe-Gly-Lys-Ala-Phe-Val-Gly-Glu-Ile-Met-Asn-Ser-OH | 4013706 | H-6570 |
| FA-Ala-Arg-OH | FA-Ala-Arg-OH | 4013709 | M-1810 |
| Z-Ala-Pro-Phe-chloromethylketone | Z-Ala-Pro-Phe-chloromethylketone | 4013720 | N-1220 |
| H-D-Pro-Phe-Arg-chloromethylketone | H-D-Pro-Phe-Arg-chloromethylketone | 4013721 | N-1210 |
| Crustacean Erythrophore Concentrating Hormone | Pyr-Leu-Asn-Phe-Ser-Pro-Gly-Trp-NH₂ | 4013731 | H-6750 |
| Calcitonin C-Terminal Flanking Peptide (human) | H-Asp-Met-Ser-Ser-Asp-Leu-Glu-Arg-Asp-His-Arg-Pro-His-Val-Ser-Met-Pro-Gln-Asn-Ala-Asn-OH | 4013739 | H-2050 |
| (Phe²,Nle⁴)-ACTH (1-24) (human, bovine, rat) | H-Ser-Phe-Ser-Nle-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-OH | 4013745 | H-6080 |
| Gastrin I (1-14) (human) | Pyr-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-OH | 4013802 | H-3095 |
| Tyr-Somatostatin-14 | H-Tyr-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys-OH (Disulfide bond) | 4013815 | H-4995 |
| (Tyr¹)-Somatostatin-14 | H-Tyr-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys-OH (Disulfide bond) | 4013817 | H-5000 |
| (D-Arg¹,D-Phe⁵,D-Trp⁷·⁹,Leu¹¹)-Substance P | H-D-Arg-Pro-Lys-Pro-D-Phe-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH₂ | 4013823 | H-6935 |
| Oxytocin (free acid) | H-Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-OH (Disulfide bond) | 4013824 | H-6885 |
| (Des-Gly¹⁰,D-Ala⁶,Pro-NHEt⁹)-LHRH (salmon) | Pyr-His-Trp-Ser-Tyr-D-Ala-Trp-Leu-Pro-NHEt | 4013835 | H-7525 |
| α-Conotoxin MI | H-Gly-Arg-Cys-Cys-His-Pro-Ala-Cys-Gly-Lys-Asn-Tyr-Ser-Cys-NH₂ (Disulfide bonds between Cys³ and Cys⁸/Cys⁴ and Cys¹⁴) | 4013838 | H-7765 |
| H-Ala-Ala-OtBu · HCl | H-Ala-Ala-OtBu · HCl | 4013847 | G-4060 |
| Suc-Phe-Ala-Ala-Phe-pNA | Suc-Phe-Ala-Ala-Phe-pNA | 4013859 | L-1675 |
| Gastrin I (rat) | Pyr-Arg-Pro-Pro-Met-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH₂ | 4013862 | H-9165 |
| (Sar⁹,Met(O₂)¹¹)-Substance P | H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Sar-Leu-Met(O₂)-NH₂ | 4013867 | H-9410 |
| Gastrin I (human) (sulfated) | Pyr-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr(SO₃H)-Gly-Trp-Met-Asp-Phe-NH₂ | 4013891 | H-9170 |
| Galanin (human) | H-Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Val-Gly-Asn-His-Arg-Ser-Phe-Ser-Asp-Lys-Asn-Gly-Leu-Thr-Ser-OH | 4013896 | H-8230 |
| Succinyl-(Pro⁵⁸,D-Glu⁶⁵)-Hirudin (56-65) (sulfated) | Suc-Phe-Glu-Pro-Ile-Pro-Glu-Glu-Tyr(SO₃H)-Leu-D-Glu-OH | 4013900 | H-8145 |
| H-Gly-Sar-Sar-OH | H-Gly-Sar-Sar-OH | 4013914 | H-6650 |
| H-Pro-Met-OH | H-Pro-Met-OH | 4014003 | G-3045 |
| Z-Tyr-Ala-OH | Z-Tyr-Ala-OH | 4014005 | C-2750 |
| 1,3-Dipalmitoyl-glycerol | 1,3-Dipalmitoyl-glycerol | 4014008 | O-1200 |
| 1-O-Octadecyl-rac-glycerol | 1-O-Octadecyl-rac-glycerol | 4014011 | O-1370 |
| Phosphoenolpyruvate potassium salt | Phosphoenolpyruvate potassium salt | 4014027 | Q-1640 |
| H-Gln-Glu-OH | H-Gln-Glu-OH | 4014165 | G-4080 |
| 4-Aminophenyl-1-thio-β-D-galactopyranoside | 4-Aminophenyl-1-thio-β-D-galactopyranoside | 4014175 | Q-1070 |
| H-Ala-Met-OH | H-Ala-Met-OH | 4014205 | G-1300 |
| Neuropeptide FF | H-Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH₂ | 4014207 | H-5655 |
| ACTH (1-17) | H-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-OH | 4014222 | H-1145 |
| H-Phe-Ile-OH | H-Phe-Ile-OH | 4014224 | G-2895 |
| D-Biotinyl-OSu | D-Biotinyl-OSu | 4014225 | Q-1760 |
| Abz-Ala-Gly-Leu-Ala-p-nitrobenzylamide | Abz-Ala-Gly-Leu-Ala-p-nitrobenzylamide | 4014232 | H-6675 |
| Cyclo(-Asp-Asp) | Cyclo(-Asp-Asp) | 4014236 | G-1680 |
| pTH (73-84) (human) | H-Ala-Asp-Val-Asn-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln-OH | 4014243 | H-5520 |
| Ac-Val-NH₂ | Ac-Val-NH₂ | 4014244 | E-1270 |
| Cyclo(-Gln-Gly) | Cyclo(-Gln-Gly) | 4014279 | G-3945 |
| Trypanothione | N¹,N⁸-Bis(glutathionyl)-spermidine disulfide | 4014289 | H-7510 |
| β-MSH (monkey) | H-Asp-Glu-Gly-Pro-Tyr-Arg-Met-Glu-His-Phe-Arg-Trp-Gly-Ser-Pro-Pro-Lys-Asp-OH | 4014290 | H-2030 |
| Motilin (canine) | H-Phe-Val-Pro-Ile-Phe-Thr-His-Ser-Glu-Leu-Gln-Lys-Ile-Arg-Glu-Lys-Glu-Arg-Asn-Lys-Gly-Gln-OH | 4014297 | H-7680 |
| H-Glu(His-OH)-OH | H-Glu(His-OH)-OH | 4014368 | G-3950 |
| L-Thyronine | H-Tyr(4-hydroxyphenyl)-OH | 4014374 | F-2460 |
| Endotoxin Inhibitor | H-Lys-Thr-Lys-Cys-Lys-Phe-Leu-Lys-Lys-Cys-OH (Disulfide bond) | 4014453 | H-1382 |
| Acetyl-Hirudin (54-65) (sulfated) | Ac-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr(SO₃H)-Leu-Gln-OH | 4014547 | H-7415 |
| Hirudin (54-65) (sulfated) | H-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr(SO₃H)-Leu-Gln-OH | 4014553 | H-7425 |
| Hirudin (54-65) (desulfated) | H-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu-Gln-OH | 4014556 | H-7420 |
| Hirudin (55-65) (sulfated) | H-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr(SO₃H)-Leu-Gln-OH | 4014557 | H-7445 |
| Acetyl-Hirudin (55-65) (sulfated) | Ac-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr(SO₃H)-Leu-Gln-OH | 4014560 | H-7435 |
| Acetyl-Hirudin (55-65) (desulfated) | Ac-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu-Gln-OH | 4014561 | H-7430 |
| Rink amide AM resin (200-400 mesh, 0.5-1.2 mmol/g) | Fmoc-2,4-dimethoxy-4'-(carboxymethyloxy)-benzhydrylamine linked to Aminomethyl resin | 4014571 | D-1675 |
| Big Endothelin-1 (human) | H-Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp-Val-Asn-Thr-Pro-Glu-His-Val-Val-Pro-Tyr-Gly-Leu-Gly-Ser-Pro-Arg-Ser-OH (Disulfide bonds between Cys¹ and Cys¹⁵/Cys³ and Cys¹¹) | 4014579 | H-9030 |
| Angiotensin I/II (3-7) | H-Val-Tyr-Ile-His-Pro-OH | 4014701 | H-6965 |
| ACTH (1-13) | H-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-OH | 4014703 | H-1135 |
| Suc-Gly-Pro-pNA | Suc-Gly-Pro-pNA | 4014710 | L-1585 |
| pTH (1-44) (human) | H-Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-Val-Ala-Leu-Gly-Ala-Pro-Leu-Ala-Pro-Arg-OH | 4014739 | H-4825 |
| Amyloid β-Protein (12-28) | H-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-OH | 4014778 | H-7910 |
| pTH (13-34) (human) | H-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-OH | 4014782 | H-4145 |
| pTH (1-38) (human) | H-Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-Val-Ala-Leu-Gly-OH | 4014853 | H-4830 |
| pTH (2-38) (human) | H-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-Val-Ala-Leu-Gly-OH | 4014888 | H-1316 |
| H-β-(3-Benzothienyl)-Ala-OH | H-β-(3-Benzothienyl)-Ala-OH | 4014923 | F-2490 |
| H-β-(3-Benzothienyl)-D-Ala-OH | H-β-(3-Benzothienyl)-D-Ala-OH | 4014932 | F-2485 |
| Ac-Phe-Lys-OH | Ac-Phe-Lys-OH | 4014983 | G-4090 |
| Exendin-3 | H-His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂ | 4015051 | H-8735 |
| Pancreatic Polypeptide (human) | H-Ala-Pro-Leu-Glu-Pro-Val-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Gln-Tyr-Ala-Ala-Asp-Leu-Arg-Arg-Tyr-Ile-Asn-Met-Leu-Thr-Arg-Pro-Arg-Tyr-NH₂ | 4015101 | H-1610 |
| Crustacean Cardioactive Peptide | H-Pro-Phe-Cys-Asn-Ala-Phe-Thr-Gly-Cys-NH₂ (Disulfide bond) | 4015114 | H-6745 |
| H-Ser-Tyr-AMC | H-Ser-Tyr-AMC | 4015204 | I-1475 |
| Fmoc-3-iodo-Tyr-OH | Fmoc-3-iodo-Tyr-OH | 4015214 | B-1740 |
| Fmoc-Thr-OH | Fmoc-Thr-OH | 4015218 | B-1745 |
| H-Asp(His-OH)-OH | H-Asp(His-OH)-OH | 4015239 | G-3980 |
| Fmoc-D-Tyr(Et)-OH | Fmoc-D-Tyr(Et)-OH | 4015247 | B-1775 |
| Suc-Ala-Leu-Pro-Phe-pNA | Suc-Ala-Leu-Pro-Phe-pNA | 4015254 | L-1620 |
| ACTH (11-24) | H-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-OH | 4015329 | H-1210 |
| H-Gly-Phe-Gly-aldehyde semicarbazone | H-Gly-Phe-Gly-aldehyde semicarbazone | 4015423 | H-7650 |
| Ac-Lys-D-Ala-D-Ala-OH | Ac-Lys-D-Ala-D-Ala-OH | 4015444 | H-8005 |
| Deltorphin I | H-Tyr-D-Ala-Phe-Asp-Val-Val-Gly-NH₂ | 4015450 | H-8055 |
| Deltorphin II | H-Tyr-D-Ala-Phe-Glu-Val-Val-Gly-NH₂ | 4015452 | H-8060 |
| β-CGRP (human) | H-Ala-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Met-Val-Lys-Ser-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH₂ (Disulfide bond) | 4015500 | H-6730 |
| Tyr-Proinsulin C-Peptide (55-89) (human) | H-Tyr-Arg-Arg-Glu-Ala-Glu-Asp-Leu-Gln-Val-Gly-Gln-Val-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Ser-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ser-Leu-Gln-Lys-Arg-OH | 4015509 | H-2465 |
| H-Arg-Gly-Glu-Ser-OH | H-Arg-Gly-Glu-Ser-OH | 4015512 | H-7745 |
| H-Arg-His-NH₂ | H-Arg-His-NH₂ | 4015519 | G-3850 |
| ACTH (7-38) (human) | H-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-OH | 4015541 | H-1205 |
| Fibrinogen-Binding Inhibitor Peptide | H-His-His-Leu-Gly-Gly-Ala-Lys-Gln-Ala-Gly-Asp-Val-OH | 4015549 | H-9140 |
| Neuropeptide Y (13-36) (porcine) | H-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH₂ | 4015552 | H-9300 |
| Neuropeptide Y (22-36) | H-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH₂ | 4015553 | H-9305 |
| Suc-Ala-Glu-Pro-Phe-pNA | Suc-Ala-Glu-Pro-Phe-pNA | 4015607 | L-1635 |
| H-Met-Ile-OH | H-Met-Ile-OH | 4015624 | G-2755 |
| FA-Gly-Phe-Leu-OH | FA-Gly-Phe-Leu-OH | 4015627 | M-1845 |
| Fmoc-L-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | Fmoc-L-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | 4015637 | B-1920 |
| Fmoc-D-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | Fmoc-D-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | 4015638 | B-1925 |
| Suc-Ala-Ala-Pro-Ala-pNA | Suc-Ala-Ala-Pro-Ala-pNA | 4015680 | L-1775 |
| EEDQ | N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline | 4015690 | Q-1735 |
| Suc-Ala-Ala-Pro-Val-AMC | Suc-Ala-Ala-Pro-Val-AMC | 4015705 | I-1490 |
| Angiotensin II Receptor Ligand | Nicotinoyl-Tyr-Lys(Z-Arg)-His-Pro-Ile-OH | 4015751 | H-9395 |
| N¹-Glutathionyl-spermidine disulfide | [H-Glu(Cys-Gly-[3-(4-amino-butylamino)-propyl]-amide)-OH]₂ | 4015761 | H-1126 |
| Glutathione-monoethyl ester (reduced) | H-Glu(Cys-Gly-OEt)-OH | 4015775 | H-1298 |
| Ac-(6-O-stearoyl)-muramyl-Ala-D-Glu-NH₂ | Ac-(6-O-stearoyl)-muramyl-Ala-D-Glu-NH₂ | 4015905 | G-1065 |
| (D-Ala¹)-Peptide T amide | H-D-Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-NH₂ | 4015906 | H-5935 |
| (d(CH₂)₅¹,Tyr(Me)²,Thr⁴,Orn⁸,Tyr-NH₂⁹)-Vasotocin | β-Mercapto-β,β-cyclopentamethylene-propionyl-Tyr(Me)-Ile-Thr-Asn-Cys-Pro-Orn-Tyr-NH₂ (Disulfide bond) | 4015938 | H-9405 |
| Suc-Ala-Phe-Pro-Phe-pNA | Suc-Ala-Phe-Pro-Phe-pNA | 4016001 | L-1605 |
| D-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid | D-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid | 4016023 | F-2585 |
| H-allo-Thr-OMe · HCl | H-allo-Thr-OMe · HCl | 4016116 | F-2545 |
| H-allo-Thr(tBu)-OH | H-allo-Thr(tBu)-OH | 4016122 | F-2540 |
| Fmoc-allo-Thr(tBu)-OH | Fmoc-allo-Thr(tBu)-OH | 4016123 | B-1815 |
| H-Leu-Glu-OH | H-Leu-Glu-OH | 4016148 | G-4065 |
| H-DL-allo-Thr-OH | H-DL-allo-Thr-OH | 4016157 | F-2635 |
| H-Gly-Pro-Gly-OH | H-Gly-Pro-Gly-OH | 4016165 | H-9745 |
| Endothelin-2 (human, canine) | H-Cys-Ser-Cys-Ser-Ser-Trp-Leu-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp-OH (Disulfide bonds between Cys¹ and Cys¹⁵/Cys³ and Cys¹¹) | 4016278 | H-9020 |
| (N-Me-Phe⁷)-Neurokinin B | H-Asp-Met-His-Asp-Phe-Phe-N-Me-Phe-Gly-Leu-Met-NH₂ | 4016322 | H-9280 |
| Kinetensin | H-Ile-Ala-Arg-Arg-His-Pro-Tyr-Phe-Leu-OH | 4016325 | H-9350 |
| Tyr-CRF (human, rat) | H-Tyr-Ser-Glu-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-Leu-Met-Glu-Ile-Ile-NH₂ | 4016329 | H-2455 |
| Z-Leu-Tyr-chloromethylketone | Z-Leu-Tyr-chloromethylketone | 4016342 | N-1255 |
| (D-Trp¹²,Tyr³⁴)-pTH (7-34) amide (bovine) | H-Phe-Met-His-Asn-Leu-D-Trp-Lys-His-Leu-Ser-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Tyr-NH₂ | 4016353 | H-9115 |
| Cyclo(-D-Ala-Pro) | Cyclo(-D-Ala-Pro) | 4016354 | G-4165 |
| (Trp⁶³,Trp⁶⁴)-C3a (63-77) | H-Trp-Trp-Gly-Lys-Lys-Tyr-Arg-Ala-Ser-Lys-Leu-Gly-Leu-Ala-Arg-OH | 4016370 | H-1264 |
| Z-Val-Val-Arg-AMC · HCl | Z-Val-Val-Arg-AMC · HCl | 4016422 | I-1540 |
| Boc-Glu(OBzl)-Gly-Arg-AMC · HCl | Boc-Glu(OBzl)-Gly-Arg-AMC · HCl | 4016428 | I-1545 |
| H-Pro-Arg-AMC · 2 HCl | H-Pro-Arg-AMC · 2 HCl | 4016432 | I-1605 |
| H-Thr-Glu-OH | H-Thr-Glu-OH | 4016437 | G-4050 |
| Antide | Ac-D-2-Nal-4-chloro-D-Phe-β-(3-pyridyl)-D-Ala-Ser-Lys(nicotinoyl)-D-Lys(nicotinoyl)-Leu-Lys(isopropyl)-Pro-D-Ala-NH₂ | 4016478 | H-9215 |
| L-1,2,3,4-Tetrahydronorharman-3-carboxylic acid | L-1,2,3,4-Tetrahydronorharman-3-carboxylic acid | 4016480 | Q-1700 |
| Z-Leu-Val-Gly-diazomethylketone | Z-Leu-Val-Gly-diazomethylketone | 4016615 | C-3455 |
| Peptide YY (13-36) (canine, mouse, porcine, rat) | H-Ser-Pro-Glu-Glu-Leu-Ser-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH₂ | 4016635 | H-9185 |
| Mitogenic Pentapeptide | Palmitoyl-Cys((RS)-2,3-di(palmitoyloxy)-propyl)-Ser-Ser-Asn-Ala-OH | 4016643 | H-9460 |
| H-Gly-Lys-His-OH | H-Gly-Lys-His-OH | 4016648 | H-3580 |
| Perisulfakinin | H-Glu-Gln-Phe-Asp-Asp-Tyr(SO₃H)-Gly-His-Met-Arg-Phe-NH₂ | 4016651 | H-1038 |
| Miraculin (1-20) | H-Asp-Ser-Ala-Pro-Asn-Pro-Val-Leu-Asp-Ile-Asp-Gly-Glu-Lys-Leu-Arg-Thr-Gly-Thr-Asn-OH | 4016657 | H-9455 |
| (Glu¹)-Fibrinopeptide B (human) | H-Glu-Gly-Val-Asn-Asp-Asn-Glu-Glu-Gly-Phe-Phe-Ser-Ala-Arg-OH | 4016660 | H-2950 |
| Neuromedin U-23 (rat) | H-Tyr-Lys-Val-Asn-Glu-Tyr-Gln-Gly-Pro-Val-Ala-Pro-Ser-Gly-Gly-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH₂ | 4016663 | H-9295 |
| BQ-123 | Cyclo(-D-Trp-D-Asp-Pro-D-Val-Leu) | 4016690 | H-1252 |
| Acetyl-Hirudin (53-65) (sulfated) | Ac-Asp-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr(SO₃H)-Leu-Gln-OH | 4016852 | H-8190 |
| Syntide 2 | H-Pro-Leu-Ala-Arg-Thr-Leu-Ser-Val-Ala-Gly-Leu-Pro-Gly-Lys-Lys-OH | 4016901 | H-9385 |
| (D-Ala²)-GRF (1-29) amide (human) | H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂ | 4016921 | H-3715 |
| pTH-Related Protein (7-34) amide (human, mouse, rat) | H-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-NH₂ | 4016931 | H-9100 |
| Fmoc-Tyr(PO₃Me₂)-OH | Fmoc-Tyr(PO₃Me₂)-OH | 4017013 | B-1990 |
| Boc-Gln-Ala-Arg-AMC · HCl | Boc-Gln-Ala-Arg-AMC · HCl | 4017019 | I-1550 |
| Bz-Ala-Arg-OH | Bz-Ala-Arg-OH | 4017070 | G-4145 |
| Boc-Leu-Arg-Arg-AMC · 2 HCl | Boc-Leu-Arg-Arg-AMC · 2 HCl | 4017087 | I-1585 |
| Boc-Leu-Lys-Arg-AMC | Boc-Leu-Lys-Arg-AMC | 4017091 | I-1570 |
| Boc-Gly-Lys-Arg-AMC · HCl | Boc-Gly-Lys-Arg-AMC · HCl | 4017092 | I-1580 |
| Boc-Gln-Arg-Arg-AMC | Boc-Gln-Arg-Arg-AMC | 4017093 | I-1655 |
| H-Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg-NH₂ | H-Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg-NH₂ | 4017117 | H-1224 |
| Z-Tyr-OBzl | Z-Tyr-OBzl | 4017301 | C-4150 |
| Boc-Asp(OBzl)-Pro-Arg-AMC · HCl | Boc-Asp(OBzl)-Pro-Arg-AMC · HCl | 4017304 | I-1560 |
| Boc-Val-Val-OH | Boc-Val-Val-OH | 4017308 | A-3200 |
| Suc-Ala-Ala-Pro-Arg-pNA | Suc-Ala-Ala-Pro-Arg-pNA | 4017320 | L-1720 |
| Suc-Ala-Ala-Pro-Lys-pNA | Suc-Ala-Ala-Pro-Lys-pNA | 4017329 | L-1725 |
| Suc-Ala-Ala-Pro-Glu-pNA | Suc-Ala-Ala-Pro-Glu-pNA | 4017343 | L-1710 |
| Fmoc-β-(3-pyridyl)-D-Ala-OH | Fmoc-β-(3-pyridyl)-D-Ala-OH | 4017389 | B-2040 |
| H-Gly-Glu-pNA | H-Gly-Glu-pNA | 4017619 | L-1730 |
| Z-Leu-Leu-Arg-AMC | Z-Leu-Leu-Arg-AMC | 4017622 | I-1615 |
| H-Arg-Ala-OH | H-Arg-Ala-OH | 4017629 | G-4170 |
| H-Val-Lys-OH | H-Val-Lys-OH | 4017637 | G-4175 |
| Fmoc-D-Tyr-OH | Fmoc-D-Tyr-OH | 4017650 | B-2085 |
| H-Tyr-OBzl | H-Tyr-OBzl | 4017661 | E-2955 |
| H-Trp(Boc)-OH | H-Trp(Boc)-OH | 4017673 | E-2975 |
| Fmoc-Trp(Boc)-OH | Fmoc-Trp(Boc)-OH | 4017674 | B-2065 |
| H-Ala-Phe-Pro-pNA | H-Ala-Phe-Pro-pNA | 4017695 | L-1795 |
| Z-Val-Lys-Met-AMC | Z-Val-Lys-Met-AMC | 4017732 | I-1625 |
| Suc-Tyr-Val-Ala-Asp-pNA | Suc-Tyr-Val-Ala-Asp-pNA | 4017745 | L-1830 |
| Ac-Tyr-Val-Ala-Asp-AMC | Ac-Tyr-Val-Ala-Asp-AMC | 4017748 | I-1630 |
| Dicarboxidine · 2 HCl | γ,γ'-(4,4'-Diamino-3,3'-biphenylylenedioxy)dibutyric acid · 2 HCl | 4017751 | Q-1195 |
| Acetyl-α-MSH (11-13) | Ac-Lys-Pro-Val-NH₂ | 4017754 | H-8685 |
| H-Phe-Pro-Ala-pNA | H-Phe-Pro-Ala-pNA | 4017802 | L-1800 |
| Fmoc-D-Trp(Boc)-OH | Fmoc-D-Trp(Boc)-OH | 4017826 | B-2125 |
| H-Tyr-Tyr-OH | H-Tyr-Tyr-OH | 4017837 | G-3480 |
| Ac-Ser(tBu)-OH | Ac-Ser(tBu)-OH | 4017866 | E-3010 |
| Sex Pheromone Inhibitor iPD1 | H-Ala-Leu-Ile-Leu-Thr-Leu-Val-Ser-OH | 4018007 | H-9985 |
| Dermaseptin | H-Ala-Leu-Trp-Lys-Thr-Met-Leu-Lys-Lys-Leu-Gly-Thr-Met-Ala-Leu-His-Ala-Gly-Lys-Ala-Ala-Leu-Gly-Ala-Ala-Ala-Asp-Thr-Ile-Ser-Gln-Gly-Thr-Gln-OH | 4018008 | H-1294 |
| Suc-Val-Pro-Phe-SBzl | Suc-Val-Pro-Phe-SBzl | 4018016 | M-1885 |
| Suc-Val-Pro-Phe-pNA | Suc-Val-Pro-Phe-pNA | 4018017 | L-1755 |
| Fmoc-Gly-Pro-Hyp-OH | Fmoc-Gly-Pro-Hyp-OH | 4018022 | B-2080 |
| Angiotensin I/II (3-8) | H-Val-Tyr-Ile-His-Pro-Phe-OH | 4018068 | H-8125 |
| H-Gly-Asp-Gly-OH | H-Gly-Asp-Gly-OH | 4018110 | H-1308 |
| Ranatensin | Pyr-Val-Pro-Gln-Trp-Ala-Val-Gly-His-Phe-Met-NH₂ | 4018117 | H-4930 |
| Pyr-Arg-Thr-Lys-Arg-AMC | Pyr-Arg-Thr-Lys-Arg-AMC | 4018149 | I-1650 |
| H-Glu-Gly-Arg-chloromethylketone | H-Glu-Gly-Arg-chloromethylketone | 4018214 | N-1325 |
| H-Arg-Gln-OH | H-Arg-Gln-OH | 4018235 | G-4230 |
| H-Gly-Gly-OEt · HCl | H-Gly-Gly-OEt · HCl | 4018277 | G-4220 |
| C-Reactive Protein (CRP) (174-185) | H-Ile-Tyr-Leu-Gly-Gly-Pro-Phe-Ser-Pro-Asn-Val-Leu-OH | 4018347 | H-1344 |
| Amyloid β-Protein (1-43) | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-Thr-OH | 4018358 | H-1586 |
| 1,2-Dilauroyl-rac-glycero-3-phosphocholine | 1,2-Dilauroyl-rac-glycero-3-phosphocholine | 4018411 | O-1510 |
| H-Trp-OtBu · HCl | H-Trp-OtBu · HCl | 4018557 | E-3105 |
| IGF-I Analog | H-Cys-Tyr-Ala-Ala-Pro-Leu-Lys-Pro-Ala-Lys-Ser-Cys-OH (Disulfide bond) | 4018631 | H-1356 |
| (Leu³¹,Pro³⁴)-Neuropeptide Y (porcine) | H-Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Leu-Thr-Arg-Pro-Arg-Tyr-NH₂ | 4018713 | H-8575 |
| Secretin (porcine) | H-His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Glu-Leu-Ser-Arg-Leu-Arg-Asp-Ser-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val-NH₂ | 4018720 | H-3780 |
| Boc-Arg-Val-Arg-Arg-AMC | Boc-Arg-Val-Arg-Arg-AMC | 4018735 | I-1645 |
| FA-Phe-Ala-OH | FA-Phe-Ala-OH | 4018823 | M-1955 |
| (Tyr⁵,D-Trp⁶·⁸·⁹,Lys-NH₂¹⁰)-Neurokinin A (4-10) | H-Asp-Tyr-D-Trp-Val-D-Trp-D-Trp-Lys-NH₂ | 4018827 | H-8565 |
| Ac-Tyr-Val-Ala-Asp-aldehyde (pseudo acid) | Ac-Tyr-Val-Ala-Asp-aldehyde (pseudo acid) | 4018830 | H-8410 |
| Palmitoyl-Cys((RS)-2,3-di(palmitoyloxy)-propyl)-Ala-Gly-OH | Palmitoyl-Cys((RS)-2,3-di(palmitoyloxy)-propyl)-Ala-Gly-OH | 4018855 | H-8820 |
| Peptide YY (3-36) (human) | H-Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH₂ | 4018880 | H-8585 |
| Mca-Pro-Leu-OH | Mca-Pro-Leu-OH | 4018898 | M-1975 |
| H-Asp-Asp-Asp-OH | H-Asp-Asp-Asp-OH | 4018907 | H-8750 |
| Ac-Thr(tBu)-OH | Ac-Thr(tBu)-OH | 4018967 | E-3050 |
| H-Val-pNA · HCl | H-Val-pNA · HCl | 4019078 | L-1855 |
| Osteostatin (1-5) (human, bovine, dog, horse, mouse, rabbit, rat) | H-Thr-Arg-Ser-Ala-Trp-OH | 4019104 | H-8645 |
| H-Gly-Cys-Gly-OH | H-Gly-Cys-Gly-OH | 4019162 | H-1552 |
| Dolastatin 15 | (5S)-1-[(2S)-O-(N,N-Dimethyl-Val-Val-N-Me-Val-Pro-Pro)-2-hydroxyisovaleryl]-2-oxo-4-methoxy-5-benzyl-3-pyrroline | 4019226 | H-8630 |
| (Tyr¹¹)-Somatostatin-14 | H-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Tyr-Thr-Ser-Cys-OH (Disulfide bond) | 4019615 | H-1495 |
| Cyano-hydroxyimino-acetic acid ethyl ester (Oxyma) | Cyano-hydroxyimino-acetic acid ethyl ester (Oxyma) | 4019721 | Q-2750 |
| C-Type Natriuretic Peptide (32-53) (human, porcine, rat) | H-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys-OH (Disulfide bond) | 4019911 | H-1296 |
| N-Me-Val-Leu-anilide | N-Me-Val-Leu-anilide | 4019919 | G-4275 |
| N-2-Cyanoethyl-Val-Leu-anilide | N-2-Cyanoethyl-Val-Leu-anilide | 4019925 | G-4285 |
| Galanin (1-13)-Bradykinin (2-9) amide | H-Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-NH₂ | 4020106 | H-1346 |
| Cyclo(-D-Tyr-Arg-Gly-Asp-Cys(carboxymethyl)-OH) sulfoxide | Cyclo(-D-Tyr-Arg-Gly-Asp-Cys(carboxymethyl)-OH) sulfoxide | 4020214 | N-1365 |
| Fmoc-Ser(Trt)-OH | Fmoc-Ser(Trt)-OH | 4020228 | B-2550 |
| Ac-Leu-Val-Lys-aldehyde | Ac-Leu-Val-Lys-aldehyde | 4020266 | N-1380 |
| Hydrin 1′ | H-Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-Gly-Lys-OH (Disulfide bond) | 4020267 | H-1558 |
| Procollagen Type I (212-216) | H-Lys-Thr-Thr-Lys-Ser-OH | 4025012 | H-1592 |
| N-2-Hydroxyethyl-Val-Leu-anilide | N-2-Hydroxyethyl-Val-Leu-anilide | 4025019 | G-4295 |
| Gluten Exorphin A5 | H-Gly-Tyr-Tyr-Pro-Thr-OH | 4025054 | H-1668 |
| S-(1,2-Dicarboxyethyl)glutathione | H-Glu(Cys(1,2-dicarboxyethyl)-Gly-OH)-OH | 4025062 | H-1556 |
| Somatostatin-14 (reduced) | H-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys-OH | 4025089 | H-4662 |
| H-Glu-Glu-Leu-OH | H-Glu-Glu-Leu-OH | 4025162 | H-1924 |
| Fmoc-D-Tyr(Me)-OH | Fmoc-D-Tyr(Me)-OH | 4025244 | B-2430 |
| H-D-Tyr(Me)-OH | H-D-Tyr(Me)-OH | 4025246 | F-3145 |
| IL-6 (88-121) (human) | H-Ile-Ile-Thr-Gly-Leu-Leu-Glu-Phe-Glu-Val-Tyr-Leu-Glu-Tyr-Leu-Gln-Asn-Arg-Phe-Glu-Ser-Ser-Glu-Glu-Gln-Ala-Arg-Ala-Val-Gln-Met-Ser-Thr-Lys-OH | 4025280 | H-1398 |
| Fmoc-Trp(Boc)-Wang resin (200-400 mesh, 0.5-0.8 mmol/g) | Fmoc-Trp(Boc)-4-alkoxybenzyl alcohol resin | 4025286 | D-1900 |
| H-D-Val-OMe · HCl | H-D-Val-OMe · HCl | 4025305 | F-3160 |
| H-Cys-psi(CH₂NH)Val-psi(CH₂NH)Phe-Met-OH | H-Cys-psi(CH₂NH)Val-psi(CH₂NH)Phe-Met-OH | 4025336 | N-1390 |
| Hirullin | H-Ser-Asp-Phe-Glu-Glu-Phe-Ser-Leu-Asp-Asp-Ile-Glu-Gln-OH | 4025345 | H-1966 |
| Myelin Basic Protein (87-99) (human, bovine, rat) | H-Val-His-Phe-Phe-Lys-Asn-Ile-Val-Thr-Pro-Arg-Thr-Pro-OH | 4025349 | H-1964 |
| Fmoc-Suberol | 5-Fmoc-amino-2-carboxymethoxy-10,11-dihydro-5H-dibenzo[a,d]cycloheptene | 4025359 | Q-2745 |
| (D-Ser⁴,D-Trp⁶)-LHRH | Pyr-His-Trp-D-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH₂ | 4025363 | H-4644 |
| (D-His²,D-Trp⁶)-LHRH | Pyr-D-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH₂ | 4025364 | H-4642 |
| 2-Chlorotrityl chloride resin (200-400 mesh, 1.5-1.9 mmol/g) | 2-Chlorotrityl chloride resin (200-400 mesh, 1.5-1.9 mmol/g) | 4025425 | D-1965 |
| Fmoc-Tyr(PO₃H₂)-OH | Fmoc-Tyr(PO₃H₂)-OH | 4025426 | B-2470 |
| H-Tyr(PO₃H₂)-OH | H-Tyr(PO₃H₂)-OH | 4025464 | F-4180 |
| (D-2-Nal⁵,Cys⁶·¹¹,Tyr⁷,D-Trp⁸,Val¹⁰,2-Nal¹²)-Somatostatin-14 (5-12) amide | H-D-2-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-2-Nal-NH₂ (Disulfide bond) | 4025467 | H-2126 |
| VIP (6-28) (human, mouse, rat) | H-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH₂ | 4025470 | H-2066 |
| N-(2-Carbamoyl-ethyl)-Val-Leu-anilide | N-(2-Carbamoyl-ethyl)-Val-Leu-anilide | 4025471 | G-4320 |
| Dnp-Pro-β-cyclohexyl-Ala-Gly-Cys(Me)-His-Ala-Lys(N-Me-Abz)-NH₂ | Dnp-Pro-β-cyclohexyl-Ala-Gly-Cys(Me)-His-Ala-Lys(N-Me-Abz)-NH₂ | 4025472 | M-2055 |
| Fmoc-DL-Isoser-OH | Fmoc-DL-Isoser-OH | 4025483 | B-2590 |
| Defensin HNP-3 (human) | H-Asp-Cys-Tyr-Cys-Arg-Ile-Pro-Ala-Cys-Ile-Ala-Gly-Glu-Arg-Arg-Tyr-Gly-Thr-Cys-Ile-Tyr-Gln-Gly-Arg-Leu-Trp-Ala-Phe-Cys-Cys-OH (Disulfide bonds between Cys² and Cys³⁰/Cys⁴ and Cys¹⁹/Cys⁹ and Cys²⁹) | 4025495 | H-9860 |
| Amyloid β-Protein (1-28) | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-OH | 4025511 | H-7865 |
| Fmoc-Ser(PO₃H₂)-OH | Fmoc-Ser(PO₃H₂)-OH | 4025534 | B-2505 |
| N-((RS)-2-Hydroxy-propyl)-Val-Leu-anilide | N-((RS)-2-Hydroxy-propyl)-Val-Leu-anilide | 4025561 | G-4330 |
| Cyclo(-Leu-Phe) | Cyclo(-Leu-Phe) | 4025585 | G-4385 |
| H-Gly-Pro-pNA · HCl | H-Gly-Pro-pNA · HCl | 4025614 | L-1880 |
| Fmoc-Thr(Trt)-OH | Fmoc-Thr(Trt)-OH | 4025725 | B-2545 |
| Osteostatin (1-5) amide (human, bovine, dog, horse, mouse, rabbit, rat) | H-Thr-Arg-Ser-Ala-Trp-NH₂ | 4025761 | H-2244 |
| Fmoc-Ser(GalNAc(Ac)₃-α-D)-OH | Fmoc-Ser(GalNAc(Ac)₃-α-D)-OH | 4025797 | B-2565 |
| Fmoc-Thr(GalNAc(Ac)₃-α-D)-OH | Fmoc-Thr(GalNAc(Ac)₃-α-D)-OH | 4025798 | B-2570 |
| Amastatin · HCl | [(2S,3R)-3-Amino-2-hydroxy-5-methylhexanoyl]-Val-Val-Asp-OH | 4025800 | N-1410 |
| Glutathione-monoisopropyl ester (reduced) | H-Glu(Cys-Gly-isopropyl ester)-OH | 4025801 | H-2236 |
| Glutathione-diethyl ester (reduced) | H-Glu(Cys-Gly-OEt)-OEt | 4025802 | H-2238 |
| Z-Phe-Lys-2,4,6-trimethylbenzoyloxy-methylketone | Z-Phe-Lys-2,4,6-trimethylbenzoyloxy-methylketone | 4025803 | N-1400 |
| 4-Abz-Gly-Pro-D-Leu-D-Ala-NHOH | 4-Abz-Gly-Pro-D-Leu-D-Ala-NHOH | 4025806 | N-1405 |
| pTH (1-31) (human) | H-Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-OH | 4025809 | H-2274 |
| Cyclo(-D-His-Pro) | Cyclo(-D-His-Pro) | 4025821 | G-4375 |
| H-Gly-Gly-Gln-OH | H-Gly-Gly-Gln-OH | 4025823 | H-2382 |
| TRAP-7 | H-Ser-Phe-Leu-Leu-Arg-Asn-Pro-OH | 4025850 | H-2234 |
| N-Hydroxysuccinimide | N-Hydroxysuccinimide | 4025878 | Q-1800 |
| α-CGRP (mouse, rat) | H-Ser-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH₂ (Disulfide bond) | 4025897 | H-2265 |
| Ac-Lys-D-Ala-D-lactic acid · acetate | Ac-Lys-D-Ala-D-lactic acid · acetate | 4025967 | G-4410 |
| (7-Methoxycoumarin-4-yl)acetic acid | (7-Methoxycoumarin-4-yl)acetic acid | 4026019 | Q-1865 |
| Ac-Asp-Glu-Val-Asp-aldehyde (pseudo acid) | Ac-Asp-Glu-Val-Asp-aldehyde (pseudo acid) | 4026022 | H-2496 |
| (Phe¹³,Tyr¹⁹)-MCH (human, mouse, rat) | H-Asp-Phe-Asp-Met-Leu-Arg-Cys-Met-Leu-Gly-Arg-Val-Phe-Arg-Pro-Cys-Trp-Gln-Tyr-OH (Disulfide bond) | 4026028 | H-2218 |
| Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH₂ | Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH₂ | 4026036 | M-1895 |
| H-D-Val-Leu-Arg-pNA · 2 AcOH | H-D-Val-Leu-Arg-pNA · 2 AcOH | 4026051 | L-1885 |
| Vasonatrin Peptide (VNP) | H-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH (Disulfide bond) | 4026076 | H-2502 |
| N-Acetyl-2-benzyl-tryptamine | N-Acetyl-2-benzyl-tryptamine | 4026095 | Q-1885 |
| TATU | N-[(7-Aza-1H-benzotriazol-1-yl)(dimethylamino)methylene]-N-methylmethanaminium tetrafluoroborate N-oxide | 4026098 | Q-2150 |
| (Glu²)-TRH | Pyr-Glu-Pro-NH₂ | 4026102 | H-2464 |
| IGF-I (1-3) | H-Gly-Pro-Glu-OH | 4026104 | H-2468 |
| BQ-788 | N-cis-2,6-Dimethylpiperidinocarbonyl-β-tBu-Ala-D-Trp(1-methoxycarbonyl)-D-Nle-OH | 4026108 | H-2492 |
| (Des-Ala³)-GHRP-2 | H-D-Ala-D-2-Nal-Trp-D-Phe-Lys-NH₂ | 4026118 | H-2528 |
| Pyr-OH | Pyr-OH | 4026127 | E-2340 |
| Xanthenyl linker resin (200-400 mesh, 0.4-0.7 mmol/g) | (4-(9-Fmoc-amino-xanthen-3-yloxy)butyryl)-4-methyl-benzhydrylamide resin | 4026167 | D-2040 |
| 3β[N-(N’,N’-Dimethylaminoethane)-carbamoyl]cholesterol | 3β[N-(N',N'-Dimethylaminoethane)-carbamoyl]cholesterol | 4026174 | O-1560 |
| Cyclo(-Arg-Gly-Asp-D-Phe-Val) | Cyclo(-Arg-Gly-Asp-D-Phe-Val) | 4026200 | H-2574 |
| Ac-Tyr-Val-Ala-Asp-pNA | Ac-Tyr-Val-Ala-Asp-pNA | 4026201 | L-1890 |
| Fibronectin CS-1 Fragment (1978-1982) | H-Glu-Ile-Leu-Asp-Val-OH | 4026203 | H-2592 |
| Carcinine | H-β-Ala-histamine | 4026204 | G-4425 |
| α-Synuclein (61-95) (human) | H-Glu-Gln-Val-Thr-Asn-Val-Gly-Gly-Ala-Val-Val-Thr-Gly-Val-Thr-Ala-Val-Ala-Gln-Lys-Thr-Val-Glu-Gly-Ala-Gly-Ser-Ile-Ala-Ala-Ala-Thr-Gly-Phe-Val-OH | 4026207 | H-2598 |
| (Des-Gly)-Glutathione-monoethyl ester (reduced) | H-Glu(Cys-OEt)-OH | 4026208 | G-4430 |
| Fmoc-3-nitro-Tyr-OH | Fmoc-3-nitro-Tyr-OH | 4026244 | B-2690 |
| SV40 Nuclear Transport Signal Peptide Analog | H-Cys-Gly-Tyr-Gly-Pro-Lys-Lys-Lys-Arg-Lys-Val-Gly-Gly-OH | 4026251 | H-8120 |
| N-Me-Trp-OH | N-Me-Trp-OH | 4026253 | E-3255 |
| Lauric acid-OSu | Lauric acid-OSu | 4026254 | Q-1920 |
| H-3-Iodo-Tyr-OH | H-3-Iodo-Tyr-OH | 4026261 | F-3350 |
| Ac-Asp-Glu-Val-Asp-AMC | Ac-Asp-Glu-Val-Asp-AMC | 4026262 | I-1660 |
| H-Gly-Cys-OH | H-Gly-Cys-OH | 4026266 | G-4440 |
| Decanoyl-Arg-Val-Arg-Lys-chloromethylketone | Decanoyl-Arg-Val-Arg-Lys-chloromethylketone | 4026281 | N-1435 |
| Annexin A1 (1-25) (dephosphorylated) (human) | Ac-Ala-Met-Val-Ser-Glu-Phe-Leu-Lys-Gln-Ala-Trp-Phe-Ile-Glu-Asn-Glu-Glu-Gln-Glu-Tyr-Val-Gln-Thr-Val-Lys-OH | 4026282 | H-3196 |
| Fmoc-Ser-OMe | Fmoc-Ser-OMe | 4026284 | B-2695 |
| pTH (44-68) (human) | H-Arg-Asp-Ala-Gly-Ser-Gln-Arg-Pro-Arg-Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly-OH | 4026306 | H-1820 |
| Z-Phe-Tyr(tBu)-diazomethylketone | Z-Phe-Tyr(tBu)-diazomethylketone | 4026334 | C-3895 |
| Ac-Tyr-OH | Ac-Tyr-OH | 4026352 | E-1240 |
| Boc-Pyr-OH | Boc-Pyr-OH | 4026369 | A-3850 |
| Fmoc-β-(3-benzothienyl)-Ala-OH | Fmoc-β-(3-benzothienyl)-Ala-OH | 4026385 | B-2830 |
| H-Ser(SO₃H)-OH | H-Ser(SO₃H)-OH | 4026389 | F-3365 |
| H-Cys-Arg-Gly-Asp-Phe-Pro-Ala-Ser-Ser-Cys-OH | H-Cys-Arg-Gly-Asp-Phe-Pro-Ala-Ser-Ser-Cys-OH (Disulfide bond) | 4026399 | H-2672 |
| Z-Asp-2,6-dichlorobenzoyloxymethylketone | Z-Asp-2,6-dichlorobenzoyloxymethylketone | 4026406 | N-1445 |
| Z-Ile-Glu(OtBu)-Ala-Leu-aldehyde | Z-Ile-Glu(OtBu)-Ala-Leu-aldehyde | 4026408 | C-3900 |
| (Met⁵,Pro⁶,D-Phe⁷,D-Trp⁹,Phe¹⁰)-α-MSH (5-13) | H-Met-Pro-D-Phe-Arg-D-Trp-Phe-Lys-Pro-Val-NH₂ | 4026419 | H-2716 |
| Fmoc-Tyr(PO₃(MDPSE)₂)-OH | Fmoc-Tyr(PO₃(MDPSE)₂)-OH | 4026422 | B-2910 |
| H-Thr-OtBu · HCl | H-Thr-OtBu · HCl | 4026444 | E-3290 |
| Abz-Arg-Val-Lys-Arg-Gly-Leu-Ala-m-nitro-Tyr-Asp-OH | Abz-Arg-Val-Lys-Arg-Gly-Leu-Ala-m-nitro-Tyr-Asp-OH | 4026550 | M-2115 |
| Fmoc-Tyr(malonyl-di-OtBu)-OH | Fmoc-Tyr(malonyl-di-OtBu)-OH | 4026574 | B-2825 |
| Autocamtide-2-Related Inhibitory Peptide | H-Lys-Lys-Ala-Leu-Arg-Arg-Gln-Glu-Ala-Val-Asp-Ala-Leu-OH | 4026616 | H-3384 |
| Galanin (1-13)-Neuropeptide Y (25-36) amide | H-Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH₂ | 4026620 | H-3374 |
| pTH (1-31) amide (human) | H-Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-NH₂ | 4026647 | H-3408 |
| N,S-Bis-Fmoc-glutathione | Fmoc-Glu(Cys(Fmoc)-Gly-OH)-OH | 4026654 | B-2855 |
| Leptin (22-56) (human) | H-Val-Pro-Ile-Gln-Lys-Val-Gln-Asp-Asp-Thr-Lys-Thr-Leu-Ile-Lys-Thr-Ile-Val-Thr-Arg-Ile-Asn-Asp-Ile-Ser-His-Thr-Gln-Ser-Val-Ser-Ser-Lys-Gln-Lys-OH | 4026665 | H-3424 |
| L-trans-Epoxysuccinyl-Ile-Pro-OH propylamide | L-trans-Epoxysuccinyl-Ile-Pro-OH propylamide | 4026670 | N-1475 |
| Ac-Ile-Tyr-Gly-Glu-Phe-NH₂ | Ac-Ile-Tyr-Gly-Glu-Phe-NH₂ | 4026672 | M-2165 |
| CRF (6-33) (human, rat) | H-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser-OH | 4026679 | H-3456 |
| H-Gly-Gly-Leu-OH | H-Gly-Gly-Leu-OH | 4026699 | H-3435 |
| Z-Pro-Pro-aldehyde-dimethyl acetal | Z-Pro-Pro-aldehyde-dimethyl acetal | 4026718 | N-1490 |
| 3-(4-Azidophenyl)propionic acid | 3-(4-Azidophenyl)propionic acid | 4026720 | Q-1995 |
| H-Ala-Pro-AFC | H-Ala-Pro-AFC | 4026747 | I-1680 |
| H-Tyr(tBu)-allyl ester · HCl | H-Tyr(tBu)-allyl ester · HCl | 4026774 | E-3335 |
| Hymenistatin I | Cyclo(-Pro-Pro-Tyr-Val-Pro-Leu-Ile-Ile) | 4026849 | H-3526 |
| H-Cys-4-Abz-Met-OH | H-Cys-4-Abz-Met-OH | 4026861 | H-3548 |
| PAR-2 (1-6) (mouse, rat) | H-Ser-Leu-Ile-Gly-Arg-Leu-OH | 4026881 | H-3586 |
| 4-(2′,4′-Dimethoxyphenyl-Fmoc-aminomethyl)-phenoxymethyl-polystyrene resin (200-400 mesh, 0.80-1.20 mmol/g) | 4-(2',4'-Dimethoxyphenyl-Fmoc-aminomethyl)-phenoxymethyl-polystyrene resin (200-400 mesh, 0.80-1.20 mmol/g) | 4026912 | D-2080 |
| IPTG (dioxane free) | Isopropyl-1-thio-β-D-galactopyranoside (dioxane free) | 4026913 | Q-2060 |
| Lys-(Des-Arg⁹)-Bradykinin | H-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-OH | 4026993 | H-3122 |
| Tricyclic amide linker resin (DL-form) (200-400 mesh, 0.5-0.8 mmol/g) | 5-Fmoc-amino-10,11-dihydro-5H-dibenzo[a,d]-cycloheptenyl-2-oxyacetyl-DL-Nle-4-methyl-benzhydrylamide resin | 4027095 | D-2200 |
| H-Trp(Boc)-OtBu · HCl | H-Trp(Boc)-OtBu · HCl | 4027105 | E-3370 |
| Calpain Inhibitor III | Z-Val-Phe-aldehyde | 4027129 | N-1535 |
| Z-Phe-Tyr-aldehyde | Z-Phe-Tyr-aldehyde | 4027130 | N-1540 |
| (Asn¹,Val⁵)-Angiotensin II | H-Asn-Arg-Val-Tyr-Val-His-Pro-Phe-OH | 4027132 | H-6010 |
| H-D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH₂ | H-D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH₂ (Disulfide bond between Cys² and Pen⁷) | 4027138 | H-3698 |
| Z-Leu-Arg-Gly-Gly-AMC | Z-Leu-Arg-Gly-Gly-AMC | 4027157 | I-1685 |
| Z-Arg-Leu-Arg-Gly-Gly-AMC | Z-Arg-Leu-Arg-Gly-Gly-AMC | 4027158 | I-1690 |
| Diphenyldiazomethane resin (200-400 mesh, 0.7-1.3 mmol/g) | Diphenyldiazomethane resin (200-400 mesh, 0.7-1.3 mmol/g) | 4027172 | D-2230 |
| H-D-Tyr(tBu)-allyl ester · HCl | H-D-Tyr(tBu)-allyl ester · HCl | 4027186 | F-3525 |
| Urocortin (human) | H-Asp-Asn-Pro-Ser-Leu-Ser-Ile-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Thr-Leu-Leu-Glu-Leu-Ala-Arg-Thr-Gln-Ser-Gln-Arg-Glu-Arg-Ala-Glu-Gln-Asn-Arg-Ile-Ile-Phe-Asp-Ser-Val-NH₂ | 4027201 | H-3722 |
| (D-Phe⁷)-Somatostatin-14 | H-Ala-Gly-Cys-Lys-Asn-Phe-D-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys-OH (Disulfide bond) | 4027206 | H-4664 |
| H-Gly-Leu-Tyr-OH | H-Gly-Leu-Tyr-OH | 4027219 | H-3560 |
| Fmoc-Val-Wang resin (100-200 mesh, 0.50-1.00 mmol/g) | Fmoc-Val-4-alkoxybenzyl alcohol resin | 4027341 | D-2275 |
| Wang resin (100-200 mesh, 0.80-1.20 mmol/g) | 4-Alkoxybenzyl alcohol resin | 4027344 | D-2115 |
| (Des-Pyr¹)-LHRH | H-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH₂ | 4027358 | H-9200 |
| H-Gly-Pen-Gly-Arg-Gly-Asp-Ser-Pro-Cys-Ala-OH | H-Gly-Pen-Gly-Arg-Gly-Asp-Ser-Pro-Cys-Ala-OH (Disulfide bond between Pen² and Cys⁹) | 4027371 | H-3964 |
| Methoxycarbonyl-Lys(Z)-Gly-Arg-pNA | Methoxycarbonyl-Lys(Z)-Gly-Arg-pNA | 4027448 | L-1970 |
| Exendin-4 (3-39) | H-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂ | 4027457 | H-3864 |
| H-Asp-Arg-OH | H-Asp-Arg-OH | 4027471 | G-4515 |
| Biotinyl-ε-aminocaproyl-D-Phe-Pro-Arg-chloromethylketone | Biotinyl-ε-aminocaproyl-D-Phe-Pro-Arg-chloromethylketone | 4027521 | N-1565 |
| Ac-Tyr-Val-Ala-Asp-AFC | Ac-Tyr-Val-Ala-Asp-AFC | 4027522 | I-1705 |
| Caffeic acid-phenethyl ester | 4027526 | Q-2305 | |
| Z-Tyr-Val-Ala-DL-Asp-fluoromethylketone | Z-Tyr-Val-Ala-DL-Asp-fluoromethylketone | 4027532 | N-1595 |
| Z-Val-Ala-Asp-AMC | Z-Val-Ala-Asp-AMC | 4027536 | I-1710 |
| Fmoc-D-allo-Thr-OH | Fmoc-D-allo-Thr-OH | 4027554 | B-3090 |
| Sauvagine | Pyr-Gly-Pro-Pro-Ile-Ser-Ile-Asp-Leu-Ser-Leu-Glu-Leu-Leu-Arg-Lys-Met-Ile-Glu-Ile-Glu-Lys-Gln-Glu-Lys-Glu-Lys-Gln-Gln-Ala-Ala-Asn-Asn-Arg-Leu-Leu-Leu-Asp-Thr-Ile-NH₂ | 4027592 | H-4890 |
| Pmc-S-methylisothiourea | Pmc-S-methylisothiourea | 4027659 | Q-2330 |
| Hydroxylamine-Wang resin (200-400 mesh, 0.8-1.1 mmol/g) | Hydroxylamine-4-alkoxybenzyl alcohol resin | 4027663 | D-2415 |
| Pyr-Trp-OH | Pyr-Trp-OH | 4027664 | G-4545 |
| H-Lys(Abz)-Pro-Pro-pNA | H-Lys(Abz)-Pro-Pro-pNA | 4027668 | L-1980 |
| Endomorphin-1 | H-Tyr-Pro-Trp-Phe-NH₂ | 4027684 | H-4002 |
| Mca-Pro-Leu-Gly-Pro-D-Lys(Dnp)-OH | Mca-Pro-Leu-Gly-Pro-D-Lys(Dnp)-OH | 4027687 | M-2270 |
| (D-Leu⁶,Pro-NHEt⁹)-LHRH (4-9) | H-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt | 4027694 | H-4008 |
| GLP-1 (9-36) amide (human, bovine, guinea pig, mouse, porcine, rat) | H-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH₂ | 4027697 | H-4012 |
| Z-Trp(Boc)-OH · DCHA | Z-Trp(Boc)-OH · DCHA | 4027713 | C-3995 |
| H-Lys-Pro-AMC | H-Lys-Pro-AMC | 4027787 | I-1745 |
| Suc-Ala-Glu-Pro-Phe-AMC | Suc-Ala-Glu-Pro-Phe-AMC | 4027817 | I-1750 |
| Cyclolinopeptide B | Cyclo(-Pro-Pro-Phe-Phe-Val-Ile-Met-Leu-Ile) | 4027863 | H-4056 |
| Ac-Trp-Glu-His-Asp-aldehyde (pseudo acid) | Ac-Trp-Glu-His-Asp-aldehyde (pseudo acid) | 4027878 | N-1630 |
| Acetyl-Calpastatin (184-210) (human) | Ac-Asp-Pro-Met-Ser-Ser-Thr-Tyr-Ile-Glu-Glu-Leu-Gly-Lys-Arg-Glu-Val-Thr-Ile-Pro-Pro-Lys-Tyr-Arg-Glu-Leu-Leu-Ala-NH₂ | 4027881 | H-4076 |
| Sar-Pro-Arg-pNA | Sar-Pro-Arg-pNA | 4027887 | L-1990 |
| MG 132 | Z-Leu-Leu-Leu-aldehyde | 4027888 | N-1635 |
| Ac-Val-Glu-Ile-Asp-aldehyde (pseudo acid) | Ac-Val-Glu-Ile-Asp-aldehyde (pseudo acid) | 4027894 | N-1640 |
| H-3-Amino-Tyr-OH · 2 HCl | H-3-Amino-Tyr-OH · 2 HCl | 4027898 | F-3675 |
| SASRIN™ resin (100-200 mesh, 0.7-1.0 mmol/g) | 2-Methoxy-4-alkoxybenzyl alcohol resin | 4027899 | D-2440 |
| Ac-Asp-Glu-Val-Asp-AFC | Ac-Asp-Glu-Val-Asp-AFC | 4027914 | I-1725 |
| FITC-Tyr-Val-Ala-Asp-Ala-Pro-Lys(Dnp)-OH (Contains FITC isomer I) | FITC-Tyr-Val-Ala-Asp-Ala-Pro-Lys(Dnp)-OH (Contains FITC isomer I) | 4027937 | M-2285 |
| Melanocyte Protein PMEL 17 (185-193) (human, bovine, mouse) | H-Ile-Thr-Asp-Gln-Val-Pro-Phe-Ser-Val-OH | 4027973 | H-4106 |
| For-Met-Leu-pNA | For-Met-Leu-pNA | 4027984 | L-2030 |
| Amyloid β-Protein (42-1) | H-Ala-Ile-Val-Val-Gly-Gly-Val-Met-Leu-Gly-Ile-Ile-Ala-Gly-Lys-Asn-Ser-Gly-Val-Asp-Glu-Ala-Phe-Phe-Val-Leu-Lys-Gln-His-His-Val-Glu-Tyr-Gly-Ser-Asp-His-Arg-Phe-Glu-Ala-Asp-OH | 4027991 | H-3976 |
| Adrenomedullin (22-52) (human) | H-Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH₂ | 4028071 | H-4144 |
| 4-Piperidylformylaminomethyl resin (200-400 mesh, 0.3-0.6 mmol/g) | 4-Piperidylformylaminomethyl resin (200-400 mesh, 0.3-0.6 mmol/g) | 4028100 | D-2455 |
| (Des-Gly¹⁰,D-Ser(tBu)⁶,Pro-NHEt⁹)-LHRH | Pyr-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-NHEt | 4028150 | H-4224 |
| N-Me-D-Tyr-OH | N-Me-D-Tyr-OH | 4028208 | F-3715 |
| Boc-N-Me-D-Tyr-OH · DCHA | Boc-N-Me-D-Tyr-OH · DCHA | 4028209 | A-4420 |
| Z-Tyr-Val-Ala-Asp-AFC | Z-Tyr-Val-Ala-Asp-AFC | 4028224 | I-1720 |
| Procathepsin B (26-50) (rat) | H-Ala-Gly-Arg-Asn-Phe-Tyr-Asn-Val-Asp-Ile-Ser-Tyr-Leu-Lys-Lys-Leu-Cys-Gly-Thr-Val-Leu-Gly-Gly-Pro-Lys-NH₂ | 4028254 | H-3942 |
| Orexin B (mouse, rat) | H-Arg-Pro-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Asn-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH₂ | 4028264 | H-4176 |
| 6-(7-Nitro-benzo[2,1,3]oxadiazol-4-ylamino)-hexanoyl-Arg-Pro-Lys-Pro-Leu-Ala-Nva-Trp-Lys((7-dimethylaminocoumarin-4-yl)-acetyl)-NH₂ | 6-(7-Nitro-benzo[2,1,3]oxadiazol-4-ylamino)-hexanoyl-Arg-Pro-Lys-Pro-Leu-Ala-Nva-Trp-Lys((7-dimethylaminocoumarin-4-yl)-acetyl)-NH₂ | 4028275 | M-2300 |
| H-Tyr-Cys-Trp-Ser-Gln-Tyr-Leu-Cys-Tyr-OH | H-Tyr-Cys-Trp-Ser-Gln-Tyr-Leu-Cys-Tyr-OH (Disulfide bond) | 4028287 | N-1685 |
| Dodecyl pentaethylene glycolether | Dodecyl pentaethylene glycolether | 4028288 | P-1160 |
| Myelin Oligodendrocyte Glycoprotein (35-55) (mouse, rat) | H-Met-Glu-Val-Gly-Trp-Tyr-Arg-Ser-Pro-Phe-Ser-Arg-Val-Val-His-Leu-Tyr-Arg-Asn-Gly-Lys-OH | 4028291 | H-4184 |
| ACV | H-Aad(Cys-D-Val-OH)-OH | 4028307 | H-4204 |
| Cyclo(-Gly-Phe) | Cyclo(-Gly-Phe) | 4028308 | G-1715 |
| LHRH (1-5) (free acid) | Pyr-His-Trp-Ser-Tyr-OH | 4028309 | H-6212 |
| (Des-Gly¹⁰,D-Leu⁶,D-Leu⁷,Pro-NHEt⁹)-LHRH | Pyr-His-Trp-Ser-Tyr-D-Leu-D-Leu-Arg-Pro-NHEt | 4028310 | H-4636 |
| (Des-Gly¹⁰,D-Tyr⁵,D-Leu⁶,Pro-NHEt⁹)-LHRH | Pyr-His-Trp-Ser-D-Tyr-D-Leu-Leu-Arg-Pro-NHEt | 4028312 | H-4638 |
| Dansyl-Ala-Arg-OH | Dansyl-Ala-Arg-OH | 4028360 | G-4600 |
| Boc-Gly-Gly-Phe-Gly-OH | Boc-Gly-Gly-Phe-Gly-OH | 4028365 | A-4450 |
| H-Val-2-chlorotrityl resin (200-400 mesh, 0.50-0.90 mmol/g) | H-Val-2-chlorotrityl resin (200-400 mesh, 0.50-0.90 mmol/g) | 4028398 | D-2490 |
| LHRH (lamprey III) | Pyr-His-Trp-Ser-His-Asp-Trp-Lys-Pro-Gly-NH₂ | 4028403 | H-4258 |
| H-Gly-D-Tyr-OH | H-Gly-D-Tyr-OH | 4028468 | G-4580 |
| H-Trp-Phe-Tyr-Ser(PO₃H₂)-Pro-Arg-pNA | H-Trp-Phe-Tyr-Ser(PO₃H₂)-Pro-Arg-pNA | 4028474 | L-2075 |
| Fmoc-3,5-dinitro-Tyr-OH | Fmoc-3,5-dinitro-Tyr-OH | 4028488 | B-3265 |
| Fmoc-Tyr(tBu)-Wang resin (100-200 mesh, 0.40-0.90 mmol/g) | Fmoc-Tyr(tBu)-4-alkoxybenzyl alcohol resin | 4028539 | D-2390 |
| Fmoc-Ser(tBu)-Wang resin (100-200 mesh, 0.3-0.6 mmol/g) | Fmoc-Ser(tBu)-4-alkoxybenzyl alcohol resin | 4028572 | D-2375 |
| Fmoc-Thr(tBu)-Wang resin (100-200 mesh, 0.40-0.80 mmol/g) | Fmoc-Thr(tBu)-4-alkoxybenzyl alcohol resin | 4028592 | D-2380 |
| Ac-Asp(Glu-OH)-OH | Ac-Asp(Glu-OH)-OH | 4028598 | G-4590 |
| (β-Asp⁵)-Delta-Sleep Inducing Peptide | H-Trp-Ala-Gly-Gly-Asp(Ala-Ser-Gly-Glu-OH)-OH | 4028635 | H-2545 |
| Boc-Trp(Boc)-OH | Boc-Trp(Boc)-OH | 4028660 | A-4550 |
| H-Lys-Ala-pNA · 2 HCl | H-Lys-Ala-pNA · 2 HCl | 4028676 | L-2085 |
| Suc-Ala-Pro-pNA | Suc-Ala-Pro-pNA | 4028677 | L-2090 |
| PAR-4 (1-6) (human) | H-Gly-Tyr-Pro-Gly-Gln-Val-OH | 4028678 | H-4348 |
| Fmoc-β-(2,2-dimethyl-4H-benzo[1,3]dioxin-6-yl)-Ala-OH | Fmoc-β-(2,2-dimethyl-4H-benzo[1,3]dioxin-6-yl)-Ala-OH | 4028689 | B-3310 |
| H-His-His-OH | H-His-His-OH | 4028691 | G-4595 |
| Z-Leu-Leu-Tyr-α-keto aldehyde | Z-Leu-Leu-Tyr-α-keto aldehyde | 4028692 | N-1715 |
| Ac-Leu-Glu-His-Asp-AFC | Ac-Leu-Glu-His-Asp-AFC | 4028699 | I-1820 |
| 3,4-Dihydro-2H-pyran-2-ylmethoxymethyl resin (200-400 mesh, 0.7-1.0 mmol/g) | 3,4-Dihydro-2H-pyran-2-ylmethoxymethyl resin (200-400 mesh, 0.7-1.0 mmol/g) | 4028707 | D-2530 |
| L-Thiazolidine-4-carboxylic acid | L-Thiazolidine-4-carboxylic acid | 4028717 | F-4175 |
| Prolactin-Releasing Peptide (1-31) (human) | H-Ser-Arg-Thr-His-Arg-His-Ser-Met-Glu-Ile-Arg-Thr-Pro-Asp-Ile-Asn-Pro-Ala-Trp-Tyr-Ala-Ser-Arg-Gly-Ile-Arg-Pro-Val-Gly-Arg-Phe-NH₂ | 4028740 | H-4382 |
| Prolactin-Releasing Peptide (1-31) (rat) | H-Ser-Arg-Ala-His-Gln-His-Ser-Met-Glu-Thr-Arg-Thr-Pro-Asp-Ile-Asn-Pro-Ala-Trp-Tyr-Thr-Gly-Arg-Gly-Ile-Arg-Pro-Val-Gly-Arg-Phe-NH₂ | 4028741 | H-4384 |
| Prolactin-Releasing Peptide (12-31) (human) | H-Thr-Pro-Asp-Ile-Asn-Pro-Ala-Trp-Tyr-Ala-Ser-Arg-Gly-Ile-Arg-Pro-Val-Gly-Arg-Phe-NH₂ | 4028744 | H-4392 |
| (Des-Gly¹⁰,D-His²,D-His(Bzl)⁶,Pro-NHEt⁹)-LHRH | Pyr-D-His-Trp-Ser-Tyr-D-His(Bzl)-Leu-Arg-Pro-NHEt | 4028762 | H-4652 |
| PAR-3 (1-6) (human) | H-Thr-Phe-Arg-Gly-Ala-Pro-OH | 4028843 | H-4452 |
| Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH₂ | Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH₂ | 4028885 | M-2350 |
| Anisindione | Anisindione | 4028913 | Q-1085 |
| H-Arg-Arg-Arg-Arg-Arg-Arg-OH | H-Arg-Arg-Arg-Arg-Arg-Arg-OH | 4028946 | H-4622 |
| N-(2-Aminoethyl)-2-(benzylphenylamino)acetamide · maleate | N-(2-Aminoethyl)-2-(benzylphenylamino)acetamide · maleate | 4028954 | Q-2730 |
| N-Me-Thr-OH | N-Me-Thr-OH | 4029013 | E-3480 |
| DOTA(OtBu)₃ | 4,7,10-Tri-(t-butyloxycarbonylmethyl)-1,4,7,10-tetraazacyclododecan-1-yl-acetic acid | 4029066 | Q-2525 |
| Parasin I | H-Lys-Gly-Arg-Gly-Lys-Gln-Gly-Gly-Lys-Val-Arg-Ala-Lys-Ala-Lys-Thr-Arg-Ser-Ser-OH | 4029070 | H-4542 |
| Bromoacetyl resin (200-400 mesh) | Bromoacetyl resin (200-400 mesh) | 4029092 | D-2555 |
| 3-(2-Pyridyldithio)-propionic acid-OSu | 3-(2-Pyridyldithio)-propionic acid-OSu | 4029094 | Q-2535 |
| Fmoc-N-Me-Ser(tBu)-OH | Fmoc-N-Me-Ser(tBu)-OH | 4029103 | B-3400 |
| Fmoc-Tyr(SO₃H)-OH | Fmoc-Tyr(SO₃H)-OH | 4029106 | B-2765 |
| Fmoc-Lys(Mtt)-Wang resin (200-400 mesh, 0.5-0.8 mmol/g) | Fmoc-Lys(Mtt)-4-alkoxybenzyl alcohol resin | 4029107 | D-2565 |
| Apelin-13 (human, bovine, mouse, rat) | H-Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe-OH | 4029109 | H-4566 |
| (Pyr¹)-Apelin-13 (human, bovine, mouse, rat) | Pyr-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe-OH | 4029110 | H-4568 |
| (D-Trp⁶)-LHRH (1-6) amide | Pyr-His-Trp-Ser-Tyr-D-Trp-NH₂ | 4029113 | H-4574 |
| Formyl-(D-Trp⁶)-LHRH (2-10) | For-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH₂ | 4029114 | H-4576 |
| (Trp⁶)-LHRH | Pyr-His-Trp-Ser-Tyr-Trp-Leu-Arg-Pro-Gly-NH₂ | 4029115 | H-4578 |
| (D-Trp⁶)-LHRH-Leu-Arg-Pro-Gly amide | Pyr-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-Leu-Arg-Pro-Gly-NH₂ | 4029116 | H-4582 |
| Ac-Leu-Glu-His-Asp-chloromethylketone | Ac-Leu-Glu-His-Asp-chloromethylketone | 4029126 | N-1750 |
| Z-Val-Ala-Asn-AMC | Z-Val-Ala-Asn-AMC | 4029129 | I-1840 |
| (Ser⁸)-GLP-1 (7-36) amide (human, bovine, guinea pig, mouse, rat) | H-His-Ser-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH₂ | 4029130 | H-4592 |
| Osteoblast-Adhesive Peptide | H-Lys-Arg-Ser-Arg-OH | 4029131 | H-4594 |
| 4-Formyl-3-methoxy-phenyloxymethyl polystyrene resin (200-400 mesh) | 4-Formyl-3-methoxy-phenyloxymethyl polystyrene resin (200-400 mesh) | 4029143 | D-2570 |
| Fmoc-N-Me-Thr(tBu)-OH | Fmoc-N-Me-Thr(tBu)-OH | 4029146 | B-3420 |
| PAR-2 (1-6) amide (human) | H-Ser-Leu-Ile-Gly-Lys-Val-NH₂ | 4029152 | H-4624 |
| 1-Naphthalenylsulfonyl-Ile-Trp-aldehyde | 1-Naphthalenylsulfonyl-Ile-Trp-aldehyde | 4029154 | N-1760 |
| (4-((2-Methylphenyl)aminocarbonyl)-aminophenyl)acetyl-Fibronectin CS-1 Fragment (1980-1983) | (4-((2-Methylphenyl)aminocarbonyl)-aminophenyl)acetyl-Leu-Asp-Val-Pro-OH | 4029156 | N-1765 |
| H-Ile-Pro-Pro-OH | H-Ile-Pro-Pro-OH | 4029177 | H-4632 |
| H-Thr(PO₃H₂)-OH | H-Thr(PO₃H₂)-OH | 4029206 | E-3575 |
| Z-D-Arg-Gly-Arg-pNA · 2 HCl | Z-D-Arg-Gly-Arg-pNA · 2 HCl | 4029223 | L-2115 |
| H-D-Pro-Phe-Arg-pNA · 2 HCl | H-D-Pro-Phe-Arg-pNA · 2 HCl | 4029234 | L-2120 |
| DEPBT | 3-(Diethoxy-phosphoryloxy)-1,2,3-benzo[d]triazin-4(3H)-one | 4029249 | Q-2565 |
| ACTH (3-24) (human, bovine, rat) | H-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-OH | 4029277 | H-4716 |
| (D-Ser¹)-ACTH (1-24) (human, bovine, rat) | H-D-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-OH | 4029278 | H-4718 |
| Fmoc-N-Me-Trp-OH | Fmoc-N-Me-Trp-OH | 4029285 | B-3430 |
| Boc-L-thiazolidine-4-carboxylic acid | Boc-L-thiazolidine-4-carboxylic acid | 4029316 | A-3945 |
| Fmoc-Ile-Thr(Psi(Me,Me)pro)-OH | Fmoc-Ile-Thr(Psi(Me,Me)pro)-OH | 4029320 | B-3440 |
| Galanin Message Associated Peptide (1-41) amide | H-Glu-Leu-Glu-Pro-Glu-Asp-Glu-Ala-Arg-Pro-Gly-Gly-Phe-Asp-Arg-Leu-Gln-Ser-Glu-Asp-Lys-Ala-Ile-Arg-Thr-Ile-Met-Glu-Phe-Leu-Ala-Phe-Leu-His-Leu-Lys-Glu-Ala-Gly-Ala-Leu-NH₂ | 4029327 | H-6780 |
| Fmoc-Ser(PO(OBzl)OH)-OH | Fmoc-Ser(PO(OBzl)OH)-OH | 4029345 | B-3455 |
| Fmoc-Thr(PO(OBzl)OH)-OH | Fmoc-Thr(PO(OBzl)OH)-OH | 4029346 | B-3460 |
| Fmoc-Val-Thr(Psi(Me,Me)pro)-OH | Fmoc-Val-Thr(Psi(Me,Me)pro)-OH | 4029363 | B-3470 |
| Urotensin II (human) | H-Glu-Thr-Pro-Asp-Cys-Phe-Trp-Lys-Tyr-Cys-Val-OH (Disulfide bond) | 4029364 | H-4768 |
| Cyclo(-Ala-Arg-Gly-Asp-3-aminomethylbenzoyl) | Cyclo(-Ala-Arg-Gly-Asp-3-aminomethylbenzoyl) | 4029366 | H-4772 |
| Somatostatin-14 (3-14) | H-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys-OH (Disulfide bond) | 4029367 | H-4774 |
| FA-Glu-Glu-OH | FA-Glu-Glu-OH | 4029372 | M-2385 |
| Biotinyl-εAhx-OH | Biotinyl-εAhx-OH | 4029390 | F-3950 |
| Biotinyl-(Gln¹)-LHRH | Biotinyl-Gln-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH₂ | 4029417 | H-4792 |
| LHRH (1-2) (free acid) | Pyr-His-OH | 4029432 | G-4700 |
| Cyclo(-D-Ala-Val) | Cyclo(-D-Ala-Val) | 4029435 | G-4710 |
| Cyclo(-Pro-Tyr) | Cyclo(-Pro-Tyr) | 4029436 | G-4715 |
| Mca-(Ala⁷,Lys(Dnp)⁹)-Bradykinin | Mca-Arg-Pro-Pro-Gly-Phe-Ser-Ala-Phe-Lys(Dnp)-OH | 4029459 | M-2405 |
| (Asn⁶⁷⁰,Leu⁶⁷¹)-Amyloid β/A4 Protein Precursor₇₇₀ (667-676) | H-Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Arg-OH | 4029475 | H-4834 |
| Mca-(Asn⁶⁷⁰,Leu⁶⁷¹)-Amyloid β/A4 Protein Precursor₇₇₀ (667-675)-Lys(Dnp) | Mca-Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Lys(Dnp)-OH | 4029476 | M-2420 |
| Amyloid β-Protein (35-25) | H-Met-Leu-Gly-Ile-Ile-Ala-Gly-Lys-Asn-Ser-Gly-OH | 4030076 | H-2964 |
| Ac-Nle-Pro-Nle-Asp-AMC | Ac-Nle-Pro-Nle-Asp-AMC | 4030084 | I-1850 |
| Ac-Gly-Asp-Tyr-Ser-His-Cys-Ser-Pro-Leu-Arg-Tyr-Tyr-Pro-Trp-Trp-Lys-Cys-Thr-Tyr-Pro-Asp-Pro-Glu-Gly-Gly-Gly-NH₂ | Ac-Gly-Asp-Tyr-Ser-His-Cys-Ser-Pro-Leu-Arg-Tyr-Tyr-Pro-Trp-Trp-Lys-Cys-Thr-Tyr-Pro-Asp-Pro-Glu-Gly-Gly-Gly-NH₂ (Disulfide bond) | 4030130 | H-6442 |
| Uroguanylin Topoisomer A (human) | H-Asn-Asp-Asp-Cys-Glu-Leu-Cys-Val-Asn-Val-Ala-Cys-Thr-Gly-Cys-Leu-OH (Disulfide bonds between Cys⁴ and Cys¹²/Cys⁷ and Cys¹⁵) | 4030148 | H-2166 |
| Adrenomedullin (rat) | H-Tyr-Arg-Gln-Ser-Met-Asn-Gln-Gly-Ser-Arg-Ser-Thr-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Met-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Gly-Met-Ala-Pro-Arg-Asn-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH₂ (Disulfide bond) | 4030175 | H-2934 |
| Amylin (8-37) (human) | H-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH₂ | 4030202 | H-2742 |
| Amyloid β-Protein (1-38) | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-OH | 4030204 | H-2966 |
| Neuropeptide K (human, porcine, rat) | H-Asp-Ala-Asp-Ser-Ser-Ile-Glu-Lys-Gln-Val-Ala-Leu-Leu-Lys-Ala-Leu-Tyr-Gly-His-Gly-Gln-Ile-Ser-His-Lys-Arg-His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH₂ | 4030282 | H-5680 |
| Ac-Glu-Asp(EDANS)-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Gly-Lys(DABCYL)-Glu-NH₂ | Ac-Glu-Asp(EDANS)-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Gly-Lys(DABCYL)-Glu-NH₂ | 4030300 | M-2295 |
| ACTH (22-39) | H-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe-OH | 4030305 | H-2898 |
| Amyloid β-Protein (1-16) | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-OH | 4030330 | H-2958 |
| Amyloid β-Protein (10-20) | H-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-OH | 4030332 | H-1388 |
| Type A Allatostatin III | H-Gly-Gly-Ser-Leu-Tyr-Ser-Phe-Gly-Leu-NH₂ | 4030340 | H-8075 |
| Acetyl-Amylin (8-37) (human) | Ac-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH₂ | 4030345 | H-2744 |
| Amylin (8-37) (mouse, rat) | H-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH₂ | 4030346 | H-2746 |
| Amylin (20-29) (human) | H-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-OH | 4030350 | H-3746 |
| (D-Ala⁷)-Angiotensin I/II (1-7) | H-Asp-Arg-Val-Tyr-Ile-His-D-Ala-OH | 4030357 | H-2888 |
| Angiotensin I/II (1-5) | H-Asp-Arg-Val-Tyr-Ile-OH | 4030360 | H-2878 |
| Angiotensin I/II (5-8) | H-Ile-His-Pro-Phe-OH | 4030363 | H-3846 |
| L-Carnosine | H-β-Ala-His-OH | 4030364 | G-1250 |
| Anthopleurin-A | H-Gly-Val-Ser-Cys-Leu-Cys-Asp-Ser-Asp-Gly-Pro-Ser-Val-Arg-Gly-Asn-Thr-Leu-Ser-Gly-Thr-Leu-Trp-Leu-Tyr-Pro-Ser-Gly-Cys-Pro-Ser-Gly-Trp-His-Asn-Cys-Lys-Ala-His-Gly-Pro-Thr-Ile-Gly-Trp-Cys-Cys-Lys-Gln-OH (Disulfide bonds between Cys⁴ and Cys⁴⁶/Cys⁶ and Cys³⁶/Cys²⁹ and Cys⁴⁷) | 4030365 | H-9590 |
| BAM-12P | H-Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly-Arg-Pro-Glu-OH | 4030371 | H-2125 |
| BAM-22P | H-Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly-Arg-Pro-Glu-Trp-Trp-Met-Asp-Tyr-Gln-Lys-Arg-Tyr-Gly-OH | 4030372 | H-2130 |
| Atrial Natriuretic Factor (1-28) (mouse, rabbit, rat) | H-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH (Disulfide bond) | 4030380 | H-2100 |
| Thr-Ala-Pro-Arg-Atrial Natriuretic Factor (1-28) (human, bovine, porcine) | H-Thr-Ala-Pro-Arg-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH (Disulfide bond) | 4030382 | H-3046 |
| (Cys¹⁸)-Atrial Natriuretic Factor (4-18) amide (mouse, rabbit, rat) | H-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Cys-NH₂ (Disulfide bond) | 4030384 | H-3134 |
| (Arg⁶,β-cyclohexyl-Ala⁸,D-Tic¹⁶,Arg¹⁷,Cys¹⁸)-Atrial Natriuretic Factor (6-18) amide (mouse, rabbit, rat) | H-Arg-Cys-β-cyclohexyl-Ala-Gly-Gly-Arg-Ile-Asp-Arg-Ile-D-Tic-Arg-Cys-NH₂ (Disulfide bond) | 4030385 | H-3048 |
| Bactenecin | H-Arg-Leu-Cys-Arg-Ile-Val-Val-Ile-Arg-Val-Cys-Arg-OH (Disulfide bond) | 4030388 | H-9585 |
| Lys-(Des-Arg⁹,Leu⁸)-Bradykinin | H-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Leu-OH | 4030394 | H-2582 |
| BPP 9a | Pyr-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro-OH | 4030395 | H-2215 |
| Boc-Ser(tBu)-OH (syrup) | Boc-Ser(tBu)-OH (syrup) | 4030424 | A-2915 |
| (D-Phe⁶,Leu-NHEt¹³,des-Met¹⁴)-Bombesin (6-14) | H-D-Phe-Gln-Trp-Ala-Val-Gly-His-Leu-NHEt | 4030433 | H-3042 |
| Calcitonin (rat) | H-Cys-Gly-Asn-Leu-Ser-Thr-Cys-Met-Leu-Gly-Thr-Tyr-Thr-Gln-Asp-Leu-Asn-Lys-Phe-His-Thr-Phe-Pro-Gln-Thr-Ser-Ile-Gly-Val-Gly-Ala-Pro-NH₂ (Disulfide bond) | 4030449 | H-3072 |
| Calcitonin N-Terminal Flanking Peptide (human) | H-Ala-Pro-Phe-Arg-Ser-Ala-Leu-Glu-Ser-Ser-Pro-Ala-Asp-Pro-Ala-Thr-Leu-Ser-Glu-Asp-Glu-Ala-Arg-Leu-Leu-Leu-Ala-Ala-Leu-Val-Gln-Asp-Tyr-Val-Gln-Met-Lys-Ala-Ser-Glu-Leu-Glu-Gln-Glu-Gln-Glu-Arg-Glu-Gly-Ser-Ser-Leu-Asp-Ser-Pro-Arg-Ser-OH | 4030454 | H-3076 |
| (D-Phe¹²,Nle²¹·³⁸,α-Me-Leu³⁷)-CRF (12-41) (human, rat) | H-D-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Nle-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-α-Me-Leu-Nle-Glu-Ile-Ile-NH₂ | 4030465 | H-3266 |
| Fluorogenic Human CMV Protease Substrate | DABCYL-Arg-Gly-Val-Val-Asn-Ala-Ser-Ser-Arg-Leu-Ala-EDANS | 4030469 | M-2060 |
| Mca-Tyr-Val-Ala-Asp-Ala-Pro-Lys(Dnp)-OH | Mca-Tyr-Val-Ala-Asp-Ala-Pro-Lys(Dnp)-OH | 4030476 | M-2195 |
| Cecropin B | H-Lys-Trp-Lys-Val-Phe-Lys-Lys-Ile-Glu-Lys-Met-Gly-Arg-Asn-Ile-Arg-Asn-Gly-Ile-Val-Lys-Ala-Gly-Pro-Ala-Ile-Ala-Val-Leu-Gly-Glu-Ala-Lys-Ala-Leu-NH₂ | 4030477 | H-3096 |
| Ac-Asp-Glu-Val-Asp-pNA | Ac-Asp-Glu-Val-Asp-pNA | 4030481 | L-1945 |
| Ac-Ile-Glu-Pro-Asp-AMC | Ac-Ile-Glu-Pro-Asp-AMC | 4030484 | I-1835 |
| Cecropin A | H-Lys-Trp-Lys-Leu-Phe-Lys-Lys-Ile-Glu-Lys-Val-Gly-Gln-Asn-Ile-Arg-Asp-Gly-Ile-Ile-Lys-Ala-Gly-Pro-Ala-Val-Ala-Val-Val-Gly-Gln-Ala-Thr-Gln-Ile-Ala-Lys-NH₂ | 4030488 | H-3094 |
| CART (55-102) (human) | H-Val-Pro-Ile-Tyr-Glu-Lys-Lys-Tyr-Gly-Gln-Val-Pro-Met-Cys-Asp-Ala-Gly-Glu-Gln-Cys-Ala-Val-Arg-Lys-Gly-Ala-Arg-Ile-Gly-Lys-Leu-Cys-Asp-Cys-Pro-Arg-Gly-Thr-Ser-Cys-Asn-Ser-Phe-Leu-Leu-Lys-Cys-Leu-OH (Disulfide bonds between Cys⁶⁸ and Cys⁸⁶/Cys⁷⁴ and Cys⁹⁴/Cys⁸⁸ and Cys¹⁰¹) | 4030508 | H-4444 |
| CART (61-102) (rat) | H-Lys-Tyr-Gly-Gln-Val-Pro-Met-Cys-Asp-Ala-Gly-Glu-Gln-Cys-Ala-Val-Arg-Lys-Gly-Ala-Arg-Ile-Gly-Lys-Leu-Cys-Asp-Cys-Pro-Arg-Gly-Thr-Ser-Cys-Asn-Ser-Phe-Leu-Leu-Lys-Cys-Leu-OH (Disulfide bonds between Cys⁶⁸ and Cys⁸⁶/Cys⁷⁴ and Cys⁹⁴/Cys⁸⁸ and Cys¹⁰¹) | 4030510 | H-4448 |
| Collagen Type II Fragment | H-Pro-Thr-Gly-Pro-Leu-Gly-Pro-Lys-Gly-Gln-Thr-Gly-Glu-Leu-Gly-Ala-Hyp-Gly-Asn-Lys-Gly-Glu-Gln-Gly-Pro-Lys-OH | 4030511 | H-1604 |
| Chymostatin (microbial product) | 4030514 | H-2430 | |
| µ-Conotoxin GIIIA | H-Arg-Asp-Cys-Cys-Thr-Hyp-Hyp-Lys-Lys-Cys-Lys-Asp-Arg-Gln-Cys-Lys-Hyp-Gln-Arg-Cys-Cys-Ala-NH₂ (Disulfide bonds between Cys³ and Cys¹⁵/Cys⁴ and Cys²⁰/Cys¹⁰ and Cys²¹) | 4030525 | H-2738 |
| CRF (bovine) | H-Ser-Gln-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Thr-Lys-Ala-Asp-Gln-Leu-Ala-Gln-Gln-Ala-His-Asn-Asn-Arg-Lys-Leu-Leu-Asp-Ile-Ala-NH₂ | 4030530 | H-3264 |
| (Tyr⁰)-C-Peptide (dog) | H-Tyr-Glu-Val-Glu-Asp-Leu-Gln-Val-Arg-Asp-Val-Glu-Leu-Ala-Gly-Ala-Pro-Gly-Glu-Gly-Gly-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ala-Leu-Gln-OH | 4030533 | H-2914 |
| C-Type Natriuretic Peptide (1-53) (human) | H-Asp-Leu-Arg-Val-Asp-Thr-Lys-Ser-Arg-Ala-Ala-Trp-Ala-Arg-Leu-Leu-Gln-Glu-His-Pro-Asn-Ala-Arg-Lys-Tyr-Lys-Gly-Ala-Asn-Lys-Lys-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys-OH (Disulfide bond) | 4030534 | H-8420 |
| Cyclo(-Gly-Gly) | Cyclo(-Gly-Gly) | 4030536 | E-1965 |
| Cyclo(-Phe-Trp) | Cyclo(-Phe-Trp) | 4030539 | G-1775 |
| H-α-Difluoro-Me-DL-Orn-OH · HCl · H₂O | H-α-Difluoro-Me-DL-Orn-OH · HCl · H₂O | 4030547 | F-2395 |
| Acetyl-β-Endorphin (human) | Ac-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr-Lys-Lys-Gly-Glu-OH | 4030549 | H-1115 |
| β-Endorphin (6-31) (human) | H-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr-Lys-Lys-Gly-Glu-OH | 4030554 | H-4024 |
| (N-Me-Tyr¹,N-Me-Arg⁷,D-Leu-NHEt⁸)-Dynorphin A (1-8) | N-Me-Tyr-Gly-Gly-Phe-Leu-Arg-N-Me-Arg-D-Leu-NHEt | 4030565 | H-3018 |
| (D-Ala²)-Leu-Enkephalin-Arg | H-Tyr-D-Ala-Gly-Phe-Leu-Arg-OH | 4030569 | H-3276 |
| Echistatin | H-Glu-Cys-Glu-Ser-Gly-Pro-Cys-Cys-Arg-Asn-Cys-Lys-Phe-Leu-Lys-Glu-Gly-Thr-Ile-Cys-Lys-Arg-Ala-Arg-Gly-Asp-Asp-Met-Asp-Asp-Tyr-Cys-Asn-Gly-Lys-Thr-Cys-Asp-Cys-Pro-Arg-Asn-Pro-His-Lys-Gly-Pro-Ala-Thr-OH (Disulfide bonds between Cys² and Cys¹¹/Cys⁷ and Cys³²/Cys⁸ and Cys³⁷/Cys²⁰ and Cys³⁹) | 4030571 | H-9010 |
| rec EGF (human) | H-Asn-Ser-Asp-Ser-Glu-Cys-Pro-Leu-Ser-His-Asp-Gly-Tyr-Cys-Leu-His-Asp-Gly-Val-Cys-Met-Tyr-Ile-Glu-Ala-Leu-Asp-Lys-Tyr-Ala-Cys-Asn-Cys-Val-Val-Gly-Tyr-Ile-Gly-Glu-Arg-Cys-Gln-Tyr-Arg-Asp-Leu-Lys-Trp-Trp-Glu-Leu-Arg-OH (Disulfide bonds between Cys⁶ and Cys²⁰/Cys¹⁴ and Cys³¹/Cys³³ and Cys⁴²) | 4030572 | H-7490 |
| β-Endorphin (rat) | H-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Val-His-Lys-Lys-Gly-Gln-OH | 4030577 | H-2814 |
| (Ala¹·³·¹¹·¹⁵)-Endothelin-1 | H-Ala-Ser-Ala-Ser-Ser-Leu-Met-Asp-Lys-Glu-Ala-Val-Tyr-Phe-Ala-His-Leu-Asp-Ile-Ile-Trp-OH | 4030582 | H-3066 |
| Fibronectin Adhesion-Promoting Peptide | H-Trp-Gln-Pro-Pro-Arg-Ala-Arg-Ile-OH | 4030597 | H-1594 |
| H-Gly-Arg-Gly-Glu-Ser-OH | H-Gly-Arg-Gly-Glu-Ser-OH | 4030608 | H-3166 |
| Human Growth Hormone (1-43) | H-Phe-Pro-Thr-Ile-Pro-Leu-Ser-Arg-Leu-Phe-Asp-Asn-Ala-Met-Leu-Arg-Ala-His-Arg-Leu-His-Gln-Leu-Ala-Phe-Asp-Thr-Tyr-Gln-Glu-Phe-Glu-Glu-Ala-Tyr-Ile-Pro-Lys-Glu-Gln-Lys-Tyr-Ser-OH | 4030633 | H-3146 |
| (Des-His¹,Glu⁹)-Glucagon (1-29) amide (human, rat, porcine) | H-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Glu-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr-NH₂ | 4030635 | H-2754 |
| Galanin (mouse, rat) | H-Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Ile-Asp-Asn-His-Arg-Ser-Phe-Ser-Asp-Lys-His-Gly-Leu-Thr-NH₂ | 4030645 | H-7450 |
| H-Gly-Gly-βNA · HBr | H-Gly-Gly-βNA · HBr | 4030649 | K-1560 |
| Glucagon (19-29) (human, rat, porcine) | H-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr-OH | 4030650 | H-2758 |
| GLP-1 (1-36) amide (human, bovine, guinea pig, mouse, rat) | H-His-Asp-Glu-Phe-Glu-Arg-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH₂ | 4030651 | H-6025 |
| (Deamino-Phe¹⁹,D-Ala²⁴,D-Pro²⁶-psi(CH₂NH)Phe²⁷)-GRP (19-27) (human, porcine, canine) | Deamino-Phe-His-Trp-Ala-Val-D-Ala-His-D-Pro-psi(CH₂NH)Phe-NH₂ | 4030653 | H-2756 |
| Galanin (1-13)-Substance P (5-11) amide | H-Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH₂ | 4030656 | H-1312 |
| Gastric Inhibitory Polypeptide (1-30) amide (porcine) | H-Tyr-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-Arg-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-NH₂ | 4030659 | H-3824 |
| H-Gly-Gly-OH | H-Gly-Gly-OH | 4030664 | G-2090 |
| H-Gly-Gly-NH₂ · HCl | H-Gly-Gly-NH₂ · HCl | 4030669 | G-2100 |
| Gluten Exorphin C | H-Tyr-Pro-Ile-Ser-Leu-OH | 4030675 | H-1412 |
| sn-Glycero-3-phosphocholine | sn-Glycero-3-phosphocholine | 4030680 | O-1590 |
| GRF (rat) | H-His-Ala-Asp-Ala-Ile-Phe-Thr-Ser-Ser-Tyr-Arg-Arg-Ile-Leu-Gly-Gln-Leu-Tyr-Ala-Arg-Lys-Leu-Leu-His-Glu-Ile-Met-Asn-Arg-Gln-Gln-Gly-Glu-Arg-Asn-Gln-Glu-Gln-Arg-Ser-Arg-Phe-Asn-OH | 4030687 | H-5440 |
| GRF (1-29) amide (human) | H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂ | 4030689 | H-3705 |
| Acetyl-(D-Arg²)-GRF (1-29) amide (human) | Ac-Tyr-D-Arg-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂ | 4030691 | H-5560 |
| (D-Lys³)-GHRP-6 | H-His-D-Trp-D-Lys-Trp-D-Phe-Lys-NH₂ | 4030692 | H-3108 |
| Guanylin (mouse, rat) | H-Pro-Asn-Thr-Cys-Glu-Ile-Cys-Ala-Tyr-Ala-Ala-Cys-Thr-Gly-Cys-OH (Disulfide bonds between Cys⁴ and Cys¹²/Cys⁷ and Cys¹⁵) | 4030694 | H-1342 |
| Tyr-Uroguanylin (mouse, rat) | H-Tyr-Thr-Asp-Glu-Cys-Glu-Leu-Cys-Ile-Asn-Val-Ala-Cys-Thr-Gly-Cys-OH (Disulfide bonds between Cys⁴ and Cys¹²/Cys⁷ and Cys¹⁵) | 4030695 | H-4148 |
| HSV-1-amide UL 26 Open Reading Frame (242-255) | H-His-Thr-Tyr-Leu-Gln-Ala-Ser-Glu-Lys-Phe-Lys-Met-Trp-Gly-NH₂ | 4030715 | M-2160 |
| DABCYL-γ-Abu-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS | DABCYL-γ-Abu-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS | 4030716 | M-1865 |
| HIV-1 gag Protein p24 (194-210) | H-Ala-Asn-Pro-Asp-Cys-Lys-Thr-Ile-Leu-Lys-Ala-Leu-Gly-Pro-Ala-Ala-Thr-OH | 4030725 | H-2986 |
| Tachyplesin I | H-Lys-Trp-Cys-Phe-Arg-Val-Cys-Tyr-Arg-Gly-Ile-Cys-Tyr-Arg-Arg-Cys-Arg-NH₂ (Disulfide bonds between Cys³ and Cys¹⁶/Cys⁷ and Cys¹²) | 4030734 | H-1202 |
| Ac-Thr-Ile-Nle-psi(CH₂NH)Nle-Gln-Arg-NH₂ | Ac-Thr-Ile-Nle-psi(CH₂NH)Nle-Gln-Arg-NH₂ | 4030744 | N-1465 |
| H-Arg-Val-Leu-psi(CH₂NH)Phe-Glu-Ala-Nle-NH₂ | H-Arg-Val-Leu-psi(CH₂NH)Phe-Glu-Ala-Nle-NH₂ | 4030746 | N-1270 |
| rec IL-2 (human) | 4030758 | H-7365 | |
| Indolicidin | H-Ile-Leu-Pro-Trp-Lys-Trp-Pro-Trp-Trp-Pro-Trp-Arg-Arg-NH₂ | 4030762 | H-1234 |
| HIV Protease Substrate VI | H-Arg-Val-Nle-p-nitro-Phe-Glu-Ala-Nle-NH₂ | 4030763 | H-1148 |
| LHRH (chicken) | Pyr-His-Trp-Ser-Tyr-Gly-Leu-Gln-Pro-Gly-NH₂ | 4030773 | H-3106 |
| LHRH II | Pyr-His-Trp-Ser-His-Gly-Trp-Tyr-Pro-Gly-NH₂ | 4030774 | H-4278 |
| Mast Cell Degranulating (MCD) Peptide | H-Ile-Lys-Cys-Asn-Cys-Lys-Arg-His-Val-Ile-Lys-Pro-His-Ile-Cys-Arg-Lys-Ile-Cys-Gly-Lys-Asn-NH₂ (Disulfide bonds between Cys³ and Cys¹⁵/Cys⁵ and Cys¹⁹) | 4030775 | H-7885 |
| IGF-I (24-41) | H-Tyr-Phe-Asn-Lys-Pro-Thr-Gly-Tyr-Gly-Ser-Ser-Ser-Arg-Arg-Ala-Pro-Gln-Thr-OH | 4030780 | H-3098 |
| H-Tyr-Ile-Gly-Ser-Arg-NH₂ | H-Tyr-Ile-Gly-Ser-Arg-NH₂ | 4030799 | H-2802 |
| H-Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg-OH | H-Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg-OH | 4030804 | H-2798 |
| IFN-γ Antagonist | H-Ala-Tyr-Cys(Acm)-Arg-Asp-Gly-Lys-Ile-Gly-Pro-Pro-Lys-Leu-Asp-Ile-Arg-Lys-Glu-Glu-Lys-Gln-Ile-OH | 4030819 | H-2722 |
| H-Leu-Trp-OH | H-Leu-Trp-OH | 4030830 | G-2605 |
| Mca-Arg-Pro-Lys-Pro-Tyr-Ala-Nva-Trp-Met-Lys(Dnp)-NH₂ | Mca-Arg-Pro-Lys-Pro-Tyr-Ala-Nva-Trp-Met-Lys(Dnp)-NH₂ | 4030841 | M-2105 |
| Margatoxin | H-Thr-Ile-Ile-Asn-Val-Lys-Cys-Thr-Ser-Pro-Lys-Gln-Cys-Leu-Pro-Pro-Cys-Lys-Ala-Gln-Phe-Gly-Gln-Ser-Ala-Gly-Ala-Lys-Cys-Met-Asn-Gly-Lys-Cys-Lys-Cys-Tyr-Pro-His-OH (Disulfide bonds between Cys⁷ and Cys²⁹/Cys¹³ and Cys³⁴/Cys¹⁷ and Cys³⁶) | 4030845 | H-2192 |
| MeOSuc-Gly-Leu-Phe-AMC | MeOSuc-Gly-Leu-Phe-AMC | 4030849 | I-1430 |
| β-MSH (human) | H-Ala-Glu-Lys-Lys-Asp-Glu-Gly-Pro-Tyr-Arg-Met-Glu-His-Phe-Arg-Trp-Gly-Ser-Pro-Pro-Lys-Asp-OH | 4030885 | H-1475 |
| (Phe²,Orn⁸)-Oxytocin | H-Cys-Phe-Ile-Gln-Asn-Cys-Pro-Orn-Gly-NH₂ (Disulfide bond) | 4030889 | H-3178 |
| (Ser⁴,Ile⁸)-Oxytocin | H-Cys-Tyr-Ile-Ser-Asn-Cys-Pro-Ile-Gly-NH₂ (Disulfide bond) | 4030890 | H-2520 |
| γ₃-MSH | H-Tyr-Val-Met-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-Gly-Arg-Arg-Asn-Gly-Ser-Ser-Ser-Ser-Gly-Val-Gly-Gly-Ala-Ala-Gln-OH | 4030911 | H-2922 |
| (β-Ala⁸)-Neurokinin A (4-10) | H-Asp-Ser-Phe-Val-β-Ala-Leu-Met-NH₂ | 4031080 | H-2786 |
| (Trp⁷,β-Ala⁸)-Neurokinin A (4-10) | H-Asp-Ser-Phe-Trp-β-Ala-Leu-Met-NH₂ | 4031081 | H-2788 |
| rec PDGF BB (human) | 4031083 | H-7530 | |
| PACAP-27 (human, mouse, ovine, porcine, rat) | H-His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-NH₂ | 4031084 | H-1172 |
| Pancreatic Polypeptide (rat) | H-Ala-Pro-Leu-Glu-Pro-Met-Tyr-Pro-Gly-Asp-Tyr-Ala-Thr-His-Glu-Gln-Arg-Ala-Gln-Tyr-Glu-Thr-Gln-Leu-Arg-Arg-Tyr-Ile-Asn-Thr-Leu-Thr-Arg-Pro-Arg-Tyr-NH₂ | 4031085 | H-6890 |
| Neuropeptide Y (3-36) (human, rat) | H-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH₂ | 4031095 | H-3326 |
| Neuropeptide Y (free acid) (human, rat) | H-Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-OH | 4031097 | H-3322 |
| (Leu³¹,Pro³⁴)-Neuropeptide Y (human, rat) | H-Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Leu-Thr-Arg-Pro-Arg-Tyr-NH₂ | 4031098 | H-3306 |
| Neuromedin U-8 (porcine) | H-Tyr-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH₂ | 4031099 | H-5505 |
| Neuromedin U-25 (porcine) | H-Phe-Lys-Val-Asp-Glu-Glu-Phe-Gln-Gly-Pro-Ile-Val-Ser-Gln-Asn-Arg-Arg-Tyr-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH₂ | 4031100 | H-5510 |
| n-Octylpolyoxyethylene | n-Octylpolyoxyethylene | 4031122 | P-1140 |
| p-Aminobenzamidine · 2 HCl | p-Aminobenzamidine · 2 HCl | 4031123 | Q-1960 |
| Pepstatin A | Isovaleryl-Val-Val-Sta-Ala-Sta-OH | 4031136 | N-1125 |
| Peptide YY (canine, mouse, porcine, rat) | H-Tyr-Pro-Ala-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Ser-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH₂ | 4031137 | H-4505 |
| Pyr-4MβNA | Pyr-4MβNA | 4031140 | J-1295 |
| PHI-27 (porcine) | H-His-Ala-Asp-Gly-Val-Phe-Thr-Ser-Asp-Phe-Ser-Arg-Leu-Leu-Gly-Gln-Leu-Ser-Ala-Lys-Lys-Tyr-Leu-Glu-Ser-Leu-Ile-NH₂ | 4031154 | H-3730 |
| PACAP-38 (6-38) (human, chicken, mouse, ovine, porcine, rat) | H-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH₂ | 4031158 | H-2734 |
| H-Pro-Thr-Glu-Phe-p-nitro-Phe-Arg-Leu-OH | H-Pro-Thr-Glu-Phe-p-nitro-Phe-Arg-Leu-OH | 4031188 | H-1002 |
| rec pTH-Related Protein (1-86) (human) | 4031190 | H-9815 | |
| pTH-Related Protein (1-40) (human, mouse, rat) | H-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Ile-Arg-Ala-Thr-Ser-OH | 4031191 | H-6810 |
| (Ile⁵,Trp²³,Tyr³⁶)-pTH-Related Protein (1-36) (human, mouse, rat) | H-Ala-Val-Ser-Glu-Ile-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Trp-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Tyr-OH | 4031192 | H-3924 |
| (Tyr³⁶)-pTH-Related Protein (1-36) (human, mouse, rat) | H-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Tyr-OH | 4031193 | H-3208 |
| Osteostatin (human) | H-Thr-Arg-Ser-Ala-Trp-Leu-Asp-Ser-Gly-Val-Thr-Gly-Ser-Gly-Leu-Glu-Gly-Asp-His-Leu-Ser-Asp-Thr-Ser-Thr-Thr-Ser-Leu-Glu-Leu-Asp-Ser-Arg-OH | 4031194 | H-3212 |
| pTH-Related Protein (1-34) amide (human, mouse, rat) | H-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-NH₂ | 4031196 | H-9095 |
| (Asn¹⁰,Leu¹¹,D-Trp¹²)-pTH-Related Protein (7-34) amide (human, mouse, rat) | H-Leu-Leu-His-Asn-Leu-D-Trp-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-NH₂ | 4031198 | H-3274 |
| pTH (28-48) (human) | H-Leu-Gln-Asp-Val-His-Asn-Phe-Val-Ala-Leu-Gly-Ala-Pro-Leu-Ala-Pro-Arg-Asp-Ala-Gly-Ser-OH | 4031201 | H-3875 |
| (Tyr³⁴)-pTH (7-34) amide (bovine) | H-Phe-Met-His-Asn-Leu-Gly-Lys-His-Leu-Ser-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Tyr-NH₂ | 4031202 | N-1110 |
| pTH (53-84) (human) | H-Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly-Glu-Ala-Asp-Lys-Ala-Asp-Val-Asn-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln-OH | 4031205 | H-4165 |
| (Tyr¹)-pTH (1-34) (human) | H-Tyr-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-OH | 4031209 | H-3092 |
| pTH (3-34) (bovine) | H-Ser-Glu-Ile-Gln-Phe-Met-His-Asn-Leu-Gly-Lys-His-Leu-Ser-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-OH | 4031211 | H-3088 |
| pTH (7-84) (human) | H-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-Val-Ala-Leu-Gly-Ala-Pro-Leu-Ala-Pro-Arg-Asp-Ala-Gly-Ser-Gln-Arg-Pro-Arg-Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly-Glu-Ala-Asp-Lys-Ala-Asp-Val-Asn-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln-OH | 4031213 | H-3084 |
| H-Trp-OH | H-Trp-OH | 4031215 | E-2500 |
| H-Trp-Val-OH | H-Trp-Val-OH | 4031217 | G-3380 |
| H-D-Ser(Bzl)-OH | H-D-Ser(Bzl)-OH | 4031223 | F-1297 |
| 1,4-Dithio-DL-threitol | Threo-1,4-dimercapto-2,3-butanediol | 4031235 | Q-1225 |
| N-Ethyl-N’-(3-dimethylaminopropyl)-carbodiimide · HCl | 4031236 | Q-1955 | |
| Z-OSu | Z-OSu | 4031237 | Q-1160 |
| Merrifield resin (100-200 mesh, 1.10-1.45 mmol/g) | Merrifield resin (100-200 mesh, 1.10-1.45 mmol/g) | 4031246 | D-2120 |
| PAL resin (200-400 mesh, 0.2-0.5 mmol/g) | 4-Alkoxy-2,6-dimethoxybenzylamine resin | 4031247 | D-2125 |
| Secretin (human) | H-His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Glu-Leu-Ser-Arg-Leu-Arg-Glu-Gly-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val-NH₂ | 4031250 | H-3022 |
| Secretin (5-27) (porcine) | H-Thr-Phe-Thr-Ser-Glu-Leu-Ser-Arg-Leu-Arg-Asp-Ser-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val-NH₂ | 4031252 | H-4940 |
| Sarafotoxin C | H-Cys-Thr-Cys-Asn-Asp-Met-Thr-Asp-Glu-Glu-Cys-Leu-Asn-Phe-Cys-His-Gln-Asp-Val-Ile-Trp-OH (Disulfide bonds between Cys¹ and Cys¹⁵/Cys³ and Cys¹¹) | 4031255 | H-7985 |
| Somatostatin-28 | H-Ser-Ala-Asn-Ser-Asn-Pro-Ala-Met-Ala-Pro-Arg-Glu-Arg-Lys-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys-OH (Disulfide bond) | 4031270 | H-4955 |
| TRAP-6 amide | H-Ser-Phe-Leu-Leu-Arg-Asn-NH₂ | 4031274 | H-2936 |
| TRAP-14 | H-Ser-Phe-Leu-Leu-Arg-Asn-Pro-Asn-Asp-Lys-Tyr-Glu-Pro-Phe-OH | 4031275 | H-8105 |
| (D-Trp⁸)-Somatostatin-14 | H-Ala-Gly-Cys-Lys-Asn-Phe-Phe-D-Trp-Lys-Thr-Phe-Thr-Ser-Cys-OH (Disulfide bond) | 4031277 | H-3198 |
| (D-Lys(nicotinoyl)¹,β-(3-pyridyl)-Ala³,3,4-dichloro-D-Phe⁵,Asn⁶,D-Trp⁷·⁹,Nle¹¹)-Substance P | H-D-Lys(nicotinoyl)-Pro-β-(3-pyridyl)-Ala-Pro-3,4-dichloro-D-Phe-Asn-D-Trp-Phe-D-Trp-Leu-Nle-NH₂ | 4031291 | H-8310 |
| Suc-Ala-Phe-Lys-AMC | Suc-Ala-Phe-Lys-AMC | 4031296 | I-1330 |
| Tertiapin | H-Ala-Leu-Cys-Asn-Cys-Asn-Arg-Ile-Ile-Ile-Pro-His-Met-Cys-Trp-Lys-Lys-Cys-Gly-Lys-Lys-NH₂ (Disulfide bonds between Cys³ and Cys¹⁴/Cys⁵ and Cys¹⁸) | 4031297 | N-1745 |
| H-D-Thr-OH | H-D-Thr-OH | 4031299 | F-2125 |
| rec TNF-α (human) | 4031300 | H-9555 | |
| Mca-(endo-1a-Dap(Dnp))-TNF-α (-5 to +6) amide (human) | Mca-Pro-Leu-Ala-Gln-Ala-Val-Dap(Dnp)-Arg-Ser-Ser-Ser-Arg-NH₂ | 4031302 | M-2255 |
| Thrombospondin-1 (1016-1023) (human, bovine, mouse) | H-Arg-Phe-Tyr-Val-Val-Met-Trp-Lys-OH | 4031305 | H-1414 |
| TGF α (1-50) (rat) | H-Val-Val-Ser-His-Phe-Asn-Lys-Cys-Pro-Asp-Ser-His-Thr-Gln-Tyr-Cys-Phe-His-Gly-Thr-Cys-Arg-Phe-Leu-Val-Gln-Glu-Glu-Lys-Pro-Ala-Cys-Val-Cys-His-Ser-Gly-Tyr-Val-Gly-Val-Arg-Cys-Glu-His-Ala-Asp-Leu-Leu-Ala-OH (Disulfide bonds between Cys⁸ and Cys²¹/Cys¹⁶ and Cys³²/Cys³⁴ and Cys⁴³) | 4031309 | H-5545 |
| Toxic Shock Syndrome Toxin-1 (TSST-1) (58-78) | H-Lys-Gly-Glu-Lys-Val-Asp-Leu-Asn-Thr-Lys-Arg-Thr-Lys-Lys-Ser-Gln-His-Thr-Ser-Glu-Gly-OH | 4031315 | H-2522 |
| H-Tyr-OH | H-Tyr-OH | 4031323 | E-2515 |
| Urocortin (rat) | H-Asp-Asp-Pro-Pro-Leu-Ser-Ile-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Thr-Leu-Leu-Glu-Leu-Ala-Arg-Thr-Gln-Ser-Gln-Arg-Glu-Arg-Ala-Glu-Gln-Asn-Arg-Ile-Ile-Phe-Asp-Ser-Val-NH₂ | 4031326 | H-3362 |
| H-Val-AMC | H-Val-AMC | 4031332 | I-1385 |
| (Arg⁸,des-Gly-NH₂⁹)-Vasopressin | H-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-OH (Disulfide bond) | 4031337 | H-3184 |
| (d(CH₂)₅¹,Tyr(Me)²,Thr⁴,Orn⁸,des-Gly-NH₂⁹)-Vasotocin | β-Mercapto-β,β-cyclopentamethylene-propionyl-Tyr(Me)-Ile-Thr-Asn-Cys-Pro-Orn-OH (Disulfide bond) | 4031339 | H-2908 |
| (Deamino-Cys¹,Val⁴,D-Arg⁸)-Vasopressin | 3-Mercaptopropionyl-Tyr-Phe-Val-Asn-Cys-Pro-D-Arg-Gly-NH₂ (Disulfide bond) | 4031341 | H-3176 |
| (Phenylac¹,D-Tyr(Et)²,Lys⁶,Arg⁸,des-Gly⁹)-Vasopressin | Phenylac-D-Tyr(Et)-Phe-Gln-Asn-Lys-Pro-Arg-NH₂ | 4031343 | H-3186 |
| (d(CH₂)₅¹,D-Tyr(Et)²,Val⁴,Arg⁸,des-Gly⁹)-Vasopressin | β-Mercapto-β,β-cyclopentamethylene-propionyl-D-Tyr(Et)-Phe-Val-Asn-Cys-Pro-Arg-NH₂ (Disulfide bond) | 4031348 | H-3192 |
| (d(CH₂)₅¹,Tyr(Me)²,Arg⁸)-Vasopressin | β-Mercapto-β,β-cyclopentamethylene-propionyl-Tyr(Me)-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH₂ (Disulfide bond) | 4031349 | H-5350 |
| VIP Antagonist | H-Lys-Pro-Arg-Arg-Pro-Tyr-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH₂ | 4031352 | H-9935 |
| Xenin 25 | H-Met-Leu-Thr-Lys-Phe-Glu-Thr-Lys-Ser-Ala-Arg-Val-Lys-Gly-Leu-Ser-Phe-His-Pro-Lys-Arg-Pro-Trp-Ile-Leu-OH | 4031355 | H-8860 |
| PyBOP | Benzotriazol-1-yloxy-tripyrrolidino-phosphonium hexafluorophosphate | 4031604 | Q-2715 |
| HATU | O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate | 4032172 | Q-2780 |
| Somatostatin-14 | H-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys-OH (Disulfide bond) | 4033009 | H-1490 |
| Calcitonin (salmon I) | H-Cys-Ser-Asn-Leu-Ser-Thr-Cys-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asn-Thr-Gly-Ser-Gly-Thr-Pro-NH₂ (Disulfide bond) | 4033011 | H-2260 |
| Delta-Sleep Inducing Peptide | H-Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu-OH | 4033012 | H-2540 |
| LHRH | Pyr-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH₂ | 4033013 | H-4005 |
| (Des-Gly¹⁰,D-Leu⁶,Pro-NHEt⁹)-LHRH | Pyr-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt | 4033014 | H-4060 |
| (D-Trp⁶)-LHRH | Pyr-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH₂ | 4033016 | H-4075 |
| Ac-Lys(Ac)-D-Ala-D-Ala-OH | Ac-Lys(Ac)-D-Ala-D-Ala-OH | 4033018 | M-1325 |
| (Des-Gly¹⁰,D-His²,D-Trp⁶,Pro-NHEt⁹)-LHRH | Pyr-D-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-NHEt | 4033056 | H-4986 |
| H-Asp(Phe-OH)-OH | H-Asp(Phe-OH)-OH | 4033064 | G-4750 |
| Ghrelin (mouse, rat) | H-Gly-Ser-Ser(octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg-OH | 4033076 | H-4862 |
| (2-{Ethyl-[4-(4-nitro-phenylazo)-phenyl]-amino}-ethoxy)-acetic acid-4-nitro-phenyl ester | (2-{Ethyl-[4-(4-nitro-phenylazo)-phenyl]-amino}-ethoxy)-acetic acid-4-nitro-phenyl ester | 4033116 | Q-2610 |
| Prion Protein (106-126) (human) (scrambled) | H-Asn-Gly-Ala-Lys-Ala-Leu-Met-Gly-Gly-His-Gly-Ala-Thr-Lys-Val-Met-Val-Gly-Ala-Ala-Ala-OH | 4033124 | H-4882 |
| Ovalbumin (257-264) (chicken) | H-Ser-Ile-Ile-Asn-Phe-Glu-Lys-Leu-OH | 4033142 | H-4866 |
| (D-Lys¹⁶)-ACTH (1-24) (human, bovine, rat) | H-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-D-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-OH | 4033149 | H-4996 |
| Mca-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys(Dnp)-D-Arg-NH₂ | Mca-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys(Dnp)-D-Arg-NH₂ | 4033156 | M-2455 |
| Galanin-Like Peptide (porcine) | H-Ala-Pro-Val-His-Arg-Gly-Arg-Gly-Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Val-Leu-His-Pro-Pro-Ser-Arg-Ala-Glu-Gly-Gly-Gly-Lys-Gly-Lys-Thr-Ala-Leu-Gly-Ile-Leu-Asp-Leu-Trp-Lys-Ala-Ile-Asp-Gly-Leu-Pro-Tyr-Pro-Gln-Ser-Gln-Leu-Ala-Ser-OH | 4033157 | H-4982 |
| Z-Ala-Ala-Asn-AMC | Z-Ala-Ala-Asn-AMC | 4033201 | I-1865 |
| PAR-2 (1-6) (human) | H-Ser-Leu-Ile-Gly-Lys-Val-OH | 4033271 | H-5042 |
| H-Met-Gly-Pro-AMC · HCl | H-Met-Gly-Pro-AMC · HCl | 4033312 | I-1900 |
| (Des-Gly¹⁰,tBu-D-Gly⁶,Pro-NHEt⁹)-LHRH | Pyr-His-Trp-Ser-Tyr-tBu-D-Gly-Leu-Arg-Pro-NHEt | 4033341 | H-5936 |
| Angiotensin I (1-9) | H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-OH | 4033395 | H-5038 |
| Ac-Ala-Leu-Cys-Asp-Asp-Pro-Arg-Val-Asp-Arg-Trp-Tyr-Cys-Gln-Phe-Val-Glu-Gly-NH₂ | Ac-Ala-Leu-Cys-Asp-Asp-Pro-Arg-Val-Asp-Arg-Trp-Tyr-Cys-Gln-Phe-Val-Glu-Gly-NH₂ (Disulfide bond) | 4033397 | H-4902 |
| H-D-Glu(Trp-OH)-OH | H-D-Glu(Trp-OH)-OH | 4033407 | G-4745 |
| PAR-2 (1-6) amide (mouse, rat) | H-Ser-Leu-Ile-Gly-Arg-Leu-NH₂ | 4033483 | H-5078 |
| Palmitoyl-Cys((RS)-2,3-di(palmitoyloxy)-propyl)-Ser-Lys-Lys-Lys-Lys-OH | Palmitoyl-Cys((RS)-2,3-di(palmitoyloxy)-propyl)-Ser-Lys-Lys-Lys-Lys-OH | 4033506 | H-5656 |
| TIP-39 | H-Ser-Leu-Ala-Leu-Ala-Asp-Asp-Ala-Ala-Phe-Arg-Glu-Arg-Ala-Arg-Leu-Leu-Ala-Ala-Leu-Glu-Arg-Arg-His-Trp-Leu-Asn-Ser-Tyr-Met-His-Lys-Leu-Leu-Val-Leu-Asp-Ala-Pro-OH | 4033516 | H-4878 |
| Dendroaspis Natriuretic Peptide | H-Glu-Val-Lys-Tyr-Asp-Pro-Cys-Phe-Gly-His-Lys-Ile-Asp-Arg-Ile-Asn-His-Val-Ser-Asn-Leu-Gly-Cys-Pro-Ser-Leu-Arg-Asp-Pro-Arg-Pro-Asn-Ala-Pro-Ser-Thr-Ser-Ala-OH (Disulfide bond) | 4033517 | H-4904 |
| Arg-Glu(EDANS)-(Asn⁶⁷⁰,Leu⁶⁷¹)-Amyloid β/A4 Protein Precursor₇₇₀ (668-675)-Lys(DABCYL)-Arg | H-Arg-Glu(EDANS)-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Lys(DABCYL)-Arg-OH | 4033536 | M-2470 |
| SAMS Peptide | H-His-Met-Arg-Ser-Ala-Met-Ser-Gly-Leu-His-Leu-Val-Lys-Arg-Arg-OH | 4033602 | H-5938 |
| (Thr¹)-PAR-1 (1-5) amide (human) | H-Thr-Phe-Leu-Leu-Arg-NH₂ | 4033683 | H-5848 |
| Mca-Amyloid β/A4 Protein Precursor₇₇₀ (667-676)-Lys(Dnp)-Arg-Arg amide | Mca-Ser-Glu-Val-Lys-Met-Asp-Ala-Glu-Phe-Arg-Lys(Dnp)-Arg-Arg-NH₂ | 4033759 | M-2460 |
| (Des-Gly¹⁰,Leu⁶,Pro-NHEt⁹)-LHRH | Pyr-His-Trp-Ser-Tyr-Leu-Leu-Arg-Pro-NHEt | 4033802 | H-6402 |
| (Des-Gly¹⁰,D-Ser⁴,D-Leu⁶,Pro-NHEt⁹)-LHRH | Pyr-His-Trp-D-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt | 4033803 | H-6168 |
| RAD16-I | Ac-Arg-Ala-Asp-Ala-Arg-Ala-Asp-Ala-Arg-Ala-Asp-Ala-Arg-Ala-Asp-Ala-NH₂ | 4033805 | |
| Fmoc-Leu-Ser(Psi(Me,Me)pro)-OH | Fmoc-Leu-Ser(Psi(Me,Me)pro)-OH | 4033837 | B-3540 |
| Fmoc-Leu-Thr(Psi(Me,Me)pro)-OH | Fmoc-Leu-Thr(Psi(Me,Me)pro)-OH | 4033838 | B-3545 |
| Fmoc-D-allo-Thr(tBu)-OH | Fmoc-D-allo-Thr(tBu)-OH | 4033844 | B-3700 |
| H-Tyr(SO₃H)-OH | H-Tyr(SO₃H)-OH | 4033889 | E-3645 |
| NFAT Inhibitor | H-Met-Ala-Gly-Pro-His-Pro-Val-Ile-Val-Ile-Thr-Gly-Pro-His-Glu-Glu-OH | 4034010 | H-4874 |
| Pyr-Pro-Arg-pNA | Pyr-Pro-Arg-pNA | 4034068 | L-2145 |
| Amyloid Bri Protein Precursor₂₇₇ (89-106) | H-Cys-Gly-Ile-Lys-Tyr-Ile-Lys-Asp-Asp-Val-Ile-Leu-Asn-Glu-Pro-Ser-Ala-Asp-OH | 4034207 | H-5048 |
| Amyloid β-Protein (17-40) | H-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH | 4034233 | H-7532 |
| Ovalbumin (323-339) (chicken, japanese quail) | H-Ile-Ser-Gln-Ala-Val-His-Ala-Ala-His-Ala-Glu-Ile-Asn-Glu-Ala-Gly-Arg-OH | 4034255 | H-5532 |
| (Deamino-Cys¹¹,D-2-Nal¹⁴,Cys¹⁸)-β-MSH (11-22) amide | 3-Mercaptopropionyl-Glu-His-D-2-Nal-Arg-Trp-Gly-Cys-Pro-Pro-Lys-Asp-NH₂ (Disulfide bond) | 4034459 | H-4942 |
| Adrenomedullin (13-52) (human) | H-Ser-Phe-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH₂ (Disulfide bond) | 4034489 | H-4936 |
| Proadrenomedullin (1-20) (human) | H-Ala-Arg-Leu-Asp-Val-Ala-Ser-Glu-Phe-Arg-Lys-Lys-Trp-Asn-Lys-Trp-Ala-Leu-Ser-Arg-NH₂ | 4034490 | H-4916 |
| OM99-2 | H-Glu-Val-Asn-[(2R,4S,5S)-5-amino-4-hydroxy-2,7-dimethyl-octanoyl]-Ala-Glu-Phe-OH | 4034503 | H-5108 |
| BQ-610 | Azepane-1-carbonyl-Leu-D-Trp(For)-D-Trp-OH | 4034542 | H-4914 |
| Acetyl-(Asn³⁰,Tyr³²)-Calcitonin (8-32) (salmon I) | Ac-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asn-Thr-Gly-Ser-Asn-Thr-Tyr-NH₂ | 4034543 | H-4922 |
| α-CGRP (8-37) (mouse, rat) | H-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH₂ | 4034544 | H-4924 |
| (Tyr⁰)-C-Peptide (human) | H-Tyr-Glu-Ala-Glu-Asp-Leu-Gln-Val-Gly-Gln-Val-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Ser-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ser-Leu-Gln-OH | 4034546 | H-4934 |
| (Asp⁷⁶)-pTH (39-84) (human) | H-Ala-Pro-Leu-Ala-Pro-Arg-Asp-Ala-Gly-Ser-Gln-Arg-Pro-Arg-Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly-Glu-Ala-Asp-Lys-Ala-Asp-Val-Asp-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln-OH | 4034547 | H-4926 |
| BIBP3226 | Diphenylacetyl-D-Arg-4-hydroxybenzylamide | 4034548 | E-3620 |
| Histone H3 (1-20) | H-Ala-Arg-Thr-Lys-Gln-Thr-Ala-Arg-Lys-Ser-Thr-Gly-Gly-Lys-Ala-Pro-Arg-Lys-Gln-Leu-OH | 4034554 | H-7796 |
| Biotinyl-Glucagon (1-29) (human, rat, porcine) | Biotinyl-His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr-OH | 4034566 | H-5676 |
| GAP 26 | H-Val-Cys-Tyr-Asp-Lys-Ser-Phe-Pro-Ile-Ser-His-Val-Arg-OH | 4034647 | H-7588 |
| Gastric Inhibitory Polypeptide (3-42) (human) | H-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln-OH | 4034653 | H-6614 |
| β-Defensin 2 (human) | H-Gly-Ile-Gly-Asp-Pro-Val-Thr-Cys-Leu-Lys-Ser-Gly-Ala-Ile-Cys-His-Pro-Val-Phe-Cys-Pro-Arg-Arg-Tyr-Lys-Gln-Ile-Gly-Thr-Cys-Gly-Leu-Pro-Gly-Thr-Lys-Cys-Cys-Lys-Lys-Pro-OH (Disulfide bonds, air oxidized) | 4034693 | H-8256 |
| (Ala¹)-PAR-4 (1-6) (mouse) | H-Ala-Tyr-Pro-Gly-Lys-Phe-OH | 4034706 | H-6134 |
| (Des-Pyr¹,Des-Gly¹⁰,D-Leu⁶,Pro-NHEt⁹)-LHRH | H-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt | 4034726 | H-6166 |
| Mca-(Asn⁶⁷⁰,Leu⁶⁷¹)-Amyloid β/A4 Protein Precursor₇₇₀ (667-675)-Lys(Dnp) amide | Mca-Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Lys(Dnp)-NH₂ | 4034744 | M-2485 |
| Z-Ile-Glu(OMe)-Thr-DL-Asp(OMe)-fluoromethylketone | Z-Ile-Glu(OMe)-Thr-DL-Asp(OMe)-fluoromethylketone | 4034771 | N-1830 |
| DYKDDDDK Epitope Peptide | H-Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys-OH | 4034775 | H-6284 |
| (D-Phe¹¹,His¹²)-Sauvagine (11-40) | H-D-Phe-His-Leu-Leu-Arg-Lys-Met-Ile-Glu-Ile-Glu-Lys-Gln-Glu-Lys-Glu-Lys-Gln-Gln-Ala-Ala-Asn-Asn-Arg-Leu-Leu-Leu-Asp-Thr-Ile-NH₂ | 4034828 | H-5844 |
| ACTH (1-39) (mouse, rat) | H-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Val-Ala-Glu-Asn-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe-OH | 4034845 | H-4998 |
| Ac-Val-Asp-Val-Ala-Asp-aldehyde (pseudo acid) | Ac-Val-Asp-Val-Ala-Asp-aldehyde (pseudo acid) | 4034851 | N-1790 |
| CART (62-76) (human, rat) | H-Tyr-Gly-Gln-Val-Pro-Met-Cys-Asp-Ala-Gly-Glu-Gln-Cys-Ala-Val-OH | 4034852 | H-5098 |
| GLP-1 (7-37) (human, bovine, guinea pig, mouse, rat) | H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly-OH | 4034865 | H-5102 |
| Abz-Ala-Phe-Ala-Phe-Asp-Val-Phe-3-nitro-Tyr-Asp-OH | Abz-Ala-Phe-Ala-Phe-Asp-Val-Phe-3-nitro-Tyr-Asp-OH | 4035170 | M-2475 |
| GLP-2 (rat) | H-His-Ala-Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Thr-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp-OH | 4034866 | H-5002 |
| (Gly²²)-Amyloid β-Protein (1-40) | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gly-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH | 4035372 | H-6694 |
| H-Tyr-Tyr-Tyr-Tyr-Tyr-Tyr-OH | H-Tyr-Tyr-Tyr-Tyr-Tyr-Tyr-OH | 4035437 | H-7608 |
| (Des-Gly¹⁰,D-His(Bzl)⁶,Pro-NHEt⁹)-LHRH | Pyr-His-Trp-Ser-Tyr-D-His(Bzl)-Leu-Arg-Pro-NHEt | 4035442 | H-9210 |
| (Ala¹)-PAR-4 (1-6) amide (mouse) | H-Ala-Tyr-Pro-Gly-Lys-Phe-NH₂ | 4035529 | H-6046 |
| Cyclo(-Ala-Gln) | Cyclo(-Ala-Gln) | 4035535 | G-4770 |
| Cyclo(-Ala-Glu) | Cyclo(-Ala-Glu) | 4035536 | G-4775 |
| PAR-4 (1-6) amide (mouse) | H-Gly-Tyr-Pro-Gly-Lys-Phe-NH₂ | 4035649 | H-6054 |
| Suc-Leu-Leu-Val-Tyr-pNA | Suc-Leu-Leu-Val-Tyr-pNA | 4035739 | L-2130 |
| Amyloid β-Protein (1-42) (mouse, rat) | H-Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | 4035885 | H-5966 |
| C-Peptide 2 (rat) | H-Glu-Val-Glu-Asp-Pro-Gln-Val-Ala-Gln-Leu-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Asp-Leu-Gln-Thr-Leu-Ala-Leu-Glu-Val-Ala-Arg-Gln-OH | 4035984 | H-6122 |
| H-Pro-Gly-Pro-OH | H-Pro-Gly-Pro-OH | 4035991 | H-7284 |
| H-Gly-Pro-Gly-NH₂ · HCl | H-Gly-Pro-Gly-NH₂ · HCl | 4035999 | H-9865 |
| Cholecystokinin-33 (human) | H-Lys-Ala-Pro-Ser-Gly-Arg-Met-Ser-Ile-Val-Lys-Asn-Leu-Gln-Asn-Leu-Asp-Pro-Ser-His-Arg-Ile-Ser-Asp-Arg-Asp-Tyr(SO₃H)-Met-Gly-Trp-Met-Asp-Phe-NH₂ | 4036693 | H-5476 |
| Z-Phe-Leu-Glu-pNA | Z-Phe-Leu-Glu-pNA | 4037068 | L-2135 |
| Prepro-Atrial Natriuretic Factor (26-55) (human) | H-Asn-Pro-Met-Tyr-Asn-Ala-Val-Ser-Asn-Ala-Asp-Leu-Met-Asp-Phe-Lys-Asn-Leu-Leu-Asp-His-Leu-Glu-Glu-Lys-Met-Pro-Leu-Glu-Asp-OH | 4037110 | H-5472 |
| Prepro-Atrial Natriuretic Factor (56-92) (human) | H-Glu-Val-Val-Pro-Pro-Gln-Val-Leu-Ser-Glu-Pro-Asn-Glu-Glu-Ala-Gly-Ala-Ala-Leu-Ser-Pro-Leu-Pro-Glu-Val-Pro-Pro-Trp-Thr-Gly-Glu-Val-Ser-Pro-Ala-Gln-Arg-OH | 4037111 | H-5474 |
| PACAP-38 (16-38) (human, chicken, mouse, ovine, porcine, rat) | H-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH₂ | 4037132 | H-5484 |
| pTH-Related Protein (1-37) (human, mouse, rat) | H-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Ile-Arg-OH | 4037178 | H-5494 |
| Secretin (rat) | H-His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Glu-Leu-Ser-Arg-Leu-Gln-Asp-Ser-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val-NH₂ | 4037181 | H-5498 |
| Calcitonin (8-32) (salmon I) | H-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asn-Thr-Gly-Ser-Gly-Thr-Pro-NH₂ | 4037182 | H-5502 |
| (Tyr²⁷)-α-CGRP (27-37) (canine, mouse, rat) | H-Tyr-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH₂ | 4037183 | H-5504 |
| Boc-Gln-Ala-Arg-pNA | Boc-Gln-Ala-Arg-pNA | 4037278 | L-2140 |
| (D-Leu⁶)-LHRH (1-8) (free acid) | Pyr-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-OH | 4037360 | H-6398 |
| Z-Leu-Leu-Glu-AMC | Z-Leu-Leu-Glu-AMC | 4037381 | I-1945 |
| Fmoc-L-thiazolidine-4-carboxylic acid | Fmoc-L-thiazolidine-4-carboxylic acid | 4037410 | B-4015 |
| Amyloid β-Protein (33-42) | H-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | 4037474 | H-5572 |
| Cortistatin-17 (human) | H-Asp-Arg-Met-Pro-Cys-Arg-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Ser-Ser-Cys-Lys-OH (Disulfide bond) | 4037520 | H-5536 |
| Neuromedin U-25 (human) | H-Phe-Arg-Val-Asp-Glu-Glu-Phe-Gln-Ser-Pro-Phe-Ala-Ser-Gln-Ser-Arg-Gly-Tyr-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH₂ | 4037521 | H-5538 |
| Kisspeptin-54 (27-54) (human) | H-Ile-Pro-Ala-Pro-Gln-Gly-Ala-Val-Leu-Val-Gln-Arg-Glu-Lys-Asp-Leu-Pro-Asn-Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH₂ | 4037533 | H-5542 |
| Kisspeptin-13 (4-13) (human) | H-Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH₂ | 4037534 | H-5544 |
| Stresscopin (human) | H-Thr-Lys-Phe-Thr-Leu-Ser-Leu-Asp-Val-Pro-Thr-Asn-Ile-Met-Asn-Leu-Leu-Phe-Asn-Ile-Ala-Lys-Ala-Lys-Asn-Leu-Arg-Ala-Gln-Ala-Ala-Ala-Asn-Ala-His-Leu-Met-Ala-Gln-Ile-NH₂ | 4037535 | H-5546 |
| GLP-1 (1-37) (human, bovine, guinea pig, mouse, rat) | H-His-Asp-Glu-Phe-Glu-Arg-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly-OH | 4037542 | H-5552 |
| H-Thr(tBu)-2-chlorotrityl resin (200-400 mesh, 0.50-0.90 mmol/g) | H-Thr(tBu)-2-chlorotrityl resin (200-400 mesh, 0.50-0.90 mmol/g) | 4037580 | D-2670 |
| Dansyl-Gly-Cys-Val-Leu-Ser-OH | Dansyl-Gly-Cys-Val-Leu-Ser-OH | 4037632 | M-2605 |
| (Pyr¹¹)-Amyloid β-Protein (11-40) | Pyr-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH | 4037661 | H-6382 |
| H-Arg-Glu-Asp-Val-OH | H-Arg-Glu-Asp-Val-OH | 4037766 | H-7578 |
| ent-Amyloid β-Protein (1-42) | H-D-Asp-D-Ala-D-Glu-D-Phe-D-Arg-D-His-D-Asp-D-Ser-Gly-D-Tyr-D-Glu-D-Val-D-His-D-His-D-Gln-D-Lys-D-Leu-D-Val-D-Phe-D-Phe-D-Ala-D-Glu-D-Asp-D-Val-Gly-D-Ser-D-Asn-D-Lys-Gly-D-Ala-D-Ile-D-Ile-Gly-D-Leu-D-Met-D-Val-Gly-Gly-D-Val-D-Val-D-Ile-D-Ala-OH | 4037836 | H-5566 |
| Fmoc-Ile-Ser(Psi(Me,Me)pro)-OH | Fmoc-Ile-Ser(Psi(Me,Me)pro)-OH | 4037908 | B-3910 |
| Myristoyl-(Lys¹²·²⁷·²⁸)-VIP-Gly-Gly-Thr (free acid) | Myristoyl-His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Lys-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Lys-Lys-Gly-Gly-Thr-OH | 4037992 | H-7292 |
| 3-Maleimido-propionic acid | 3-Maleimido-propionic acid | 4038126 | Q-2620 |
| H-Val-Pro-Pro-OH | H-Val-Pro-Pro-OH | 4038134 | H-4634 |
| TRH | Pyr-His-Pro-NH₂ | 4038214 | H-4915 |
| Humanin (human) | H-Met-Ala-Pro-Arg-Gly-Phe-Ser-Cys-Leu-Leu-Leu-Leu-Thr-Ser-Glu-Ile-Asp-Leu-Pro-Val-Lys-Arg-Arg-Ala-OH | 4038276 | H-5574 |
| (Gly¹⁴)-Humanin (human) | H-Met-Ala-Pro-Arg-Gly-Phe-Ser-Cys-Leu-Leu-Leu-Leu-Thr-Gly-Glu-Ile-Asp-Leu-Pro-Val-Lys-Arg-Arg-Ala-OH | 4038277 | H-5576 |
| rec Leptin (human) | 4038283 | H-5578 | |
| rec Leptin (mouse) | 4038284 | H-5582 | |
| rec β-Defensin 2 (human) | 4038287 | H-5586 | |
| rec Brain-Derived Neurotrophic Factor (human) | 4038290 | H-5594 | |
| Fmoc-Tyr(PO(OBzl)OH)-OH | Fmoc-Tyr(PO(OBzl)OH)-OH | 4038299 | B-3565 |
| Apelin-12 (human, bovine, mouse, rat) | H-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe-OH | 4038636 | H-5806 |
| Neuropeptide VF (124-131) (human) | H-Val-Pro-Asn-Leu-Pro-Gln-Arg-Phe-NH₂ | 4038666 | H-5608 |
| Biotinyl-Pancreatic Polypeptide (human) | Biotinyl-Ala-Pro-Leu-Glu-Pro-Val-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Gln-Tyr-Ala-Ala-Asp-Leu-Arg-Arg-Tyr-Ile-Asn-Met-Leu-Thr-Arg-Pro-Arg-Tyr-NH₂ | 4038714 | H-7622 |
| Biotinyl-Amyloid β-Protein (1-42) | Biotinyl-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | 4038795 | H-5642 |
| Boc-AOAc-OH | Boc-AOAc-OH | 4038799 | A-4605 |
| Human CMV pp65 (495-503) | H-Asn-Leu-Val-Pro-Met-Val-Ala-Thr-Val-OH | 4039108 | H-6218 |
| (D-Phe⁵,Cys⁶·¹¹,N-Me-D-Trp⁸)-Somatostatin-14 (5-12) amide | H-D-Phe-Cys-Phe-N-Me-D-Trp-Lys-Thr-Cys-Thr-NH₂ (Disulfide bond) | 4039201 | H-5648 |
| Urocortin III (human) | H-Phe-Thr-Leu-Ser-Leu-Asp-Val-Pro-Thr-Asn-Ile-Met-Asn-Leu-Leu-Phe-Asn-Ile-Ala-Lys-Ala-Lys-Asn-Leu-Arg-Ala-Gln-Ala-Ala-Ala-Asn-Ala-His-Leu-Met-Ala-Gln-Ile-NH₂ | 4039202 | H-5634 |
| Hemokinin 1 (mouse, rat) | H-Arg-Ser-Arg-Thr-Arg-Gln-Phe-Tyr-Gly-Leu-Met-NH₂ | 4039262 | H-5952 |
| (Des-Gly¹⁰,D-Ser(tBu)⁶,Pro-NHNH₂⁹)-LHRH | Pyr-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-NHNH₂ | 4039400 | H-5762 |
| Biotinyl-(Arg⁸)-Vasopressin | Biotinyl-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH₂ (Disulfide bond) | 4039551 | H-5714 |
| Relaxin H3 (human) | (H-Asp-Val-Leu-Ala-Gly-Leu-Ser-Ser-Ser-Cys-Cys-Lys-Trp-Gly-Cys-Ser-Lys-Ser-Glu-Ile-Ser-Ser-Leu-Cys-OH)A(H-Arg-Ala-Ala-Pro-Tyr-Gly-Val-Arg-Leu-Cys-Gly-Arg-Glu-Phe-Ile-Arg-Ala-Val-Ile-Phe-Thr-Cys-Gly-Gly-Ser-Arg-Trp-OH)B (Disulfide bonds between Cys¹⁰A and Cys¹⁵A/Cys¹¹A and Cys¹⁰B/Cys²⁴A and Cys²²B) | 4039569 | H-7322 |
| Pheromone Biosynthesis Activating Neuropeptide (Helicoverpa assulta, Heliothis zea) | H-Leu-Ser-Asp-Asp-Met-Pro-Ala-Thr-Pro-Ala-Asp-Gln-Glu-Met-Tyr-Arg-Gln-Asp-Pro-Glu-Gln-Ile-Asp-Ser-Arg-Thr-Lys-Tyr-Phe-Ser-Pro-Arg-Leu-NH₂ | 4039571 | H-5774 |
| Z-Asn-Gly-OH | Z-Asn-Gly-OH | 4039578 | C-4175 |
| GLP-2 (1-33) (human) | H-His-Ala-Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Ala-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp-OH | 4039611 | H-5662 |
| (D-Trp⁶)-LHRH | Pyr-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH₂ | 4039648 | H-6150 |
| Cetrorelix | Ac-D-2-Nal-4-chloro-D-Phe-β-(3-pyridyl)-D-Ala-Ser-Tyr-D-Cit-Leu-Arg-Pro-D-Ala-NH₂ | 4039760 | H-6682 |
| Acetyl-(Nle⁴,Asp⁵,D-Phe⁷,Lys¹⁰)-cyclo-α-MSH (4-10) amide | Ac-Nle-cyclo(-Asp-His-D-Phe-Arg-Trp-Lys-NH₂) | 4039778 | H-3902 |
| Ac-Trp-NHMe | Ac-Trp-NHMe | 4039807 | E-3675 |
| Amylin (1-13) (human) | H-Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-OH (Disulfide bond) | 4039860 | H-5708 |
| Cecropin P1 | H-Ser-Trp-Leu-Ser-Lys-Thr-Ala-Lys-Lys-Leu-Glu-Asn-Ser-Ala-Lys-Lys-Arg-Ile-Ser-Glu-Gly-Ile-Ala-Ile-Ala-Ile-Gln-Gly-Gly-Pro-Arg-OH | 4039862 | H-5718 |
| Substance P (5-11) | H-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH₂ | 4039865 | H-5726 |
| Adipokinetic Hormone (Apis mellifera ligustica, Bombyx mori, Heliothis zea, Manduca sexta) | Pyr-Leu-Thr-Phe-Thr-Ser-Ser-Trp-Gly-NH₂ | 4039868 | H-5792 |
| PACAP-38 (28-38) (human, chicken, mouse, ovine, porcine, rat) | H-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH₂ | 4039890 | H-5758 |
| Cyclo(-Pro-Thr) | Cyclo(-Pro-Thr) | 4039970 | G-4780 |
| 1,3-Dipalmitoyl-glycero-2-phosphoethanolamine | 1,3-Dipalmitoyl-glycero-2-phosphoethanolamine | 4040080 | O-1605 |
| 2-Chlorotrityl chloride resin (100-200 mesh, 1.5-1.9 mmol/g) | 2-Chlorotrityl chloride resin (100-200 mesh, 1.5-1.9 mmol/g) | 4040104 | D-2930 |
| H-Glu(D-Glu-OH)-OH | H-Glu(D-Glu-OH)-OH | 4040111 | G-4785 |
| (Ala¹¹·²²·²⁸)-VIP (human, mouse, rat) | H-His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Ala-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Ala-Leu-Asn-Ser-Ile-Leu-Ala-NH₂ | 4040136 | H-5802 |
| Fmoc-N-Me-Trp(Boc)-OH | Fmoc-N-Me-Trp(Boc)-OH | 4040147 | B-3625 |
| GLP-1 (7-36) amide (chicken, common turkey) | H-His-Ala-Glu-Gly-Thr-Tyr-Thr-Ser-Asp-Ile-Thr-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Asn-Gly-Arg-NH₂ | 4040190 | H-5824 |
| Urocortin III (mouse) | H-Phe-Thr-Leu-Ser-Leu-Asp-Val-Pro-Thr-Asn-Ile-Met-Asn-Ile-Leu-Phe-Asn-Ile-Asp-Lys-Ala-Lys-Asn-Leu-Arg-Ala-Lys-Ala-Ala-Ala-Asn-Ala-Gln-Leu-Met-Ala-Gln-Ile-NH₂ | 4040194 | H-5828 |
| RFRP-3 (rat) | H-Ala-Asn-Met-Glu-Ala-Gly-Thr-Met-Ser-His-Phe-Pro-Ser-Leu-Pro-Gln-Arg-Phe-NH₂ | 4040360 | H-5846 |
| Galnon | Fmoc-β-cyclohexyl-Ala-Lys-AMC | 4040530 | B-3645 |
| Gastric Inhibitory Polypeptide (6-30) amide (human) | H-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-NH₂ | 4040632 | H-6102 |
| N-Me-Tyr-OMe · HCl | N-Me-Tyr-OMe · HCl | 4040760 | E-3730 |
| KLD12 | Ac-Lys-Leu-Asp-Leu-Lys-Leu-Asp-Leu-Lys-Leu-Asp-Leu-NH₂ | 4040853 | |
| Urocortin II (human) | H-Ile-Val-Leu-Ser-Leu-Asp-Val-Pro-Ile-Gly-Leu-Leu-Gln-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Ala-Arg-Ala-Ala-Arg-Glu-Gln-Ala-Thr-Thr-Asn-Ala-Arg-Ile-Leu-Ala-Arg-Val-Gly-His-Cys-NH₂ | 4040984 | H-5852 |
| Fmoc-Pro-Pro-Pro-Pro-Pro-OH | Fmoc-Pro-Pro-Pro-Pro-Pro-OH | 4041053 | B-3660 |
| Myelin Oligodendrocyte Glycoprotein (35-55) amide (rat, mouse) | H-Met-Glu-Val-Gly-Trp-Tyr-Arg-Ser-Pro-Phe-Ser-Arg-Val-Val-His-Leu-Tyr-Arg-Asn-Gly-Lys-NH₂ | 4041119 | H-7866 |
| Amyloid β-Protein (5-42) | H-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | 4041241 | H-7436 |
| Amyloid β-Protein (31-35) | H-Ile-Ile-Gly-Leu-Met-OH | 4041418 | H-5866 |
| Antazoline · 0.5 H₂SO₄ | 2-(N-Phenyl-N-benzyl-aminomethyl)-imidazoline · 0.5 H₂SO₄ | 4041457 | Q-2115 |
| (Phe¹,Ser²,Tyr⁶)-PAR-1 (1-6) amide (human) | H-Phe-Ser-Leu-Leu-Arg-Tyr-NH₂ | 4041474 | H-6286 |
| Osteogenic Growth Peptide (10-14) | H-Tyr-Gly-Phe-Gly-Gly-OH | 4041514 | H-5878 |
| H-p-Chloro-Phe-D-Cys-β-(3-pyridyl)-Ala-D-Trp-N-Me-Lys-Thr-Cys-2-Nal-NH₂ | H-p-Chloro-Phe-D-Cys-β-(3-pyridyl)-Ala-D-Trp-N-Me-Lys-Thr-Cys-2-Nal-NH₂ (Disulfide bond) | 4041641 | H-5884 |
| BIM-23627 | H-p-Chloro-Phe-D-Cys-β-(2-pyridyl)-Ala-Trp-Lys-Val-Cys-2-Nal-NH₂ (Disulfide bond) | 4041642 | H-5886 |
| H-Arg-Arg-Arg-Arg-Arg-Arg-Arg-OH | H-Arg-Arg-Arg-Arg-Arg-Arg-Arg-OH | 4041657 | H-5898 |
| Tyr-(D-Dab⁴,Arg⁵,D-Trp⁸)-cyclo-Somatostatin-14 (4-11) | H-Tyr-cyclo(-D-Dab-Arg-Phe-Phe-D-Trp-Lys-Thr-Phe) | 4041674 | H-6276 |
| Proadrenomedullin (1-20) (rat) | H-Ala-Arg-Leu-Asp-Thr-Ser-Ser-Gln-Phe-Arg-Lys-Lys-Trp-Asn-Lys-Trp-Ala-Leu-Ser-Arg-NH₂ | 4041751 | H-7684 |
| Liraglutide trifluoroacetate salt | H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(γ-Glu-palmitoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH | 4041752 | |
| Fmoc-Thr(tBu)-Ser(Psi(Me,Me)pro)-OH | Fmoc-Thr(tBu)-Ser(Psi(Me,Me)pro)-OH | 4041800 | B-3915 |
| Cyclo(-Gly-Arg-Gly-Asp-Ser-Pro) | Cyclo(-Gly-Arg-Gly-Asp-Ser-Pro) | 4041891 | |
| H-Leu-Pro-Pro-OH | H-Leu-Pro-Pro-OH | 4041904 | H-6226 |
| Fmoc-N-Me-Tyr(tBu)-OH | Fmoc-N-Me-Tyr(tBu)-OH | 4042033 | B-3890 |
| (Des-Bromo)-Neuropeptide B (1-23) (human) | H-Trp-Tyr-Lys-Pro-Ala-Ala-Gly-His-Ser-Ser-Tyr-Ser-Val-Gly-Arg-Ala-Ala-Gly-Leu-Leu-Ser-Gly-Leu-OH | 4042034 | H-5906 |
| Myelin Oligodendrocyte Glycoprotein (35-55) (human) | H-Met-Glu-Val-Gly-Trp-Tyr-Arg-Pro-Pro-Phe-Ser-Arg-Val-Val-His-Leu-Tyr-Arg-Asn-Gly-Lys-OH | 4042037 | H-5912 |
| LHRH | Pyr-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH₂ | 4042106 | H-6728 |
| Fmoc-Ser(GlcNAc(Ac)₃-β-D)-OH | Fmoc-Ser(GlcNAc(Ac)₃-β-D)-OH | 4042305 | B-3865 |
| Spinorphin (bovine) | H-Leu-Val-Val-Tyr-Pro-Trp-Thr-OH | 4042431 | H-7576 |
| Fmoc-Tyr(Me)-OH | Fmoc-Tyr(Me)-OH | 4042449 | B-4255 |
| H-β-(3-Pyridyl)-D-Ala-OH · 2 HCl | H-β-(3-Pyridyl)-D-Ala-OH · 2 HCl | 4042478 | F-4205 |
| (D-Trp⁶)-LHRH (2-10) | H-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH₂ | 4042497 | H-6404 |
| Z-Val-Asp(OMe)-Val-Ala-DL-Asp(OMe)-fluoromethylketone | Z-Val-Asp(OMe)-Val-Ala-DL-Asp(OMe)-fluoromethylketone | 4042557 | N-1940 |
| (Leu¹³)-Motilin (human, porcine) | H-Phe-Val-Pro-Ile-Phe-Thr-Tyr-Gly-Glu-Leu-Gln-Arg-Leu-Gln-Glu-Lys-Glu-Arg-Asn-Lys-Gly-Gln-OH | 4042601 | H-5934 |
| (Des-octanoyl)-Ghrelin (human) | H-Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His-Gln-Arg-Val-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg-OH | 4042605 | H-5946 |
| GLP-1 (7-36)-Lys(6-FAM) amide (human, bovine, guinea pig, mouse, rat) | H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Lys(fluorescein-6-carbonyl)-NH₂ | 4042610 | H-5954 |
| Kisspeptin-13 (human) | H-Leu-Pro-Asn-Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH₂ | 4042612 | H-5962 |
| Mca-Ala-Pro-Lys(Dnp)-OH | Mca-Ala-Pro-Lys(Dnp)-OH | 4042638 | M-2710 |
| Octreotide | H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-L-threoninol (Disulfide bond) | 4042822 | H-5972 |
| H-Arg-Arg-Arg-Arg-OH | H-Arg-Arg-Arg-Arg-OH | 4042835 | H-7354 |
| pTH (1-34) amide (human) | H-Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-NH₂ | 4043012 | H-5964 |
| GLP-1 (7-37) (human, bovine, guinea pig, mouse, rat) | H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly-OH | 4043014 | H-9560 |
| BNP-32 (rat) | H-Asn-Ser-Lys-Met-Ala-His-Ser-Ser-Ser-Cys-Phe-Gly-Gln-Lys-Ile-Asp-Arg-Ile-Gly-Ala-Val-Ser-Arg-Leu-Gly-Cys-Asp-Gly-Leu-Arg-Leu-Phe-OH (Disulfide bond) | 4043015 | H-5968 |
| PAR-4 (1-6) amide (human) | H-Gly-Tyr-Pro-Gly-Gln-Val-NH₂ | 4043019 | H-6346 |
| pTH (1-37) (human) | H-Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-Val-Ala-Leu-OH | 4043021 | H-5974 |
| H-Glu(EDANS)-Lys-Pro-Ala-Lys-Phe-Phe-Arg-Leu-Lys(DABCYL)-NH₂ | H-Glu(EDANS)-Lys-Pro-Ala-Lys-Phe-Phe-Arg-Leu-Lys(DABCYL)-NH₂ | 4043075 | M-2535 |
| Orphan GPCR SP9155 Agonist P518 (human) | H-Thr-Ser-Gly-Pro-Leu-Gly-Asn-Leu-Ala-Glu-Glu-Leu-Asn-Gly-Tyr-Ser-Arg-Lys-Lys-Gly-Gly-Phe-Ser-Phe-Arg-Phe-NH₂ | 4043081 | H-5984 |
| H-Gly-Arg-Ala-Asp-Ser-Pro-OH | H-Gly-Arg-Ala-Asp-Ser-Pro-OH | 4043208 | H-6048 |
| Fmoc-D-Ser(PO(OBzl)OH)-OH | Fmoc-D-Ser(PO(OBzl)OH)-OH | 4043238 | B-3805 |
| (Met(O)²⁷)-Glucagon (1-29) (human, rat, porcine) | H-His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met(O)-Asn-Thr-OH | 4043506 | H-6148 |
| DOTA-(Tyr³)-Octreotide | 4,7,10-Tricarboxymethyl-1,4,7,10-tetraaza-cyclododecan-1-yl-acetyl-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-L-threoninol (Disulfide bond) | 4043535 | H-4136 |
| Fmoc-Tyr(Et)-OH | Fmoc-Tyr(Et)-OH | 4043686 | B-4260 |
| Urotensin II-Related Peptide (human, mouse, rat) | H-Ala-Cys-Phe-Trp-Lys-Tyr-Cys-Val-OH (Disulfide bond) | 4043726 | H-6076 |
| Abz-Phe-Arg-Lys(Dnp)-Pro-OH | Abz-Phe-Arg-Lys(Dnp)-Pro-OH | 4043877 | M-2590 |
| Peptide YY (3-36) (canine, mouse, porcine, rat) | H-Ala-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Ser-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH₂ | 4044052 | H-6042 |
| DYKDDDDK Epitope Peptide | H-Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys-OH | 4044101 | H-7748 |
| Acetyl-PHF6 amide | Ac-Val-Gln-Ile-Val-Tyr-Lys-NH₂ | 4044146 | H-8112 |
| H-p-Chloro-Phe-D-Cys-β-(3-pyridyl)-Ala-D-Trp-Lys-tBu-Gly-Cys-2-Nal-NH₂ | H-p-Chloro-Phe-D-Cys-β-(3-pyridyl)-Ala-D-Trp-Lys-tBu-Gly-Cys-2-Nal-NH₂ (Disulfide bond) | 4044525 | H-6056 |
| Oxyntomodulin (human, mouse, rat) | H-His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr-Lys-Arg-Asn-Arg-Asn-Asn-Ile-Ala-OH | 4044527 | H-6058 |
| GRPP (human) | H-Arg-Ser-Leu-Gln-Asp-Thr-Glu-Glu-Lys-Ser-Arg-Ser-Phe-Ser-Ala-Ser-Gln-Ala-Asp-Pro-Leu-Ser-Asp-Pro-Asp-Gln-Met-Asn-Glu-Asp-OH | 4044528 | H-6062 |
| Intermedin (human) | H-Thr-Gln-Ala-Gln-Leu-Leu-Arg-Val-Gly-Cys-Val-Leu-Gly-Thr-Cys-Gln-Val-Gln-Asn-Leu-Ser-His-Arg-Leu-Trp-Gln-Leu-Met-Gly-Pro-Ala-Gly-Arg-Gln-Asp-Ser-Ala-Pro-Val-Asp-Pro-Ser-Ser-Pro-His-Ser-Tyr-NH₂ (Disulfide bond) | 4044529 | H-6064 |
| Intermedin (rat) | H-Pro-His-Ala-Gln-Leu-Leu-Arg-Val-Gly-Cys-Val-Leu-Gly-Thr-Cys-Gln-Val-Gln-Asn-Leu-Ser-His-Arg-Leu-Trp-Gln-Leu-Val-Arg-Pro-Ser-Gly-Arg-Arg-Asp-Ser-Ala-Pro-Val-Asp-Pro-Ser-Ser-Pro-His-Ser-Tyr-NH₂ (Disulfide bond) | 4044531 | H-6068 |
| Fmoc-Phe-Ser(Psi(Me,Me)pro)-OH | Fmoc-Phe-Ser(Psi(Me,Me)pro)-OH | 4044683 | B-3920 |
| Fmoc-Tyr(tBu)-Ser(Psi(Me,Me)pro)-OH | Fmoc-Tyr(tBu)-Ser(Psi(Me,Me)pro)-OH | 4044686 | B-3925 |
| Integrin Binding Peptide | Ac-Gly-Cys-Gly-Tyr-Gly-Arg-Gly-Asp-Ser-Pro-Gly-NH₂ | 4044799 | H-7942 |
| Z-D-allo-Thr(tBu)-OH · DCHA | Z-D-allo-Thr(tBu)-OH · DCHA | 4044802 | C-4210 |
| Chlorotoxin | H-Met-Cys-Met-Pro-Cys-Phe-Thr-Thr-Asp-His-Gln-Met-Ala-Arg-Lys-Cys-Asp-Asp-Cys-Cys-Gly-Gly-Lys-Gly-Arg-Gly-Lys-Cys-Tyr-Gly-Pro-Gln-Cys-Leu-Cys-Arg-NH₂ (Disulfide bonds between Cys² and Cys¹⁹/Cys⁵ and Cys²⁸/Cys¹⁶ and Cys³³/Cys²⁰ and Cys³⁵) | 4044876 | H-6086 |
| Boc-Leu-Ser-Thr-Arg-AMC | Boc-Leu-Ser-Thr-Arg-AMC | 4044927 | I-1940 |
| Fmoc-Ser-OH · H₂O | Fmoc-Ser-OH · H₂O | 4044985 | B-3745 |
| 5-Carboxy-fluorescein | 5-Carboxy-fluorescein | 4045141 | Q-2660 |
| 6-Carboxy-fluorescein | 6-Carboxy-fluorescein | 4045142 | Q-2665 |
| 5(6)-Carboxy-tetramethylrhodamine | 5(6)-Carboxy-tetramethylrhodamine | 4045146 | Q-2680 |
| Abz-(Asn⁶⁷⁰,Leu⁶⁷¹)-Amyloid β/A4 Protein Precursor₇₇₀ (669-674)-EDDnp | Abz-Val-Asn-Leu-Asp-Ala-Glu-EDDnp | 4045326 | M-2565 |
| (Des-Thr⁵)-Glucagon | H-His-Ser-Gln-Gly-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr-OH | 4045345 | H-6156 |
| (Des-Thr⁷)-Glucagon | H-His-Ser-Gln-Gly-Thr-Phe-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr-OH | 4045365 | H-6158 |
| Ac-Arg-Cys-Met-5-aminopentanoyl-Arg-Val-Tyr-5-aminopentanoyl-Cys-NH₂ | Ac-Arg-Cys-Met-5-aminopentanoyl-Arg-Val-Tyr-5-aminopentanoyl-Cys-NH₂ (Disulfide bond) | 4045499 | H-6408 |
| Retrocyclin-1 | Cyclo(-Gly-Ile-Cys-Arg-Cys-Ile-Cys-Gly-Arg-Gly-Ile-Cys-Arg-Cys-Ile-Cys-Gly-Arg) (Disulfide bonds between Cys³ and Cys¹⁶/Cys⁵ and Cys¹⁴/Cys⁷ and Cys¹²) | 4045698 | H-6126 |
| Biotinyl-εAhx-ω-Conotoxin GVIA | Biotinyl-εAhx-Cys-Lys-Ser-Hyp-Gly-Ser-Ser-Cys-Ser-Hyp-Thr-Ser-Tyr-Asn-Cys-Cys-Arg-Ser-Cys-Asn-Hyp-Tyr-Thr-Lys-Arg-Cys-Tyr-NH₂ (Disulfide bonds between Cys² and Cys¹⁷/Cys⁹ and Cys²⁰/ Cys¹⁶ and Cys²⁷) | 4045700 | H-6132 |
| Neuropeptide S (human) | H-Ser-Phe-Arg-Asn-Gly-Val-Gly-Thr-Gly-Met-Lys-Lys-Thr-Ser-Phe-Gln-Arg-Ala-Lys-Ser-OH | 4045743 | H-6162 |
| Compstatin | H-Ile-Cys-Val-Val-Gln-Asp-Trp-Gly-His-His-Arg-Cys-Thr-NH₂ (Disulfide bond) | 4045832 | H-6516 |
| Fluorescein-6-carbonyl-Asp(OMe)-Glu(OMe)-Val-DL-Asp(OMe)-fluoromethylketone | Fluorescein-6-carbonyl-Asp(OMe)-Glu(OMe)-Val-DL-Asp(OMe)-fluoromethylketone | 4045855 | N-1905 |
| C-Peptide 1 (rat) | H-Glu-Val-Glu-Asp-Pro-Gln-Val-Pro-Gln-Leu-Glu-Leu-Gly-Gly-Gly-Pro-Glu-Ala-Gly-Asp-Leu-Gln-Thr-Leu-Ala-Leu-Glu-Val-Ala-Arg-Gln-OH | 4045921 | H-6136 |
| Acetyl-(Pro¹⁸,Asp²¹)-Amyloid β-Protein (17-21) amide | Ac-Leu-Pro-Phe-Phe-Asp-NH₂ | 4045708 | H-6138 |
| (Des-Gly¹⁰,D-Pyr¹,D-Leu⁶,Pro-NHEt⁹)-LHRH | D-Pyr-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt | 4046113 | H-6642 |
| 3X DYKDDDDK Peptide | H-Met-Asp-Tyr-Lys-Asp-His-Asp-Gly-Asp-Tyr-Lys-Asp-His-Asp-Ile-Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys-OH | 4046200 | H-7536 |
| Renin Substrate 1 | H-Arg-Glu(EDANS)-Ile-His-Pro-Phe-His-Leu-Val-Ile-His-Thr-Lys(DABCYL)-Arg-OH | 4046362 | M-2715 |
| Fmoc-Lys(Boc)-Thr(Psi(Me,Me)pro)-OH | Fmoc-Lys(Boc)-Thr(Psi(Me,Me)pro)-OH | 4046772 | B-3930 |
| Amyloid β-Protein (3-40) | H-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH | 4046796 | H-7672 |
| Neuropeptide S (rat) | H-Ser-Phe-Arg-Asn-Gly-Val-Gly-Ser-Gly-Val-Lys-Lys-Thr-Ser-Phe-Arg-Arg-Ala-Lys-Gln-OH | 4046860 | H-6164 |
| Galanin-Like Peptide (rat) | H-Ala-Pro-Ala-His-Arg-Gly-Arg-Gly-Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Val-Leu-His-Leu-Ser-Ser-Lys-Ala-Asn-Gln-Gly-Arg-Lys-Thr-Asp-Ser-Ala-Leu-Glu-Ile-Leu-Asp-Leu-Trp-Lys-Ala-Ile-Asp-Gly-Leu-Pro-Tyr-Ser-Arg-Ser-Pro-Arg-Met-Thr-OH | 4047028 | H-6204 |
| Mating Factor α | H-Trp-His-Trp-Leu-Gln-Leu-Lys-Pro-Gly-Gln-Pro-Met-Tyr-OH | 4047325 | H-7724 |
| Boc-Ala-D-Glu-NH₂ | Boc-Ala-D-Glu-NH₂ | 4047445 | A-1165 |
| Degarelix | Ac-D-2-Nal-D-4-Cpa-D-3-Pal-Ser-4-amino-Phe(L-4,5-dihydroorotyl)-4-ureido-D-Phe-Leu-Lys(isopropyl)-Pro-D-Ala-NH₂ | 4047459 | H-7428 |
| Galanin (2-11) amide | H-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-NH₂ | 4047489 | H-7582 |
| PAR-1 (1-6) (mouse, rat) | H-Ser-Phe-Phe-Leu-Arg-Asn-OH | 4047522 | H-6416 |
| H-Ser-Ile-Tyr-Arg-Tyr-Tyr-Gly-Leu-OH | H-Ser-Ile-Tyr-Arg-Tyr-Tyr-Gly-Leu-OH | 4047704 | |
| (D-Ser⁶,Azagly¹⁰)-LHRH | Pyr-His-Trp-Ser-Tyr-D-Ser-Leu-Arg-Pro-Azagly-NH₂ | 4047922 | H-6266 |
| (Sar¹,Ile⁴·⁸)-Angiotensin II | Sar-Arg-Val-Ile-Ile-His-Pro-Ile-OH | 4048101 | H-6252 |
| Urocortin II (mouse) | H-Val-Ile-Leu-Ser-Leu-Asp-Val-Pro-Ile-Gly-Leu-Leu-Arg-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Tyr-Lys-Ala-Ala-Arg-Asn-Gln-Ala-Ala-Thr-Asn-Ala-Gln-Ile-Leu-Ala-His-Val-NH₂ | 4048157 | H-6238 |
| Z-Ile-Leu-aldehyde | Z-Ile-Leu-aldehyde | 4048245 | N-1895 |
| (Des-Gly¹⁰,D-His²,D-Ser⁴,D-Leu⁶,Pro-NHEt⁹)-LHRH | Pyr-D-His-Trp-D-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt | 4048380 | H-6638 |
| (Z-Asp-Glu-Val-Asp)₂-Rhodamine 110 | (Z-Asp-Glu-Val-Asp)₂-Rhodamine 110 | 4048381 | M-2615 |
| (2-Furoyl)-PAR-2 (2-6)-Orn amide (mouse, rat) | (2-Furoyl)-Leu-Ile-Gly-Arg-Leu-Orn-NH₂ | 4048620 | H-6246 |
| Acetyl-(D-Phe²,Lys¹⁵,Arg¹⁶,Leu²⁷)-VIP (1-7)-GRF (8-27) | Ac-His-D-Phe-Asp-Ala-Val-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Lys-Arg-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-NH₂ | 4048647 | H-7286 |
| (Des-Gly¹⁰,D-Leu⁶,[¹³C₆]Leu⁷,Pro-NHEt⁹)-LHRH | Pyr-His-Trp-Ser-Tyr-D-Leu-[¹³C₆]Leu-Arg-Pro-NHEt | 4048762 | H-6258 |
| 4-Methyl-benzhydrylamine resin (100-200 mesh, 0.70-1.30 mmol/g) · HCl | 4-Methyl-benzhydrylamine resin (100-200 mesh, 0.70-1.30 mmol/g) · HCl | 4049216 | D-2715 |
| Abz-Gly-Ile-Val-Arg-Ala-Lys(Dnp)-OH | Abz-Gly-Ile-Val-Arg-Ala-Lys(Dnp)-OH | 4049308 | M-2595 |
| (Des-octanoyl)-Ghrelin (mouse, rat) | H-Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg-OH | 4049310 | H-6264 |
| Fmoc-D-Tyr(PO(OBzl)OH)-OH | Fmoc-D-Tyr(PO(OBzl)OH)-OH | 4049433 | B-3795 |
| Ac-Lys-Gln-Leu-Arg-AFC | Ac-Lys-Gln-Leu-Arg-AFC | 4049682 | I-2005 |
| Bivalirudin | H-D-Phe-Pro-Arg-Pro-Gly-Gly-Gly-Gly-Asn-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu-OH | 4049766 | H-6668 |
| BNP-32 (human) | H-Ser-Pro-Lys-Met-Val-Gln-Gly-Ser-Gly-Cys-Phe-Gly-Arg-Lys-Met-Asp-Arg-Ile-Ser-Ser-Ser-Ser-Gly-Leu-Gly-Cys-Lys-Val-Leu-Arg-Arg-His-OH (Disulfide bond) | 4049848 | H-8354 |
| Ghrelin-Cys(BMCC-biotinyl) (human) | H-Gly-Ser-Ser(octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Arg-Val-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg-Cys(BMCC-biotinyl)-OH | 4049999 | H-6334 |
| Toolbox Fmoc-Amino Acid Derivatives | 4050008 | B-3840 | |
| Acetyl-Heme-Binding Protein 1 (1-21) (human) | Ac-Met-Leu-Gly-Met-Ile-Lys-Asn-Ser-Leu-Phe-Gly-Ser-Val-Glu-Thr-Trp-Pro-Trp-Gln-Val-Leu-OH | 4050026 | H-6294 |
| Apelin-17 (human, bovine, mouse, rat) | H-Lys-Phe-Arg-Arg-Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe-OH | 4050029 | H-6302 |
| (Ala¹³)-Apelin-13 (human, bovine, mouse, rat) (Salt form trifluoroacetate) | H-Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Ala-OH | 4050032 | H-6308 |
| (Pyr³)-Amyloid β-Protein (3-40) | Pyr-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH | 4050043 | H-7422 |
| HIV-2 Peptide | H-Lys-Asp-Gln-Ala-Gln-Leu-Asn-Ser-Trp-Gly-Cys-Ala-Phe-Arg-Gln-Val-Cys-His-Thr-OH (Disulfide bond) | 4050175 | H-8338 |
| pTH (1-84) (dog) | H-Ser-Val-Ser-Glu-Ile-Gln-Phe-Met-His-Asn-Leu-Gly-Lys-His-Leu-Ser-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-Val-Ala-Leu-Gly-Ala-Pro-Ile-Ala-His-Arg-Asp-Gly-Ser-Ser-Gln-Arg-Pro-Leu-Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-Tyr-Gln-Lys-Ser-Leu-Gly-Glu-Ala-Asp-Lys-Ala-Asp-Val-Asp-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln-OH | 4050212 | H-6438 |
| N-[(RS)-1-Carboxy-3-phenyl-propyl]-Ala-Ala-Phe-4-Abz-OH | N-[(RS)-1-Carboxy-3-phenyl-propyl]-Ala-Ala-Phe-4-Abz-OH | 4050213 | N-1985 |
| Fluorescein-6-carbonyl-Tyr-Val-Ala-DL-Asp(OMe)-fluoromethylketone | Fluorescein-6-carbonyl-Tyr-Val-Ala-DL-Asp(OMe)-fluoromethylketone | 4050391 | N-1960 |
| Obestatin (rat) | H-Phe-Asn-Ala-Pro-Phe-Asp-Val-Gly-Ile-Lys-Leu-Ser-Gly-Ala-Gln-Tyr-Gln-Gln-His-Gly-Arg-Ala-Leu-NH₂ | 4050405 | H-6338 |
| Amyloid β-Protein (1-46) | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-Thr-Val-Ile-Val-OH | 4050409 | H-6406 |
| Obestatin (human) | H-Phe-Asn-Ala-Pro-Phe-Asp-Val-Gly-Ile-Lys-Leu-Ser-Gly-Val-Gln-Tyr-Gln-Gln-His-Ser-Gln-Ala-Leu-NH₂ | 4050435 | H-6356 |
| C5a Anaphylatoxin (human) | H-Thr-Leu-Gln-Lys-Lys-Ile-Glu-Glu-Ile-Ala-Ala-Lys-Tyr-Lys-His-Ser-Val-Val-Lys-Lys-Cys-Cys-Tyr-Asp-Gly-Ala-Cys-Val-Asn-Asn-Asp-Glu-Thr-Cys-Glu-Gln-Arg-Ala-Ala-Arg-Ile-Ser-Leu-Gly-Pro-Arg-Cys-Ile-Lys-Ala-Phe-Thr-Glu-Cys-Cys-Val-Val-Ala-Ser-Gln-Leu-Arg-Ala-Asn-Ile-Ser-His-Lys-Asp-Met-Gln-Leu-Gly-Arg-OH (Disulfide bonds between Cys²¹ and Cys⁴⁷/Cys²² and Cys⁵⁴/Cys³⁴ and Cys⁵⁵) | 4050444 | H-6322 |
| Dansyl-Glu-Gly-Arg-chloromethylketone | Dansyl-Glu-Gly-Arg-chloromethylketone | 4050449 | N-1970 |
| H-Glu(EDANS)-Pro-Leu-Phe-Ala-Glu-Arg-Lys(DABCYL)-OH | H-Glu(EDANS)-Pro-Leu-Phe-Ala-Glu-Arg-Lys(DABCYL)-OH | 4050532 | M-2655 |
| Abz-Ser-Pro-3-nitro-Tyr-OH | Abz-Ser-Pro-3-nitro-Tyr-OH | 4050533 | M-2660 |
| Virstatin | 4-(N-(1,8-Naphthalimido))-n-butyric acid | 4050838 | F-4195 |
| Preptin (rat) | H-Asp-Val-Ser-Thr-Ser-Gln-Ala-Val-Leu-Pro-Asp-Asp-Phe-Pro-Arg-Tyr-Pro-Val-Gly-Lys-Phe-Phe-Lys-Phe-Asp-Thr-Trp-Arg-Gln-Ser-Ala-Gly-Arg-Leu-OH | 4050843 | H-6572 |
| Amyloid β-Protein (17-42) | H-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | 4050878 | |
| Fmoc-Ser(tBu)-Thr(Psi(Me,Me)pro)-OH | Fmoc-Ser(tBu)-Thr(Psi(Me,Me)pro)-OH | 4050935 | B-4305 |
| Fmoc-Gly-Thr(Psi(Me,Me)pro)-OH | Fmoc-Gly-Thr(Psi(Me,Me)pro)-OH | 4050936 | B-4085 |
| (Gln²²)-Amyloid β-Protein (1-42) | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gln-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | 4050945 | H-7844 |
| H-Ser-Ile-Gly-Ser-Leu-Ala-Lys-OH | H-Ser-Ile-Gly-Ser-Leu-Ala-Lys-OH | 4051150 | H-7706 |
| SDF-1α (human) | H-Lys-Pro-Val-Ser-Leu-Ser-Tyr-Arg-Cys-Pro-Cys-Arg-Phe-Phe-Glu-Ser-His-Val-Ala-Arg-Ala-Asn-Val-Lys-His-Leu-Lys-Ile-Leu-Asn-Thr-Pro-Asn-Cys-Ala-Leu-Gln-Ile-Val-Ala-Arg-Leu-Lys-Asn-Asn-Asn-Arg-Gln-Val-Cys-Ile-Asp-Pro-Lys-Leu-Lys-Trp-Ile-Gln-Glu-Tyr-Leu-Glu-Lys-Ala-Leu-Asn-Lys-OH (Disulfide bonds between Cys⁹ and Cys³⁴/Cys¹¹ and Cys⁵⁰) | 4051449 | H-6394 |
| Exendin-4 (1-8) | H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-NH₂ | 4051740 | H-6454 |
| Ac-Pro-Gly-Pro-OH | Ac-Pro-Gly-Pro-OH | 4051879 | H-6412 |
| Amyloid β-Protein (1-6) | H-Asp-Ala-Glu-Phe-Arg-His-OH | 4052027 | H-8362 |
| Amyloid β-Protein (1-12) | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-OH | 4052029 | H-8358 |
| Fmoc-Trp(Me)-OH | Fmoc-Trp(Me)-OH | 4052226 | B-3875 |
| Boc-Thr(Me)-OH | Boc-Thr(Me)-OH | 4052560 | A-4795 |
| H-Ile-Lys-Val-Ala-Val-OH | H-Ile-Lys-Val-Ala-Val-OH | 4052600 | |
| Fmoc-D-Trp(Me)-OH | Fmoc-D-Trp(Me)-OH | 4052724 | B-3880 |
| 2-(N-Phenyl-N-benzyl-aminomethyl)-imidazole | 2-(N-Phenyl-N-benzyl-aminomethyl)-imidazole | 4052755 | Q-2755 |
| H-Ser-Leu-Ser-Leu-Ser-Pro-Gly-OH | H-Ser-Leu-Ser-Leu-Ser-Pro-Gly-OH | 4052978 | H-6534 |
| Ac-Gly-Pro-AFC | Ac-Gly-Pro-AFC | 4053025 | I-2000 |
| Ovalbumin (257-264) (chicken) | H-Ser-Ile-Ile-Asn-Phe-Glu-Lys-Leu-OH | 4053142 | H-7738 |
| Ac-Arg-Leu-Arg-AMC | Ac-Arg-Leu-Arg-AMC | 4053458 | I-1955 |
| Cortistatin-29 (rat) | Pyr-Glu-Arg-Pro-Pro-Leu-Gln-Gln-Pro-Pro-His-Arg-Asp-Lys-Lys-Pro-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Ser-Ser-Cys-Lys-OH (Disulfide bond) | 4053466 | H-6444 |
| H-Leu-Gly-Leu-Leu-Leu-Arg-His-Leu-Arg-His-His-Ser-Asn-Leu-Leu-Ala-Asn-Ile-OH | H-Leu-Gly-Leu-Leu-Leu-Arg-His-Leu-Arg-His-His-Ser-Asn-Leu-Leu-Ala-Asn-Ile-OH | 4053517 | |
| (D-Pro⁷)-Angiotensin I/II (1-7) | H-Asp-Arg-Val-Tyr-Ile-His-D-Pro-OH | 4053534 | H-7698 |
| Mca-Pro-Leu-Gly-Leu-Glu-Glu-Ala-Dap(Dnp)-NH₂ | Mca-Pro-Leu-Gly-Leu-Glu-Glu-Ala-Dap(Dnp)-NH₂ | 4053570 | M-2670 |
| Cortistatin-29 (human) | Pyr-Glu-Gly-Ala-Pro-Pro-Gln-Gln-Ser-Ala-Arg-Arg-Asp-Arg-Met-Pro-Cys-Arg-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Ser-Ser-Cys-Lys-OH (Disulfide bond) | 4053572 | H-6458 |
| Amyloid β-Protein (16-22) | H-Lys-Leu-Val-Phe-Phe-Ala-Glu-OH | 4054257 | H-8092 |
| Catestatin (human) | H-Ser-Ser-Met-Lys-Leu-Ser-Phe-Arg-Ala-Arg-Ala-Tyr-Gly-Phe-Arg-Gly-Pro-Gly-Pro-Gln-Leu-OH | 4054324 | H-6488 |
| (D-Ala²)-Gastric Inhibitory Polypeptide (human) | H-Tyr-D-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln-OH | 4054476 | H-7586 |
| Kisspeptin-54 (human) | H-Gly-Thr-Ser-Leu-Ser-Pro-Pro-Pro-Glu-Ser-Ser-Gly-Ser-Arg-Gln-Gln-Pro-Gly-Leu-Ser-Ala-Pro-His-Ser-Arg-Gln-Ile-Pro-Ala-Pro-Gln-Gly-Ala-Val-Leu-Val-Gln-Arg-Glu-Lys-Asp-Leu-Pro-Asn-Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH₂ | 4054937 | H-6514 |
| Angiotensin A | H-Ala-Arg-Val-Tyr-Ile-His-Pro-Phe-OH | 4055087 | H-6498 |
| Galacto-RGD | Cyclo(-Arg-Gly-Asp-D-Phe-Lys(SAA)) | 4055350 | H-6532 |
| PAR-2 (6-1) amide (mouse, rat) | H-Leu-Arg-Gly-Ile-Leu-Ser-NH₂ | 4055394 | H-6508 |
| Fmoc-Ser(tBu)-Ser(Psi(Me,Me)pro)-OH | Fmoc-Ser(tBu)-Ser(Psi(Me,Me)pro)-OH | 4055645 | B-3935 |
| CRAMP (mouse) | H-Gly-Leu-Leu-Arg-Lys-Gly-Gly-Glu-Lys-Ile-Gly-Glu-Lys-Leu-Lys-Lys-Ile-Gly-Gln-Lys-Ile-Lys-Asn-Phe-Phe-Gln-Lys-Leu-Val-Pro-Gln-Pro-Glu-Gln-OH | 4056438 | H-6526 |
| CRAMP-18 (mouse) | H-Gly-Glu-Lys-Leu-Lys-Lys-Ile-Gly-Gln-Lys-Ile-Lys-Asn-Phe-Phe-Gln-Lys-Leu-OH | 4056439 | H-6528 |
| HIV-1 tat Protein (47-57) amide | H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-NH₂ | 4056474 | |
| Gliadorphin-7 | H-Tyr-Pro-Gln-Pro-Gln-Pro-Phe-OH | 4057062 | H-6712 |
| Fmoc-Asp(OtBu)-Ser(Psi(Me,Me)pro)-OH | Fmoc-Asp(OtBu)-Ser(Psi(Me,Me)pro)-OH | 4057074 | B-4275 |
| Lactoferricin B (4-14) (bovine) | H-Arg-Arg-Trp-Gln-Trp-Arg-Met-Lys-Lys-Leu-Gly-OH | 4057344 | H-7688 |
| (Hyp³,β-(2-thienyl)-Ala⁵,Tyr(Me)⁸-psi(CH₂NH)Arg⁹)-Bradykinin | H-Arg-Pro-Hyp-Gly-β-(2-thienyl)-Ala-Ser-Pro-Tyr(Me)-psi(CH₂NH)Arg-OH | 4057654 | H-6578 |
| (Glu¹³·¹⁷·²⁰)-Osteocalcin (1-46) (mouse) | H-Tyr-Leu-Gly-Ala-Ser-Val-Pro-Ser-Pro-Asp-Pro-Leu-Glu-Pro-Thr-Arg-Glu-Gln-Cys-Glu-Leu-Asn-Pro-Ala-Cys-Asp-Glu-Leu-Ser-Asp-Gln-Tyr-Gly-Leu-Lys-Thr-Ala-Tyr-Lys-Arg-Ile-Tyr-Gly-Ile-Thr-Ile-OH (Disulfide bond) | 4057685 | H-6552 |
| Histone H3 (21-44) | H-Ala-Thr-Lys-Ala-Ala-Arg-Lys-Ser-Ala-Pro-Ala-Thr-Gly-Gly-Val-Lys-Lys-Pro-His-Arg-Tyr-Arg-Pro-Gly-OH | 4058109 | H-7798 |
| Fmoc-Lys(Boc)-Ser(Psi(Me,Me)pro)-OH | Fmoc-Lys(Boc)-Ser(Psi(Me,Me)pro)-OH | 4058310 | B-4295 |
| Met-RANTES (human) | H-Met-Ser-Pro-Tyr-Ser-Ser-Asp-Thr-Thr-Pro-Cys-Cys-Phe-Ala-Tyr-Ile-Ala-Arg-Pro-Leu-Pro-Arg-Ala-His-Ile-Lys-Glu-Tyr-Phe-Tyr-Thr-Ser-Gly-Lys-Cys-Ser-Asn-Pro-Ala-Val-Val-Phe-Val-Thr-Arg-Lys-Asn-Arg-Gln-Val-Cys-Ala-Asn-Pro-Glu-Lys-Lys-Trp-Val-Arg-Glu-Tyr-Ile-Asn-Ser-Leu-Glu-Met-Ser-OH (Disulfide bonds between Cys¹¹ and Cys³⁵/Cys¹² and Cys⁵¹) | 4058353 | H-6544 |
| (D-Arg⁰,Hyp³,Igl⁵,D-Igl⁷,Oic⁸)-Bradykinin | H-D-Arg-Arg-Pro-Hyp-Gly-Igl-Ser-D-Igl-Oic-Arg-OH | 4058780 | H-7556 |
| (Des-Gly¹⁰,D-Trp³,D-Leu⁶,Pro-NHEt⁹)-LHRH | Pyr-His-D-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt | 4058815 | H-6636 |
| BQ-788 | N-cis-2,6-Dimethylpiperidinocarbonyl-β-tBu-Ala-D-Trp(1-methoxycarbonyl)-D-Nle-OH | 4058874 | H-8152 |
| MEGA-9 | MEGA-9 | 4058964 | P-1165 |
| Uroguanylin Topoisomer B (human) | H-Asn-Asp-Asp-Cys-Glu-Leu-Cys-Val-Asn-Val-Ala-Cys-Thr-Gly-Cys-Leu-OH (Disulfide bonds between Cys⁴ and Cys¹²/Cys⁷ and Cys¹⁵) | 4059285 | H-8142 |
| Fmoc-Gly-Ser(Psi(Me,Me)pro)-OH | Fmoc-Gly-Ser(Psi(Me,Me)pro)-OH | 4059332 | B-4055 |
| 5-FAM-Woodtide | Fluorescein-5-carbonyl-Lys-Lys-Ile-Ser-Gly-Arg-Leu-Ser-Pro-Ile-Met-Thr-Glu-Gln-NH₂ | 4059397 | H-7644 |
| Autoinducing Peptide I | H-Tyr-Ser-Thr-cyclo(-Cys-Asp-Phe-Ile-Met) | 4059504 | H-7612 |
| ACTH (2-24) (human, bovine, rat) | H-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-OH | 4059983 | H-6738 |
| (Des-Ser³)-ACTH (1-24) (human, bovine, rat) | H-Ser-Tyr-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-OH | 4059984 | H-6742 |
| Alarin (human) | H-Ala-Pro-Ala-His-Arg-Ser-Ser-Thr-Phe-Pro-Lys-Trp-Val-Thr-Lys-Thr-Glu-Arg-Gly-Arg-Gln-Pro-Leu-Arg-Ser-OH | 4059926 | H-6574 |
| Acetyl-ACTH (3-24) (human, bovine, rat) | Ac-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-OH | 4059986 | H-6744 |
| Pasireotide | Cyclo(-Hyp(2-aminoethyl-carbamoyl)-Phg-D-Trp-Lys-Tyr(Bzl)-Phe) | 4060221 | H-7542 |
| Pseudin-2 | H-Gly-Leu-Asn-Ala-Leu-Lys-Lys-Val-Phe-Gln-Gly-Ile-His-Glu-Ala-Ile-Lys-Leu-Ile-Asn-Asn-His-Val-Gln-OH | 4060547 | H-6586 |
| Cilengitide | Cyclo(-Arg-Gly-Asp-D-Phe-N-Me-Val) | 4060586 | H-8174 |
| Ac-Gly-Ala-Lys-AMC | Ac-Gly-Ala-Lys-AMC | 4060672 | I-1980 |
| H-Gly-Arg-Gly-Asp-Ser-NH₂ | H-Gly-Arg-Gly-Asp-Ser-NH₂ | 4060989 | H-7936 |
| Melittin (free acid) | H-Gly-Ile-Gly-Ala-Val-Leu-Lys-Val-Leu-Thr-Thr-Gly-Leu-Pro-Ala-Leu-Ile-Ser-Trp-Ile-Lys-Arg-Lys-Arg-Gln-Gln-OH | 4061024 | H-7646 |
| n-Dodecyl-β-D-maltoside | n-Dodecyl-β-D-maltoside | 4061027 | P-1170 |
| Terlipressin | H-Gly-Gly-Gly-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH₂ (Disulfide bond) | 4061053 | H-6604 |
| Angiotensin (1-12) (human) | H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile-OH | 4061269 | H-6608 |
| RF9 | 1-Adamantanecarbonyl-Arg-Phe-NH₂ | 4061350 | G-4800 |
| Furin Inhibitor II | H-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-NH₂ | 4061351 | N-2000 |
| Fmoc-Asn(Trt)-Ser(Psi(Me,Me)pro)-OH | Fmoc-Asn(Trt)-Ser(Psi(Me,Me)pro)-OH | 4061400 | B-4090 |
| Dermcidin-1L (human) | H-Ser-Ser-Leu-Leu-Glu-Lys-Gly-Leu-Asp-Gly-Ala-Lys-Lys-Ala-Val-Gly-Gly-Leu-Gly-Lys-Leu-Gly-Lys-Asp-Ala-Val-Glu-Asp-Leu-Glu-Ser-Val-Gly-Lys-Gly-Ala-Val-His-Asp-Val-Lys-Asp-Val-Leu-Asp-Ser-Val-Leu-OH | 4061590 | H-7316 |
| Acetyl-ACTH (2-24) (human, bovine, rat) | Ac-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-OH | 4062041 | H-6746 |
| Acetyl-ACTH (4-24) (human, bovine, rat) | Ac-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-OH | 4062042 | H-6748 |
| Fmoc-Asn(Trt)-Thr(Psi(Me,Me)pro)-OH | Fmoc-Asn(Trt)-Thr(Psi(Me,Me)pro)-OH | 4062083 | B-4095 |
| (Pro³)-Gastric Inhibitory Polypeptide (human) | H-Tyr-Ala-Pro-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln-OH | 4062141 | H-7584 |
| Amyloid β-Protein (1-37) | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-OH | 4062195 | H-7462 |
| Enfuvirtide | Ac-Tyr-Thr-Ser-Leu-Ile-His-Ser-Leu-Ile-Glu-Glu-Ser-Gln-Asn-Gln-Gln-Glu-Lys-Asn-Glu-Gln-Glu-Leu-Leu-Glu-Leu-Asp-Lys-Trp-Ala-Ser-Leu-Trp-Asn-Trp-Phe-NH₂ | 4062216 | H-6684 |
| PHF6 | H-Val-Gln-Ile-Val-Tyr-Lys-OH | 4062344 | H-8098 |
| COMU | 1-[1-(Cyano-2-ethoxy-2-oxoethylideneaminooxy)-dimethylamino-morpholino]-uronium hexafluorophosphate | 4062545 | Q-2735 |
| Vapreotide | H-D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Trp-NH₂ (Disulfide bond) | 4062833 | H-6634 |
| Acetyl-ACTH (7-24) (human, bovine, rat) | Ac-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-OH | 4062898 | H-6752 |
| Eptifibatide | 3-Mercaptopropionyl-Homoarg-Gly-Asp-Trp-Pro-Cys-NH₂ (Disulfide bond) | 4063191 | H-6654 |
| (Glu¹⁷·²¹·²⁴)-Osteocalcin (1-49) (human) | H-Tyr-Leu-Tyr-Gln-Trp-Leu-Gly-Ala-Pro-Val-Pro-Tyr-Pro-Asp-Pro-Leu-Glu-Pro-Arg-Arg-Glu-Val-Cys-Glu-Leu-Asn-Pro-Asp-Cys-Asp-Glu-Leu-Ala-Asp-His-Ile-Gly-Phe-Gln-Glu-Ala-Tyr-Arg-Arg-Phe-Tyr-Gly-Pro-Val-OH (Disulfide bond) | 4063516 | H-7534 |
| (Des-His⁶)-ACTH (1-24) (human, bovine, rat) | H-Ser-Tyr-Ser-Met-Glu-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-OH | 4063586 | H-6754 |
| (Des-Glu⁵)-ACTH (1-24) (human, bovine, rat) | H-Ser-Tyr-Ser-Met-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-OH | 4063587 | H-6756 |
| Endo-4a-Glu-ACTH (1-24) (human, bovine, rat) | H-Ser-Tyr-Ser-Met-Glu-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-OH | 4063588 | H-6758 |
| H-Ser(tBu)-2-chlorotrityl resin (100-200 mesh, 0.50-0.90 mmol/g) | H-Ser(tBu)-2-chlorotrityl resin (100-200 mesh, 0.50-0.90 mmol/g) | 4063685 | D-3010 |
| Adropin (34-76) (human, mouse, rat) | H-Cys-His-Ser-Arg-Ser-Ala-Asp-Val-Asp-Ser-Leu-Ser-Glu-Ser-Ser-Pro-Asn-Ser-Ser-Pro-Gly-Pro-Cys-Pro-Glu-Lys-Ala-Pro-Pro-Pro-Gln-Lys-Pro-Ser-His-Glu-Gly-Ser-Tyr-Leu-Leu-Gln-Pro-OH (Disulfide bond) | 4064212 | H-6686 |
| LL-37 RKS | H-Arg-Lys-Ser-Lys-Glu-Lys-Ile-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-Thr-Glu-Ser-OH | 4064380 | H-7882 |
| LL-37 KRI | H-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-Thr-Glu-Ser-OH | 4064381 | H-7876 |
| (Lys²²)-Amyloid β-Protein (1-42) | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Lys-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | 4064438 | H-7848 |
| Amyloid β-Protein (1-42) (scrambled) | H-Ala-Ile-Ala-Glu-Gly-Asp-Ser-His-Val-Leu-Lys-Glu-Gly-Ala-Tyr-Met-Glu-Ile-Phe-Asp-Val-Gln-Gly-His-Val-Phe-Gly-Gly-Lys-Ile-Phe-Arg-Val-Val-Asp-Leu-Gly-Ser-His-Asn-Val-Ala-OH | 4064853 | H-7406 |
| (Des-Gly¹⁰,Des-Ser⁴,D-Leu⁶,Pro-NHEt⁹)-LHRH | Pyr-His-Trp-Tyr-D-Leu-Leu-Arg-Pro-NHEt | 4065127 | H-6714 |
| (Des-Gly¹⁰,D-Leu⁶,Orn⁸,Pro-NHEt⁹)-LHRH | Pyr-His-Trp-Ser-Tyr-D-Leu-Leu-Orn-Pro-NHEt | 4065128 | H-6716 |
| Hepcidin-22 (human) | H-Phe-Pro-Ile-Cys-Ile-Phe-Cys-Cys-Gly-Cys-Cys-His-Arg-Ser-Lys-Cys-Gly-Met-Cys-Cys-Lys-Thr-OH (Disulfide bonds, air oxidized) | 4065376 | H-7362 |
| Atosiban | 3-Mercaptopropionyl-D-Tyr(Et)-Ile-Thr-Asn-Cys-Pro-Orn-Gly-NH₂ (Disulfide bond) | 4065438 | H-6722 |
| N-Biotinyl-3,6-dioxa-1,8-octanediamine | N-Biotinyl-3,6-dioxa-1,8-octanediamine | 4065553 | Q-2790 |
| Tertiapin-Q | H-Ala-Leu-Cys-Asn-Cys-Asn-Arg-Ile-Ile-Ile-Pro-His-Gln-Cys-Trp-Lys-Lys-Cys-Gly-Lys-Lys-NH₂ (Disulfide bonds between Cys³ and Cys¹⁴/Cys⁵ and Cys¹⁸) | 4065562 | N-2005 |
| Octaarginine | H-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-OH | 4065816 | H-4518 |
| PEG30K-Cys-AEEAc-Fibrinopeptide A (1-15) | PEG30K-Cys-AEEAc-Ala-Asp-Ser-Gly-Glu-Gly-Asp-Phe-Leu-Ala-Glu-Gly-Gly-Gly-Val-OH | 4066201 | H-8348 |
| Copeptin (human) | H-Ala-Ser-Asp-Arg-Ser-Asn-Ala-Thr-Gln-Leu-Asp-Gly-Pro-Ala-Gly-Ala-Leu-Leu-Leu-Arg-Leu-Val-Gln-Leu-Ala-Gly-Ala-Pro-Glu-Pro-Phe-Glu-Pro-Ala-Gln-Pro-Asp-Ala-Tyr-OH | 4066428 | H-6718 |
| Copeptin (rat) | H-Ala-Arg-Glu-Gln-Ser-Asn-Ala-Thr-Gln-Leu-Asp-Gly-Pro-Ala-Arg-Glu-Leu-Leu-Leu-Arg-Leu-Val-Gln-Leu-Ala-Gly-Thr-Gln-Glu-Ser-Val-Asp-Ser-Ala-Lys-Pro-Arg-Val-Tyr-OH | 4066687 | H-6726 |
| 6-Azido-hexanoic acid | 6-Azido-hexanoic acid | 4066756 | Q-2740 |
| (Des-Gly¹⁰,D-Trp⁶,Pro-NHEt⁹)-LHRH High acetate salt | Pyr-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-NHEt High acetate salt | 4066809 | H-4116 |
| Fmoc-Gln(Trt)-Thr(Psi(Me,Me)pro)-OH | Fmoc-Gln(Trt)-Thr(Psi(Me,Me)pro)-OH | 4066931 | B-4105 |
| Maxadilan | H-Cys-Asp-Ala-Thr-Cys-Gln-Phe-Arg-Lys-Ala-Ile-Asp-Asp-Cys-Gln-Lys-Gln-Ala-His-His-Ser-Asn-Val-Leu-Gln-Thr-Ser-Val-Gln-Thr-Thr-Ala-Thr-Phe-Thr-Ser-Met-Asp-Thr-Ser-Gln-Leu-Pro-Gly-Asn-Ser-Val-Phe-Lys-Glu-Cys-Met-Lys-Gln-Lys-Lys-Lys-Glu-Phe-Lys-Ala-NH₂ (Disulfide bonds between Cys¹ and Cys⁵/Cys¹⁴ and Cys⁵¹) | 4067317 | H-6734 |
| H-D-Pro-Pro-Glu-NH₂ | H-D-Pro-Pro-Glu-NH₂ | 4067627 | H-7468 |
| M65 | H-Cys-Asp-Ala-Thr-Cys-Gln-Phe-Arg-Lys-Ala-Ile-Asp-Asp-Cys-Gln-Lys-Gln-Ala-His-His-Ser-Asn-Val-Pro-Gly-Asn-Ser-Val-Phe-Lys-Glu-Cys-Met-Lys-Gln-Lys-Lys-Lys-Glu-Phe-Lys-Ala-NH₂ (Disulfide bonds between Cys¹ and Cys⁵/Cys¹⁴ and Cys³²) | 4067721 | H-6736 |
| Lanreotide | H-D-2-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH₂ (Disulfide bond) | 4067760 | H-9055 |
| C-Peptide (human) | H-Glu-Ala-Glu-Asp-Leu-Gln-Val-Gly-Gln-Val-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Ser-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ser-Leu-Gln-OH | 4068086 | H-7722 |
| Fmoc-Phe-Thr(Psi(Me,Me)pro)-OH | Fmoc-Phe-Thr(Psi(Me,Me)pro)-OH | 4068194 | B-4300 |
| Fmoc-Thr(tBu)-Thr(Psi(Me,Me)pro)-OH | Fmoc-Thr(tBu)-Thr(Psi(Me,Me)pro)-OH | 4068198 | B-4310 |
| Fmoc-Tyr(tBu)-Thr(Psi(Me,Me)pro)-OH | Fmoc-Tyr(tBu)-Thr(Psi(Me,Me)pro)-OH | 4068201 | B-4325 |
| Fmoc-Ala-Ser(Psi(Me,Me)pro)-OH | Fmoc-Ala-Ser(Psi(Me,Me)pro)-OH | 4068251 | B-4270 |
| Fmoc-Val-Ser(Psi(Me,Me)pro)-OH | Fmoc-Val-Ser(Psi(Me,Me)pro)-OH | 4068255 | B-4330 |
| H-Tyr(tBu)-2-chlorotrityl resin (200-400 mesh, 0.20-0.49 mmol/g) | H-Tyr(tBu)-2-chlorotrityl resin (200-400 mesh, 0.20-0.49 mmol/g) | 4068311 | D-2890 |
| Fmoc-Gln(Trt)-Ser(Psi(Me,Me)pro)-OH | Fmoc-Gln(Trt)-Ser(Psi(Me,Me)pro)-OH | 4068507 | B-4100 |
| H-Tyr(tBu)-2-chlorotrityl resin (200-400 mesh, 0.50-0.90 mmol/g) | H-Tyr(tBu)-2-chlorotrityl resin (200-400 mesh, 0.50-0.90 mmol/g) | 4068547 | D-2980 |
| pTH (2-34) (human) | H-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-OH | 4069253 | H-6786 |
| ([ring-D₅]Phe³)-Octreotide | H-D-Phe-Cys-[ring-D₅]Phe-D-Trp-Lys-Thr-Cys-L-threoninol (Disulfide bond) | 4069671 | H-7238 |
| HDMC | N-[(5-Chloro-1H-benzotriazol-1-yl)-dimethylamino-morpholino]-uronium hexafluorophosphate N-oxide | 4069891 | Q-2765 |
| Amyloid β-Protein (1-42)-Lys(biotinyl) amide | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-Lys(biotinyl)-NH₂ | 4069996 | |
| Cyclo(-Arg-Ala-Asp-D-Phe-Cys) | Cyclo(-Arg-Ala-Asp-D-Phe-Cys) | 4070810 | H-7232 |
| (Glu²⁴)-Glucagon (1-29) (human, rat, porcine) | H-His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Glu-Trp-Leu-Met-Asn-Thr-OH | 4071253 | H-8266 |
| Fmoc-Trp(Boc)-Thr(Psi(Me,Me)pro)-OH | Fmoc-Trp(Boc)-Thr(Psi(Me,Me)pro)-OH | 4071270 | B-4320 |
| Acetyl-Octreotide | Ac-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-L-threoninol (Disulfide bond) | 4071290 | |
| (Cys(S)²)-Octreotide | H-D-Phe-Cys(S)-Phe-D-Trp-Lys-Thr-Cys-L-threoninol (Trisulfide bond) | 4071291 | |
| PyOxim | (Ethyl cyano(hydroxyimino)acetato-O₂)-tri-(1-pyrrolidinyl)-phosphonium hexafluorophosphate | 4071639 | Q-2760 |
| Fmoc-Trp(Boc)-Ser(Psi(Me,Me)pro)-OH | Fmoc-Trp(Boc)-Ser(Psi(Me,Me)pro)-OH | 4071647 | B-4315 |
| TLQP-21 (human) | H-Thr-Leu-Gln-Pro-Pro-Ser-Ala-Leu-Arg-Arg-Arg-His-Tyr-His-His-Ala-Leu-Pro-Pro-Ser-Arg-OH | 4071858 | H-7268 |
| TLQP-21 (mouse, rat) | H-Thr-Leu-Gln-Pro-Pro-Ala-Ser-Ser-Arg-Arg-Arg-His-Phe-His-His-Ala-Leu-Pro-Pro-Ala-Arg-OH | 4071859 | H-7272 |
| ([¹³C₆]Leu¹⁵)-pTH (1-34) (human) | H-Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-[¹³C₆]Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-OH | 4072021 | H-7234 |
| ([¹³C₆]Leu¹⁴)-Glucagon (1-29) (human, rat, porcine) | H-His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-[¹³C₆]Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr-OH | 4072022 | H-7236 |
| ([¹³C₆]Leu⁵)-Ghrelin (human) | H-Gly-Ser-Ser(octanoyl)-Phe-[¹³C₆]Leu-Ser-Pro-Glu-His-Gln-Arg-Val-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg-OH | 4072025 | H-7252 |
| ([ring-D₅]Phe⁶)-Somatostatin-14 | H-Ala-Gly-Cys-Lys-Asn-[ring-D₅]Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys-OH (Disulfide bond) | 4072026 | H-7246 |
| ([ring-D₅]Phe⁸)-Angiotensin II | H-Asp-Arg-Val-Tyr-Ile-His-Pro-[ring-D₅]Phe-OH | 4072030 | H-7256 |
| (Des-Gly²)-Exenatide | H-His-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂ | 4072221 | H-7486 |
| Acetyl-Exenatide | Ac-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂ | 4072222 | H-7488 |
| Endo-38a-Pro-Exenatide | H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Pro-Ser-NH₂ | 4072223 | H-7492 |
| (D-His¹)-Exenatide | H-D-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂ | 4072224 | H-7494 |
| Amyloid β-Protein (11-42) | H-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | 4073393 | H-7668 |
| (D-Ser(tBu)⁶,Azagly¹⁰)-LHRH (free base) | Pyr-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-Azagly-NH₂ | 4073798 | H-7296 |
| Amylin (free acid) (human) | H-Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-OH (Disulfide bond) | 4073878 | H-7692 |
| Amyloid β-Protein (1-39) | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-OH | 4073896 | H-7458 |
| Prokineticin 2 Isoform 2 (human) | H-Ala-Val-Ile-Thr-Gly-Ala-Cys-Asp-Lys-Asp-Ser-Gln-Cys-Gly-Gly-Gly-Met-Cys-Cys-Ala-Val-Ser-Ile-Trp-Val-Lys-Ser-Ile-Arg-Ile-Cys-Thr-Pro-Met-Gly-Lys-Leu-Gly-Asp-Ser-Cys-His-Pro-Leu-Thr-Arg-Lys-Val-Pro-Phe-Phe-Gly-Arg-Arg-Met-His-His-Thr-Cys-Pro-Cys-Leu-Pro-Gly-Leu-Ala-Cys-Leu-Arg-Thr-Ser-Phe-Asn-Arg-Phe-Ile-Cys-Leu-Ala-Gln-Lys-OH (Disulfide bonds, air oxidized) | 4074529 | H-7342 |
| H-Gly-His-Arg-Pro-NH₂ | H-Gly-His-Arg-Pro-NH₂ | 4075030 | H-7318 |
| Fmoc-Dopa(acetonide)-OH | Fmoc-Dopa(acetonide)-OH | 4076682 | B-4250 |
| Octreotide | H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-L-threoninol (Disulfide bond) | 4076740 | H-8346 |
| Sulfo-N-succinimidyl 4-maleimidobutyrate sodium salt | Sulfo-N-succinimidyl 4-maleimidobutyrate sodium salt | 4077463 | Q-2770 |
| Calcium-Like Peptide 3 | H-Val-Lys-Phe-Gly-Val-Gly-Phe-Lys-OH | 4078801 | H-7344 |
| (Glu³)-Glucagon (1-29) (human, rat, porcine) | H-His-Ser-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr-OH | 4079054 | H-8258 |
| (Glu²⁰)-Glucagon (1-29) (human, rat, porcine) | H-His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Glu-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr-OH | 4079055 | H-8262 |
| (Asp²⁸)-Glucagon (1-29) (human, rat, porcine) | H-His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asp-Thr-OH | 4079056 | H-8264 |
| (Thr(PO₃H₂)²³¹)-Tau Peptide (225-237) | H-Lys-Val-Ala-Val-Val-Arg-Thr(PO₃H₂)-Pro-Pro-Lys-Ser-Pro-Ser-OH | 4079221 | H-8048 |
| Chlorotoxin | H-Met-Cys-Met-Pro-Cys-Phe-Thr-Thr-Asp-His-Gln-Met-Ala-Arg-Lys-Cys-Asp-Asp-Cys-Cys-Gly-Gly-Lys-Gly-Arg-Gly-Lys-Cys-Tyr-Gly-Pro-Gln-Cys-Leu-Cys-Arg-NH₂ (Disulfide bonds between Cys² and Cys¹⁹/Cys⁵ and Cys²⁸/Cys¹⁶ and Cys³³/Cys²⁰ and Cys³⁵) | 4079411 | H-8352 |
| Octreotide trifluoroacetate salt (Dimer, Parallel) | (H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-L-threoninol)₂ trifluoroacetate salt (Disulfide bonds between Cys²A and Cys²B/Cys⁷A and Cys⁷B) | 4080983 | H-7374 |
| Octreotide trifluoroacetate salt (Dimer, Antiparallel) | (H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-L-threoninol)₂ trifluoroacetate salt (Disulfide bonds between Cys²A and Cys⁷B/Cys⁷A and Cys²B) | 4080984 | H-7376 |
| (Orn(Ac)⁸)-Atosiban | 3-Mercaptopropionyl-D-Tyr(Et)-Ile-Thr-Asn-Cys-Pro-Orn(Ac)-Gly-NH₂ (Disulfide bond) | 4081126 | |
| Atosiban (1-8) lactam | 3-Mercaptopropionyl-D-Tyr(Et)-Ile-Thr-Asn-Cys-Pro-Orn-lactam (Disulfide bond) | 4081127 | |
| Fmoc-amino-PEG2-ethylamino-Suc-OH | Fmoc-amino-PEG2-ethylamino-Suc-OH | 4082329 | Q-2815 |
| Fmoc-Tyr(SO₂(ONeopentyl))-OH | Fmoc-Tyr(SO₂(ONeopentyl))-OH | 4082682 | B-4230 |
| Fmoc-Thr(GalNAc(Ac)₃-β-D)-OH | Fmoc-Thr(GalNAc(Ac)₃-β-D)-OH | 4082689 | B-4240 |
| Fmoc-Thr(GlcNAc(Ac)₃-β-D)-OH | Fmoc-Thr(GlcNAc(Ac)₃-β-D)-OH | 4082690 | B-4245 |
| Met(O)¹⁴-Exenatide | H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met(O)-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂ | 4082706 | H-7498 |
| Atosiban (free acid) | 3-Mercaptopropionyl-D-Tyr(Et)-Ile-Thr-Asn-Cys-Pro-Orn-Gly-OH (Disulfide bond) | 4083914 | |
| (Orn(Atosiban (free acid))⁸)-Atosiban | 3-Mercaptopropionyl-D-Tyr(Et)-Ile-Thr-Asn-Cys-Pro-Orn(Gly-Orn-Pro-Cys-Asn-Thr-Ile-D-Tyr(Et)-3-mercaptopropionyl)-Gly-NH₂ (Disulfide bonds between 3-Mercaptopropionyl A and Cys A/Cys B and 3-Mercaptopropionyl B) | 4083915 | |
| Lixisenatide | H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Ser-Lys-Lys-Lys-Lys-Lys-Lys-NH₂ | 4084106 | H-7426 |
| Hepcidin-24 (human) | H-Thr-His-Phe-Pro-Ile-Cys-Ile-Phe-Cys-Cys-Gly-Cys-Cys-His-Arg-Ser-Lys-Cys-Gly-Met-Cys-Cys-Lys-Thr-OH (Disulfide bonds, air oxidized) | 4084346 | H-7378 |
| (D-Asn²⁸)-Exenatide | H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-D-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂ | 4084643 | H-8192 |
| (Asp²⁸)-Exenatide | H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asp-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂ | 4085312 | H-7496 |
| (D-Asp²⁸)-Exenatide | H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-D-Asp-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂ | 4085313 | H-8184 |
| (β-Asp²⁸)-Exenatide | H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asp(Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂)-OH | 4085314 | H-8186 |
| (β-D-Asp²⁸)-Exenatide | H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-D-Asp(Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂)-OH | 4085315 | H-8188 |
| Endotrophin (mouse) | H-Thr-Glu-Pro-Leu-Phe-Leu-Thr-Lys-Thr-Asp-Ile-Cys-Lys-Leu-Ser-Arg-Asp-Ala-Gly-Thr-Cys-Val-Asp-Phe-Lys-Leu-Leu-Trp-His-Tyr-Asp-Leu-Glu-Ser-Lys-Ser-Cys-Lys-Arg-Phe-Trp-Tyr-Gly-Gly-Cys-Gly-Gly-Asn-Glu-Asn-Arg-Phe-His-Ser-Gln-Glu-Glu-Cys-Glu-Lys-Met-Cys-Ser-Pro-Glu-Leu-Thr-Val-OH (Disulfide bonds, air oxidized) | 4085553 | H-7382 |
| Cyclo(-Arg-Gly-Asp-D-Phe-Glu) | Cyclo(-Arg-Gly-Asp-D-Phe-Glu) | 4086218 | |
| (Asp³⁷¹)-Tyrosinase (369-377) (human) | H-Tyr-Met-Asp-Gly-Thr-Met-Ser-Gln-Val-OH | 4086336 | H-7732 |
| H-Glu[cyclo(-Arg-Gly-Asp-D-Phe-Lys)]-cyclo(-Arg-Gly-Asp-D-Phe-Lys) | H-Glu[cyclo(-Arg-Gly-Asp-D-Phe-Lys)]-cyclo(-Arg-Gly-Asp-D-Phe-Lys) | 4086610 | H-7952 |
| Lactoferricin B25 | H-Phe-Lys-Cys-Arg-Arg-Trp-Gln-Trp-Arg-Met-Lys-Lys-Leu-Gly-Ala-Pro-Ser-Ile-Thr-Cys-Val-Arg-Arg-Ala-Phe-OH (Disulfide bond) | 4087382 | H-7388 |
| 4-Maleimidobutyric acid N-hydroxysuccinimide ester | 4087894 | Q-2775 | |
| Tau Peptide (255-314) (Repeat 2 Domain) (human) | H-Asn-Val-Lys-Ser-Lys-Ile-Gly-Ser-Thr-Glu-Asn-Leu-Lys-His-Gln-Pro-Gly-Gly-Gly-Lys-Val-Gln-Ile-Ile-Asn-Lys-Lys-Leu-Asp-Leu-Ser-Asn-Val-Gln-Ser-Lys-Cys-Gly-Ser-Lys-Asp-Asn-Ile-Lys-His-Val-Pro-Gly-Gly-Gly-Ser-Val-Gln-Ile-Val-Tyr-Lys-Pro-Val-Asp-OH | 4088071 | H-8038 |
| Glucagon (1-29) (human, rat, porcine) | H-His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr-OH | 4088814 | H-7754 |
| Biotinyl-Tau Peptide (306-336) (Repeat 3 Domain) (human) | Biotinyl-Val-Gln-Ile-Val-Tyr-Lys-Pro-Val-Asp-Leu-Ser-Lys-Val-Thr-Ser-Lys-Cys-Gly-Ser-Leu-Gly-Asn-Ile-His-His-Lys-Pro-Gly-Gly-Gly-Gln-OH | 4088980 | H-8028 |
| Ac-Trp-Glu-His-Asp-AFC | Ac-Trp-Glu-His-Asp-AFC | 4089441 | I-2010 |
| 5-FAM-Amylin (human) | Fluorescein-5-carbonyl-Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH₂ (Disulfide bond) | 4089771 | H-7392 |
| Biotinyl-Amylin (mouse, rat) | Biotinyl-Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH₂ (Disulfide bond) | 4089772 | H-7394 |
| Amyloid β-Protein (1-42) | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | 4089802 | H-7404 |
| (Gln²²,Asn²³)-Amyloid β-Protein (1-40) | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gln-Asn-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH | 4089804 | H-7412 |
| Amyloid β-Protein (3-42) | H-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | 4090137 | H-7432 |
| Amyloid β-Protein (4-42) | H-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | 4090138 | H-7434 |
| 5-TAMRA-Amyloid β-Protein (1-42) | 5-TAMRA-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | 4090153 | H-7448 |
| 5-TAMRA-Amyloid β-Protein (1-40) | 5-TAMRA-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH | 4090154 | H-7452 |
| H-Pro-Pro-Asp-NH₂ | H-Pro-Pro-Asp-NH₂ | 4090413 | H-7464 |
| H-Pro-Pro-Gln-OH | H-Pro-Pro-Gln-OH | 4090414 | H-7466 |
| Biotinyl-(Glu¹)-Orexin A (human, mouse, rat) | Biotinyl-Glu-Pro-Leu-Pro-Asp-Cys-Cys-Arg-Gln-Lys-Thr-Cys-Ser-Cys-Arg-Leu-Tyr-Glu-Leu-Leu-His-Gly-Ala-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Leu-NH₂ (Disulfide bonds between Cys⁶ and Cys¹²/Cys⁷ and Cys¹⁴) | 4091432 | H-7478 |
| H-Cys(NPys)-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-NH₂ | H-Cys(NPys)-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-NH₂ | 4091590 | H-7504 |
| Hel 13-5 | H-Lys-Leu-Leu-Lys-Leu-Leu-Leu-Lys-Leu-Trp-Leu-Lys-Leu-Leu-Lys-Leu-Leu-Leu-OH | 4091591 | H-7506 |
| Semaglutide | H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEAc-AEEAc-γ-Glu-17-carboxyheptadecanoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH | 4091661 | H-7894 |
| Orexin A (17-33) | H-Tyr-Glu-Leu-Leu-His-Gly-Ala-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Leu-NH₂ | 4092130 | H-7526 |
| Atrial Natriuretic Factor (1-28) (human) | H-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH (Disulfide bond) | 4092396 | H-7716 |
| Fmoc-Tyr(tBu)-OH | Fmoc-Tyr(tBu)-OH | 4093144 | B-1255 |
| Fmoc-Val-OH | Fmoc-Val-OH | 4093145 | B-1455 |
| Fmoc-Glu(OtBu)-Ser(Psi(Me,Me)pro)-OH | Fmoc-Glu(OtBu)-Ser(Psi(Me,Me)pro)-OH | 4095292 | B-4285 |
| Fmoc-Ala-Thr(Psi(Me,Me)pro)-OH | Fmoc-Ala-Thr(Psi(Me,Me)pro)-OH | 4095294 | B-3535 |
| Tau Peptide (306-336) (Repeat 3 Domain) | H-Val-Gln-Ile-Val-Tyr-Lys-Pro-Val-Asp-Leu-Ser-Lys-Val-Thr-Ser-Lys-Cys-Gly-Ser-Leu-Gly-Asn-Ile-His-His-Lys-Pro-Gly-Gly-Gly-Gln-OH | 4095430 | H-7814 |
| Ac-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Ile-Glu-Thr-Asp-aldehyde | Ac-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Ile-Glu-Thr-Asp-aldehyde | 4095478 | N-2015 |
| Atrial Natriuretic Factor (5-27) (human) | H-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-OH (Disulfide bond) | 4095498 | H-7548 |
| β-Bag Cell Peptide (Aplysia californica) | H-Arg-Leu-Arg-Phe-His-OH | 4095499 | H-7552 |
| BNP-45 (mouse) | H-Ser-Gln-Gly-Ser-Thr-Leu-Arg-Val-Gln-Gln-Arg-Pro-Gln-Asn-Ser-Lys-Val-Thr-His-Ile-Ser-Ser-Cys-Phe-Gly-His-Lys-Ile-Asp-Arg-Ile-Gly-Ser-Val-Ser-Arg-Leu-Gly-Cys-Asn-Ala-Leu-Lys-Leu-Leu-OH (Disulfide bond) | 4095506 | H-7558 |
| CART (55-76) (rat) | H-Ile-Pro-Ile-Tyr-Glu-Lys-Lys-Tyr-Gly-Gln-Val-Pro-Met-Cys-Asp-Ala-Gly-Glu-Gln-Cys-Ala-Val-OH (Disulfide bond) | 4095507 | H-7562 |
| Dynorphin A (1-13) amide | H-Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-NH₂ | 4095508 | H-7564 |
| Big Endothelin-2 (human) | H-Cys-Ser-Cys-Ser-Ser-Trp-Leu-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp-Val-Asn-Thr-Pro-Glu-Gln-Thr-Ala-Pro-Tyr-Gly-Leu-Gly-Asn-Pro-Pro-Arg-OH (Disulfide bonds between Cys¹ and Cys¹⁵/Cys³ and Cys¹¹) | 4095509 | H-7566 |
| Big Endothelin-3 (22-41) amide (human) | H-Ile-Asn-Thr-Pro-Glu-Gln-Thr-Val-Pro-Tyr-Gly-Leu-Ser-Asn-Tyr-Arg-Gly-Ser-Phe-Arg-NH₂ | 4095510 | H-7568 |
| (Ser(Ac)³)-Ghrelin (mouse, rat) | H-Gly-Ser-Ser(Ac)-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg-OH | 4095528 | H-7638 |
| GAP 27 | H-Ser-Arg-Pro-Thr-Glu-Lys-Thr-Ile-Phe-Ile-Ile-OH | 4095532 | H-7592 |
| WRW4 | H-Trp-Arg-Trp-Trp-Trp-Trp-NH₂ | 4095537 | H-7596 |
| Caloxin 2A1 | H-Val-Ser-Asn-Ser-Asn-Trp-Pro-Ser-Phe-Pro-Ser-Ser-Gly-Gly-Gly-NH₂ | 4095538 | N-2020 |
| Antifreeze Polypeptide 6 (winter flounder) | H-Asp-Thr-Ala-Ser-Asp-Ala-Ala-Ala-Ala-Ala-Ala-Leu-Thr-Ala-Ala-Asn-Ala-Lys-Ala-Ala-Ala-Glu-Leu-Thr-Ala-Ala-Asn-Ala-Ala-Ala-Ala-Ala-Ala-Ala-Thr-Ala-Arg-OH | 4095546 | H-7602 |
| TRAF6 Peptide | H-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Glu-Ser-Ala-Ser-Gly-Pro-Ser-Glu-Asp-Pro-Ser-Val-Asn-Phe-Leu-Lys-OH | 4095548 | H-7604 |
| TRAF6 Control Peptide | H-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Glu-Ser-Ala-Ser-Gly-Ala-Ser-Ala-Asp-Ala-Ser-Val-Asn-Phe-Leu-Lys-OH | 4095549 | H-7606 |
| Suc-Ala-Ala-Pro-Abu-pNA | Suc-Ala-Ala-Pro-Abu-pNA | 4095552 | L-2160 |
| 1,3-Bis-(Z-Leu-Leu)-diaminoacetone | Z-Leu-Leu-NH-CH₂-CO-CH₂-NH-Leu-Leu-Z | 4095624 | C-4275 |
| PKA Inhibitor (6-22) amide | H-Thr-Tyr-Ala-Asp-Phe-Ile-Ala-Ser-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-NH₂ | 4095625 | N-2040 |
| Phalloidin | Cyclo(-Ala-D-Thr-Cys-cis-Hyp-Ala-Trp-(4R)-4,5-dihydroxy-Leu) (Sulfide bond between Cys and indol-2-yl) | 4095642 | H-7598 |
| ((R)-4-Hydroxy-4-methyl-Orn(FITC)⁷)-Phalloidin | Cyclo(-Ala-D-Thr-Cys-cis-Hyp-Ala-Trp-(4R)-4-hydroxy-4-Me-Orn(FITC)) (Sulfide bond between Cys and indol-2-yl) | 4095643 | H-7624 |
| ((R)-4-Hydroxy-4-methyl-Orn(5-TAMRA)⁷)-Phalloidin | Cyclo(-Ala-D-Thr-Cys-cis-Hyp-Ala-Trp-(4R)-4-hydroxy-4-Me-Orn(5-TAMRA)) (Sulfide bond between Cys and indol-2-yl) | 4095644 | H-7626 |
| ((R)-4-Hydroxy-4-methyl-Orn(TRITC)⁷)-Phalloidin | Cyclo(-Ala-D-Thr-Cys-cis-Hyp-Ala-Trp-(4R)-4-hydroxy-4-Me-Orn(TRITC)) (Sulfide bond between Cys and indol-2-yl) | 4095645 | H-7628 |
| ((R)-4-Hydroxy-4-methyl-Orn(CPM-β-Mpa)⁷)-Phalloidin | Cyclo(-Ala-D-Thr-Cys-cis-Hyp-Ala-Trp-(4R)-4-hydroxy-4-Me-Orn(3-(3-(N-(4-(7-diethylamino-4-methylcoumarin-3-yl)phenyl)succinimido)sulfanyl)propanoyl)) (Sulfide bond between Cys and indol-2-yl) | 4095646 | H-7632 |
| ((R)-4-Hydroxy-4-methyl-Orn⁷)-Phalloidin | Cyclo(-Ala-D-Thr-Cys-cis-Hyp-Ala-Trp-(4R)-4-hydroxy-4-Me-Orn) (Sulfide bond between Cys and indol-2-yl) | 4095647 | H-7634 |
| (Lys⁷)-Phalloidin | Cyclo(-Ala-D-Thr-Cys-cis-Hyp-Ala-Trp-Lys) (Sulfide bond between Cys and indol-2-yl) | 4095648 | H-7636 |
| α-Conotoxin EI (free acid) | H-Arg-Asp-Hyp-Cys-Cys-Tyr-His-Pro-Thr-Cys-Asn-Met-Ser-Asn-Pro-Gln-Ile-Cys-OH (Disulfide bonds between Cys⁴ and Cys¹⁰/Cys⁵ and Cys¹⁸) | 4095662 | H-7704 |
| TAT 2-4 | H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Gly-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Gly-OH | 4095685 | H-7648 |
| (His(3-Me)²)-TRH | Pyr-His(3-Me)-Pro-NH₂ | 4095712 | H-7652 |
| Amyloid β-Protein (1-24) | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-OH | 4095720 | H-7656 |
| Acetyl-(N-Me-Leu¹⁷,N-Me-Phe¹⁹)-Amyloid β-Protein (16-20) amide | Ac-Lys-N-Me-Leu-Val-N-Me-Phe-Phe-NH₂ | 4095735 | H-7658 |
| Adrenomedullin (porcine) | H-Tyr-Arg-Gln-Ser-Met-Asn-Asn-Phe-Gln-Gly-Leu-Arg-Ser-Phe-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Gly-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH₂ (Disulfide bond) | 4095741 | H-7682 |
| Ac-Asp-Glu-Val-Asp-chloromethylketone | Ac-Asp-Glu-Val-Asp-chloromethylketone | 4095742 | N-2025 |
| Cecropin B (free acid) | H-Lys-Trp-Lys-Val-Phe-Lys-Lys-Ile-Glu-Lys-Met-Gly-Arg-Asn-Ile-Arg-Asn-Gly-Ile-Val-Lys-Ala-Gly-Pro-Ala-Ile-Ala-Val-Leu-Gly-Glu-Ala-Lys-Ala-Leu-OH | 4095745 | H-7696 |
| Biotinyl-PEG2-maleimide | Biotinyl-PEG2-maleimide | 4095746 | Q-2785 |
| ACTH (1-14) | H-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-OH | 4095839 | H-7708 |
| C-Type Natriuretic Peptide (32-53) (human, porcine, rat) | H-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys-OH (Disulfide bond) | 4095840 | H-7712 |
| Angiotensin II | H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-OH | 4095850 | H-7714 |
| Atrial Natriuretic Factor (1-28) (human) | H-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH (Disulfide bond) | 4095851 | H-7718 |
| MART-1 (27-35) (human) | H-Ala-Ala-Gly-Ile-Gly-Ile-Leu-Thr-Val-OH | 4095854 | H-7734 |
| pTH (1-34) (human) | H-Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-OH | 4095855 | H-7736 |
| GLP-2 (1-33) (human) | H-His-Ala-Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Ala-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp-OH | 4095874 | H-7742 |
| Matrix Protein M1 (58-66) (Influenza A virus) | H-Gly-Ile-Leu-Gly-Phe-Val-Phe-Thr-Leu-OH | 4095875 | H-7744 |
| (Ala¹³)-Apelin-13 (human, bovine, mouse, rat) (Salt form acetate) | H-Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Ala-OH | 4095877 | H-7752 |
| Thymosin α₁ | Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH | 4095878 | H-7756 |
| Galanin (human) | H-Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Val-Gly-Asn-His-Arg-Ser-Phe-Ser-Asp-Lys-Asn-Gly-Leu-Thr-Ser-OH | 4095896 | H-7762 |
| TRAP-6 | H-Ser-Phe-Leu-Leu-Arg-Asn-OH | 4095909 | H-7764 |
| C-Type Natriuretic Peptide (1-53) (human) | H-Asp-Leu-Arg-Val-Asp-Thr-Lys-Ser-Arg-Ala-Ala-Trp-Ala-Arg-Leu-Leu-Gln-Glu-His-Pro-Asn-Ala-Arg-Lys-Tyr-Lys-Gly-Ala-Asn-Lys-Lys-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys-OH (Disulfide bond) | 4095913 | H-7766 |
| Endothelin-3 (human, mouse, rabbit, rat) | H-Cys-Thr-Cys-Phe-Thr-Tyr-Lys-Asp-Lys-Glu-Cys-Val-Tyr-Tyr-Cys-His-Leu-Asp-Ile-Ile-Trp-OH (Disulfide bonds between Cys¹ and Cys¹⁵/Cys³ and Cys¹¹) | 4095915 | H-7772 |
| BNP-32 (human) | H-Ser-Pro-Lys-Met-Val-Gln-Gly-Ser-Gly-Cys-Phe-Gly-Arg-Lys-Met-Asp-Arg-Ile-Ser-Ser-Ser-Ser-Gly-Leu-Gly-Cys-Lys-Val-Leu-Arg-Arg-His-OH (Disulfide bond) | 4095916 | H-7774 |
| Kemptide | H-Leu-Arg-Arg-Ala-Ser-Leu-Gly-OH | 4095917 | M-2725 |
| Fmoc-Gly-Cys(Psi(Dmp,H)pro)-OH | Fmoc-Gly-Cys(Psi(Dmp,H)pro)-OH | 4096169 | B-4395 |
| Fmoc-Lys(Boc)-Cys(Psi(Dmp,H)pro)-OH | Fmoc-Lys(Boc)-Cys(Psi(Dmp,H)pro)-OH | 4096176 | B-4405 |
| Fmoc-Val-Cys(Psi(Dmp,H)pro)-OH | Fmoc-Val-Cys(Psi(Dmp,H)pro)-OH | 4096177 | B-4410 |
| Fmoc-Thr(tBu)-OH | Fmoc-Thr(tBu)-OH | 4096755 | B-1245 |
| (Lys(Ac)⁵·⁸·¹²·¹⁶)-Histone H4 (1-25)-Gly-Ser-Gly-Ser-Lys(biotinyl) | H-Ser-Gly-Arg-Gly-Lys(Ac)-Gly-Gly-Lys(Ac)-Gly-Leu-Gly-Lys(Ac)-Gly-Gly-Ala-Lys(Ac)-Arg-His-Arg-Lys-Val-Leu-Arg-Asp-Asn-Gly-Ser-Gly-Ser-Lys(biotinyl)-OH | 4097460 | H-7776 |
| (Lys(Ac)¹²)-Histone H4 (1-21)-Gly-Gly-Lys(biotinyl) | Ac-Ser-Gly-Arg-Gly-Lys-Gly-Gly-Lys-Gly-Leu-Gly-Lys(Ac)-Gly-Gly-Ala-Lys-Arg-His-Arg-Lys-Val-Gly-Gly-Lys(biotinyl)-OH | 4097495 | H-7778 |
| (Lys(Me)₂⁴)-Histone H3 (1-21)-Gly-Gly-Lys(biotinyl) | H-Ala-Arg-Thr-Lys(Me)₂-Gln-Thr-Ala-Arg-Lys-Ser-Thr-Gly-Gly-Lys-Ala-Pro-Arg-Lys-Gln-Leu-Ala-Gly-Gly-Lys(biotinyl)-OH | 4097928 | H-7784 |
| (Lys(Me)₃²⁷)-Histone H3 (21-44)-Gly-Lys(biotinyl) | H-Ala-Thr-Lys-Ala-Ala-Arg-Lys(Me)₃-Ser-Ala-Pro-Ala-Thr-Gly-Gly-Val-Lys-Lys-Pro-His-Arg-Tyr-Arg-Pro-Gly-Gly-Lys(biotinyl)-OH | 4097929 | H-7786 |
| (Lys(Me)₃⁴)-Histone H3 (1-21)-Gly-Gly-Lys(biotinyl) amide | H-Ala-Arg-Thr-Lys(Me)₃-Gln-Thr-Ala-Arg-Lys-Ser-Thr-Gly-Gly-Lys-Ala-Pro-Arg-Lys-Gln-Leu-Ala-Gly-Gly-Lys(biotinyl)-NH₂ | 4097931 | H-7788 |
| (Lys(Me)₃⁹)-Histone H3 (1-21)-Gly-Gly-Lys(biotinyl) amide | H-Ala-Arg-Thr-Lys-Gln-Thr-Ala-Arg-Lys(Me)₃-Ser-Thr-Gly-Gly-Lys-Ala-Pro-Arg-Lys-Gln-Leu-Ala-Gly-Gly-Lys(biotinyl)-NH₂ | 4097932 | H-7792 |
| Big Endothelin-1 (rat) | H-Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp-Val-Asn-Thr-Pro-Glu-Arg-Val-Val-Pro-Tyr-Gly-Leu-Gly-Ser-Pro-Ser-Arg-Ser-OH (Disulfide bonds between Cys¹ and Cys¹⁵/Cys³ and Cys¹¹) | 4099185 | H-8138 |
| Tau Peptide (45-73) (Exon 2/Insert 1 Domain) | H-Glu-Ser-Pro-Leu-Gln-Thr-Pro-Thr-Glu-Asp-Gly-Ser-Glu-Glu-Pro-Gly-Ser-Glu-Thr-Ser-Asp-Ala-Lys-Ser-Thr-Pro-Thr-Ala-Glu-OH | 4099382 | H-7804 |
| Tau Peptide (74-102) (Exon 3/Insert 2 Domain) | H-Asp-Val-Thr-Ala-Pro-Leu-Val-Asp-Glu-Gly-Ala-Pro-Gly-Lys-Gln-Ala-Ala-Ala-Gln-Pro-His-Thr-Glu-Ile-Pro-Glu-Gly-Thr-Thr-OH | 4099384 | H-7806 |
| Acetyl-Tau Peptide (244-274) (Repeat 1 Domain) | Ac-Gln-Thr-Ala-Pro-Val-Pro-Met-Pro-Asp-Leu-Lys-Asn-Val-Lys-Ser-Lys-Ile-Gly-Ser-Thr-Glu-Asn-Leu-Lys-His-Gln-Pro-Gly-Gly-Gly-Lys-OH | 4099385 | H-7808 |
| Tau Peptide (275-305) (Repeat 2 Domain) | H-Val-Gln-Ile-Ile-Asn-Lys-Lys-Leu-Asp-Leu-Ser-Asn-Val-Gln-Ser-Lys-Cys-Gly-Ser-Lys-Asp-Asn-Ile-Lys-His-Val-Pro-Gly-Gly-Gly-Ser-OH | 4099386 | H-7812 |
| Microtubule-Associated Protein (142-161) (human) | H-Ser-Pro-Gln-Leu-Ala-Thr-Leu-Ala-Asp-Glu-Val-Ser-Ala-Ser-Leu-Ala-Lys-Gln-Gly-Leu-OH | 4099393 | H-8062 |
| Tau Peptide (401-411)-Lys-Lys | H-Gly-Asp-Thr-Ser-Pro-Arg-His-Leu-Ser-Asn-Val-Lys-Lys-OH | 4099395 | H-7818 |
| Tau Peptide (245-274) (Repeat 1 Domain) | H-Thr-Ala-Pro-Val-Pro-Met-Pro-Asp-Leu-Lys-Asn-Val-Lys-Ser-Lys-Ile-Gly-Ser-Thr-Glu-Asn-Leu-Lys-His-Gln-Pro-Gly-Gly-Gly-Lys-OH | 4099396 | H-7978 |
| Tau Peptide (244-274) (Repeat 1 Domain) | H-Gln-Thr-Ala-Pro-Val-Pro-Met-Pro-Asp-Leu-Lys-Asn-Val-Lys-Ser-Lys-Ile-Gly-Ser-Thr-Glu-Asn-Leu-Lys-His-Gln-Pro-Gly-Gly-Gly-Lys-OH | 4099397 | H-7982 |
| Tau Peptide (512-525) amide | H-Ser-Gly-Tyr-Ser-Ser-Pro-Gly-Ser-Pro-Gly-Thr-Pro-Gly-Ser-NH₂ | 4099402 | H-7984 |
| HHV-2 Envelope Glycoprotein G (552-574) | H-Pro-Pro-Pro-Pro-Glu-His-Arg-Gly-Gly-Pro-Glu-Glu-Phe-Glu-Gly-Ala-Gly-Asp-Gly-Glu-Pro-Pro-Glu-OH | 4099405 | H-7998 |
| FITC-εAhx-HHV-2 Envelope Glycoprotein G (561-578) | FITC-εAhx-Pro-Glu-Glu-Phe-Glu-Gly-Ala-Gly-Asp-Gly-Glu-Pro-Pro-Glu-Asp-Asp-Asp-Ser-OH | 4099407 | H-8002 |
| Tau Peptide (268-282) | H-His-Gln-Pro-Gly-Gly-Gly-Lys-Val-Gln-Ile-Ile-Asn-Lys-Lys-Leu-OH | 4099418 | H-8068 |
| Tau Peptide (274-288) | H-Lys-Val-Gln-Ile-Ile-Asn-Lys-Lys-Leu-Asp-Leu-Ser-Asn-Val-Gln-OH | 4099419 | H-8072 |
| Tau Peptide (277-291) | H-Ile-Ile-Asn-Lys-Lys-Leu-Asp-Leu-Ser-Asn-Val-Gln-Ser-Lys-Cys-OH | 4099420 | H-8074 |
| Tau Peptide (295-309) | H-Asp-Asn-Ile-Lys-His-Val-Pro-Gly-Gly-Gly-Ser-Val-Gln-Ile-Val-OH | 4099421 | H-8076 |
| Tau Peptide (298-312) | H-Lys-His-Val-Pro-Gly-Gly-Gly-Ser-Val-Gln-Ile-Val-Tyr-Lys-Pro-OH | 4099422 | H-8078 |
| Tau Peptide (301-315) | H-Pro-Gly-Gly-Gly-Ser-Val-Gln-Ile-Val-Tyr-Lys-Pro-Val-Asp-Leu-OH | 4099423 | H-8082 |
| Tau Peptide (304-318) | H-Gly-Ser-Val-Gln-Ile-Val-Tyr-Lys-Pro-Val-Asp-Leu-Ser-Lys-Val-OH | 4099425 | H-8084 |
| Tau Peptide (307-321) | H-Gln-Ile-Val-Tyr-Lys-Pro-Val-Asp-Leu-Ser-Lys-Val-Thr-Ser-Lys-OH | 4099426 | H-8086 |
| Lactoferrin (322-329) (human) | H-Asn-Ala-Gly-Asp-Val-Ala-Phe-Val-OH | 4099427 | H-8088 |
| Amylin (14-20) (human) | H-Asn-Phe-Leu-Val-His-Ser-Ser-OH | 4099428 | H-8094 |
| Tau Peptide (306-317) | H-Val-Gln-Ile-Val-Tyr-Lys-Pro-Val-Asp-Leu-Ser-Lys-OH | 4099429 | H-8096 |
| Tau Peptide (273-284) | H-Gly-Lys-Val-Gln-Ile-Ile-Asn-Lys-Lys-Leu-Asp-Leu-OH | 4099430 | H-8102 |
| Acetyl-PHF5 amide | Ac-Gln-Ile-Val-Tyr-Lys-NH₂ | 4099440 | H-8104 |
| Acetyl-PHF4 amide | Ac-Ile-Val-Tyr-Lys-NH₂ | 4099441 | H-8106 |
| Ac-Val-Tyr-Lys-NH₂ | Ac-Val-Tyr-Lys-NH₂ | 4099442 | H-8108 |
| Acetyl-PHF6YA amide | Ac-Val-Gln-Ile-Val-Ala-Lys-NH₂ | 4099445 | H-8116 |
| Acetyl-PHF6QV amide | Ac-Val-Val-Ile-Val-Tyr-Lys-NH₂ | 4099446 | H-8118 |
| Acetyl-PHF6KE amide | Ac-Val-Gln-Ile-Val-Tyr-Glu-NH₂ | 4099447 | H-8122 |
| (Cysteinol⁷,des-L-threoninol⁸)-Octreotide | H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-cysteinol (Disulfide bond) | 4099461 | |
| (Des-L-threoninol⁸)-Octreotide amide | H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-NH₂ (Disulfide bond) | 4099462 | |
| (L-Threoninol(Ac)⁸)-Octreotide | H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-L-threoninol(Ac) (Disulfide bond) | 4099463 | |
| (D-Cys⁷,des-L-threoninol⁸)-Octreotide | H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-D-Cys-OH (Disulfide bond) | 4099464 | |
| (Lys(Ac)⁵)-Octreotide | H-D-Phe-Cys-Phe-D-Trp-Lys(Ac)-Thr-Cys-L-threoninol (Disulfide bond) | 4099465 | |
| Fmoc-Asp(OtBu)-Thr(Psi(Me,Me)pro)-OH | Fmoc-Asp(OtBu)-Thr(Psi(Me,Me)pro)-OH | 4099473 | B-4280 |
| Tau Peptide (337-368) (Repeat 4 Domain) | H-Val-Glu-Val-Lys-Ser-Glu-Lys-Leu-Asp-Phe-Lys-Asp-Arg-Val-Gln-Ser-Lys-Ile-Gly-Ser-Leu-Asp-Asn-Ile-Thr-His-Val-Pro-Gly-Gly-Gly-Asn-OH | 4099613 | H-7816 |
| Tau Peptide (1-16) (human) | H-Met-Ala-Glu-Pro-Arg-Gln-Glu-Phe-Glu-Val-Met-Glu-Asp-Met-Ala-Gly-OH | 4099614 | H-8004 |
| Lys-Trp-Lys-(Ser(GlcNAc-β-D)⁴⁰⁰)-Tau Peptide (388 – 411)-Lys-Lys(biotinyl) amide | H-Lys-Trp-Lys-His-Gly-Ala-Glu-Ile-Val-Tyr-Lys-Ser-Pro-Val-Val-Ser(GlcNAc-β-D)-Gly-Asp-Thr-Ser-Pro-Arg-His-Leu-Ser-Asn-Val-Lys-Lys(biotinyl)-NH₂ | 4099615 | H-7822 |
| T-Peptide | Ac-D-Val-D-Gln-D-Ile-D-Val-D-Tyr-D-Lys-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-NH₂ | 4099620 | H-8126 |
| Tau Peptide (472-487)-PEG6-(507-526) (human) | H-Arg-Gly-Ala-Ala-Pro-Pro-Gly-Gln-Lys-Gly-Gln-Ala-Asn-Ala-Thr-Arg-amino-PEG6-propionyl-Lys-Ser-Gly-Asp-Arg-Ser-Gly-Tyr-Ser-Ser-Pro-Gly-Ser-Pro-Gly-Thr-Pro-Gly-Ser-Arg-OH | 4099622 | H-7988 |
| (Asp³⁷)-Amyloid β-Protein (1-42) | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Asp-Gly-Val-Val-Ile-Ala-OH | 4099631 | H-7842 |
| (Ala²)-Endothelin-3 (human, mouse, rabbit, rat) | H-Cys-Ala-Cys-Phe-Thr-Tyr-Lys-Asp-Lys-Glu-Cys-Val-Tyr-Tyr-Cys-His-Leu-Asp-Ile-Ile-Trp-OH (Disulfide bonds between Cys¹ and Cys¹⁵/Cys³ and Cys¹¹) | 4099639 | H-7918 |
| Azido-PEG3-DYKDDDDK | Azido-PEG3-propionyl-Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys-OH | 4099640 | H-7924 |
| RGD Negative Control | Cyclo(-Arg-Ala-Asp-D-Phe-Glu) | 4099641 | |
| Cyclo(-Arg-Gly-Asp-D-Tyr-ε-azido-Nle) | Cyclo(-Arg-Gly-Asp-D-Tyr-ε-azido-Nle) | 4099642 | |
| 5-FAM-Amyloid β-Protein (1-42) (scrambled) | Fluorescein-5-carbonyl-Ala-Ile-Ala-Glu-Gly-Asp-Ser-His-Val-Leu-Lys-Glu-Gly-Ala-Tyr-Met-Glu-Ile-Phe-Asp-Val-Gln-Gly-His-Val-Phe-Gly-Gly-Lys-Ile-Phe-Arg-Val-Val-Asp-Leu-Gly-Ser-His-Asn-Val-Ala-OH | 4099694 | H-7836 |
| LL-37 FK-13 | H-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-OH | 4099695 | H-7868 |
| LL-37 GKE | H-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-OH | 4099696 | H-7872 |
| LL-37 FKR | H-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-Thr-Glu-Ser-OH | 4099697 | H-7874 |
| LL-37 LLG | H-Leu-Leu-Gly-Asp-Phe-Phe-Arg-Lys-Ser-Lys-Glu-Lys-Ile-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-OH | 4099698 | H-7878 |
| LL-37 SKE | H-Ser-Lys-Glu-Lys-Ile-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-OH | 4099699 | H-7884 |
| LL-37 (scrambled) | H-Gly-Leu-Lys-Leu-Arg-Phe-Glu-Phe-Ser-Lys-Ile-Lys-Gly-Glu-Phe-Leu-Lys-Thr-Pro-Glu-Val-Arg-Phe-Arg-Asp-Ile-Lys-Leu-Lys-Asp-Asn-Arg-Ile-Ser-Val-Gln-Arg-OH | 4099707 | H-7886 |
| 5-FAM-LL-37 (scrambled) | Fluorescein-5-carbonyl-Gly-Leu-Lys-Leu-Arg-Phe-Glu-Phe-Ser-Lys-Ile-Lys-Gly-Glu-Phe-Leu-Lys-Thr-Pro-Glu-Val-Arg-Phe-Arg-Asp-Ile-Lys-Leu-Lys-Asp-Asn-Arg-Ile-Ser-Val-Gln-Arg-OH | 4099708 | H-7888 |
| Biotinyl-εAhx-LL-37 (scrambled) | Biotinyl-εAhx-Gly-Leu-Lys-Leu-Arg-Phe-Glu-Phe-Ser-Lys-Ile-Lys-Gly-Glu-Phe-Leu-Lys-Thr-Pro-Glu-Val-Arg-Phe-Arg-Asp-Ile-Lys-Leu-Lys-Asp-Asn-Arg-Ile-Ser-Val-Gln-Arg-OH | 4099709 | H-7896 |
| LL-37 (37-1) | H-Ser-Glu-Thr-Arg-Pro-Val-Leu-Asn-Arg-Leu-Phe-Asp-Lys-Ile-Arg-Gln-Val-Ile-Arg-Lys-Phe-Glu-Lys-Gly-Ile-Lys-Glu-Lys-Ser-Lys-Arg-Phe-Phe-Asp-Gly-Leu-Leu-OH | 4099710 | H-7898 |
| Tyr-LL-37 | H-Tyr-Leu-Leu-Gly-Asp-Phe-Phe-Arg-Lys-Ser-Lys-Glu-Lys-Ile-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-Thr-Glu-Ser-OH | 4099712 | H-7902 |
| Biotinyl-KR-12 (human) | Biotinyl-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-OH | 4099713 | H-7904 |
| Biotinyl-LL-37 | Biotinyl-Leu-Leu-Gly-Asp-Phe-Phe-Arg-Lys-Ser-Lys-Glu-Lys-Ile-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-Thr-Glu-Ser-OH | 4099715 | H-7906 |
| Orexin A (16-33) | H-Leu-Tyr-Glu-Leu-Leu-His-Gly-Ala-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Leu-NH₂ | 4099716 | H-7908 |
| (Cys(Acm)⁶·¹²)-Orexin A (human, mouse, rat) | Pyr-Pro-Leu-Pro-Asp-Cys(Acm)-Cys-Arg-Gln-Lys-Thr-Cys(Acm)-Ser-Cys-Arg-Leu-Tyr-Glu-Leu-Leu-His-Gly-Ala-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Leu-NH₂ (Disulfide bond) | 4099717 | H-7912 |
| Orexin A (1-15) (free acid) | Pyr-Pro-Leu-Pro-Asp-Cys-Cys-Arg-Gln-Lys-Thr-Cys-Ser-Cys-Arg-OH (Disulfide bonds between Cys⁶ and Cys¹²/Cys⁷ and Cys¹⁴) | 4099718 | H-7914 |
| Biotinyl-(Gln¹)-Orexin A (human, mouse, rat) | Biotinyl-Gln-Pro-Leu-Pro-Asp-Cys-Cys-Arg-Gln-Lys-Thr-Cys-Ser-Cys-Arg-Leu-Tyr-Glu-Leu-Leu-His-Gly-Ala-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Leu-NH₂ (Disulfide bonds between Cys⁶ and Cys¹²/Cys⁷ and Cys¹⁴) | 4099719 | H-7916 |
| Cyclo(-Gly-Arg-Gly-Glu-Ser-Pro) | Cyclo(-Gly-Arg-Gly-Glu-Ser-Pro) | 4099720 | H-7934 |
| Biotinyl-εAhx-Gly-Arg-Gly-Asp-Ser-OH | Biotinyl-εAhx-Gly-Arg-Gly-Asp-Ser-OH | 4099722 | H-7938 |
| FITC-εAhx-Gly-Arg-Gly-Asp-Ser-Pro-OH | FITC-εAhx-Gly-Arg-Gly-Asp-Ser-Pro-OH | 4099723 | H-7944 |
| RGD-4C | H-Ala-Cys-Asp-Cys-Arg-Gly-Asp-Cys-Phe-Cys-Gly-OH (Disulfide bonds between Cys² and Cys¹⁰/Cys⁴ and Cys⁸) | 4099725 | H-7946 |
| RGD-targeted Proapoptotic Peptide | H-Ala-Cys-Asp-Cys-Arg-Gly-Asp-Cys-Phe-Cys-Gly-Gly-D-Lys-D-Leu-D-Ala-D-Lys-D-Leu-D-Ala-D-Lys-D-Lys-D-Leu-D-Ala-D-Lys-D-Leu-D-Ala-D-Lys-OH (Disulfide bonds between Cys² and Cys¹⁰/Cys⁴ and Cys⁸) | 4099726 | H-7948 |
| FSL-1-DYKDDDDK | H-Cys((RS)-2,3-di(palmitoyloxy)-propyl)-Gly-Asp-Pro-Lys-His-Pro-Lys-Ser-Phe-Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys-OH | 4099727 | H-7926 |
| Polybia-MP1 | H-Ile-Asp-Trp-Lys-Lys-Leu-Leu-Asp-Ala-Ala-Lys-Gln-Ile-Leu-NH₂ | 4099795 | H-8154 |
| (Lys(Me)₂²⁷)-Histone H3 (21-44)-Gly-Lys(biotinyl) | H-Ala-Thr-Lys-Ala-Ala-Arg-Lys(Me)₂-Ser-Ala-Pro-Ala-Thr-Gly-Gly-Val-Lys-Lys-Pro-His-Arg-Tyr-Arg-Pro-Gly-Gly-Lys(biotinyl)-OH | 4099858 | H-8156 |
| (Lys(Me)₂⁹)-Histone H3 (1-21)-Gly-Gly-Lys(biotinyl) | H-Ala-Arg-Thr-Lys-Gln-Thr-Ala-Arg-Lys(Me)₂-Ser-Thr-Gly-Gly-Lys-Ala-Pro-Arg-Lys-Gln-Leu-Ala-Gly-Gly-Lys(biotinyl)-OH | 4099861 | H-8162 |
| (Ser(PO₃H₂)³⁹⁶·⁴⁰⁴)-Tau Peptide (379-408) | H-Arg-Glu-Asn-Ala-Lys-Ala-Lys-Thr-Asp-His-Gly-Ala-Glu-Ile-Val-Tyr-Lys-Ser(PO₃H₂)-Pro-Val-Val-Ser-Gly-Asp-Thr-Ser(PO₃H₂)-Pro-Arg-His-Leu-OH | 4099862 | H-8164 |
| (Ser(PO₃H₂)²⁰²,Thr(PO₃H₂)²⁰⁵)-Tau Peptide (194-213) | H-Arg-Ser-Gly-Tyr-Ser-Ser-Pro-Gly-Ser(PO₃H₂)-Pro-Gly-Thr(PO₃H₂)-Pro-Gly-Ser-Arg-Ser-Arg-Thr-Pro-OH | 4099870 | H-8166 |
| Acetyl-Tau Peptide (273-284) amide | Ac-Gly-Lys-Val-Gln-Ile-Ile-Asn-Lys-Lys-Leu-Asp-Leu-NH₂ | 4099871 | H-8168 |
| Tau Peptide (379-408) | H-Arg-Glu-Asn-Ala-Lys-Ala-Lys-Thr-Asp-His-Gly-Ala-Glu-Ile-Val-Tyr-Lys-Ser-Pro-Val-Val-Ser-Gly-Asp-Thr-Ser-Pro-Arg-His-Leu-OH | 4099872 | H-8172 |
| Fmoc-statine | (3S,4S)-4-(Fmoc-amino)-3-hydroxy-6-methyl-heptanoic acid | 4100293 | B-4555 |
| Leptin (116-130) amide (mouse) | H-Ser-Cys-Ser-Leu-Pro-Gln-Thr-Ser-Gly-Leu-Gln-Lys-Pro-Glu-Ser-NH₂ | 4100832 | H-8244 |
| Tide Fluor™ 5WS-Amyloid β-Protein (1-42) | Tide Fluor™ 5WS-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | 4101188 | |
| Tide Fluor™ 5WS-Amyloid β-Protein (1-40) | Tide Fluor™ 5WS-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH | 4101189 | H-8202 |
| DOTA(allyl ester)₃ | 4,7,10-Tri-(allyloxycarbonylmethyl)-1,4,7,10-tetraazacyclododecan-1-yl-acetic acid | 4101428 | Q-2795 |
| H-Thr-Pro-Asn-Gln-Arg-Gln-Asn-Val-Cys-OH | H-Thr-Pro-Asn-Gln-Arg-Gln-Asn-Val-Cys-OH | 4101923 | H-8208 |
| H-Leu-Ser-Pro-Phe-Pro-Phe-Asp-Leu-OH | H-Leu-Ser-Pro-Phe-Pro-Phe-Asp-Leu-OH | 4101924 | H-8212 |
| CBP501 Affinity Peptide | H-Asn-Ser-Asp-Cys-Ile-Ile-Ser-Arg-Lys-Ile-Glu-Gln-Lys-Glu-OH | 4101925 | H-8214 |
| Biotinyl-CBP501 Affinity Peptide | Biotinyl-Asn-Ser-Asp-Cys-Ile-Ile-Ser-Arg-Lys-Ile-Glu-Gln-Lys-Glu-OH | 4101926 | H-8216 |
| H-Val-Leu-His-Asp-Asp-Leu-Leu-Glu-Ala-OH | H-Val-Leu-His-Asp-Asp-Leu-Leu-Glu-Ala-OH | 4101928 | H-8218 |
| H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Leu-Tyr-Arg-Ser-Pro-Ala-Ser-Met-Pro-Glu-Asn-Leu-OH | H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Leu-Tyr-Arg-Ser-Pro-Ala-Ser-Met-Pro-Glu-Asn-Leu-OH | 4101929 | H-8222 |
| H-Gly-Gly-Arg-Ser-Pro-Ala-Met-Pro-Glu-OH | H-Gly-Gly-Arg-Ser-Pro-Ala-Met-Pro-Glu-OH | 4101930 | H-8224 |
| H-Leu-Ala-Ala-Val-Ser-Asp-Leu-Asn-Pro-Asn-Ala-Pro-Arg-OH | H-Leu-Ala-Ala-Val-Ser-Asp-Leu-Asn-Pro-Asn-Ala-Pro-Arg-OH | 4101931 | H-8226 |
| H-Tyr-Leu-Ala-Asp-Gly-Asp-Leu-His-Ser-Asp-Gly-Pro-Gly-Arg-OH | H-Tyr-Leu-Ala-Asp-Gly-Asp-Leu-His-Ser-Asp-Gly-Pro-Gly-Arg-OH | 4101932 | H-8228 |
| (D-Ala²,D-Leu⁵)-Enkephalin | H-Tyr-D-Ala-Gly-Phe-D-Leu-OH | 4102085 | H-8232 |
| H-Gly-Arg-Gly-Asp-Ser-Pro-Lys-OH | H-Gly-Arg-Gly-Asp-Ser-Pro-Lys-OH | 4102088 | H-8234 |
| Calcitonin C-Terminal Flanking Peptide (human) | H-Asp-Met-Ser-Ser-Asp-Leu-Glu-Arg-Asp-His-Arg-Pro-His-Val-Ser-Met-Pro-Gln-Asn-Ala-Asn-OH | 4102089 | H-8236 |
| H-Arg-Gly-Asp-Ser-Pro-Ala-Ser-Ser-Lys-Pro-OH | H-Arg-Gly-Asp-Ser-Pro-Ala-Ser-Ser-Lys-Pro-OH | 4102090 | H-8238 |
| BQ-788 | N-cis-2,6-Dimethylpiperidinocarbonyl-β-tBu-Ala-D-Trp(1-methoxycarbonyl)-D-Nle-OH | 4102091 | H-8242 |
| (Pyr³)-Amyloid β-Protein (3-42) | Pyr-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | 4102120 | H-8248 |
| Z-Val-Glu-Ile-Asp-AFC | Z-Val-Glu-Ile-Asp-AFC | 4102124 | H-8246 |
| Protein LMWP | H-Val-Ser-Arg-Arg-Arg-Arg-Arg-Arg-Gly-Gly-Arg-Arg-Arg-Arg-OH | 4102128 | |
| Defensin 5 (human) | H-Ala-Thr-Cys-Tyr-Cys-Arg-Thr-Gly-Arg-Cys-Ala-Thr-Arg-Glu-Ser-Leu-Ser-Gly-Val-Cys-Glu-Ile-Ser-Gly-Arg-Leu-Tyr-Arg-Leu-Cys-Cys-Arg-OH (Disulfide bonds, air oxidized) | 4102158 | H-8252 |
| Ovalbumin (154-159) | H-Thr-Asn-Gly-Ile-Ile-Arg-OH | 4102542 | H-8272 |
| Ovotransferrin (328-332) | H-Arg-Val-Pro-Ser-Leu-OH | 4102545 | H-8274 |
| ([¹³C₆;¹⁵N]Leu³·¹⁶·¹⁹·²⁰·³¹·³³)-Orexin A (human, mouse, rat) | Pyr-Pro-[¹³C₆;¹⁵N]Leu-Pro-Asp-Cys-Cys-Arg-Gln-Lys-Thr-Cys-Ser-Cys-Arg-[¹³C₆;¹⁵N]Leu-Tyr-Glu-[¹³C₆;¹⁵N]Leu-[¹³C₆;¹⁵N]Leu-His-Gly-Ala-Gly-Asn-His-Ala-Ala-Gly-Ile-[¹³C₆;¹⁵N]Leu-Thr-[¹³C₆;¹⁵N]Leu-NH₂ (Disulfide bonds between Cys⁶ and Cys¹²/Cys⁷ and Cys¹⁴) | 4103871 | H-8336 |
| 5-FAM-LL-37 | Fluorescein-5-carbonyl-Leu-Leu-Gly-Asp-Phe-Phe-Arg-Lys-Ser-Lys-Glu-Lys-Ile-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-Thr-Glu-Ser-OH | 4104169 | H-8284 |
| Tide Fluor™ 2-LL-37 | Tide Fluor™ 2-Leu-Leu-Gly-Asp-Phe-Phe-Arg-Lys-Ser-Lys-Glu-Lys-Ile-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-Thr-Glu-Ser-OH | 4104170 | H-8286 |
| Tide Fluor™ 2-LL-37 (scrambled) | Tide Fluor™ 2-Gly-Leu-Lys-Leu-Arg-Phe-Glu-Phe-Ser-Lys-Ile-Lys-Gly-Glu-Phe-Leu-Lys-Thr-Pro-Glu-Val-Arg-Phe-Arg-Asp-Ile-Lys-Leu-Lys-Asp-Asn-Arg-Ile-Ser-Val-Gln-Arg-OH | 4104171 | H-8288 |
| Cyclo(-Arg-Gly-Asp-D-Tyr-Lys(Tide Fluor™ 7WS)) | Cyclo(-Arg-Gly-Asp-D-Tyr-Lys(Tide Fluor™ 7WS)) | 4104202 | H-8322 |
| (Thr²)-Amyloid β-Protein (1-42) | H-Asp-Thr-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | 4104329 | |
| (Val²)-Amyloid β-Protein (1-6) | H-Asp-Val-Glu-Phe-Arg-His-OH | 4104331 | H-8296 |
| (Pyr¹)-Apelin-13 (human, bovine, mouse, rat) | Pyr-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe-OH | 4104812 | H-8298 |
| (Thr⁵⁰⁶)-α-1,3-Glucosyltransferase (500-520) | H-Ala-Val-Gly-Ile-Thr-Tyr-Thr-Trp-Thr-Arg-Leu-Tyr-Ala-Ser-Val-Leu-Thr-Gly-Ser-Leu-Val-OH | 4104892 | |
| (Thr¹⁷)-c-Jun (11-23) | H-Asp-Asp-Ala-Leu-Asn-Ala-Thr-Phe-Leu-Pro-Ser-Glu-Gly-OH | 4104893 | M-2730 |
| (Ser(PO₃H₂)³²³)-Hrr25 (312-323) (S. cerevisiae) | H-Asp-Leu-Asn-Ala-Asn-Ser-Asn-Ala-Ala-Ser-Ala-Ser(PO₃H₂)-OH | 4104894 | H-8304 |
| Cullin-Associated NEDD8-Dissociated Protein 1 (548-566) | H-Lys-Val-Ile-Arg-Pro-Leu-Asp-Gln-Pro-Ser-Ser-Phe-Asp-Ala-Thr-Pro-Tyr-Ile-Lys-OH | 4104895 | H-8306 |
| Checkpoint Protein Hus1 (213-232) (human) | H-Leu-Ala-Ser-Glu-Ser-Thr-His-Glu-Asp-Arg-Asn-Val-Glu-His-Met-Ala-Glu-Val-His-Ile-OH | 4104896 | H-8308 |
| (Ser(PO₃H₂)²⁷³)-Nek11 (268-283) | H-Leu-Asn-Lys-Asn-Pro-Ser(PO₃H₂)-Leu-Arg-Pro-Ser-Ala-Ile-Glu-Ile-Leu-Cys-OH | 4104897 | H-8312 |
| Cdc25A (80-93) (human) | H-Thr-Asp-Ser-Gly-Phe-Cys-Leu-Asp-Ser-Pro-Gly-Pro-Leu-Asp-OH | 4104898 | H-8314 |
| (Ser(GlcNAc-β-D)²³⁶)-EMSY (230-240) | H-Thr-Ile-Thr-Val-Pro-Val-Ser(GlcNAc-β-D)-Gly-Ser-Pro-Lys-OH | 4104899 | H-8316 |
| (Ser(PO₃H₂)⁵¹⁶)-Artemis (511-523) | H-Thr-Val-Ala-Gly-Gly-Ser(PO₃H₂)-Gln-Ser-Pro-Lys-Leu-Phe-Ser-OH | 4104900 | H-8318 |
| Baceridin | Cyclo(-D-Ala-D-allo-Ile-Val-D-Leu-Leu-Trp) | 4105366 | N-2045 |
| Hispidalin | H-Ser-Asp-Tyr-Leu-Asn-Asn-Asn-Pro-Leu-Phe-Pro-Arg-Tyr-Asp-Ile-Gly-Asn-Val-Glu-Leu-Ser-Thr-Ala-Tyr-Arg-Ser-Phe-Ala-Asn-Gln-Lys-Ala-Pro-Gly-Arg-Leu-Asn-Gln-Asn-Trp-Ala-Leu-Thr-Ala-Asp-Tyr-Thr-Tyr-Arg-OH | 4105367 | H-8324 |
| EcAMP3 | H-Gly-Ala-Asp-Arg-Cys-Arg-Glu-Arg-Cys-Glu-Arg-Arg-His-Arg-Gly-Asp-Trp-Gln-Gly-Lys-Gln-Arg-Cys-Leu-Met-Glu-Cys-Arg-Arg-Arg-Glu-Gln-Glu-Glu-Asp-OH (Disulfide bonds between Cys⁵ and Cys²⁷/Cys⁹ and Cys²³) | 4105368 | H-8326 |
| Crotalicidin | H-Lys-Arg-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Val-Lys-Lys-Ser-Val-Lys-Lys-Arg-Leu-Lys-Lys-Ile-Phe-Lys-Lys-Pro-Met-Val-Ile-Gly-Val-Thr-Ile-Pro-Phe-NH₂ | 4105369 | H-8328 |
| H-Gly-Arg-NH₂ · 2 HCl | H-Gly-Arg-NH₂ · 2 HCl | 4106215 | |
| Tide Fluor™ 5WS-ω-Conotoxin GVIA | Tide Fluor™ 5WS-Cys-Lys-Ser-Hyp-Gly-Ser-Ser-Cys-Ser-Hyp-Thr-Ser-Tyr-Asn-Cys-Cys-Arg-Ser-Cys-Asn-Hyp-Tyr-Thr-Lys-Arg-Cys-Tyr-NH₂ (Disulfide bonds between Cys¹ and Cys¹⁶/Cys⁸ and Cys¹⁹/ Cys¹⁵ and Cys²⁶) | 4106769 | H-8356 |
| SnapIt | H-DL-β-(5-Norbornen-2-yl)-DL-Ser-OH | 4106861 | F-4340 |
| Q-Peptide | H-Gln-His-Arg-Glu-Asp-Gly-Ser-OH | 4107156 | H-8364 |
| Amyloid β-Protein (1-6) amide | H-Asp-Ala-Glu-Phe-Arg-His-NH₂ | 4107157 | H-8366 |
| Acetyl-Amyloid β-Protein (1-6) amide | Ac-Asp-Ala-Glu-Phe-Arg-His-NH₂ | 4107158 | H-8368 |
| Leptin (116-130) (human) | H-Ser-Cys-His-Leu-Pro-Trp-Ala-Ser-Gly-Leu-Glu-Thr-Leu-Asp-Ser-OH | 4107160 | H-8372 |
| Biotinyl-εAhx-SCC1 (263-268)-2,4,6-trimethylbenzoyloxy-methylketone (S. cerevisiae) | Biotinyl-εAhx-Ser-Val-Glu-Gln-Gly-Arg-2,4,6-trimethylbenzoyloxy-methylketone | 4107300 | N-2050 |
| α-Synuclein Binding Peptide | Ac-Lys-Asp-Gly-Ile-Val-Asn-Gly-Val-Lys-Ala-NH₂ | 4107364 | H-8374 |
| α-Synuclein (45-54) (human) | H-Lys-Glu-Gly-Val-Val-His-Gly-Val-Ala-Thr-OH | 4107365 | H-8376 |
| α-Synuclein (71-82) (human) | H-Val-Thr-Gly-Val-Thr-Ala-Val-Ala-Gln-Lys-Thr-Val-OH | 4107366 | H-8378 |
| Amyloid β-Protein (42-1) (HFIP-treated) | H-Ala-Ile-Val-Val-Gly-Gly-Val-Met-Leu-Gly-Ile-Ile-Ala-Gly-Lys-Asn-Ser-Gly-Val-Asp-Glu-Ala-Phe-Phe-Val-Leu-Lys-Gln-His-His-Val-Glu-Tyr-Gly-Ser-Asp-His-Arg-Phe-Glu-Ala-Asp-OH (HFIP-treated) | 4107743 | H-8388 |
| (Val¹²⁵⁹)-Laminin α-4 Chain (1259-1266) (human) | H-Val-Gly-Phe-Asn-Phe-Arg-Thr-Leu-OH | 4107887 | |
| Prepro-Killer Cell Immunoglobulin-Like Receptor 3DL3 (23-31) | H-Val-Gly-Gly-Gln-Asp-Lys-Pro-Phe-Leu-OH | 4107888 | |
| Tau Peptide (294-305) (human) | H-Lys-Asp-Asn-Ile-Lys-His-Val-Pro-Gly-Gly-Gly-Ser-OH | 4109331 | |
| α-Synuclein (34-45) (human) | H-Lys-Glu-Gly-Val-Leu-Tyr-Val-Gly-Ser-Lys-Thr-Lys-OH | 4107367 | H-8382 |
| α-Synuclein (67-78) (human) | H-Gly-Gly-Ala-Val-Val-Thr-Gly-Val-Thr-Ala-Val-Ala-OH | 4107368 | H-8384 |
| H-Arg-Gly-Asp-Ser-Pro-OH | H-Arg-Gly-Asp-Ser-Pro-OH | 4109334 | |
| Ac-Gly-Ala-Val-Ile-Leu-Arg-Arg-NH₂ | Ac-Gly-Ala-Val-Ile-Leu-Arg-Arg-NH₂ | 4109338 | |
| Ac-Arg-Ala-Asp-Ala-Asp-Ala-Asp-Ala-Arg-Ala-Asp-Ala-Asp-Ala-Asp-Ala-NH₂ | Ac-Arg-Ala-Asp-Ala-Asp-Ala-Asp-Ala-Arg-Ala-Asp-Ala-Asp-Ala-Asp-Ala-NH₂ | 4109339 | |
| EAK16-II | Ac-Ala-Glu-Ala-Glu-Ala-Lys-Ala-Lys-Ala-Glu-Ala-Glu-Ala-Lys-Ala-Lys-NH₂ | 4109371 | |
| Prepro-von Willebrand factor (641-650) (bovine) | H-Trp-Arg-Glu-Pro-Ser-Phe-Cys-Ala-Leu-Ser-OH | 4109375 | |
| Bonemarrow-Derived Mesenchymal Stem Cells Affinity Peptide | H-Glu-Pro-Leu-Gln-Leu-Lys-Met-OH | 4109379 | |
| H-Val-Pro-Leu-Ser-Leu-Tyr-Ser-Gly-OH | H-Val-Pro-Leu-Ser-Leu-Tyr-Ser-Gly-OH | 4109381 | |
| FGF basic (93-110) (human, bovine) | H-Phe-Phe-Phe-Glu-Arg-Leu-Glu-Ser-Asn-Asn-Tyr-Asn-Thr-Tyr-Arg-Ser-Arg-Lys-OH | 4109388 | |
| Nesfatin-1-Like Peptide (mouse) | H-Val-Pro-Val-Asp-Arg-Ala-Ala-Pro-Pro-Gln-Glu-Asp-Ser-Gln-Ala-Thr-Glu-Thr-Pro-Asp-Thr-Gly-Leu-Tyr-Tyr-His-Arg-Tyr-Leu-Gln-Glu-Val-Ile-Asn-Val-Leu-Glu-Thr-Asp-Gly-His-Phe-Arg-Glu-Lys-Leu-Gln-Ala-Ala-Asn-Ala-Glu-Asp-Ile-Lys-Ser-Gly-Lys-Leu-Ser-Gln-Glu-Leu-Asp-Phe-Val-Ser-His-Asn-Val-Arg-Thr-Lys-Leu-Asp-Glu-Leu-OH | 4143074 | |
| (Deamino-Cys¹)-Oxytocin | 3-Mercaptopropionyl-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH₂ (Disulfide bond) | 4144371 | |
| (Deamino-Cys¹,Arg⁸)-Vasopressin | 3-Mercaptopropionyl-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH₂ (Disulfide bond) | 4144380 | |
| (Deamino-Cys¹,Lys⁸)-Oxytocin | 3-Mercaptopropionyl-Tyr-Ile-Gln-Asn-Cys-Pro-Lys-Gly-NH₂ (Disulfide bond) | 4144383 | |
| (Deamino-Cys¹,β-cyclohexyl-Ala⁴,Dab⁸)-Vasopressin | 3-Mercaptopropionyl-Tyr-Phe-β-cyclohexyl-Ala-Asn-Cys-Pro-Dab-Gly-NH₂ (Disulfide bond) | 4144384 | |
| (Deamino-Cys¹,Tyr(Me)²,Val⁴,D-Arg⁸)-Vasopressin | 3-Mercaptopropionyl-Tyr(Me)-Phe-Val-Asn-Cys-Pro-D-Arg-Gly-NH₂ (Disulfide bond) | 4144385 | |
| (d(CH₂)₅¹,Tyr(Me)²,Dab⁵,Arg⁸,Tyr⁹)-Vasopressin | β-Mercapto-β,β-cyclopentamethylene-propionyl-Tyr(Me)-Phe-Gln-Dab-Cys-Pro-Arg-Tyr-NH₂ (Disulfide bond) | 4144387 | |
| (D-Arg⁸)-Inotocin | H-Cys-Leu-Ile-Thr-Asn-Cys-Pro-D-Arg-Gly-NH₂ (Disulfide bond) | 4144388 | |
| (d(CH₂)₅¹,D-Ile²,Ile⁴,Arg⁸,Tyr⁹)-Vasopressin | β-Mercapto-β,β-cyclopentamethylene-propionyl-D-Ile-Phe-Ile-Asn-Cys-Pro-Arg-Tyr-NH₂ (Disulfide bond) | 4144389 | |
| (Val⁹)-Oxytocin | H-Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Val-NH₂ (Disulfide bond) | 4144390 | |
| (Gly⁵,Thr⁷,Ser⁹)-Oxytocin | H-Cys-Tyr-Ile-Gln-Gly-Cys-Thr-Leu-Ser-NH₂ (Disulfide bond) | 4144391 | |
| (Val³,Pro⁸)-Oxytocin | H-Cys-Tyr-Val-Gln-Asn-Cys-Pro-Pro-Gly-NH₂ (Disulfide bond) | 4145233 | |
| (d(CH₂)₅¹,Tyr(Me)²,Dab⁵,Arg⁸)-Vasopressin | β-Mercapto-β,β-cyclopentamethylene-propionyl-Tyr(Me)-Phe-Gln-Dab-Cys-Pro-Arg-Gly-NH₂ (Disulfide bond) | 4145234 | |
| Covidyte™ EN450 | H-Lys(DABCYL)-Thr-Ser-Ala-Val-Leu-Gln-Ser-Gly-Phe-Arg-Lys-Met-Glu-EDANS | 4152544 | |
| Covidyte™ ED450 | EDANS-Val-Asn-Ser-Thr-Leu-Gln-Ser-Gly-Leu-Arg-Lys(DABCYL)-Met-OH | 4152545 | |
| Covidyte™ IF670 | H-Cys(iFluor 647)-Val-Asn-Ser-Thr-Leu-Gln-Ser-Gly-Leu-Arg-Lys(TQ5)-Met-OH | 4152547 |
Illumina公司，基因组学研究领域的技术与市场领导者。借助新一代测序（NGS）与基因芯片（MicroArray）技术与平台，秉承“解锁基因组奥秘，推动人类健康事业”的愿景，为全球科研、医疗、制药、公共卫生等领域提供基因组学完整解决方案。Illumina公司主要提供Sequencing Kits、Library Preparation Kits、Cluster Generation & Sequencing Reagents、Microarray Kits、Clinical Research Products和Informatics Products等类型的产品。
Illumina的主要产品包括：
（1）Browse by Area of Interest:
Cancer Genomics Products
Reproductive Health Products
Microbial Genomics Products
Complex Disease Genomics Products
Genetic Health Products
Forensic Genomics Products
Agrigenomics Products
Genomics in Drug Development Products
（2）Browse by System:
HiSeq 2500 Products
HiSeq 3000/HiSeq 4000 Products
HiSeq X Five/HiSeq X Ten Products
iScan Products
iSeq Products
MiniSeq Products
MiSeq Products
MiSeqDx Products
MiSeq FGx Products
NextSeq Products
NovaSeq Products
<更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
< " data-original="http://genvivo.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Illumina"> Illumina
艾美捷科技代理STEMCELL Technologies品牌。
STEMCELL Technologies为世界各地从事干细胞、免疫学、癌症、再生医学和细胞治疗研究的科学家提供高质量的细胞培养基、细胞分离技术、仪器和配套产品。
STEMCELL Technologies特色产品包括：
（1）EasySep™ 总核酸提取试剂盒：磁性总核酸（DNA 和 RNA）提取试剂盒
（2）CellAdhere™ Laminin-521：与 TeSR™ 维持培养基结合用于维持人 ES 和 iPS 细胞的基质
（3）EasySep™ 人骨髓 CD138 阳性选择试剂盒 (IVD)：从骨髓中免疫磁性阳性选择人 CD138+ 细胞用于体外诊断 (IVD) 应用的样品
（4）GyneCult™ 输卵管类器官培养基：无血清和性类固醇模块化试剂盒，用于人类输卵管类器官的扩增和分化
<< " data-original="http://genvivo.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="STEMCELL Technologies Inc."> STEMCELL Technologies Inc.
Prozyme公司位于美国加州，为广大客户提供诊断和科研所需的标记物、蛋白质与酶。Prozyme 于2003年1月收购了Glyko®产品线，包括研究糖类的酶及相关试剂。其中也包括Glyko®于1999年收购的Oxford GlycoSciences,Ltd 公司生化试剂产品线。
ProZyme is now a part of Agilent Technologies, Inc.
ProZyme, Inc. was founded in 1990 with a vision of establishing a high-quality, value-added and customer-driven biochemical reagent company. We are proud to continue to provide the highest level of products, services and support to our customers at large and small biotechnology, biopharmaceutical and academic institutions across the world.
ProZyme公司产品系列:
（1）糖生物学研究工具（Glyko.系列）
（2）PhycoLink. 荧光结合试剂（ 抗体/ 蛋白标记） PE, PerCP conjugates, BPE conjugates, CPC conjugates,生物素，纯化试剂盒，结合试剂盒，标记二抗
（3）PhycoLink.纯化与标记试剂盒/ Purification and Conjugation Kits
（4） PhycoProTM 藻胆蛋白/ Phycobiliproteins
（5）生物素结合蛋白/ Biotin-binding Proteins 链亲和素
（6）固定化链亲和素/ Immobilized Streptavidin 琼脂糖-链亲和素
（7）)链亲和素结合物/ Streptavidin Conjugates 链亲和素- AP，链亲和素- HRP
（8） Marker Enzyme 半乳糖苷酶
（9）位点特异性蛋白酶/ Site-specific Protease Factor Xa (lyophilized)
（10）客户定制结合服务或其他
<更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
Zedira是一家临床阶段的生物技术公司，专门从事转谷氨酰胺酶的研究，开发一系列小分子药物候选物。Zedira公司正致力于药物发现的前沿领域，该领域涉及阻止调节失调的转谷氨酰胺酶的小分子。此外，Zedira是一个全球品牌，专门用于转谷氨酰胺酶领域的研发和诊断试剂，其独特和高质量的产品有助于推动转谷氨酰胺酶的研究和应用。
Zedira is a clinical stage biotech company specialised in transglutaminase. Zedira conducts its own development of small molecular drug candidates. In doing so, the company is working at the cutting edge of drug discovery involving small molecules that block dysregulated transglutaminases. In addition, Zedira is a global brand for specialty reagents for research & development as well as diagnostics in the transglutaminase field. Numerous unique and high quality products help pushing forward transglutaminase-related science – both in academia and industry.
Zedira公司主要产品：
Transglutaminases
Microbial Transglutaminase
Assays and Substrates
Inhibitors
Antibodies and Microarrays
Proteases
Protein Labeling
Blood Coagulation
Cereal Proteins
Celiac Disease Products
更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
Zedira产品详情请咨询我司客服人员：
| 产品编号 | 产品名称 | 产品规格 |
| A003 | Polyclonal antibody to human tissue transglutaminase (TG2) | 100 ug |
| A004 | Monoclonal antibody to tissue transglutaminase (TG2) | 100 ug |
| A008 | Polyclonal antibody to human transglutaminase 5 (TG5) | 500 ug |
| A011 | Monoclonal antibody to gliadin (clone XGY1) | 1 mg |
| A013 | Monoclonal antibody to gliadin (clone XGY7) | 1 mg |
| A014 | Polyclonal antibody to human tissue transglutaminase (TG2) | 500 ug |
| A015 | Polyclonal antibody to human epidermal transglutaminase (TG3) | 500 ug |
| A016 | Polyclonal antibody to human blood coagulation factor XIII (A-subunit) | 500 ug |
| A017 | Polyclonal antibody to human neuronal transglutaminase (TG6) | 500 ug |
| A018 | Polyclonal antibody to human keratinocyte transglutaminase (TGI) | 500 ug |
| A020 | Polyclonal antibody to microbial protransglutaminase (pro-MTG, pro-BTG) | 500 ug |
| A021 | Polyclonal antibody to human plasminogen (rhPLG) | 500 ug |
| A022 | Polyclonal antibody to human prostate transglutaminase (TG4) | 500 ug |
| A023 | Monoclonal antibody to N'-ly-L-glutamylpL-lysine-isopeptide bond | 100 ug |
| A024 | Monoclonal Antibody to microbial (bacterial) Transglutaminase | 100 ug |
| A028 | FITC-labeled polyclonal antibody to human TG2 | 200 ug |
| A029 | FITC-labeled polyclonal antibody to human TGI | 200 ug |
| A030 | FITC-labeled polyclonal antibody to human TG3 | 200 ug |
| A031 | FITC-labeled polyclonal antibody to human TG6 | 200 ug |
| A032 | FITC-labeled polyclonal antibody to human factor XIII (A-subunit) | 200 ug |
| A033 | Monoclonal antibody to human TG2 (Catalytic Domain, clone XTG17) | 200 ug |
| A034 | Monoclonal antibody to human TG2 (Beta Sheet Domain, clone XTG 1 1) | 200 ug |
| A035 | Monoclonal antibodies to gliadin (Set No 1) | 1 Set |
| A036 | Monoclonal antibody to human TG2 (Beta Barrel 1 Domain, clone XTG21) | 200 ug |
| A037 | Monoclonal antibody to human TG2 (Beta Barrel 2 Domain, clone XTG1 8) | 200 ug |
| A040 | Polyclonal antibody to human transglutaminase 7 (TG7) | 200 ug |
| A042 | Monoclonal antibody to human TGI (clone XTG3 1) | 200 ug |
| A044 | FITC-labeled polyclonal antibody to human TG5 | 200 ug |
| A046 | D-Dimer monoclonal mouse antibody, clone 3B6 | 100 ug |
| A047 | D-Dimer monoclonal mouse antibody, clone 1 D2 | 100 ug |
| A051 | Biotinylated polyclonal antibody to microbial transglutaminase (MTG) | 50 ug |
| A052 | Biotinylated polyclonal antibody to human factor XIII (A-subunit) | 50 ug |
| A053 | Biotinylated polyclonal antibody to human TG2 | 50 ug |
| A054 | Monoclonal antibody to gliadin (clone XGY6) | 1 mg |
| A057 | Monoclonal antibody to deamidated gliadin | 100 ug |
| A058 | Monoclonal antibody to gliadin (clone XGY5) | 1 mg |
| A059 | Monoclonal antibody to gliadin (clone XGY9) | 1 mg |
| A060 | Monoclonal antibody to gliadin (clone XGY10) | 1 mg |
| A061 | Monoclonal antibody to gliadin (clone XGY 1 6) | 1 mg |
| A062 | Monoclonal antibody to deamidated and non-deamidated gliadin | 100 ug |
| A063 | Monoclonal antibody to gliadin (clone XGY2) | 1 mg |
| A064 | Monoclonal antibody to gliadin (clone XGY4) | 1 mg |
| A065 | Monoclonal antibody to gliadin (clone XGY8) | 1 mg |
| A066 | Monoclonal antibody to gliadin (clone XGY 1 2) | 1 mg |
| A067 | Monoclonal antibody to gliadin (clone XGY 1 5) | 1 mg |
| A068 | Monoclonal antibody to gliadin (clone XGY 1 7) | 1 mg |
| A069 | Monoclonal antibody to gliadin (clone XGY23) | 1 mg |
| A070 | Monoclonal antibody to gliadin (clone XGY24) | 1 mg |
| A071 | Monoclonal antibody to hordein (clone XH4) | 1 mg |
| A072 | polyclonal antibody to mouse tissue Transglutaminse | 200 ug |
| A074 | Polyclonal antibody to human blood coagulation factor XIII (B-subunit) | 200 ug |
| A075 | FITC-labeled polyclonal antibody to mouse TG2 | 200 ug |
| A076 | DD-XLink-mab | 100 ug |
| A077 | FITC-labeled polyclonal antibody to human factor XIII (B-subunit) | 200 ug |
| A078 | Polyclonal antibody to human epidermal transglutaminase (TG3) Protein A | 250 ug |
| A079 | Biotin-DD-XLink-mab | 50 ug |
| A082 | Monoclonal antibody to human TG3 (clone XTG45) | 200 ug |
| A101 | FXIII-Assay Substance, Abz-NE(CAD-DNP)EQVSPLTLLK-OH | 10 mg |
| A102 | TG2-Assay Substance. Abz-APE(CAD-DNP)QEA-OH | 10 mg |
| A105 | NQEQVSPLTLLK, alpha2-Antiplasmin peptide (1-12) | 25 mg |
| A106 | (ATTO-48 8TM)cadaveri ne | 1 mg |
| A108 | Ac-(D)-Asp-MA-N le-Nle-Leu-Pro-Trp-Pro-OH | 5 mg |
| A109 | β-Amyloid peptide 1-42 (Aβ 1-42) | 1 mg |
| A112 | (ATTO-532)cadaverine | 1 mg |
| A113 | (ATTO-550)cadaverine | 1 mg |
| A114 | (AnO-647N)cadaverine | 1 mg |
| A115 | (ATTO-700)cadaverme | 1 mg |
| A125 | Factor XIII activation peptide | 10 mg |
| A132 | Ac-WALQRPHYSYPD | 10 mg |
| A139 | Monoclonal antibody to human TG6 (Catalytic Domain, clone XTG52) | 200 ug |
| A140 | Monoclonal antibody to human TG6 (Beta Barrel 1 Domain, clone XTG39) | 200 ug |
| A141 | Monoclonal antibody to human TG6 (Beta Barrel 1 Domain, clone XTG68) | 200 ug |
| A142 | Monoclonal antibody to human TG6 (Beta Barrel 2 Domain, clone XTG57) | 200 ug |
| A143 | Monoclonal antibody to microbial Transglutaminase (clone XM67) | 200 ug |
| A144 | Monoclonal antibody to microbial Transglutaminase (clone XM68) | 200 ug |
| A145 | Polyclonal Antibody to microbial Transglutaminase | 200 ug |
| A152 | 3-Azido-l -propanamine | 100 mg |
| A153 | 4-Azidobutan-l-amine | 100 mg |
| A154 | Monoclonal antibody to human factor XIII (Activation Peptide, clone XTG09) | 200 ug |
| A155 | Monoclonal antibody to human factor XIII (Catalytic Domain, clone XTG02) | 200 ug |
| B001 | Biotinyl-Thr-Val-GIn-GIn-Glu-Leu-OH | 5 mg 25 mg |
| B002 | N-(Biotinyl)cadaverine | 25 mg 100 mg |
| B003 | Boc-DON-Gln-lle-Val-OMez "Boc-DON” | 10 mg |
| B006 | Thr-Val-Gln-Gln-Glu-Leu-OH | 25 mg |
| B007 | Keratinocyte transglutaminase (TGI )-substrate-peptide K5 | 10 mg |
| B008 | Tissue transglutaminase (TG2)-substrate-peptide T26 | 10 mg |
| B009 | Epidermal transglutaminase (TG3)-substrate-peptide E51 | 10 mg |
| B010 | Blood coagulation FXIII-substrate-peptide Fl 1 KA | 10 mg |
| B013 | Neuronal transglutaminase (TG6)-substrate peptide Y25 | 10 mg |
| B014 | Transglutaminase 7 (TG7)-substrate peptide Z3S | 10 mg |
| B015 | Biotin-Ahx-MA-QPL-OMe | 10 mg |
| B017 | Microbial Transglutaminase (MTG)-substrate peptide M48 | 10 mg |
| B019 | Biotin-Ahx-QVPL-OMe | 10 mg |
| C001 | Z-GIn-Gly-OH | 1g |
| C002 | Z-GIn-Gly-CAD-DNS | 25 mg 100 mg |
| C074 | Z-Gln-Gly-CAD-(AnO-488) | 1 mg |
| C075 | Z-Gln-Gly-CAD-(ATTO-532) | 1 mg |
| C076 | Z-Gln-Gly-CAD-(AnO-550) | 1 mg |
| C077 | Z-Gln-Gly-CAD-(ATTO-647N) | 1 mg |
| C078 | Z-Gln-Gly-CAD-(AnO-700) | 1 mg |
| C079 | Z-GIn-Gly-PEG(3)-N3 | 25 mg |
| C080 | Z-Gln-Gly-PEG(11)-N3 | 25 mg |
| C090 | Z-GIn-Gly-CAD-TAMRA | 25 mg |
| C091 | Z-GIn-Gly-CAD-Biotin | 25 mg |
| C092 | Z-Gln-Gly-(PEG1,088), monodisperse | 25 mg |
| C093 | Z-Gln-Gly-(PEG5,000), polydisperse | 25 mg |
| C094 | Tosyl-ε-aminopentyl-CMK | 1 mg |
| C095 | Dansyl-ε-aminopentyl-CMK | 1 mg |
| C102 | MTG Blocker | 10 mg 25 mg |
| D001 | Dansyl-ε-aminohexanoyl-GIn-GIn-lle-Val-OH | 25 mg 100 mg |
| D002 | N-(2,4-Dinitrophenyl)cadaverine | 100 mg |
| D003 | 1,3-Dimethyl-2[(2-oxo-propyl)thio]imidazolium chloride | 100 mg |
| D004 | 1,3-Dimelhyl-4,5-diphenyl-2-[(2-oxopropyl)thio]imidazolium | 10 mg |
| D005 | Metalloprotease-Assay-Substance, DABCYL-Ser-Phe-EDANS | 2 mg |
| D006 | N-(Dansyl)cadaverine | 100 mg |
| D007 | Cadaverine | 100 mg |
| D008 | "DALP", DNP-aminohexanoic acid-Lys-aminopropanol | 5 mg |
| D009 | DALP-methyl carbamate | 5 mg |
| D0I 6 | LDN 27219 | 10 mg |
| E018 | ZediXclusive Tissue Transglutaminase EIA | 1 Kit |
| E021 | ZediXclusive Microbial Transglutaminase (MTG) ELISA | 1 Kit |
| E103 | ZediXclusive TG6-ab ELISA (IgA) | 1 Kit (96 wells) |
| E104 | ZediXclusive TG6-ab ELISA (IgG) | 1 Kit (96 wells) |
| F001 | FXIII-Assay Kit | 1 Kit |
| F002 | Tissue Transglutaminase Assay Kit | 1 Kit |
| F004 | Fibrinogen, purified from human plasma | 50 mg |
| F006 | FITC-labeled Fibrinogen | 5 mg |
| F007 | Fibrin Glue (porcine) | 1 Kit |
| F008 | Fibrin Glue (bovine) | 1 Kit |
| F011 | Cross-linked fibrin degradation products, xFDPs | 200 ug |
| F012 | Fibrin degradation products, FDPs | 200 ug |
| G001 | Alpha2-gliadin, 33mer (aa56-88), biotinylated | 5 mg |
| G002 | Deamidated alpha2-gliadin, 33mer (aa56-88), biotinylated | 5 mg |
| G003 | Ac-PLQPEQPFPK(ε-Biotin), Deamidated gliodin peptide | 10 mg |
| G004 | Ac-PEQLPQFEEK(ε-Biotin), Deamidated gliadin peptide | 10 mg |
| G005 | DGPx4 (Fusion protein of 4 deamidated gliadin peptides) | 500 ug |
| G006 | DGPx2 (Fusion protein of 2 deamidated gliadin peptides) | 500 ug |
| G007 | DGPxl (deamidated gliadin peptide) | 500 ug |
| G008 | Omega-5 gliadin | 500 ug |
| G009 | Alpha2-gliadin, 33mer (aa 56-88) | 5 mg |
| G011 | Deamidated alpha2-gliadin, 33mer, (Acetyl-aa56-88-amide, Q65E) | 5 mg |
| G013 | QPFPQPQLPYPQPQ-amide | 10 mg |
| G014 | QPFPQPELPYPQPQ-amide | 10 mg |
| G017 | Biotinylated DGPx1 | 100 ug |
| G018 | Barley albumin and globulin | 5 mg |
| G019 | Barley prolamin (Hordein) | 5 mg |
| G020 | Barley glutelin (Hordenin) | 5 mg |
| G021 | Rye albumin and globulin | 5 mg |
| G022 | Rye prolamin (Secalin) | 5 mg |
| G023 | Rye glutelin (Secalinin) | 5 mg |
| G024 | Corn albumin and globulin | 5 mg |
| G025 | Corn prolamin (Zein) | 5 mg |
| G026 | Corn glutelin (Zeanin) | 5 mg |
| G027 | Rice albumin and globulin | 5 mg |
| G028 | Rice prolamin (Oryzin) | 5 mg |
| G029 | Rice glutelin (Oryzenin) | 5 mg |
| G030 | Spell albumin and globulin | 5 mg |
| G031 | Spelt prolamin | 5 mg |
| G032 | Spelt glutelin | 5 mg |
| G033 | Oat albumin and globulin | 5 mg |
| G034 | Oat prolamin (Avenin) | 5 mg |
| G035 | Oat glutelin (Avenalin) | 5 mg |
| G036 | Wheat albumin and globulin (Leukosin and Edestin) | 5 mg |
| G037 | Wheat prolamin (Gliadin) | 5 mg |
| G038 | Wheat glutelin (Glutenin) | 5 mg |
| G039 | Durum wheat albumin and globulin | 5 mg |
| G040 | Durum wheat prolamin | 5 mg |
| G041 | Durum wheat glutelin | 5 mg |
| G042 | Soy protein, saline soluble fraction | 5 mg |
| G043 | Soy protein, ethanol soluble fraction | 5 mg |
| G044 | Soy protein, propanol/urea/DTE soluble fraction | 5 mg |
| G045 | Millet (Sorghum) albumin and globulin | 5 mg |
| G046 | Millet (Sorghum) prolamin (Kafirin) | 5 mg |
| G047 | Millet (Sorghum) glutelin | 5 mg |
| G048 | L-Glutamic acid γ-monohydroxamate | 100 mg |
| G051 | 26mer gliadin peptide | 250 ug |
| G052 | 33mer gliadin peptide | 250 ug |
| G054 | 33mer DGP | 250 ug |
| G055 | Carrier protein control | 250 ug |
| G056 | DGP and Gliadin peptides (Set No 1) | 1 Set |
| G057 | Alpha2-gliadin, 33mer (aa56-88), TAMRA labeled | 5 mg |
| G058 | Alpha2-gliadin, 33mer (aa56-88), TAMRA and Biotin labeled | 5 mg |
| G101 | Gly-Pro-Arg-Pro-amide | 25 mg |
| I001 | Involucrme, recombinant human | 500 ug |
| K004 | "KxD", Boc-Lys-en-DNS | 10 mg |
| L001 | Substrate Finder Kit | 1 Kit |
| L101 | Biotin TGase Protein Q-Labeling Kit | 1 Kit |
| L102 | PEG1,088 TGase Protein Q-Labeling Kit | 1 Kit |
| L103 | PEG5,000 TGase Protein Q-Labeling Kit | 1 kit |
| L104 | ATTO-488™ TGase Protein Q-Labeling Kit | 1 Kit |
| L105 | ATTO-532™ TGase Protein Q-Labeling Kit | 1 Kit |
| L106 | ATTO-550™ TGase Protein Q-Labeling Kit | 1 Kit |
| L107 | ATTO-647N™ TGase Protein Q-Labeling Kit | 1 Kit |
| L108 | ATTO-700™ TGase Protein Q-Labeling Kit | 1 Kit |
| L201 | Biotin TGase Protein K-Labeling Kit | 1 Kit |
| L202 | PEG1,088 TGase Protein K-Labeling Kit | 1 Kit |
| L203 | PEG5,000 TGase Protein K-Labeling Kit | 1 Kit |
| L204 | ATTO-488™ TGase Protein K-Labeling Kit | 1 Kit |
| L205 | ATTO-532™ TGase Protein K-Labeling Kit | 1 Kit |
| L206 | ATTO-550™ TGase Protein K-Labeling Kit | 1 Kit |
| L207 | ATTO-647N™ TGase Protein K-Labeling Kit | 1 Kit |
| L208 | ATTO-700™ TGase Protein K-Labeling Kit | 1 Kit |
| M001 | MTG-ANiTA-Kit | 1 Kit |
| M003 | Tissue Transglutaminase Pico-Assay Kit | 1 Kit |
| P003 | Prolylendopeptidase from Myxococcus xanthus, recombinant | 150U |
| P004 | PT-Gluten | 1 mg 10 mg |
| P009 | human Pro-Glu-Plasminogen, recombinant | 100 ug |
| P010 | (PEG1,088)amine, monodisperse | 10 mg |
| P011 | (PEG5,000)amine, polydisperse | 10 mg |
| P012 | human Plasmin, recombinant | 100 ug |
| P0U | Urokinase | 1 mg |
| P015 | Streptokinase (bacterial plasminogen activator) | 1 mg |
| P016 | Tissue Plasminogen Activator | 100 ug |
| P111 | PEPperCHIP Pan-Transglutaminase Microarray | 1 Chip |
| P112 | PEPperCHIP Custom Transglutaminase Microarray | 1 Chip |
| P113 | PEPperCHIP Transglutaminase Microarray Service | 1 Sample |
| P114 | PepSlide Analyzer | 3-Month/1-Year/Perpetual License |
| P115 | PEPperCHIP Incubation Tray 3/1 | 1 Tray |
| P116 | PEPperCHIP Staining Kit | 1 Kit |
| P117 | PEPperCHIP Transglutaminase 2 Microarray | 1 Chip |
| P118 | PEPperCHIP Incubation Tray 3/5 | 1 Tray |
| R001 | N-(Tetrametylrhodaminyl)cadaverine | 10 mg |
| R002 | TAMRA-DON | 5 mg 10 mg |
| T001 | Microbial (bacterial) transglutaminase | 25 U; 1 x 250 U;10x 25 U; lx 500 U; 20x 25 U |
| T002 | Human tissue transglutaminase (TG2) | 250 ug 1mg |
| T004 | N-(p-Tosyl)-Gly-Pro-Lys-pNA | 25 mg |
| T006 | Guinea pig liver transglutaminase | 10U |
| T009 | Human keratinocyte transglutaminase (TG1) | 150 ug |
| T011 | Human transglutaminase 7 | 250 ug |
| T013 | Human epidermal transglutaminase, Dispose activated | 200 ug |
| T016 | Microbial (bacterial) Pro-transglutaminase | 250 ug |
| T018 | Inactive human tissue transglutaminase | 250 ug 1 mg |
| T021 | Human neuronal transglutaminase (TG6) | 250 ug |
| T022 | Human tissue transglutaminase (TG2) | 250 ug 1 mg |
| T024 | Human epidermal transglutaminase (TG3) | 200 ug |
| T027 | Human blood coagulation Factor Xlll-A z recombinant | 200 ug |
| T034 | Human tissue transglutaminase (TG2) | 100 ug |
| T035 | Human keratinocyte transglutaminase (TGI) | 150 ug |
| T036 | Transglutaminase Assay Kit, fluorescent, Casein, Dansylcadaverine | 1 Kit |
| T038 | Rat tissue transglutaminase | 250 ug 1 mg |
| T039 | Guinea pig liver transglutaminase, recombinant | 10U |
| T040 | Mouse tissue transglutaminase | 250 ug 1 mg |
| T042 | Human prostate Transglutaminase (TG4) | 100 ug |
| T050 | Human blood coagulation Factor XIII B subunit | 200 ug |
| T051 | Open tTG™ | 250 ug |
| T055 | Tissue Transglutaminase Microassay Kit, colorimetric | 1 Kit |
| T056 | Human alpha thrombin, highly active | 200 U |
| T057 | Inhibited human epidermal transglutaminase | 250 ug |
| T061 | Mouse blood coagulation Factor Xlll-A2 | 200 ug |
| T062 | Dog blood coagulation Factor Xlll-A2 | 200 ug |
| T063 | Human blood coagulation Factor Xlll-A2 , Val34Leu-mutant | 200 ug |
| T064 | Inhibited human neuronal transglutaminase | 250 ug |
| T065 | Rat blood coagulation Factor Xlll-A2 | 200 ug |
| T066 | Pig blood coagulation Factor Xlll-A2 | 200 ug |
| T067 | Human tissue transglutaminase (TG2), endotoxin free | 250 ug 1 mg |
| T070 | Human Factor Xllla, Thrombin activated | 200 ug |
| T072 | Dog tissue transglutaminase | 250 ug 1 mg |
| T086 | Human Transglutaminase 5 | 100 ug |
| T087 | Tridegin | 200 ug |
| T092 | Human blood coagulation Factor Xlll-A2 | 100 ug |
| T101 | 1,3,4,5-Tetramethyl-2[(2-oxo-propyl)thio] imidazolium chloride | 10 mg |
| T102 | Mouse Open TG2 | 250 ug 1 mg |
| T106 | Biotinylated human tissue transglutaminase (TG2) | 100 ug 250 ug |
| T108 | Cynomolgus tissue transglutaminase | 250 ug |
| T109 | Cynomolgus open TG2 | 100 ug |
| T1 10 | Recombinant TG2 [E.coli] | 500 ug |
| T1 14 | Blood Coagulation Factor Xlll-Microassay Kit, colorimetric | 1 Kit |
| T117 | Biotinylated inactive hTG2 (Cys277Ser) | 250 ug 1 mg |
| T122 | Recombinant TG2 (insect cells) | 500 ug |
| T123 | Biotinylated human tissue transglutaminase (TG2) | 50 ug |
| T124 | Recombinant TG3 (insect cells) | 400 ug |
| T127 | Biotinylated human blood coagulation Factor XIII | 50 ug |
| T134 | Open tTG™ | 100 ug |
| T139 | Rabbit tissue transglutaminase | 250 ug 1mg |
| T140 | Biotinylated human epidermal transglutaminase | 100 ug |
| T141 | Biotinylated human neuronal transglutaminase | 100 ug |
| T142 | Biotinylated mouse blood coagulation Factor Xlll-A2 | 50 ug |
| T146 | Mouse neuronal transglutaminase | 250 ug |
| T148 | Biotinylated human Open tTG™ | 50 ug 1 mg |
| T149 | Oxidized inactive human tissue transglutaminase | 250 ug 1 mg |
| T150 | Biotinylated mouse open TG2 | 50 ug |
| T151 | Biotinylated oxidized inactive human tissue transglutaminase | 250 ug 1 mg |
| T152 | Rabbit blood coagulation Factor Xlll-A2 | 200 ug |
| T153 | Microbial (bacterial) transglutaminase, edotoxin free | 25 U;10x 25 U;20x 25 U |
| T156 | Biotinylated mouse tissue transglutaminase | 250 ug; 1 mg |
| T159 | Pig tissue transglutaminase | 250 ug; 1 mg |
| T160 | Biotinylated cynomolgus tissue transglutaminase | 50 ug |
| T161 | Cynomolgus blood coagulation Factor Xlll-A2 | 200 ug |
| T167 | Short human tissue transglutaminase, aa 1-475 | 250 ug |
| T168 | Human tissue transglutaminase, C23OA mutant | 250 ug;1 mg |
| T169 | Human tissue transglutaminase, R580A mutant | 250 ug;1 mg |
| T173 | Human tissue transglutaminase, R116C mutant | 1 mg |
| T178 | Microbial transglutaminase with C-terminal His6-tag | 25 U;10 x 25 U;20 x 25 U |
| T184 | Cat tissue transglutaminase | 200 ug |
| T187 | Factor XIII activation peptide, recombinant | 500 ug |
| T197 | Coagulation factor XIII, recombinant human Factor Xlll-A2 | 100E;250E |
| T222 | Human alpha Thrombin, recombinant | 100 NIH Units |
| Z004 | Z-Gln-GIn-Pro-Leu-OH | 25 mg |
| Z006 | Z-DON-Val-Pro-Leu-OMe,"Z-DON" | 10 mg |
| Z009 | ZediXclusive Microbial Transglutaminase Assay Kit | 1 Kit |
| Z010 | ZediXclusive Tissue Transglutaminase Assay Kit | 1 Kit |
| Z011 | Z-(D)-DON-Val-Pro-Leu-OMe | 10 mg |
| Z013 | Z-MA-QPL-OMe | 10 mg |
| Z015 | Keillor inhibitor AA9 | 10 mg |
| Z016 | Keillor inhibitor NC9 | 10 mg |
| Z017 | Keillor inhibitor VA4 | 10 mg |
地址：武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话：18771997407
传真：13212737804
邮箱：sales@amyjet.com
0.4563
